data_1ybj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ybj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.866 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.6 t80 . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 p -173.9 165.3 4.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.307 0.575 . . . . 0.0 110.945 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.645 HG23 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.97 125.69 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.779 171.148 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.571 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 30.9 m-80 -101.75 49.4 0.86 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.746 0.784 . . . . 0.0 110.402 -176.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.959 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 26.1 p90 -74.42 148.48 41.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.589 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.7 t70 -63.27 106.62 0.91 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.7 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 10.2 t -39.25 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.841 1.338 . . . . 0.0 112.502 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 7' ' ' ASP . 13.5 t -173.7 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.967 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.528 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 85.5 m-85 -94.23 15.16 18.04 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.071 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.18 68.62 1.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.679 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.26 8.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 164' ' ' THR . 22.1 m-85 -92.57 146.88 23.33 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 122.163 0.185 . . . . 0.0 110.968 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 m -71.11 132.62 45.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.728 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -46.15 -53.31 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.569 0.622 . . . . 0.0 111.377 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.49 ' HB2' HG23 ' A' ' 161' ' ' VAL . 23.0 t-80 -61.07 -24.57 66.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.582 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.15 -44.82 28.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -71.12 -41.97 69.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.354 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 14.3 mt -56.33 -39.78 73.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.304 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -42.18 96.78 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.113 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 24' ' ' SER . 8.2 tt0 -61.89 -38.21 87.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 49.0 t90 -60.43 -46.36 90.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.867 175.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.83 -26.59 67.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.295 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 36.0 t -57.75 -55.51 33.88 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.038 0.447 . . . . 0.0 109.997 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.85 -32.39 73.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.603 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.467 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.0 t80 -61.78 -47.16 86.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.95 -30.67 76.37 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.284 -0.484 . . . . 0.0 113.766 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.27 109.0 8.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 60' ' ' ALA . 17.1 m . . . . . 0 C--N 1.328 -0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.4 -8.13 54.6 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.088 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.29 -5.88 32.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.382 0.61 . . . . 0.0 109.563 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.593 HG23 ' HA3' ' A' ' 96' ' ' GLY . 41.1 t -102.18 114.41 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.179 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -100.18 -73.55 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.52 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -57.14 8.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.069 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.48 73.52 0.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.064 0.935 . . . . 0.0 111.035 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 13.7 m-80 -84.58 135.03 34.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.456 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 69.2 m -74.86 -40.3 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.479 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 124.79 -124.97 5.56 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.447 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 59.79 2.96 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 61.3 m-85 60.6 -178.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.712 0.768 . . . . 0.0 112.976 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.503 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 36.9 t80 -142.02 -69.21 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.503 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.16 55.82 3.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.153 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 50' ' ' SER . . . 168.43 157.06 10.86 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.33 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.446 ' O ' HD22 ' A' ' 49' ' ' LEU . 4.0 m -82.06 -27.89 32.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.322 0.582 . . . . 0.0 109.896 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 48' ' ' SER . 6.8 mt -154.67 -40.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.452 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.774 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 10.4 p -116.04 148.25 40.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.839 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.8 -137.76 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.782 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 p -94.71 -57.92 2.33 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 54.2 tt0 -114.75 152.24 32.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.105 -167.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.685 ' CD1' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -145.12 94.77 2.58 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.723 0.773 . . . . 0.0 111.47 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.43 151.44 19.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.824 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.961 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.8 mm -146.45 129.42 8.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 123.197 0.599 . . . . 0.0 110.618 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.3 t -112.87 147.3 37.29 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 43.2 t -45.6 117.4 1.44 Allowed 'General case' 0 C--O 1.207 -1.163 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.535 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -12.93 56.52 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.977 -0.452 . . . . 0.0 110.843 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.417 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . . . -80.66 -60.73 2.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.834 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -115.5 -0.67 13.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.793 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.8 mt-30 33.77 42.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -173.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.444 HG11 ' N ' ' A' ' 64' ' ' THR . 7.3 p -121.83 -53.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.858 166.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.467 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 32.5 m -64.19 103.89 0.68 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.216 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.02 -176.95 3.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -169.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.768 ' CE1' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -159.82 120.15 3.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.267 -176.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 69.1 t -102.46 109.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.567 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.768 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . . . -97.18 151.62 19.63 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.56 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.29 139.56 6.52 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.014 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 -117.87 0.48 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.373 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 2.5 t-20 -145.91 73.15 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.685 HD13 ' CD1' ' A' ' 54' ' ' TYR . 16.4 mt -83.29 161.08 21.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.657 -164.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.585 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 52.8 m -155.75 121.57 5.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.481 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.908 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 44.1 t80 -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.421 0.629 . . . . 0.0 109.991 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.486 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . 13.0 p -81.87 47.61 1.12 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -171.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.908 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -60.02 -57.74 11.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.245 1.384 . . . . 0.0 111.987 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -89.92 1.72 55.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.508 0.67 . . . . 0.0 109.514 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.486 ' HB2' ' CA ' ' A' ' 75' ' ' THR . 29.7 m-80 -89.02 179.07 6.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.349 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.871 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 33.7 mm-40 -53.27 -67.8 0.54 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 51.6 Cg_exo -56.66 -28.16 73.89 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 121.666 1.578 . . . . 0.0 113.13 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.36 115.43 0.05 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.655 0.74 . . . . 0.0 112.64 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 54.04 51.36 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.277 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.712 HG21 ' CE1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -134.97 178.98 6.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.703 -174.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.404 ' H ' ' ND1' ' A' ' 132' ' ' HIS . 14.4 tp -125.75 142.23 51.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.67 ' HB2' ' HG ' ' A' ' 121' ' ' SER . 16.9 p90 -153.95 -159.53 0.98 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.93 -163.32 19.35 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.307 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.687 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 1.2 tm0? -93.36 165.94 12.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.788 0.804 . . . . 0.0 112.137 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 88' ' ' LEU . 25.3 tp -156.12 132.83 10.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.985 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -132.14 -45.0 0.93 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.262 0.553 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.52 134.39 46.06 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.526 HD13 ' HE1' ' A' ' 66' ' ' PHE . 3.1 mm? -108.13 175.55 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.903 169.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.631 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 12.6 t -167.22 103.78 0.53 Allowed 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.502 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.661 ' CE1' HD11 ' A' ' 138' ' ' LEU . 4.4 m-30 -95.87 145.19 25.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.666 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 177.04 170.92 40.07 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.906 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.8 114.63 26.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 111.594 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' A' ' 36' ' ' VAL . . . 85.01 107.44 0.65 Allowed Glycine 0 C--O 1.223 -0.558 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.781 169.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 105' ' ' TYR . 48.1 mt -86.59 155.77 20.31 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.231 0.539 . . . . 0.0 110.29 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.402 ' HA ' HD21 ' A' ' 40' ' ' ASN . 1.8 m -145.42 173.67 11.8 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.13 175.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.155 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -172.843 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.503 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 25.6 Cg_exo . . . . . 0 N--CA 1.464 -0.241 0 N-CA-C 111.452 -0.249 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.479 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 48.3 m-85 -68.06 141.74 56.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.815 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.0 p -150.79 147.09 26.86 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.335 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.666 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.1 mp -79.42 130.17 36.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.109 0.48 . . . . 0.0 110.82 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.79 -44.48 93.2 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.156 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.92 82.82 2.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.8 111.21 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.523 2.815 . . . . 0.0 112.908 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 49.4 m-20 -104.48 -150.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.376 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.959 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 48.4 t -59.71 143.25 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.698 0.761 . . . . 0.0 111.572 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.571 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -140.74 178.83 7.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.339 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.593 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.8 m-85 -135.19 148.27 49.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -162.51 140.51 6.59 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.824 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.866 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 99.17 11.87 44.25 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.2 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.563 ' HA ' HD11 ' A' ' 153' ' ' ILE . 16.7 mt -57.98 -50.53 73.09 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 56.15 52.2 10.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.764 0.792 . . . . 0.0 110.519 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 23.7 mt -113.74 110.14 19.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.478 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.582 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 72.4 p -115.02 130.71 57.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.67 ' HG ' ' HB2' ' A' ' 85' ' ' TYR . 81.2 p -98.02 147.2 24.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.723 0.297 . . . . 0.0 110.493 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.61 171.32 14.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.855 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -49.62 -55.39 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.92 10.23 8.31 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.417 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 19.3 mm-40 -79.84 67.78 5.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.52 -103.61 0.01 OUTLIER Glycine 0 C--O 1.224 -0.519 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.434 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -83.41 -14.81 51.85 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.11 -0.641 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.498 ' HA ' HE21 ' A' ' 133' ' ' GLN . 17.3 t70 -87.43 -18.81 29.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 125' ' ' GLN . . . -65.25 121.42 20.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.54 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.0 m -49.57 -32.77 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.11 -41.6 92.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.27 0.486 . . . . 0.0 110.718 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.712 ' CE1' HG21 ' A' ' 83' ' ' THR . 4.9 t-160 -65.28 -37.84 88.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 109.85 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.54 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 6.8 mt-30 -65.41 -58.14 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.731 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 146' ' ' LEU . 24.9 m -58.31 -39.35 73.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.373 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.561 ' O ' ' HG3' ' A' ' 139' ' ' MET . 13.0 p -67.68 -50.04 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.755 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.433 ' N ' HG11 ' A' ' 135' ' ' VAL . 14.0 m-85 -71.01 -27.19 63.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.695 0.283 . . . . 0.0 110.823 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.98 -56.8 18.69 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.702 HD23 HD12 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -49.5 -50.4 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.145 0.578 . . . . 0.0 111.1 176.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.961 ' HG2' HG13 ' A' ' 56' ' ' ILE . 48.6 mtp -54.87 -33.15 61.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.41 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.2 m -94.1 -6.41 45.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.17 23.44 29.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.506 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -107.76 135.48 49.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 19' ' ' LEU . 37.4 p -117.94 10.16 13.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.798 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.484 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.03 -19.27 78.3 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.69 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.27 -36.02 14.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 0.0 110.647 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.702 HD12 HD23 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -67.34 -39.59 85.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.929 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.655 ' HB2' HG13 ' A' ' 161' ' ' VAL . 10.9 pt-20 -56.61 -35.25 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.82 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 -35.69 53.15 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.996 0.426 . . . . 0.0 109.964 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.46 82.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.615 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 96.3 mt -55.96 -42.06 75.67 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.88 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -54.65 -10.35 0.43 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.171 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.0 -39.85 53.12 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.411 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 117' ' ' LEU . 3.5 mp -85.52 -46.49 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 120.727 0.299 . . . . 0.0 110.436 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.61 HD13 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.28 -44.65 80.0 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.911 -177.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.63 -22.86 67.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.678 0.275 . . . . 0.0 111.514 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.12 -35.13 79.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.499 . . . . 0.0 110.019 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.444 ' HE2' HG21 ' A' ' 153' ' ' ILE . 34.5 m-85 -96.06 -14.68 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 99.19 24.11 10.69 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.756 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -104.4 -161.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.189 0.495 . . . . 0.0 110.377 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.408 ' H ' ' HB3' ' A' ' 159' ' ' LEU . 66.7 p -162.61 -179.94 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.819 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 147' ' ' GLU . 9.1 p -59.06 -20.35 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.062 0.458 . . . . 0.0 111.392 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.87 13.52 12.46 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.048 -0.408 . . . . 0.0 111.022 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.62 ' HB3' HG21 ' A' ' 168' ' ' VAL . 8.5 t -84.01 148.7 26.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.7 m -72.81 149.44 43.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.988 -175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.669 ' CE1' HD12 ' A' ' 15' ' ' ILE . 10.7 m-30 -53.19 -22.7 7.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.585 0.754 . . . . 0.0 111.46 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.46 -51.04 7.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.457 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -66.85 -43.63 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 163' ' ' SER . 3.2 t -55.58 -58.52 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.02 73.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.16 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 173' ' ' ALA . . . -66.84 -35.83 80.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.57 -30.86 57.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.385 0.612 . . . . 0.0 110.245 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.3 p -85.2 -15.26 44.23 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.92 0.867 . . . . 0.0 109.034 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.268 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.752 ' O ' ' HB ' ' A' ' 172' ' ' THR . 44.4 t80 . . . . . 0 C--O 1.222 -0.395 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -162.41 168.35 22.23 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.729 0.812 . . . . 0.0 109.221 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.639 HG21 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.9 128.19 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.654 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 25.3 m-80 -103.9 49.97 0.81 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 0.0 110.328 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.941 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 32.6 p90 -71.49 151.4 43.97 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.097 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 9' ' ' SER . 25.5 t70 -62.36 103.08 0.36 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.644 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 5.3 t -34.94 77.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.113 1.508 . . . . 0.0 112.974 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.4 t -173.35 -30.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.298 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 66.5 m-85 -95.74 19.81 10.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.004 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 59.2 2.31 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -172.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -166.32 16.9 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.554 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 26.4 m-85 -93.66 139.86 30.31 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.163 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 m -67.55 131.54 45.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 160.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.763 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.5 mm -45.65 -51.56 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 117.917 0.326 . . . . 0.0 111.499 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -56.14 -34.79 66.45 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.559 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.25 -53.35 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.394 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.469 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 73.6 t80 -68.86 -39.64 79.75 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.583 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.763 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 12.1 mt -56.69 -40.84 76.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.955 0.407 . . . . 0.0 110.244 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.62 -41.58 99.61 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.017 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.25 -39.85 94.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.631 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 44.8 t90 -59.16 -42.33 90.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.25 0.548 . . . . 0.0 110.202 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.38 -25.05 66.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.2 t -62.96 -55.78 22.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.024 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.3 -31.02 72.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.773 0.32 . . . . 0.0 111.073 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.555 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 32.1 t80 -58.85 -41.13 86.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.922 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.43 -18.64 78.46 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.433 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 90.33 2.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.414 0.626 . . . . 0.0 111.573 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' A' ' 60' ' ' ALA . 29.6 m . . . . . 0 C--N 1.324 -0.537 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.414 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 44.2 t-20 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -6.78 56.3 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.419 -0.42 . . . . 0.0 114.064 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -112.98 -5.29 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.492 0.646 . . . . 0.0 111.534 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 63' ' ' VAL . 46.1 t -102.42 118.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.13 0.49 . . . . 0.0 111.743 -175.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.92 -62.83 1.39 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.46 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.91 -72.7 0.3 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.01 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 68.97 87.04 0.12 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.378 0.609 . . . . 0.0 112.247 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -83.72 154.38 23.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.86 175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -82.22 -37.65 25.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.406 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.29 170.73 39.3 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.154 -174.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.906 ' HA2' ' HE2' ' A' ' 105' ' ' TYR . . . -98.55 -111.67 3.12 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -168.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 55.96 64.96 1.57 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.952 0.882 . . . . 0.0 109.024 -164.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 52' ' ' SER . 2.2 t80 -73.12 -23.92 60.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.668 -173.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.84 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.95 -19.66 64.82 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.376 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.02 -145.59 8.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.453 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 m -75.04 -30.42 61.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.767 0.318 . . . . 0.0 110.958 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -166.43 40.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.284 0.564 . . . . 0.0 111.397 -175.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 p -164.67 177.65 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.35 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.84 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 106.49 -163.65 13.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.297 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 16.6 m -88.54 127.57 35.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 68' ' ' ALA . 5.3 tt0 80.21 105.72 0.07 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.178 171.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.414 ' CD2' HG23 ' A' ' 135' ' ' VAL . 2.0 t80 -102.05 101.6 11.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.329 172.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.526 ' H ' ' HA3' ' A' ' 43' ' ' GLY . . . -90.52 152.78 20.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.003 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 1.008 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.1 mm -147.18 132.86 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.318 0.647 . . . . 0.0 109.51 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 19.8 t -121.86 149.28 43.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 40.9 t -48.06 119.4 2.88 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.399 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -66.64 -10.3 44.66 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.821 -0.549 . . . . 0.0 111.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.434 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . . . -83.81 -49.87 8.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.674 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -127.76 -3.81 5.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.86 -172.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 58' ' ' SER . 63.7 mt-30 33.8 45.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.947 1.299 . . . . 0.0 114.168 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 36' ' ' VAL . 7.4 t -116.66 -63.38 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.669 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 21.6 m -61.84 102.59 0.28 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.337 -175.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.45 -178.43 3.38 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.54 -169.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.611 ' HE1' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -157.74 126.01 5.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.757 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 29.0 t -108.67 111.27 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 53' ' ' GLN . . . -90.29 107.69 19.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 0.0 111.03 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.86 117.91 5.36 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.852 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.67 -139.39 3.69 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.406 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.553 ' HB2' ' CB ' ' A' ' 87' ' ' GLN . 8.7 m-80 -136.24 47.74 2.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.027 0.918 . . . . 0.0 109.222 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 35.6 mt -70.31 149.92 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.639 -1.619 . . . . 0.0 112.015 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.4 ' HG1' ' C ' ' A' ' 72' ' ' LEU . 92.7 m -155.05 137.19 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.142 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.753 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 33.7 t80 -89.21 123.66 33.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.564 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 69.1 p -70.91 -32.55 69.52 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -171.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.753 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER 42.09 -92.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.836 0.854 . . . . 0.0 113.117 -168.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.528 ' H ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.63 7.29 46.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.718 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 33.8 m-80 -77.16 176.57 8.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.761 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 39.8 mt-10 -48.52 -63.13 1.7 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -170.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.761 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -55.65 -35.77 93.58 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.616 1.544 . . . . 0.0 112.433 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.63 128.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.894 0.746 . . . . 0.0 112.463 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 38.09 60.28 1.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.059 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.569 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -143.32 165.64 26.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.847 -174.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.676 HD21 HG13 ' A' ' 135' ' ' VAL . 11.7 tp -108.94 146.91 33.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 17.0 p90 -153.65 -160.7 1.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 85' ' ' TYR . . . 98.97 -166.56 21.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.929 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.678 HE22 ' HB2' ' A' ' 89' ' ' ASP . 17.8 tm0? -92.58 158.03 16.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.687 0.756 . . . . 0.0 111.906 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.56 ' CD2' HG21 ' A' ' 134' ' ' VAL . 57.1 tp -143.76 110.24 5.5 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.045 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.678 ' HB2' HE22 ' A' ' 87' ' ' GLN . 36.1 t70 -126.54 -28.82 2.98 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.882 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.488 ' O ' HD12 ' A' ' 91' ' ' LEU . 31.0 t -134.89 160.19 39.05 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.05 0.928 . . . . 0.0 112.327 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.611 HD13 ' HE1' ' A' ' 66' ' ' PHE . 3.0 mm? -144.46 163.7 33.04 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 19.9 t -162.82 106.93 1.1 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.163 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.631 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 2.4 m-30 -97.64 135.05 40.01 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.634 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.42 160.88 28.77 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.013 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.83 110.82 20.22 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.258 0.551 . . . . 0.0 110.734 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.96 110.51 2.36 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.801 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 105' ' ' TYR . 6.6 mt -83.89 155.14 23.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.486 . . . . 0.0 109.846 170.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 t -145.95 170.2 17.1 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.908 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.536 -177.549 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 C--O 1.235 0.363 0 CA-C-O 121.07 0.363 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.906 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 48.8 m-85 -75.8 165.19 25.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.404 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.6 p -147.77 139.76 24.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.996 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.713 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -81.61 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.624 -174.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.14 -48.16 77.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.053 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.75 88.37 7.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.87 93.9 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 123.142 2.561 . . . . 0.0 112.354 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 30.3 m-20 -93.45 -155.56 0.45 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.413 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.941 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 20.7 t -62.0 113.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.427 1.108 . . . . 0.0 112.422 -175.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.654 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 68.5 m -103.02 176.65 5.08 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.327 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.759 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.0 m-85 -137.07 141.28 42.39 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -156.45 128.92 2.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.155 -1.498 . . . . 0.0 113.047 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.698 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 111.38 10.0 20.68 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.25 174.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 89' ' ' ASP . 1.7 mm? -49.88 -53.04 28.3 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.063 0.945 . . . . 0.0 110.52 174.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.4 t30 53.68 47.62 23.38 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.58 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.4 mt -105.22 102.55 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.498 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.57 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 69.5 p -106.16 128.5 53.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.268 0.556 . . . . 0.0 110.851 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.7 t -108.71 119.16 38.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 122' ' ' LEU . 9.9 mp -59.14 167.49 1.71 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.297 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -51.65 -57.84 8.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.877 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.528 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -83.36 15.15 3.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -165.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -72.98 -31.09 64.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 66.18 -119.91 14.37 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.203 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.436 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 6.1 t-80 -88.77 -24.06 22.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.42 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.497 ' HA ' HE21 ' A' ' 133' ' ' GLN . 32.7 t70 -81.06 -21.49 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.822 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 125.99 40.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.281 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 134' ' ' VAL . 18.6 m -51.18 -32.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.3 -42.23 94.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.52 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.9 t-160 -65.05 -40.36 94.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.779 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.497 HE21 ' HA ' ' A' ' 128' ' ' ASP . 23.2 mm-40 -59.77 -65.31 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.926 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.674 HG13 ' HA ' ' A' ' 146' ' ' LEU . 27.1 m -55.86 -39.84 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.014 -174.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.676 HG13 HD21 ' A' ' 84' ' ' LEU . 8.3 p -69.68 -46.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.256 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.407 ' N ' HG11 ' A' ' 135' ' ' VAL . 12.2 m-85 -73.35 -24.77 60.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.54 -54.96 19.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.547 HD23 HD23 ' A' ' 146' ' ' LEU . 0.2 OUTLIER -48.7 -50.72 32.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.158 0.583 . . . . 0.0 110.82 176.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 1.008 ' HG2' HG13 ' A' ' 56' ' ' ILE . 41.5 mtp -52.72 -34.61 53.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.133 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m -90.99 -2.81 57.65 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 14.89 69.33 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.597 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -106.88 104.16 13.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.182 0.515 . . . . 0.0 110.302 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.602 HG23 ' HB3' ' A' ' 19' ' ' LEU . 3.5 p -92.16 11.86 24.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.481 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.19 -29.1 72.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.776 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.73 39.46 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.434 -0.451 . . . . 0.0 110.431 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.674 ' HA ' HG13 ' A' ' 134' ' ' VAL . 47.1 tp -68.39 -43.13 77.96 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.589 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.656 ' CB ' HG13 ' A' ' 161' ' ' VAL . 10.6 pt-20 -57.85 -31.08 66.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.658 0.266 . . . . 0.0 110.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -36.12 58.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.57 75.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.928 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 94.1 mt -55.45 -39.22 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.8 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -56.28 -10.19 0.83 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.451 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.35 -36.24 63.29 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.389 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.1 mp -84.4 -47.98 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 122.705 -0.291 . . . . 0.0 110.58 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.758 HD13 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.63 -43.09 75.86 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.8 -30.78 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.94 -31.84 72.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.137 0.494 . . . . 0.0 110.818 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -98.86 -6.11 29.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.299 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.38 39.31 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.308 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 mp -101.4 -167.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.1 p -167.85 175.41 6.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.286 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.656 HG13 ' CB ' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -61.71 -13.27 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.271 . . . . 0.0 111.669 172.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -89.73 10.62 22.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.956 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -87.17 -116.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.184 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.404 ' CG2' ' HA2' ' A' ' 12' ' ' GLY . 7.2 m -157.31 146.83 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.771 -174.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.672 ' CE1' HD12 ' A' ' 15' ' ' ILE . 6.7 m-30 -54.47 -45.26 73.12 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.455 0.302 . . . . 0.0 111.025 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.13 -41.1 90.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.656 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -66.78 -48.18 69.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.758 HG22 HD13 ' A' ' 154' ' ' LEU . 4.0 t -56.23 -54.95 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.686 0.279 . . . . 0.0 110.272 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.21 76.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.017 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.607 ' O ' ' HB2' ' A' ' 173' ' ' ALA . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.278 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.74 59.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.752 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 38.0 p -86.27 -11.84 51.19 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.06 0.933 . . . . 0.0 109.146 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 N--CA 1.445 -0.71 0 CA-C-N 113.868 -1.514 . . . . 0.0 108.949 171.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.701 ' O ' ' HB ' ' A' ' 172' ' ' THR . 42.7 t80 . . . . . 0 CA--C 1.515 -0.394 0 CA-C-O 120.682 0.277 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -160.75 168.42 24.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.965 172.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.597 HG21 ' CD1' ' A' ' 165' ' ' PHE . 0.5 OUTLIER -88.19 130.17 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.482 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 44.5 m-20 -106.32 46.82 0.9 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.871 0.844 . . . . 0.0 110.814 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.986 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 20.4 p90 -70.56 145.4 50.82 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.261 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 9' ' ' SER . 32.7 t70 -63.82 104.84 0.73 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.347 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 p -25.15 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.726 1.61 . . . . 0.0 114.579 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ASP . 42.2 t -174.64 -32.07 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.26 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.596 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 74.7 m-85 -94.21 16.86 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.15 70.81 0.61 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.511 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.62 23.24 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.663 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 25.7 m-85 -107.77 141.36 39.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.522 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.55 129.59 38.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 161.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.713 HD11 HG22 ' A' ' 168' ' ' VAL . 5.0 mm -47.24 -43.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -170.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -63.2 -33.34 75.27 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.569 0.223 . . . . 0.0 111.316 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.28 -36.14 82.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 110.766 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.899 ' CE1' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -72.1 -48.12 46.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 175.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.862 HD22 ' CE2' ' A' ' 18' ' ' TYR . 15.9 mt -53.05 -46.54 68.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.774 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.2 -44.7 94.77 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.68 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -62.96 -43.46 98.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.652 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 55.6 t90 -58.69 -45.13 90.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.551 . . . . 0.0 109.916 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.4 -24.03 64.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.2 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -62.52 -53.2 58.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -34.35 78.04 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.488 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.2 t80 -56.8 -42.41 79.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.519 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.14 -21.41 79.21 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.239 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 7.3 t70 -75.96 104.03 6.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 111.0 -174.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.402 ' CG1' ' HB3' ' A' ' 60' ' ' ALA . 20.1 m . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.62 -6.77 63.42 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.996 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -118.37 3.88 11.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 117.628 0.714 . . . . 0.0 111.745 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.478 HG23 ' HA3' ' A' ' 96' ' ' GLY . 25.5 t -98.11 112.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.293 0.568 . . . . 0.0 112.378 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.78 -67.07 0.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.653 172.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -75.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.148 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.455 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 65.11 63.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.459 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.434 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 40.1 m-80 -86.23 147.99 25.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.365 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.495 ' HA ' ' CB ' ' A' ' 57' ' ' SER . 71.8 m -93.65 -39.11 10.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.997 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.72 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 114.3 -129.13 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.397 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.95 62.44 2.01 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 121.201 -0.524 . . . . 0.0 113.067 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 66.33 130.66 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.493 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 17.5 t80 -107.88 -24.65 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.269 172.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.48 19.8 8.28 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.132 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.76 -132.02 7.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.633 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -75.89 -52.18 10.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.543 0.211 . . . . 0.0 111.419 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.618 HD12 ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -164.44 21.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.1 p -161.62 156.65 23.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.82 -64.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.243 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.605 ' C ' ' HA2' ' A' ' 70' ' ' GLY . 23.1 t -148.77 -144.75 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 121.349 -0.14 . . . . 0.0 110.631 -170.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 12.3 mt-30 -43.93 141.75 1.56 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.806 0.842 . . . . 0.0 112.104 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HB3' HD12 ' A' ' 72' ' ' LEU . 3.9 t80 -130.99 96.98 4.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.504 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.542 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -89.76 146.77 24.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.558 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 1.004 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.3 mm -145.12 121.1 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.564 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.719 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.1 t -104.73 165.97 10.7 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.436 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.691 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 33.4 t -61.13 152.78 27.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.09 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.9 p -101.53 -14.09 17.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.019 0.438 . . . . 0.0 110.115 168.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.402 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . . . -75.47 -54.5 6.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.293 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 37.9 p30 -115.3 0.98 13.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.154 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.691 ' HA ' ' O ' ' A' ' 58' ' ' SER . 69.5 mt-30 30.0 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.455 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.8 p -128.64 -51.64 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.459 171.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 17.1 m -63.33 107.5 1.1 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.719 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -121.27 -178.22 3.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -170.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.725 ' HE1' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -156.37 131.78 9.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.869 -176.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 58.1 t -110.98 119.99 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.542 0.211 . . . . 0.0 110.694 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.78 14.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.949 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.619 ' O ' ' HG2' ' A' ' 53' ' ' GLN . . . -63.29 -99.3 0.01 OUTLIER Glycine 0 C--O 1.217 -0.921 0 N-CA-C 116.61 1.404 . . . . 0.0 116.61 -167.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.605 ' HA2' ' C ' ' A' ' 52' ' ' SER . . . -179.68 34.13 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 118.826 -1.654 . . . . 0.0 115.495 -170.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.652 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -146.39 27.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.756 1.278 . . . . 0.0 111.03 169.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.557 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 73.1 mt -79.05 144.6 34.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.973 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.9 m -144.38 124.33 13.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.383 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.618 ' HB3' HD12 ' A' ' 49' ' ' LEU . 58.3 t80 -82.07 123.09 28.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.846 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 80.7 p -61.4 -38.96 88.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.626 -171.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.409 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 11.5 tp 55.53 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 123.812 0.695 . . . . 0.0 111.337 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.409 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 18.9 m-85 -100.76 8.39 43.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.742 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.846 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 94.2 m-20 -76.44 179.03 6.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 111.536 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.757 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 6.0 mm-40 -51.4 -56.83 17.27 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.757 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -57.6 -37.3 97.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.754 1.636 . . . . 0.0 112.513 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.86 125.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.833 0.708 . . . . 0.0 112.372 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 47.53 58.82 4.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.11 169.05 20.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.333 -175.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.726 HD21 HG13 ' A' ' 135' ' ' VAL . 12.2 tp -108.81 138.8 44.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -157.01 139.01 14.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 166.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 72' ' ' LEU . . . -168.65 -131.2 1.27 Allowed Glycine 0 C--N 1.298 -1.542 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.187 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.675 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 1.8 tm0? -142.42 151.59 41.95 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 113.889 -1.155 . . . . 0.0 108.831 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.554 HD23 HD11 ' A' ' 91' ' ' LEU . 18.9 tp -138.99 116.25 11.11 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 16.6 t70 -110.89 -56.62 2.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.645 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.489 ' O ' HD12 ' A' ' 91' ' ' LEU . 4.9 p -107.74 155.07 20.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.323 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.725 HD13 ' HE1' ' A' ' 66' ' ' PHE . 3.0 mm? -141.15 160.52 39.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.638 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 58.0 m -149.76 111.33 4.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.675 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.689 ' HE2' HD23 ' A' ' 19' ' ' LEU . 3.9 m-30 -99.72 129.38 45.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.04 165.32 35.83 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.535 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -90.11 123.13 33.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.197 0.523 . . . . 0.0 111.618 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.478 ' HA3' HG23 ' A' ' 36' ' ' VAL . . . 82.76 110.04 0.47 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.469 171.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.542 HD11 ' HB1' ' A' ' 55' ' ' ALA . 77.0 mt -87.01 151.59 23.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.052 0.453 . . . . 0.0 109.979 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 p -131.19 154.04 48.81 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.998 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.673 174.036 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.8 Cg_exo . . . . . 0 N--CA 1.459 -0.507 0 CA-C-O 121.129 0.387 . . . . 0.0 111.917 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.72 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 64.1 m-85 -67.74 150.7 48.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.322 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 97' ' ' LEU . 18.2 p -144.06 152.75 41.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.544 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.0 mp -85.98 119.08 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.643 0.259 . . . . 0.0 110.907 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 39' ' ' ALA . 41.7 mt-30 -65.04 -47.22 78.14 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.408 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 33.5 t -105.16 87.83 2.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 34.0 Cg_endo -63.25 100.7 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.372 2.715 . . . . 0.0 112.453 -176.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.475 ' OD2' HG23 ' A' ' 112' ' ' VAL . 10.1 t70 -106.1 -147.19 0.4 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.986 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 15.4 t -69.79 149.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.355 0.598 . . . . 0.0 111.892 -177.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.482 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 36.2 m -142.9 -177.49 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.123 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.706 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.0 m-85 -134.35 152.7 51.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.114 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.35 135.74 4.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.515 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.94 13.63 31.21 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.551 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 mt -55.41 -51.71 65.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.509 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 64.8 t30 53.4 43.26 31.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.208 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -106.29 128.8 54.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 171.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.675 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 51.2 p -131.17 139.04 49.68 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.983 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.5 p -98.55 151.44 20.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.864 0.364 . . . . 0.0 111.392 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.59 162.94 26.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -48.13 -55.56 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.7 11.35 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.433 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 15.0 mm100 -77.44 55.42 1.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 112.134 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 128' ' ' ASP . . . -64.24 104.33 0.88 Allowed Glycine 0 C--O 1.225 -0.422 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.526 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 74.95 -26.17 0.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.609 0.764 . . . . 0.0 111.35 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 126' ' ' GLY . 24.1 t70 -83.65 -23.21 31.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.091 0.472 . . . . 0.0 110.207 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -60.34 122.14 28.9 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.095 173.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.51 ' O ' HG21 ' A' ' 134' ' ' VAL . 22.9 m -51.52 -33.34 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 88' ' ' LEU . 12.5 m -64.83 -44.87 96.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.561 0.22 . . . . 0.0 110.958 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.536 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.5 t-160 -60.38 -40.42 90.79 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.423 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 32.6 mt-30 -59.09 -63.24 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 146' ' ' LEU . 23.7 m -60.01 -40.49 83.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.022 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.726 HG13 HD21 ' A' ' 84' ' ' LEU . 10.7 p -68.99 -45.47 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.325 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.92 -22.44 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 0.0 110.601 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.9 -54.8 19.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.625 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -47.95 -52.17 20.71 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.344 0.658 . . . . 0.0 110.88 176.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 1.004 ' HG2' HG13 ' A' ' 56' ' ' ILE . 45.4 mtp -54.63 -33.64 60.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.392 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.5 t -89.67 -15.47 32.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.25 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.5 16.58 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.635 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.61 127.1 48.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.528 ' HB ' HD12 ' A' ' 19' ' ' LEU . 21.7 p -114.61 5.48 15.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.119 0.485 . . . . 0.0 110.979 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.48 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.99 -20.93 80.16 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.583 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.02 -35.45 21.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.581 ' HA ' HG13 ' A' ' 134' ' ' VAL . 36.1 tp -68.06 -40.93 82.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.492 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.642 ' HB2' HG13 ' A' ' 161' ' ' VAL . 11.8 pt-20 -56.67 -34.53 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.716 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -35.4 61.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.116 0.484 . . . . 0.0 110.053 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.21 -46.27 74.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.525 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 95.9 mt -55.26 -41.91 72.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.049 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -52.8 -14.32 0.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.331 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -72.87 -43.65 40.87 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.78 -175.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.411 HG21 ' HE2' ' A' ' 157' ' ' TYR . 3.8 mp -80.27 -43.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.285 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.488 ' HB3' ' C ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -59.18 -44.63 92.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.28 -25.73 67.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 111.389 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.09 -29.5 70.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.446 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 25.5 m-85 -100.47 -12.54 19.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.276 175.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 97.37 18.24 29.11 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.429 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.488 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -102.83 -163.07 0.96 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.421 0.611 . . . . 0.0 110.522 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.9 p -161.69 -176.66 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.974 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 147' ' ' GLU . 8.5 p -58.02 -23.16 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 111.034 174.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -88.77 18.39 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.295 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.706 ' HB3' HG21 ' A' ' 168' ' ' VAL . 16.6 t -83.76 143.42 30.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 168' ' ' VAL . 47.0 m -75.36 141.04 43.38 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.567 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.663 ' CE2' ' HB2' ' A' ' 13' ' ' TYR . 7.0 m-30 -39.82 -49.96 2.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.833 0.853 . . . . 0.0 113.187 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.19 -38.58 88.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.948 0.404 . . . . 0.0 110.742 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.478 HE21 ' HB ' ' A' ' 164' ' ' THR . 52.5 mt-30 -73.99 -38.95 63.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.289 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.713 HG22 HD11 ' A' ' 15' ' ' ILE . 17.9 t -62.07 -52.33 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 109.986 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.38 82.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.84 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 173' ' ' ALA . . . -65.83 -35.35 80.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.74 -28.04 60.61 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.364 0.602 . . . . 0.0 110.638 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.701 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.8 p -89.96 -12.94 37.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.071 0.938 . . . . 0.0 109.594 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.512 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.818 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 17.0 t80 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -173.7 160.53 3.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.221 0.534 . . . . 0.0 110.967 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.902 HG11 HD13 ' A' ' 15' ' ' ILE . 11.8 m -97.86 115.96 39.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.752 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.475 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 34.4 m-80 -96.45 59.32 1.82 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.623 -169.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.642 ' CE2' ' HA ' ' A' ' 8' ' ' SER . 38.9 p90 -74.23 149.7 40.69 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.049 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.5 t70 -62.73 94.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.642 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.5 p -24.99 72.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 114.92 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 20.7 t -173.79 -26.23 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.392 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.531 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 83.6 m-85 -90.04 10.24 24.94 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.931 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.2 69.23 1.09 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.974 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.61 21.83 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 164' ' ' THR . 21.8 m-85 -107.42 140.14 40.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.942 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m -68.89 133.24 47.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 162.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.902 HD13 HG11 ' A' ' 4' ' ' VAL . 6.3 mm -51.26 -47.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 118.134 0.424 . . . . 0.0 111.604 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -65.21 -25.22 67.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.947 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.43 -51.12 25.65 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.566 ' CE1' HG23 ' A' ' 112' ' ' VAL . 56.8 t80 -69.51 -49.2 56.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 16.3 mt -57.42 -38.99 75.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.029 0.442 . . . . 0.0 110.242 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.29 -41.01 94.76 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.86 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.84 -45.44 92.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.953 0.406 . . . . 0.0 110.988 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.734 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 9.3 t90 -52.69 -51.08 61.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.816 174.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.67 -28.92 68.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -57.79 -52.09 66.88 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -27.37 66.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.421 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.541 ' CE2' ' HE1' ' A' ' 66' ' ' PHE . 18.0 t80 -60.44 -49.9 75.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.54 0.209 . . . . 0.0 110.488 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.83 -28.26 73.7 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.254 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -73.25 103.9 4.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 110.962 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' A' ' 60' ' ' ALA . 27.9 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.384 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 . . . . . 0 CA--C 1.522 -0.103 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -10.32 62.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.065 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.77 -7.12 53.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.593 0.711 . . . . 0.0 109.293 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.526 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 23.4 t -94.91 120.42 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 m -92.7 -57.45 2.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.407 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.487 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 4.5 t70 -98.44 -68.81 0.79 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.286 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 38' ' ' ASP . . . 79.92 81.25 0.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 124.972 1.42 . . . . 0.0 109.66 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.662 ' HB3' ' HE1' ' A' ' 105' ' ' TYR . 8.3 m-80 -78.51 135.74 37.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.256 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 60.2 p -76.56 -45.69 29.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.428 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.0 178.06 27.21 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 44' ' ' PHE . . . -167.56 -45.24 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 117.311 -2.376 . . . . 0.0 117.725 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.8 m-85 70.29 95.38 0.07 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.916 0.858 . . . . 0.0 109.543 -153.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -79.53 -17.42 54.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.55 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.36 17.58 37.82 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.939 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.08 -118.71 4.31 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.351 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.4 m -76.85 -54.35 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.769 0.318 . . . . 0.0 111.778 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -164.99 43.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.664 0.745 . . . . 0.0 110.781 -173.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 p -158.29 -178.32 7.2 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.356 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.86 -166.35 25.67 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.99 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -87.83 -39.1 15.13 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -117.77 155.24 30.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.48 0.657 . . . . 0.0 111.609 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -145.5 101.57 3.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.07 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.52 ' HB3' ' CD1' ' A' ' 97' ' ' LEU . . . -92.91 142.49 27.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.776 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.619 HG13 ' SD ' ' A' ' 139' ' ' MET . 31.7 mm -143.49 129.6 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 O-C-N 123.679 0.612 . . . . 0.0 109.945 177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 22.9 t -112.95 155.79 24.15 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.627 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 38.1 t -48.81 128.85 16.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.829 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 p -76.55 -14.88 59.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.171 0.51 . . . . 0.0 109.866 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.477 ' HB3' HG12 ' A' ' 29' ' ' VAL . . . -80.82 -60.06 2.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.891 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -116.33 1.52 13.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.053 0.454 . . . . 0.0 111.503 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.1 mm-40 39.0 36.24 0.15 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -175.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 64' ' ' THR . 13.9 p -124.08 -51.11 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.686 172.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.417 ' N ' HG11 ' A' ' 63' ' ' VAL . 38.1 m -64.54 102.98 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -120.62 175.51 5.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.299 0.571 . . . . 0.0 112.205 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.734 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -159.73 131.36 6.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.592 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.52 115.03 48.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.222 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.692 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -86.96 155.25 20.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.61 125.27 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.524 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -177.93 -104.19 0.18 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.628 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 2.4 t-20 -150.4 41.26 0.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.5 145.3 55.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.081 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.2 m -154.55 131.81 11.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.475 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.594 ' HB3' HD12 ' A' ' 49' ' ' LEU . 55.0 t80 -90.46 129.15 36.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.406 HG21 ' CD1' ' A' ' 85' ' ' TYR . 71.0 p -65.29 -35.81 82.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -172.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.509 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 8.8 tp 51.7 -96.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.689 0.796 . . . . 0.0 112.166 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.509 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 4.9 m-85 -101.58 7.78 42.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.103 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.75 178.44 6.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.938 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.75 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 41.0 mt-10 -48.35 -62.23 2.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -169.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.75 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 86.8 Cg_exo -50.73 -51.4 11.21 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.978 1.786 . . . . 0.0 112.992 175.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 71.68 130.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.882 0.739 . . . . 0.0 112.402 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 51.8 m80 54.49 49.91 17.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.268 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.624 HG21 ' HE1' ' A' ' 132' ' ' HIS . 0.6 OUTLIER -146.49 166.34 26.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 -175.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.658 ' CD2' HG13 ' A' ' 135' ' ' VAL . 13.9 tp -110.74 151.53 27.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.406 ' CD1' HG21 ' A' ' 75' ' ' THR . 18.6 p90 -153.49 -153.46 0.47 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 170.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.19 -144.46 17.35 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.199 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.696 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 24.7 tm0? -140.97 158.79 43.44 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.548 HD23 HD23 ' A' ' 91' ' ' LEU . 32.0 tp -144.22 135.15 25.21 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.525 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 19.0 t70 -133.02 -55.14 0.92 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.431 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.637 ' O ' HD22 ' A' ' 91' ' ' LEU . 5.7 p -108.31 158.33 17.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.515 -176.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 68' ' ' ALA . 2.4 mm? -140.23 156.89 46.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 172.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.556 ' HB3' HD13 ' A' ' 107' ' ' ILE . 3.7 m -147.09 106.02 3.85 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.285 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.607 ' HZ ' HD13 ' A' ' 146' ' ' LEU . 2.4 m-30 -91.97 147.64 22.81 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.623 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 173.36 163.56 27.2 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.781 173.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.0 117.98 29.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.336 0.589 . . . . 0.0 111.043 176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 104.87 0.88 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.42 172.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.52 ' CD1' ' HB3' ' A' ' 55' ' ' ALA . 50.5 mt -88.93 161.12 16.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.263 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 t -146.96 168.47 21.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.517 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.699 175.416 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo . . . . . 0 N--CA 1.459 -0.519 0 N-CA-C 110.762 -0.515 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.662 ' HE1' ' HB3' ' A' ' 40' ' ' ASN . 38.4 m-85 -65.38 144.25 57.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.584 0.707 . . . . 0.0 111.614 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 p -143.21 138.11 29.45 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.388 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.623 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.0 mp -79.62 123.83 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 78.2 mt-30 -64.58 -48.43 75.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.308 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.77 90.23 12.57 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.79 102.09 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.816 3.011 . . . . 0.0 113.919 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.6 m-20 -84.7 -164.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.716 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 84.5 t -63.28 138.02 23.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.824 0.821 . . . . 0.0 112.393 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.475 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 58.4 m -116.77 179.7 3.94 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.635 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.638 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 91.7 m-85 -143.56 153.16 42.28 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.26 134.09 3.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.636 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.818 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 103.89 15.67 21.54 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.308 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.415 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 22.6 mt -58.52 -45.74 88.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.644 0.722 . . . . 0.0 109.632 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.525 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 14.9 t30 59.98 19.0 8.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.436 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -92.36 132.08 37.03 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.559 0.695 . . . . 0.0 110.236 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.696 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 59.9 p -133.21 165.15 25.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.657 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.444 ' OG ' HG23 ' A' ' 131' ' ' VAL . 78.2 p -144.48 150.86 38.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.027 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.43 165.84 15.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.6 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -51.06 -56.3 13.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.995 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.548 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -81.77 15.79 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.95 -15.86 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.321 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 44.47 -123.83 5.35 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.705 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.415 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 1.4 t-80 -78.52 -20.14 51.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.441 ' HA ' HE21 ' A' ' 133' ' ' GLN . 17.0 t70 -85.17 -17.26 37.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -173.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.01 122.98 31.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.18 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.592 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.2 m -50.2 -33.62 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.444 HG23 ' OG ' ' A' ' 121' ' ' SER . 27.2 m -64.74 -41.25 91.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.624 ' HE1' HG21 ' A' ' 83' ' ' THR . 3.9 t-160 -64.0 -38.28 90.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.592 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 4.2 mm-40 -63.4 -62.77 1.46 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.59 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 130' ' ' VAL . 15.9 m -58.75 -37.1 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.264 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.658 HG13 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -66.35 -43.97 91.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.379 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.574 ' HD1' HG11 ' A' ' 135' ' ' VAL . 22.2 m-85 -71.94 -27.47 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.308 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -54.29 38.07 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 170.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.549 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.25 -60.62 2.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.544 0.688 . . . . 0.0 110.085 176.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.698 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 71.2 mtm -55.59 -25.97 41.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.463 -1.244 . . . . 0.0 114.071 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 m -94.09 -3.2 51.57 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.563 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.42 48.67 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.16 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -106.95 135.18 48.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.161 0.505 . . . . 0.0 110.616 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.7 p -111.75 8.5 20.66 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' A' ' 147' ' ' GLU . . . -74.71 -42.94 30.43 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.553 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.62 -27.02 60.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.219 0.533 . . . . 0.0 109.688 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.607 HD13 ' HZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -73.74 -48.05 34.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.271 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.588 ' HB2' HG13 ' A' ' 161' ' ' VAL . 10.3 pt-20 -56.69 -36.16 69.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -38.28 69.09 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.187 0.518 . . . . 0.0 109.767 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.72 -47.35 75.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.74 -46.47 77.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.517 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.93 -15.86 3.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.753 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.86 -39.94 58.59 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.623 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.0 mp -81.43 -51.12 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.281 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.742 HD13 HG12 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -54.77 -41.93 71.09 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.77 -23.15 67.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.26 -24.11 63.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 110.106 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 9.2 m-85 -112.29 0.82 15.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.188 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 90.49 16.96 54.26 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.78 -0.646 . . . . 0.0 113.847 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 2.2 mm? -98.7 -170.88 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.627 0.713 . . . . 0.0 109.536 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 78.6 p -164.21 176.92 8.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.22 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.588 HG13 ' HB2' ' A' ' 147' ' ' GLU . 4.9 p -57.55 -26.45 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.083 0.468 . . . . 0.0 110.632 174.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -90.26 28.91 1.33 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.824 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 14' ' ' SER . 25.3 t -84.55 -134.62 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.661 ' HB ' HE21 ' A' ' 167' ' ' GLN . 98.6 m -158.25 142.39 15.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.645 ' CE1' HD12 ' A' ' 15' ' ' ILE . 10.9 m-30 -44.12 -49.76 8.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -173.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.69 -23.23 62.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.234 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.661 HE21 ' HB ' ' A' ' 164' ' ' THR . 49.8 mt-30 -84.26 -51.52 6.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.742 HG12 HD13 ' A' ' 154' ' ' LEU . 61.5 t -56.34 -57.03 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.255 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.17 69.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.72 84.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.28 -29.29 62.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.194 0.521 . . . . 0.0 110.81 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.715 HG23 ' CD2' ' A' ' 2' ' ' PHE . 40.5 p -88.98 -21.1 23.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.851 0.834 . . . . 0.0 109.645 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.973 178.462 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.812 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 47.0 t80 . . . . . 0 C--O 1.224 -0.279 0 N-CA-C 110.674 -0.121 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -163.42 168.75 19.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.845 0.715 . . . . 0.0 109.094 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.51 HG13 ' HB2' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -88.26 122.59 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.472 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 63.9 m-20 -97.94 45.65 1.02 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.186 0.994 . . . . 0.0 110.366 -174.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.919 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -72.26 150.47 43.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.627 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 9' ' ' SER . 27.6 t70 -64.58 110.28 2.28 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.172 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.433 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.3 p -39.4 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.241 1.416 . . . . 0.0 113.338 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.7 t -170.84 -32.85 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.131 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.431 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 45.8 m-85 -89.44 18.39 5.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.587 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.39 76.82 0.92 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.619 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.27 -8.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.488 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 36.3 m-85 -73.5 133.58 43.66 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 122.825 -0.22 . . . . 0.0 110.478 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 17' ' ' ASP . 15.5 m -66.37 132.95 49.47 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 163.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.685 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 4.8 mm -46.78 -49.53 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 118.062 0.392 . . . . 0.0 111.697 -172.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.483 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 2.4 t-80 -58.48 -29.88 66.55 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.298 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' SER . 4.0 m-20 -68.2 -58.96 3.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.452 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -63.94 -45.56 88.67 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.661 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.804 ' HB3' HG23 ' A' ' 143' ' ' THR . 13.1 mt -57.13 -42.04 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.151 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.64 -40.4 97.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.08 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.08 -42.04 99.55 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 122.631 0.373 . . . . 0.0 111.354 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.4 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 39.9 t90 -60.35 -42.7 96.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.408 0.623 . . . . 0.0 109.724 176.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 141' ' ' GLY . . . -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.091 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.0 t -63.58 -54.38 36.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 p -64.34 -35.18 80.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.808 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 19.7 t80 -55.65 -42.93 75.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.213 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.98 -21.21 79.15 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.919 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 29.9 t70 -73.81 104.6 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.201 0.5 . . . . 0.0 111.374 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 60' ' ' ALA . 24.9 m . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.47 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t-20 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.72 -13.56 63.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.001 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -111.13 15.68 21.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.706 HG22 ' NE2' ' A' ' 108' ' ' GLN . 0.5 OUTLIER -134.82 134.32 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -112.56 -74.69 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.043 0.449 . . . . 0.0 111.745 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.16 -67.0 0.5 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.513 -173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.38 80.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.754 0.659 . . . . 0.0 111.592 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 98' ' ' SER . 33.2 m-80 -79.79 157.76 26.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.449 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 58.0 m -93.26 -24.43 18.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -168.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.17 135.93 3.09 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.005 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.36 59.63 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.245 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.589 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 39.2 m-85 62.93 159.17 0.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.996 0.903 . . . . 0.0 112.553 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.856 ' HE1' ' HD3' ' A' ' 104' ' ' PRO . 5.3 t80 -126.72 -36.2 2.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.072 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.85 -21.83 58.84 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.21 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -138.87 4.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.467 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -77.08 -30.17 55.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.725 0.298 . . . . 0.0 110.912 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.589 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -164.25 27.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.604 -175.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -149.25 176.3 10.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.56 173.45 15.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.175 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 t -85.97 -3.17 58.87 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 28.6 tt0 -147.23 150.97 35.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.278 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -154.33 97.17 2.0 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 105' ' ' TYR . . . -91.72 155.69 18.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.702 HG21 ' HG2' ' A' ' 139' ' ' MET . 9.4 mm -150.76 146.81 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.551 0.741 . . . . 0.0 109.254 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 t -122.36 170.95 9.42 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 30.0 t -55.54 141.51 36.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.384 0.611 . . . . 0.0 111.403 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -85.92 -20.36 29.12 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.113 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.435 ' HB3' HG12 ' A' ' 29' ' ' VAL . . . -81.11 -54.08 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.6 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 34.4 p30 -119.64 -1.15 10.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 111.909 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.9 mm-40 42.11 38.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.506 HG11 ' N ' ' A' ' 64' ' ' THR . 11.7 p -122.78 -57.15 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 122.306 -0.247 . . . . 0.0 110.783 169.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.559 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 19.8 m -58.87 106.84 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 110.495 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -116.74 179.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.573 ' HZ ' HG21 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -157.42 133.43 9.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.753 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 22.4 t -115.05 114.18 45.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.264 -0.272 . . . . 0.0 110.684 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.559 ' O ' ' HG3' ' A' ' 53' ' ' GLN . . . -89.34 149.55 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.708 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.69 124.95 1.88 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.139 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.91 -115.5 0.46 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.438 ' HB3' ' CB ' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -148.38 48.62 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.2 mt -62.86 144.87 56.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.909 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -149.92 138.62 20.83 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.795 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.588 ' HB3' HD12 ' A' ' 49' ' ' LEU . 58.1 t80 -93.61 133.8 36.56 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.594 HG23 ' HB ' ' A' ' 83' ' ' THR . 31.9 p -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.525 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 8.2 tp 56.4 -94.45 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.079 0.552 . . . . 0.0 111.143 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.525 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 3.5 m-85 -98.57 -1.75 40.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.137 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -75.45 167.05 22.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.612 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 23.8 mm-40 -46.99 -60.08 4.4 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -165.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 99.7 Cg_exo -49.75 -38.27 46.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.769 1.646 . . . . 0.0 113.17 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 65.07 117.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.427 0.632 . . . . 0.0 112.617 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 56.7 60.16 3.2 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.512 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.805 HG22 ' HA2' ' A' ' 126' ' ' GLY . 26.5 m -149.3 153.36 37.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.147 -172.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.715 HD21 HG13 ' A' ' 135' ' ' VAL . 14.8 tp -101.12 148.05 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.424 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -156.05 -153.55 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.33 -167.31 24.81 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.258 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 12.5 tm0? -95.96 165.57 12.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.395 0.617 . . . . 0.0 111.594 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 88' ' ' LEU . 33.5 tp -152.85 136.71 16.22 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.007 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.03 -54.48 0.71 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.112 0.482 . . . . 0.0 110.716 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.452 ' C ' HD21 ' A' ' 91' ' ' LEU . 4.5 p -112.56 155.37 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -175.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 3.0 mm? -138.59 161.52 36.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 172.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 55.5 m -151.6 112.53 4.26 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 122.187 -0.321 . . . . 0.0 110.783 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.637 ' CE2' HD23 ' A' ' 19' ' ' LEU . 4.6 m-30 -99.77 139.13 35.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.58 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -179.79 163.86 31.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.522 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.43 132.79 34.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.129 0.464 . . . . 0.0 110.705 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.544 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . 68.23 112.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 174.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 54.8 mt -87.04 156.36 19.78 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.199 -0.589 . . . . 0.0 109.953 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.417 ' HA ' HD21 ' A' ' 40' ' ' ASN . 10.1 t -150.8 -177.55 6.06 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.789 174.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.914 175.505 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.856 ' HD3' ' HE1' ' A' ' 45' ' ' TYR . 7.2 Cg_endo . . . . . 0 C--O 1.234 0.313 0 N-CA-C 114.522 0.932 . . . . 0.0 114.522 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.523 ' CD2' ' HB1' ' A' ' 55' ' ' ALA . 50.4 m-85 -76.45 169.42 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.91 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 p -151.49 142.64 23.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.58 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.1 mp -84.31 120.46 35.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.706 ' NE2' HG22 ' A' ' 36' ' ' VAL . 20.0 mt-30 -65.45 -41.44 93.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.138 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.48 89.9 6.56 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.51 92.37 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.3 2.667 . . . . 0.0 112.49 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -99.32 -153.61 0.44 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.331 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.919 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -62.83 144.66 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.521 0.676 . . . . 0.0 111.549 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.472 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -136.6 179.31 6.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.589 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 95.6 m-85 -138.79 148.71 44.14 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.7 145.22 10.22 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.693 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.812 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.57 8.23 46.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.628 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 19.4 mt -56.73 -51.68 67.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.073 0.436 . . . . 0.0 109.947 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.403 ' HA ' ' NE2' ' A' ' 87' ' ' GLN . 63.0 t30 49.28 50.98 17.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.693 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 21.5 mt -106.8 107.62 18.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.704 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 17.9 p -105.82 131.07 53.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.4 t -103.73 141.96 35.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -74.22 169.45 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.582 HE22 HG22 ' A' ' 75' ' ' THR . 21.8 tp60 -58.96 -56.73 18.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.136 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.02 8.33 3.29 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.51 ' NE2' ' HA2' ' A' ' 129' ' ' GLY . 4.9 mm100 -77.04 52.86 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.892 175.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.805 ' HA2' HG22 ' A' ' 83' ' ' THR . . . -62.95 109.22 2.55 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.066 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.408 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 1.9 t-80 73.4 -40.16 0.46 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.137 0.975 . . . . 0.0 111.926 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HA ' HE21 ' A' ' 133' ' ' GLN . 27.2 t70 -81.86 -11.03 59.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -176.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.51 ' HA2' ' NE2' ' A' ' 125' ' ' GLN . . . -64.37 125.73 32.03 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 170.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 134' ' ' VAL . 4.8 p -55.31 -29.4 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.9 -44.69 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.551 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.4 t-160 -62.49 -36.38 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.471 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.488 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 26.3 mt-30 -63.38 -63.73 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.885 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 146' ' ' LEU . 20.6 m -58.58 -39.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.807 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.715 HG13 HD21 ' A' ' 84' ' ' LEU . 10.1 p -68.03 -44.39 84.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.593 0.235 . . . . 0.0 110.784 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.451 ' HD1' HG11 ' A' ' 135' ' ' VAL . 9.7 m-85 -73.03 -31.37 64.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.577 0.227 . . . . 0.0 110.453 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.54 -53.22 45.63 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.635 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -50.47 -50.91 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.07 0.462 . . . . 0.0 110.568 175.265 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.702 ' HG2' HG21 ' A' ' 56' ' ' ILE . 55.7 mtp -57.72 -27.55 63.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.486 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m -95.45 -12.27 26.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.6 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . 88.75 29.01 19.84 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.868 -175.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -116.14 126.11 53.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.012 0.434 . . . . 0.0 110.725 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.804 HG23 ' HB3' ' A' ' 19' ' ' LEU . 20.1 p -111.4 15.22 21.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.794 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.12 -15.8 81.26 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.558 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.31 -32.2 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.095 0.474 . . . . 0.0 110.22 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.524 ' HA ' HG13 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -66.01 -37.6 86.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.669 ' HA ' ' CG1' ' A' ' 161' ' ' VAL . 11.8 pt-20 -54.45 -38.78 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.529 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -38.83 69.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.072 0.463 . . . . 0.0 110.251 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.48 72.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 90.8 mt -56.48 -42.67 78.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.156 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.8 -7.49 0.46 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.673 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.65 -38.64 61.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.526 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.78 -48.35 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.061 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.627 ' HB3' ' HB2' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -53.85 -37.4 63.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.62 -27.93 66.76 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.92 -29.5 69.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.472 0.653 . . . . 0.0 110.07 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.429 ' HB2' ' HG ' ' A' ' 159' ' ' LEU . 20.1 m-85 -106.55 -3.05 21.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.29 18.36 64.74 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.78 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.627 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 19.3 mt -95.2 -172.5 2.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.851 0.326 . . . . 0.0 111.0 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.5 p -166.69 -172.18 2.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.892 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.669 ' CG1' ' HA ' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -58.5 -25.53 28.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 176.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.416 ' HA ' ' HB3' ' A' ' 14' ' ' SER . 8.2 p30 -86.3 14.25 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.334 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.3 m -89.88 148.15 23.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 16.1 p -69.76 158.42 35.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.682 ' CE1' HD12 ' A' ' 15' ' ' ILE . 15.7 m-30 -54.47 -31.78 56.43 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.37 -62.17 1.86 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.938 174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.2 -48.39 80.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 154' ' ' LEU . 93.9 t -59.33 -55.54 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.58 0.229 . . . . 0.0 111.324 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.51 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -57.22 -48.02 79.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.21 81.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.5 -27.29 55.99 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.065 0.46 . . . . 0.0 111.144 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.783 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.5 p -91.95 -19.9 21.94 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.999 0.904 . . . . 0.0 109.981 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.869 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.047 177.418 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.781 ' O ' ' HB ' ' A' ' 172' ' ' THR . 28.5 t80 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.673 0.273 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 p -169.37 159.29 8.59 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.93 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.538 HG12 HG13 ' A' ' 168' ' ' VAL . 25.6 m -93.43 114.36 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.257 174.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.0 m-80 -94.55 52.42 1.54 Allowed 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.934 0.873 . . . . 0.0 110.648 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.857 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -76.95 151.18 35.81 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.234 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 9' ' ' SER . 18.5 t70 -62.74 103.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.409 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.2 p -37.01 78.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 124.74 1.275 . . . . 0.0 113.464 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ASP . 22.9 t -174.63 -29.08 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.684 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.512 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 68.2 m-85 -93.67 15.15 16.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.286 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.516 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -69.22 70.55 0.47 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.57 -173.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -169.78 0.02 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.513 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 28.5 m-85 -86.25 136.02 33.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.73 -0.235 . . . . 0.0 110.411 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 163' ' ' SER . 19.7 m -68.99 134.5 49.56 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 160.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.617 HD12 ' CE1' ' A' ' 165' ' ' PHE . 5.1 mm -48.31 -48.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 118.389 0.54 . . . . 0.0 111.705 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.507 ' HD1' ' CD ' ' A' ' 147' ' ' GLU . 36.1 t60 -57.65 -30.86 65.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.628 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.0 -46.87 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.795 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.461 ' CE2' HG23 ' A' ' 112' ' ' VAL . 68.7 t80 -72.64 -46.13 55.53 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.906 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 14.6 mt -56.59 -34.2 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.288 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.69 -45.06 93.77 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.137 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -61.65 -41.37 97.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.858 0.361 . . . . 0.0 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.676 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 22.3 t90 -54.71 -51.72 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.638 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.41 63.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.052 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 t -61.5 -51.14 69.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.727 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -65.45 -32.12 73.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.759 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.48 ' HB2' HG22 ' A' ' 64' ' ' THR . 19.8 t80 -59.4 -37.2 77.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.848 0.356 . . . . 0.0 110.264 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.99 -18.41 77.71 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.292 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 25.1 t70 -75.57 93.29 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.185 0.517 . . . . 0.0 111.835 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.758 HG13 ' HB2' ' A' ' 60' ' ' ALA . 22.8 m . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.768 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.2 t30 . . . . . 0 N--CA 1.462 0.131 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.42 -9.28 61.0 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.454 ' OD1' HG22 ' A' ' 36' ' ' VAL . 9.8 p30 -104.83 -18.73 14.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.807 0.813 . . . . 0.0 110.718 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.463 HG21 HG21 ' A' ' 63' ' ' VAL . 49.3 t -87.72 114.04 25.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.376 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -101.24 -70.3 0.75 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.773 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.43 -73.19 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.848 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 69.18 86.5 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.784 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -80.89 141.58 34.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 51.5 m -71.81 -36.35 70.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.78 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 108.13 -123.09 6.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.584 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 64.18 2.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.898 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 60.56 -176.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.43 0.634 . . . . 0.0 112.708 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -144.61 -56.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.826 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.31 22.18 21.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.076 -173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.25 -179.47 40.84 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.453 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -81.48 -68.3 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 14.0 mt -76.56 -31.03 57.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.578 -176.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 11.0 p -147.9 163.74 35.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.558 -175.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.3 39.59 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.65 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.6 m 65.87 -60.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.517 0.727 . . . . 0.0 112.709 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -95.66 159.53 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.881 0.372 . . . . 0.0 111.072 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' HD2' HG23 ' A' ' 135' ' ' VAL . 1.5 t80 -153.32 99.22 2.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.858 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -93.12 144.96 24.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.433 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.664 HG13 ' HG2' ' A' ' 139' ' ' MET . 27.8 mm -146.25 127.65 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.036 0.446 . . . . 0.0 110.85 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 41' ' ' SER . 18.9 t -112.69 151.87 29.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.523 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 61' ' ' ASN . 47.0 t -49.99 136.05 19.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 112.079 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.74 27.57 3.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.296 0.569 . . . . 0.0 111.321 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.758 ' HB2' HG13 ' A' ' 29' ' ' VAL . . . -157.65 -33.39 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.991 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -103.33 -14.61 16.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.672 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.8 mm-40 31.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.748 -1.569 . . . . 0.0 115.213 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.463 HG21 HG21 ' A' ' 36' ' ' VAL . 10.4 p -138.21 -44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.269 169.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 26' ' ' PHE . 38.6 m -63.03 97.54 0.11 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -117.1 171.12 8.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.293 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.676 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -158.0 123.89 4.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.009 -178.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.2 t -105.56 102.57 14.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.886 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -85.43 154.58 21.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.033 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.96 127.99 2.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.777 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.11 -108.52 0.22 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -146.75 45.34 1.19 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.485 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 41.6 mt -64.26 124.75 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.279 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 31.6 m -137.35 119.13 15.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.46 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 47.1 t80 -68.36 122.94 19.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 82.7 p -63.7 -33.48 75.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.456 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 11.7 tp 52.3 -92.27 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.456 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 20.2 m-85 -98.91 0.1 43.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.738 -174.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.521 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 93.1 m-20 -73.18 170.34 15.17 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.954 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.595 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 10.9 mm-40 -48.94 -53.51 37.08 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 53.0 Cg_exo -56.83 -41.95 69.91 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.513 1.475 . . . . 0.0 112.221 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.95 130.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.77 0.795 . . . . 0.0 112.837 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 54.59 47.56 22.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.605 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.502 HG23 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -142.79 178.25 7.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.65 -174.123 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.881 HD21 HG13 ' A' ' 135' ' ' VAL . 18.1 tp -126.38 82.51 2.08 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -89.23 146.56 24.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 171.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 72' ' ' LEU . . . -168.09 178.31 41.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.401 -1.38 . . . . 0.0 114.006 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -97.65 167.7 10.8 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.595 ' HG ' HD12 ' A' ' 117' ' ' LEU . 27.9 tp -148.72 126.35 11.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.584 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.492 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 12.6 t70 -126.7 -48.9 1.51 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.172 0.51 . . . . 0.0 110.485 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.425 ' O ' HD22 ' A' ' 91' ' ' LEU . 19.4 p -132.81 158.92 41.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 122.005 0.907 . . . . 0.0 113.034 -173.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.1 mm? -134.9 169.11 17.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.772 -1.558 . . . . 0.0 106.878 174.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 19.8 t -163.06 99.38 0.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.819 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.632 ' CE1' HD11 ' A' ' 138' ' ' LEU . 1.2 m-30 -93.39 134.74 35.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.451 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -169.82 163.42 36.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 118.151 -1.976 . . . . 0.0 115.18 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.58 104.83 15.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.466 -0.867 . . . . 0.0 111.448 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 112.37 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.649 -1.159 . . . . 0.0 113.808 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 105' ' ' TYR . 46.7 mt -85.9 160.59 19.37 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.101 -0.646 . . . . 0.0 110.041 171.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 t -143.4 172.9 12.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.252 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.228 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -175.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo . . . . . 0 C--O 1.233 0.239 0 CA-C-O 120.947 0.311 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.587 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 62.9 m-85 -73.63 149.08 42.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.366 -174.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 p -146.38 140.65 26.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.954 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.612 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.3 mp -78.63 133.26 30.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.92 -44.22 90.22 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.421 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 16.9 t -118.17 91.64 40.79 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 13.3 Cg_endo -56.66 101.91 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.234 2.622 . . . . 0.0 112.969 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -93.02 -162.39 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.924 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.857 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 41.3 t -60.11 128.69 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.333 1.063 . . . . 0.0 112.453 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.545 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 61.2 m -119.37 178.94 4.35 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.306 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 94.0 m-85 -140.42 146.35 38.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.29 140.44 6.64 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.704 -1.236 . . . . 0.0 112.402 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.51 12.84 37.06 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.996 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.595 HD12 ' HG ' ' A' ' 88' ' ' LEU . 48.5 mt -56.41 -53.92 51.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.492 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 52.7 t30 51.39 50.87 18.0 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.158 0.98 . . . . 0.0 110.257 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 19.4 mt -104.79 105.99 16.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.087 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.8 p -105.3 129.97 53.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.161 0.505 . . . . 0.0 110.617 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.81 ' HB3' HE22 ' A' ' 125' ' ' GLN . 74.7 m -103.73 165.91 10.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.418 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.525 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 44.4 mt -87.15 154.22 20.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.355 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -57.88 -60.0 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.828 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.559 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -77.0 17.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 1.099 ' HB3' ' HA ' ' A' ' 128' ' ' ASP . 26.9 mt-30 -74.67 -40.31 61.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 80' ' ' PRO . . . 83.47 -106.89 2.86 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.872 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.627 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 5.6 t-80 -68.01 -12.68 61.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 1.099 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 0.0 OUTLIER 78.49 172.5 0.18 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 156.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.417 ' N ' ' CG ' ' A' ' 128' ' ' ASP . . . -85.31 -35.69 11.85 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.314 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 134' ' ' VAL . 9.8 p -154.08 -40.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.547 HG23 ' OD2' ' A' ' 128' ' ' ASP . 13.6 m -67.17 -54.62 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.963 1.256 . . . . 0.0 112.697 -174.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.627 ' ND1' ' HA ' ' A' ' 127' ' ' HIS . 4.5 t-160 -58.67 -37.13 75.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -61.56 -65.91 0.62 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.502 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 130' ' ' VAL . 31.5 m -56.62 -39.29 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.035 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.881 HG13 HD21 ' A' ' 84' ' ' LEU . 10.0 p -67.96 -40.57 83.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -74.34 -30.68 62.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.32 79.97 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 173.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.632 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -49.42 -59.53 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.576 0.703 . . . . 0.0 109.566 174.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.664 ' HG2' HG13 ' A' ' 56' ' ' ILE . 71.8 mtm -55.97 -25.27 43.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.183 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -91.66 0.04 57.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.665 0.269 . . . . 0.0 111.502 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.08 29.49 64.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.232 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.76 121.93 43.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.467 . . . . 0.0 110.315 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.643 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 49.8 p -91.23 -16.96 26.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.022 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.38 -42.69 50.77 Favored Glycine 0 C--N 1.334 0.444 0 O-C-N 123.836 0.71 . . . . 0.0 113.477 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.75 -42.19 82.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -66.73 -39.76 88.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.96 ' HG2' HG21 ' A' ' 161' ' ' VAL . 52.5 mt-10 -54.13 -43.2 70.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.266 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -34.59 75.13 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.902 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.2 71.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.171 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 90.6 mt -54.2 -44.2 71.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.904 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -55.52 -8.87 0.41 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.359 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.75 -45.16 45.51 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.235 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.0 -45.92 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 120.645 0.259 . . . . 0.0 110.924 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.728 HD13 HG11 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -57.89 -42.95 85.73 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.0 -20.71 66.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.441 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.67 -33.14 75.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.363 0.601 . . . . 0.0 109.852 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.31 -5.65 29.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.018 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 88.42 17.36 57.27 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.991 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 17.3 mt -97.24 -174.28 2.9 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.938 0.369 . . . . 0.0 110.158 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -156.57 -176.77 6.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.96 HG21 ' HG2' ' A' ' 147' ' ' GLU . 11.9 p -56.99 -26.71 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.903 0.382 . . . . 0.0 111.707 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.53 30.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.06 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 14' ' ' SER . 13.7 t -98.62 147.76 24.49 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 168' ' ' VAL . 3.5 m -70.74 145.22 50.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.442 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.617 ' CE1' HD12 ' A' ' 15' ' ' ILE . 12.9 m-30 -47.98 -38.63 17.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 0.0 110.385 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.86 -54.02 47.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.18 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -63.57 -51.05 67.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.222 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.728 HG11 HD13 ' A' ' 154' ' ' LEU . 17.4 t -58.24 -55.91 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 O-C-N 123.019 0.2 . . . . 0.0 110.984 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.405 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . . . -53.54 -45.51 69.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.307 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 173' ' ' ALA . . . -64.9 -36.51 84.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.205 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.09 -25.81 58.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.31 0.576 . . . . 0.0 110.496 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.781 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.1 p -88.97 -13.05 39.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.081 0.943 . . . . 0.0 109.556 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.944 175.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.841 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 36.1 t80 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -166.0 166.87 17.02 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.879 0.737 . . . . 0.0 109.146 171.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.804 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -91.28 126.96 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.579 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 31.5 m-80 -104.25 56.2 0.72 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.834 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 53.8 p90 -69.14 152.25 45.36 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.62 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.0 67.67 0.15 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t 17.66 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 113.811 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -168.99 -28.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.489 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.566 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 82.9 m-85 -87.73 12.71 12.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.702 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA2' ' CB ' ' A' ' 165' ' ' PHE . . . -70.4 68.89 0.7 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.44 -172.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.66 19.74 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.488 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 27.6 m-85 -106.17 135.26 47.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.316 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' HIS . 1.8 m -74.74 67.93 1.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.675 HD12 ' CD1' ' A' ' 165' ' ' PHE . 3.4 mm 28.28 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 114.141 -172.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 14' ' ' SER . 11.5 t-160 -50.74 -29.16 10.72 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.673 0.389 . . . . 0.0 111.186 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -53.35 -62.73 1.46 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.881 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.414 ' HH ' ' CG ' ' A' ' 111' ' ' ASP . 84.5 t80 -66.95 -38.78 86.75 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.341 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.743 HD23 ' HE2' ' A' ' 93' ' ' PHE . 14.3 mt -54.31 -40.42 67.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.07 93.24 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.138 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.15 -38.49 86.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.989 0.516 . . . . 0.0 111.52 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.534 ' O ' HG22 ' A' ' 64' ' ' THR . 40.7 t90 -55.63 -45.06 77.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.957 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 26' ' ' PHE . . . -72.8 -13.69 61.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.909 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 t -63.54 -56.22 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.701 0.286 . . . . 0.0 110.536 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.6 p -65.2 -31.16 72.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' A' ' 62' ' ' GLN . 31.7 t80 -64.45 -28.17 69.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.876 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.25 75.71 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.795 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.586 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 32.6 t70 -78.51 165.64 23.51 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.462 0.631 . . . . 0.0 111.446 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.548 HG12 ' C ' ' A' ' 28' ' ' ASP . 29.1 m . . . . . 0 N--CA 1.45 -0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 112.144 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.74 ' HB3' HG22 ' A' ' 36' ' ' VAL . 56.1 t-20 . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -1.51 19.98 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.46 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -115.02 6.81 15.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.838 HG23 HG21 ' A' ' 63' ' ' VAL . 12.6 t -87.55 114.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.271 0.558 . . . . 0.0 111.804 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.6 p -100.22 -73.9 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.284 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -89.24 -67.02 0.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 -172.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.439 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 74.14 74.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.656 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -86.71 156.09 20.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.783 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.5 m -96.84 -33.57 11.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.674 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 112.96 -135.8 12.95 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.932 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.601 ' HA2' ' HE1' ' A' ' 54' ' ' TYR . . . 80.99 74.61 1.13 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.753 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.564 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 46.0 m-85 66.11 -178.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.542 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 23.0 t80 -152.95 -71.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.247 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.04 45.45 3.3 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.203 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 170.69 36.51 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.808 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -76.04 -25.49 55.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.035 0.445 . . . . 0.0 110.113 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -167.79 32.33 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 p -158.86 166.9 30.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.205 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.81 -134.33 5.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.632 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.437 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 31.6 m -135.54 6.07 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.496 0.188 . . . . 0.0 110.918 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -141.61 143.33 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.318 . . . . 0.0 110.776 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.601 ' HE1' ' HA2' ' A' ' 43' ' ' GLY . 2.6 t80 -154.94 96.06 1.81 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -96.05 157.77 15.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.022 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 1.026 HG13 ' HG2' ' A' ' 139' ' ' MET . 11.6 mm -147.31 121.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 110.15 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.647 ' HG ' ' HB2' ' A' ' 65' ' ' ALA . 8.9 t -138.28 112.51 8.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.316 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.616 ' HB2' ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER 41.53 160.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 118.574 2.805 . . . . 0.0 118.574 -178.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.451 ' H ' ' NE2' ' A' ' 62' ' ' GLN . 20.7 p -132.06 13.39 4.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.726 -2.033 . . . . 0.0 109.915 163.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.04 -58.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.264 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.639 ' O ' HG12 ' A' ' 63' ' ' VAL . 7.2 t30 -146.1 -33.68 0.32 Allowed 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.616 ' C ' ' HB2' ' A' ' 58' ' ' SER . 0.5 OUTLIER -53.05 54.7 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 126.564 2.415 . . . . 0.0 113.457 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.838 HG21 HG23 ' A' ' 36' ' ' VAL . 1.4 p -66.4 -6.64 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 22' ' ' TRP . 92.9 m -53.14 112.05 0.8 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 110.099 -3.228 . . . . 0.0 107.366 161.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB2' ' HG ' ' A' ' 57' ' ' SER . . . -122.41 -179.39 4.18 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.35 -169.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.706 ' HZ ' HG21 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -160.3 121.64 3.09 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.813 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.6 112.82 41.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.269 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.628 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . . . -88.92 152.71 21.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 52' ' ' SER . . . -150.84 122.96 1.44 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.91 -110.16 0.26 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.571 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 2.7 t-20 -147.86 37.4 0.88 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.503 0.668 . . . . 0.0 109.235 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -59.24 139.92 56.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.787 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -149.62 134.39 17.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.722 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.61 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 58.4 t80 -84.61 127.44 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.58 HG22 ' NE2' ' A' ' 123' ' ' GLN . 44.5 p -62.55 -33.55 75.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.648 -170.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.464 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 9.6 tp 51.57 -95.53 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.954 0.784 . . . . 0.0 111.827 -176.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.464 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 5.3 m-85 -98.84 2.58 46.88 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -175.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -76.04 178.34 6.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.549 0.214 . . . . 0.0 111.206 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.803 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 19.6 mm-40 -47.51 -62.71 1.88 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -170.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.803 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 54.2 Cg_exo -55.35 -38.02 94.17 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.777 1.651 . . . . 0.0 112.873 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 66.63 122.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.837 0.827 . . . . 0.0 112.855 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 53.27 54.41 10.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.425 -1.261 . . . . 0.0 111.484 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -146.49 169.0 19.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.307 -176.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.628 HD21 HG13 ' A' ' 135' ' ' VAL . 11.2 tp -106.58 149.06 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.819 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 86' ' ' GLY . 20.0 p90 -156.45 -154.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.405 ' N ' ' CD2' ' A' ' 85' ' ' TYR . . . 99.03 -164.25 20.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.904 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 6.3 tm0? -99.98 164.51 11.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 111.59 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.463 ' HA ' HD12 ' A' ' 88' ' ' LEU . 30.4 tp -151.58 129.95 12.08 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.726 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.554 ' HA ' ' HB2' ' A' ' 117' ' ' LEU . 17.4 t70 -136.0 -60.22 0.73 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.387 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.419 ' C ' HD21 ' A' ' 91' ' ' LEU . 13.2 p -97.99 149.81 22.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.762 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.646 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.9 mm? -134.53 169.55 17.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 9.5 t -163.76 109.55 1.07 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.147 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.743 ' HE2' HD23 ' A' ' 19' ' ' LEU . 3.9 m-30 -97.77 140.43 32.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.648 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.97 172.01 42.8 Favored Glycine 0 C--N 1.314 -0.684 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.723 ' H ' HG11 ' A' ' 109' ' ' VAL . 24.9 m-20 -97.77 124.86 42.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 119.362 1.581 . . . . 0.0 111.414 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 63' ' ' VAL . . . 87.47 116.06 1.13 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.477 -0.783 . . . . 0.0 113.091 171.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.604 HD11 ' HB1' ' A' ' 55' ' ' ALA . 41.0 mt -86.55 153.75 21.59 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.12 168.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.8 t -138.59 168.8 18.99 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.45 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.875 0 O-C-N 123.947 0.779 . . . . 0.0 111.65 -175.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.542 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.9 Cg_exo . . . . . 0 N--CA 1.463 -0.273 0 CA-C-O 121.196 0.415 . . . . 0.0 112.364 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.674 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 37.8 m-85 -71.85 151.62 43.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.361 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.9 p -149.07 143.95 26.37 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.681 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.648 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.5 mp -80.88 129.21 37.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.044 0.45 . . . . 0.0 110.857 -175.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.461 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 71.7 mt-30 -64.23 -59.07 4.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.578 176.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.723 HG11 ' H ' ' A' ' 95' ' ' ASP . 2.4 p -109.15 87.53 4.91 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 121.628 0.728 . . . . 0.0 110.017 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.09 122.71 10.55 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.95 2.433 . . . . 0.0 111.597 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.414 ' CG ' ' HH ' ' A' ' 18' ' ' TYR . 3.9 t0 -118.91 -143.27 0.36 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 19.4 t -61.16 115.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.338 1.066 . . . . 0.0 112.344 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 69.1 m -101.86 177.3 4.94 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.811 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.646 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 95.5 m-85 -138.56 149.62 45.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.57 141.67 7.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.807 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.841 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 102.02 11.83 35.95 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.704 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.554 ' HA ' HD11 ' A' ' 153' ' ' ILE . 16.8 mt -55.8 -46.73 77.94 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.343 0.572 . . . . 0.0 109.723 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 t30 49.46 45.61 23.81 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.022 0.915 . . . . 0.0 110.244 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 20.7 mt -108.6 115.82 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.015 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 38.8 p -111.2 132.64 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.283 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.41 ' HB2' HG23 ' A' ' 131' ' ' VAL . 41.5 m -101.76 147.97 25.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.28 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.4 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 69.9 mt -80.41 157.13 26.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.782 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.58 ' NE2' HG22 ' A' ' 75' ' ' THR . 19.0 tp60 -48.27 -54.41 13.78 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.488 0.493 . . . . 0.0 112.16 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.54 3.06 14.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -170.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.587 ' HB3' ' N ' ' A' ' 129' ' ' GLY . 37.2 mt-30 -78.86 58.16 2.29 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.014 0.435 . . . . 0.0 110.516 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.83 103.96 0.65 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.45 ' HA ' ' CG ' ' A' ' 132' ' ' HIS . 3.3 t-80 79.39 -29.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.845 0.858 . . . . 0.0 111.397 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.519 ' HA ' HE21 ' A' ' 133' ' ' GLN . 14.7 t70 -80.38 -30.43 37.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.543 0.211 . . . . 0.0 111.307 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.587 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -55.79 129.48 47.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.627 -0.796 . . . . 0.0 111.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.5 m -50.87 -33.21 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 132' ' ' HIS . 33.1 m -63.35 -47.16 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.796 0.331 . . . . 0.0 110.594 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.595 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.8 t-160 -63.5 -39.43 94.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.966 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.519 HE21 ' HA ' ' A' ' 128' ' ' ASP . 27.1 mm-40 -59.85 -64.7 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.4 t -53.89 -46.51 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.348 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.706 HG21 ' HZ ' ' A' ' 66' ' ' PHE . 11.0 p -65.86 -45.97 89.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.259 -175.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.409 ' HD1' HG11 ' A' ' 135' ' ' VAL . 12.5 m-85 -72.24 -27.5 62.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.818 0.342 . . . . 0.0 110.796 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.35 -53.29 33.44 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -49.63 -49.59 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.1 0.56 . . . . 0.0 111.095 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 1.026 ' HG2' HG13 ' A' ' 56' ' ' ILE . 83.4 mtp -57.67 -30.75 65.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.034 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -91.3 -0.67 57.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.26 9.47 81.95 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.698 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -98.82 103.96 15.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.565 0.698 . . . . 0.0 110.79 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.475 ' HB ' HD12 ' A' ' 19' ' ' LEU . 2.8 p -89.48 2.42 54.58 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.069 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.529 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -62.78 -31.21 79.47 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.735 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.59 -33.29 64.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.557 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.4 OUTLIER -67.76 -33.6 75.17 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.612 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.918 ' HG2' HG21 ' A' ' 161' ' ' VAL . 46.1 mt-10 -52.91 -44.72 67.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -33.17 73.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.952 -175.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.57 64.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.32 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.2 mt -55.49 -45.37 77.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.831 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -58.64 -8.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.968 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.08 -41.68 26.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.035 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 117' ' ' LEU . 3.8 mp -86.51 -49.03 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.787 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.6 HD13 HG11 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -53.08 -40.93 64.42 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.67 -27.17 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.39 -34.22 77.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.227 0.537 . . . . 0.0 109.845 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.442 ' HE2' HG21 ' A' ' 153' ' ' ILE . 41.6 m-85 -95.63 -13.58 24.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.284 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 94.75 27.94 10.8 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.602 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.409 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -109.15 -166.98 1.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.135 0.468 . . . . 0.0 110.952 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.6 p -163.52 171.91 15.17 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.38 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.918 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.5 p -52.55 -36.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -88.82 40.22 0.96 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -88.9 -105.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.744 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 168' ' ' VAL . 15.6 m -163.05 146.91 11.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.675 ' CD1' HD12 ' A' ' 15' ' ' ILE . 6.1 m-30 -52.96 -42.35 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.353 0.524 . . . . 0.0 111.111 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.63 -52.22 33.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.853 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -59.74 -46.3 89.57 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -176.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.6 HG11 HD13 ' A' ' 154' ' ' LEU . 89.6 t -60.52 -56.67 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.491 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.472 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -54.36 -44.65 72.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 123.447 0.467 . . . . 0.0 110.993 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 173' ' ' ALA . . . -62.64 -40.87 98.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.49 -29.91 61.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.208 0.528 . . . . 0.0 110.57 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.686 HG23 ' CD2' ' A' ' 2' ' ' PHE . 38.3 p -85.74 -14.15 46.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.865 0.84 . . . . 0.0 109.624 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.653 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.801 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 t80 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.485 0.183 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -172.22 167.51 5.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.62 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.704 HG11 ' HB ' ' A' ' 168' ' ' VAL . 0.2 OUTLIER -90.35 125.54 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.559 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 27.0 m-80 -101.82 48.84 0.87 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.729 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.99 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.0 p90 -70.5 150.04 46.56 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.735 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.8 t70 -62.06 105.35 0.57 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.619 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 4.4 p -37.52 74.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 125.082 1.489 . . . . 0.0 113.894 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.1 t -174.2 -25.62 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.341 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.494 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 96.0 m-85 -92.39 15.5 13.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.08 68.12 1.38 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.322 -173.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.45 22.85 0.16 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.557 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 45.3 m-85 -114.31 131.26 56.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.017 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 163' ' ' SER . 11.4 p -68.13 132.44 47.21 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 161.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.672 HD12 ' CE1' ' A' ' 165' ' ' PHE . 4.8 mm -46.56 -48.76 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -167.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -60.14 -30.37 69.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.648 0.261 . . . . 0.0 111.007 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.28 -49.17 58.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.371 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.453 ' HB2' ' CG ' ' A' ' 13' ' ' TYR . 72.0 t80 -70.72 -45.34 65.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.608 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.795 ' HB3' HG22 ' A' ' 143' ' ' THR . 12.0 mt -56.92 -44.4 82.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.18 94.81 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.975 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.432 ' O ' ' HB3' ' A' ' 24' ' ' SER . 3.7 tt0 -64.87 -43.34 93.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 122.89 0.476 . . . . 0.0 111.463 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -62.43 -42.21 99.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.919 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.14 67.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.791 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 25.1 t -62.23 -54.14 45.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -35.64 81.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.056 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 20.0 t80 -56.07 -39.43 72.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.346 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.89 -29.51 73.68 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.463 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 11.9 t70 -76.12 100.88 5.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.705 -176.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.404 ' HA ' ' HB3' ' A' ' 61' ' ' ASN . 35.4 m . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.04 -7.49 76.54 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 114.446 0.538 . . . . 0.0 114.446 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -116.38 3.57 13.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.849 0.825 . . . . 0.0 111.684 -175.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.665 HG23 ' HA3' ' A' ' 96' ' ' GLY . 45.6 t -101.83 116.39 45.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 p -103.08 -76.11 0.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.295 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.89 -68.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.902 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.41 83.86 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.527 0.68 . . . . 0.0 111.972 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -83.88 137.86 33.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.956 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -74.62 -37.74 62.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.49 134.74 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.348 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.55 59.19 0.11 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.901 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 57.8 m-85 62.1 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.941 0.877 . . . . 0.0 113.326 -175.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.419 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 50.5 t80 -91.75 -13.24 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.768 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.807 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.58 -28.02 44.98 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.382 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.45 -118.6 0.75 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.899 -1.143 . . . . 0.0 113.084 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -76.62 -50.13 14.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 0.0 110.281 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -167.35 43.29 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.765 0.793 . . . . 0.0 109.782 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.648 ' HB3' ' HD1' ' A' ' 74' ' ' TYR . 20.9 p -154.03 -176.28 5.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.228 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.807 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 128.1 -172.43 19.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 t -92.95 -14.22 27.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.828 0.314 . . . . 0.0 111.265 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 14.9 tt0 -134.0 151.84 51.6 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.323 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.749 ' CD1' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -149.19 94.76 2.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.879 -173.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -94.82 153.16 17.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.861 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 1.014 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.0 mm -146.43 140.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 t -131.92 97.36 4.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.542 0.211 . . . . 0.0 110.517 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 33.1 t 18.48 115.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -19.5 65.89 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.425 -0.797 . . . . 0.0 110.472 171.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.02 -61.48 1.95 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.062 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 35.0 p30 -114.75 3.35 14.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.119 0.485 . . . . 0.0 111.59 -172.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 57' ' ' SER . 2.3 mm-40 39.79 38.26 0.43 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.447 HG11 ' N ' ' A' ' 64' ' ' THR . 9.1 p -129.37 -55.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.714 168.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.447 ' N ' HG11 ' A' ' 63' ' ' VAL . 4.5 m -58.0 101.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.243 0.544 . . . . 0.0 110.206 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -110.28 173.19 6.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -165.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.753 ' CE1' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -160.67 118.07 2.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.73 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 79.2 t -103.53 107.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.627 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . . . -91.12 157.14 17.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.91 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.11 135.62 4.95 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.201 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.34 -128.82 1.08 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.94 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -146.34 72.89 1.3 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 0.0 109.383 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.749 HD13 ' CD1' ' A' ' 54' ' ' TYR . 6.5 mt -92.14 166.93 12.39 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 122.377 1.084 . . . . 0.0 113.629 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.6 m -164.52 134.05 3.79 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 112.416 -2.175 . . . . 0.0 106.76 171.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.954 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 1.8 p90 -95.47 144.76 25.7 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 77.6 p -72.11 -68.4 0.47 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.954 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 13.4 tp 57.4 -87.55 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.018 0.927 . . . . 0.0 111.295 -169.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.402 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 21.8 m-85 -91.76 0.04 57.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.194 0.521 . . . . 0.0 110.897 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.493 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-80 -77.05 166.67 22.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.443 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.748 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 47.4 mm-40 -46.42 -61.54 2.56 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -168.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.748 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 77.2 Cg_exo -55.43 -40.42 85.61 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.935 1.756 . . . . 0.0 113.759 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 70.83 134.86 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.398 0.618 . . . . 0.0 112.483 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.4 m80 47.67 54.33 9.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.84 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.677 HG21 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -151.03 162.58 40.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.768 -171.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.459 ' H ' ' ND1' ' A' ' 132' ' ' HIS . 17.0 tp -108.83 156.02 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.974 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -158.21 -161.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.8 -159.04 22.81 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.26 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.3 tm0? -97.94 169.95 9.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.543 0.687 . . . . 0.0 112.742 -170.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.559 ' CD2' HG21 ' A' ' 134' ' ' VAL . 27.3 tp -155.34 135.51 13.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.53 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -134.94 -50.26 0.76 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.958 0.408 . . . . 0.0 111.28 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.498 ' O ' HD12 ' A' ' 91' ' ' LEU . 5.7 p -130.2 157.12 43.34 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -171.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.729 HD13 ' HE1' ' A' ' 66' ' ' PHE . 2.4 mm? -138.02 160.55 39.05 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 9.1 m -147.93 108.82 4.22 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 117.824 0.284 . . . . 0.0 110.951 176.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.63 ' CE1' HD11 ' A' ' 138' ' ' LEU . 4.6 m-30 -91.56 147.87 22.69 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.634 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.5 -152.33 11.35 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.732 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.413 ' O ' HG21 ' A' ' 109' ' ' VAL . 3.9 m-20 -134.57 126.97 30.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 110.742 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.665 ' HA3' HG23 ' A' ' 36' ' ' VAL . . . 76.2 110.09 0.12 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.836 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.0 mt -83.96 141.4 31.26 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.38 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -99.08 154.42 18.13 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.535 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.048 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.202 -166.636 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo . . . . . 0 C--O 1.233 0.27 0 CA-C-O 121.279 0.45 . . . . 0.0 113.035 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -66.03 155.03 37.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.579 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 p -142.38 155.64 45.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.347 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.634 HG21 ' HA3' ' A' ' 94' ' ' GLY . 1.1 mp -89.1 122.76 40.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.414 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.98 -39.71 94.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.185 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 95' ' ' ASP . 1.9 t -112.0 88.16 9.75 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.487 170.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 36.0 Cg_endo -65.16 96.55 0.27 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.268 2.645 . . . . 0.0 112.838 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.464 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 33.1 m-20 -94.66 -154.47 0.42 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.264 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.99 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 46.6 t -58.31 138.5 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.707 0.765 . . . . 0.0 111.931 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.559 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 75.6 m -129.11 178.8 6.15 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.391 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.584 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 95.9 m-85 -138.82 146.79 41.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -160.58 142.06 7.86 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.921 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.801 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.22 11.15 40.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.411 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.415 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 26.3 mt -57.08 -50.5 72.59 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.0 t30 55.43 43.35 28.85 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.695 0.76 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.8 mt -106.11 112.56 25.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.381 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 34.5 p -107.04 130.84 54.6 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.815 0.341 . . . . 0.0 110.523 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.0 m -108.28 145.8 33.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.827 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -80.96 165.14 22.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.503 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -52.93 -61.1 2.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.583 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -79.66 14.61 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -168.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 34.8 mt-30 -77.15 -25.9 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.289 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 56.38 -118.1 10.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.221 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.461 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 4.7 t-80 -80.24 -22.76 41.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.537 0.335 . . . . 0.0 110.765 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.584 ' HA ' HE21 ' A' ' 133' ' ' GLN . 15.1 t70 -84.82 -19.63 32.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -59.45 126.59 42.63 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 174.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.61 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 18.2 m -52.69 -32.62 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.737 ' O ' HG22 ' A' ' 135' ' ' VAL . 18.1 m -63.63 -49.67 81.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.157 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.677 ' HE1' HG21 ' A' ' 83' ' ' THR . 4.8 t-160 -57.02 -41.25 78.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.035 0.445 . . . . 0.0 110.008 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.61 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 6.1 mm-40 -56.73 -63.97 1.03 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.31 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.559 HG21 ' CD2' ' A' ' 88' ' ' LEU . 16.1 m -56.63 -39.21 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.469 -172.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 131' ' ' VAL . 2.2 t -66.1 -57.81 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 CA-C-O 121.455 0.645 . . . . 0.0 110.061 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.34 -18.21 64.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.34 -56.23 7.04 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 167.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.63 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.92 -52.61 31.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.111 0.564 . . . . 0.0 111.226 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 1.014 ' HG2' HG13 ' A' ' 56' ' ' ILE . 50.7 mtp -55.82 -26.74 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.111 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.1 m -99.45 -6.53 27.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.752 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.36 32.14 20.45 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.244 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -121.11 130.59 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.795 HG22 ' HB3' ' A' ' 19' ' ' LEU . 53.9 p -108.15 2.03 22.62 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.78 -39.44 61.72 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 123.523 0.514 . . . . 0.0 114.04 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.76 -26.92 29.26 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.411 -0.464 . . . . 0.0 110.824 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -68.92 -51.02 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.676 ' HB3' HG21 ' A' ' 161' ' ' VAL . 5.0 pt-20 -58.0 -33.51 69.01 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.283 0.563 . . . . 0.0 110.181 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 28.0 m -67.67 -47.95 68.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.848 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.01 99.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.219 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 99.1 mt -55.58 -43.15 75.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.398 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -57.08 -9.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.331 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -75.39 -40.16 33.96 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.299 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.479 HG21 ' HE2' ' A' ' 157' ' ' TYR . 3.9 mp -86.47 -48.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.029 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.445 ' HB3' ' C ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -53.31 -41.51 65.73 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.66 -23.85 63.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.95 -28.97 62.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.1 m-85 -101.8 -7.37 22.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.105 0.479 . . . . 0.0 110.14 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.13 29.77 12.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.352 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.496 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 1.9 mm? -111.19 -165.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.34 0.57 . . . . 0.0 110.513 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 p -163.1 -178.91 6.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.069 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.676 HG21 ' HB3' ' A' ' 147' ' ' GLU . 9.7 p -57.5 -23.3 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 111.375 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.79 14.45 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.707 0.289 . . . . 0.0 111.716 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.667 ' HB3' HG22 ' A' ' 168' ' ' VAL . 12.8 t -88.96 143.68 26.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.61 ' O ' HG21 ' A' ' 168' ' ' VAL . 38.3 m -69.2 141.26 54.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.672 ' CE1' HD12 ' A' ' 15' ' ' ILE . 5.2 m-30 -38.24 -53.01 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.71 0.804 . . . . 0.0 112.739 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.53 -48.42 79.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.708 0.29 . . . . 0.0 110.224 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.478 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 1.7 mp0 -69.04 -5.33 21.23 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.704 ' HB ' HG11 ' A' ' 4' ' ' VAL . 34.0 t -96.31 -54.05 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.249 0.547 . . . . 0.0 109.819 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.61 84.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.622 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.05 72.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.707 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 167' ' ' GLN . . . -70.32 -35.83 73.88 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.533 0.682 . . . . 0.0 110.581 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.559 HG23 ' CD2' ' A' ' 2' ' ' PHE . 16.5 p -82.56 -18.97 39.51 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.993 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.675 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.939 175.835 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.79 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 31.7 t80 . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.177 0.513 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -174.1 160.02 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.761 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.446 HG21 ' HB ' ' A' ' 168' ' ' VAL . 10.5 m -91.68 111.7 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.411 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 51.7 m-20 -94.62 50.18 1.31 Allowed 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.186 -167.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 1.06 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.6 p90 -67.58 149.03 50.63 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.547 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.3 t70 -62.16 100.06 0.16 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.454 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 8.4 m -30.14 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.827 1.651 . . . . 0.0 114.397 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.6 t -172.21 -31.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.098 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.573 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 81.9 m-85 -88.97 15.67 8.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.0 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.6 71.75 1.05 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.518 -172.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.45 5.73 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.511 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 32.2 m-85 -95.17 140.76 29.63 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.78 -0.21 . . . . 0.0 110.762 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -70.22 129.54 39.63 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 160.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.639 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 3.4 mm -44.89 -48.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -172.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 40.1 t-80 -57.13 -32.61 66.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.145 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.31 -51.52 23.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.24 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.431 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 57.6 t80 -68.13 -41.28 81.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.961 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.744 ' HB3' HG23 ' A' ' 143' ' ' THR . 17.0 mt -55.52 -41.13 72.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.874 0.369 . . . . 0.0 110.457 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.54 97.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.062 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -62.81 -40.53 97.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.757 0.423 . . . . 0.0 111.945 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -61.46 -43.64 98.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.59 -33.05 74.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.839 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.0 t -60.05 -51.77 68.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -68.25 -31.14 70.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.615 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 10.7 t80 -61.05 -52.78 63.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.231 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.41 -26.34 74.33 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.267 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -73.09 108.84 6.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 110.942 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.607 HG12 ' HB2' ' A' ' 60' ' ' ALA . 35.6 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.062 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.46 56.0 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.979 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.8 1.5 37.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.571 0.7 . . . . 0.0 109.84 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.422 HG21 ' CG2' ' A' ' 63' ' ' VAL . 32.3 t -95.63 114.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.925 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 -71.5 0.66 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.725 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.86 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.518 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 66.89 74.29 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.021 0.915 . . . . 0.0 111.0 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.34 136.06 33.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.007 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.463 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 70.4 m -73.02 -38.0 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.283 -172.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.436 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 109.51 -135.87 13.17 Favored Glycine 0 C--N 1.317 -0.475 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.892 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.34 70.38 1.32 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.763 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.481 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 64.1 m-85 56.87 -171.36 0.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.494 0.317 . . . . 0.0 111.765 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 44' ' ' PHE . 29.3 t80 -178.4 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.329 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -80.76 7.95 57.24 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.853 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.06 -98.74 0.13 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.1 m -152.18 -63.15 0.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 1.9 mp -77.27 -44.07 31.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.557 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.576 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 17.7 p -140.33 170.12 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 158.57 45.0 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.212 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.1 m 68.33 -54.04 0.53 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.458 ' HG2' ' N ' ' A' ' 54' ' ' TYR . 7.7 tt0 -93.74 149.62 21.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.481 ' HD1' ' H ' ' A' ' 44' ' ' PHE . 2.3 t80 -147.96 103.36 3.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 146.6 23.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.366 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 1.08 HG13 ' HG2' ' A' ' 139' ' ' MET . 9.1 mm -146.52 122.06 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 92.5 p -106.23 158.77 16.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.378 174.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 42.0 t -51.46 139.39 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.292 0.568 . . . . 0.0 111.968 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -85.45 -19.44 31.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.425 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.607 ' HB2' HG12 ' A' ' 29' ' ' VAL . . . -81.04 -60.52 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -111.73 1.32 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.824 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.63 ' HA ' ' O ' ' A' ' 58' ' ' SER . 2.9 mm-40 40.12 37.42 0.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.477 -1.238 . . . . 0.0 114.214 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.435 HG11 ' N ' ' A' ' 64' ' ' THR . 14.8 p -126.6 -51.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.921 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.435 ' N ' HG11 ' A' ' 63' ' ' VAL . 23.2 m -62.65 103.55 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.525 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -112.46 179.59 3.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.687 0.756 . . . . 0.0 112.924 -169.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.734 ' HE1' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -156.99 131.81 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.811 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.62 114.96 45.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.166 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.55 148.04 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.6 104.79 0.26 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.018 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.48 -92.29 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.194 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -147.92 30.14 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.482 0.641 . . . . 0.0 110.906 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 77.9 mt -59.24 143.73 48.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.34 0.591 . . . . 0.0 111.774 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 99.2 m -148.61 129.99 14.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.67 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.576 ' H ' ' HB3' ' A' ' 50' ' ' SER . 48.1 t80 -86.07 122.76 30.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 48.2 p -64.87 -41.29 95.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.623 -171.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.438 HD22 HD23 ' A' ' 49' ' ' LEU . 13.5 tp 51.08 -88.02 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.755 0.822 . . . . 0.0 111.978 -174.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.411 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 22.1 m-85 -95.08 -3.04 48.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.557 0.535 . . . . 0.0 111.711 -175.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.635 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 94.5 m-20 -75.51 -179.4 4.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.72 0.295 . . . . 0.0 111.623 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.872 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 32.7 mm-40 -45.83 -67.79 0.35 Allowed Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.9 Cg_exo -56.88 -36.6 99.01 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.415 1.41 . . . . 0.0 112.441 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 68.67 123.53 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.578 0.751 . . . . 0.0 112.247 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 60.35 59.99 2.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.992 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.789 HG22 ' HA2' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -143.88 166.34 25.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.074 -171.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.827 HD21 HG13 ' A' ' 135' ' ' VAL . 13.6 tp -119.23 144.18 46.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 7.9 p90 -158.15 -157.92 0.68 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 71' ' ' ASN . . . 95.04 -163.93 24.63 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.606 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.595 ' HG3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -103.43 172.96 6.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.529 HD13 HD11 ' A' ' 91' ' ' LEU . 1.5 pt? -139.62 -41.43 0.45 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.974 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HB2' ' OE1' ' A' ' 87' ' ' GLN . 37.2 t70 61.28 -58.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.685 1.194 . . . . 0.0 113.654 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 114' ' ' PHE . 8.0 m -136.29 135.26 38.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.902 0.858 . . . . 0.0 112.36 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.734 HD13 ' HE1' ' A' ' 66' ' ' PHE . 2.5 mm? -102.63 166.44 10.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.997 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.4 m -151.64 111.54 4.05 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 122.315 -0.241 . . . . 0.0 110.863 174.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.717 ' HE2' HD23 ' A' ' 19' ' ' LEU . 4.8 m-30 -97.62 141.56 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.612 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.28 164.71 31.83 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.015 172.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -87.08 120.83 28.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.159 0.504 . . . . 0.0 111.221 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.13 113.24 0.43 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.593 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' A' ' 105' ' ' TYR . 55.3 mt -89.03 153.89 20.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.582 . . . . 0.0 110.549 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -131.67 167.9 18.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.274 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.095 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo . . . . . 0 N--CA 1.465 -0.191 0 CA-C-O 121.155 0.398 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.436 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 52.5 m-85 -71.93 151.37 43.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.579 -174.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -146.59 152.58 39.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.868 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.612 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.3 mp -83.53 122.07 37.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.517 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.93 -48.45 74.07 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.424 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 21.5 t -112.51 87.55 9.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.404 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 24.5 Cg_endo -61.71 107.11 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.12 2.546 . . . . 0.0 112.639 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 12.1 m-20 -96.33 -148.73 0.31 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.293 174.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 1.06 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -61.22 143.54 14.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.632 0.73 . . . . 0.0 111.459 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.411 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 74.4 m -135.24 179.54 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.746 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.648 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.3 m-85 -139.04 146.04 40.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.36 141.71 7.62 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.632 -1.27 . . . . 0.0 112.396 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.22 11.59 41.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.761 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.508 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 14.6 mt -55.22 -49.21 72.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.3 t30 57.24 36.27 27.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.986 0.898 . . . . 0.0 109.588 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.538 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 19.2 mt -102.98 124.27 48.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.267 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.595 ' HB3' ' HG3' ' A' ' 87' ' ' GLN . 22.6 p -131.13 138.52 49.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.058 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.462 ' OG ' HG21 ' A' ' 131' ' ' VAL . 91.2 p -114.6 135.09 54.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 110.139 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.4 mp -60.69 161.86 7.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.159 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -51.55 -56.32 14.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.41 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.06 17.25 4.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.402 ' OE1' ' HB2' ' A' ' 121' ' ' SER . 21.5 mt-30 -77.13 -37.06 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.533 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.789 ' HA2' HG22 ' A' ' 83' ' ' THR . . . 77.88 -124.4 6.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.337 174.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -78.91 -14.88 58.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.55 ' HA ' HE21 ' A' ' 133' ' ' GLN . 38.9 t70 -85.84 -16.11 39.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.872 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.56 125.2 30.74 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.216 -0.992 . . . . 0.0 110.641 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.544 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 23.9 m -52.8 -35.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.462 HG21 ' OG ' ' A' ' 121' ' ' SER . 25.5 m -65.18 -41.24 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.462 0.574 . . . . 0.0 110.48 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.468 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.2 t-160 -60.69 -38.38 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.545 0.688 . . . . 0.0 109.448 175.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.55 HE21 ' HA ' ' A' ' 128' ' ' ASP . 2.8 mt-30 -67.26 -60.62 2.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.868 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 130' ' ' VAL . 18.9 m -60.28 -37.92 75.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.807 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.827 HG13 HD21 ' A' ' 84' ' ' LEU . 8.9 p -68.3 -46.3 81.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.83 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.61 -30.28 66.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 110.198 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.31 -54.98 32.76 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.709 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -50.25 -47.76 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.016 0.527 . . . . 0.0 111.013 176.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 1.08 ' HG2' HG13 ' A' ' 56' ' ' ILE . 53.0 mtp -56.09 -33.59 65.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.822 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.9 m -91.55 -13.52 31.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.413 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.51 10.26 53.81 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.93 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.67 120.74 30.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.11 0.481 . . . . 0.0 110.969 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 19' ' ' LEU . 17.3 p -108.5 9.15 27.55 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.606 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.12 -27.44 68.4 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.955 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.26 -30.31 23.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.991 0.424 . . . . 0.0 110.053 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -64.78 -47.91 76.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.035 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.565 ' HA ' HG13 ' A' ' 161' ' ' VAL . 1.5 pt-20 -55.15 -34.04 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.054 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.485 ' N ' ' HG3' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -75.1 -36.76 61.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.059 0.457 . . . . 0.0 109.8 -175.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.79 -47.15 69.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.527 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 98.3 mt -55.26 -43.49 74.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.048 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -55.29 -13.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.315 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.13 -37.65 55.38 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.39 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.582 HG22 ' HB3' ' A' ' 2' ' ' PHE . 3.2 mp -85.31 -46.26 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.724 HD13 HG12 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.74 -44.2 81.44 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.98 -24.73 67.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.99 -38.09 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.511 . . . . 0.0 110.219 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.504 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 13.7 m-85 -97.18 -7.71 31.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.91 16.63 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.379 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.531 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 1.9 mm? -110.85 -174.25 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.258 0.529 . . . . 0.0 110.335 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.5 p -165.39 -176.2 3.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.381 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' A' ' 147' ' ' GLU . 2.5 m -61.1 -13.15 6.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -88.75 4.49 47.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 168' ' ' VAL . 19.5 m -92.28 152.44 19.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.858 176.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.5 m -70.72 142.77 51.45 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.573 ' HD2' ' O ' ' A' ' 10' ' ' PHE . 4.1 m-30 -37.72 -64.38 0.4 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.386 0.674 . . . . 0.0 112.58 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.17 -40.85 82.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.112 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.57 -42.3 87.26 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.827 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.724 HG12 HD13 ' A' ' 154' ' ' LEU . 92.7 t -65.02 -52.02 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.33 78.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.727 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.34 83.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.611 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.63 -33.56 74.22 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.363 0.601 . . . . 0.0 110.864 -173.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.584 HG23 ' CD2' ' A' ' 2' ' ' PHE . 12.2 p -83.01 -25.2 32.43 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.009 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.312 179.898 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.822 ' O ' ' HB ' ' A' ' 172' ' ' THR . 38.7 t80 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.464 0.173 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.414 ' HG ' ' C ' ' A' ' 2' ' ' PHE . 10.0 m -161.51 163.35 30.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.394 0.678 . . . . 0.0 109.335 171.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.616 HG23 ' HD1' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.3 128.16 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.5 m-80 -105.35 49.57 0.8 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.625 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 1.055 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 25.5 p90 -73.18 152.84 40.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.547 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.2 t70 -62.15 100.71 0.18 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.463 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 22.3 t -35.46 75.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.665 1.586 . . . . 0.0 113.722 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.2 t -172.96 -30.64 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.859 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.469 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 53.7 m-85 -91.21 22.06 4.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.793 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.8 66.98 0.82 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.209 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -165.13 2.16 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.626 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 38.6 m-85 -83.23 141.8 31.62 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.5 m -71.44 138.08 48.77 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 159.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.731 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -47.01 -48.14 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 119.098 0.863 . . . . 0.0 110.842 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.533 ' HB2' HG11 ' A' ' 161' ' ' VAL . 44.4 t-80 -55.23 -32.23 62.13 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.74 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -65.46 -55.79 16.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.946 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 112' ' ' VAL . 83.2 t80 -66.59 -43.51 84.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.359 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 8.8 mt -55.88 -46.81 78.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.719 0.295 . . . . 0.0 110.573 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.52 -43.37 98.91 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.829 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.25 -43.01 99.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.578 0.351 . . . . 0.0 111.877 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 54.0 t90 -60.44 -43.55 96.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.04 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.85 71.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.481 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -62.4 -49.08 76.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 -28.18 67.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.59 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 38.6 t80 -62.25 -50.05 73.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.236 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -19.87 75.14 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.378 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.04 96.39 1.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.537 0.684 . . . . 0.0 110.906 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.485 ' CG1' ' HB3' ' A' ' 60' ' ' ALA . 16.8 m . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.835 0.35 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 3.73 20.21 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.273 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -106.11 -0.62 24.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.496 . . . . 0.0 109.887 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.439 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 19.9 t -89.93 122.88 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.973 -177.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -92.37 -81.09 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.327 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -75.23 -62.1 1.67 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.755 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.439 ' HB1' ' CG1' ' A' ' 36' ' ' VAL . . . 66.78 80.63 0.21 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.622 -172.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -78.7 134.19 37.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.497 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.4 m -79.84 -31.77 40.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.146 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.65 -172.43 44.75 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' CA ' ' HE2' ' A' ' 105' ' ' TYR . . . -148.15 -83.36 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.858 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.62 60.97 2.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.744 0.783 . . . . 0.0 109.073 -158.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -84.22 71.72 10.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.617 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.607 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -157.97 -36.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.945 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.35 -125.14 0.97 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.253 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -73.51 -38.95 65.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.576 0.227 . . . . 0.0 111.524 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -168.73 28.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.375 0.607 . . . . 0.0 110.623 -175.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -154.04 175.97 12.78 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.549 -176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.607 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 149.83 -164.78 29.6 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.284 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -91.64 -18.54 23.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.661 0.267 . . . . 0.0 111.212 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 40.8 tt0 -135.9 147.63 48.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 111.216 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.12 108.51 3.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.114 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.83 155.39 17.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.466 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 1.111 HG13 ' HG2' ' A' ' 139' ' ' MET . 8.6 mm -148.8 137.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.887 0.742 . . . . 0.0 109.166 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 20.7 t -129.76 150.93 50.86 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.744 0.307 . . . . 0.0 110.38 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 30.0 t -50.55 122.37 7.04 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.733 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 p -83.04 40.77 0.72 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.673 0.749 . . . . 0.0 110.179 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.485 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . . . -146.52 -45.08 0.19 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.599 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -122.65 -1.83 8.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.18 0.514 . . . . 0.0 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.5 mt-30 31.59 41.42 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 p -127.91 -43.94 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.032 170.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 13.6 m -67.2 96.11 0.45 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -111.12 -179.9 3.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 112.346 -171.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.817 ' HE1' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -157.7 131.31 7.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.245 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 35.2 t -110.17 118.63 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . . . -94.12 149.9 20.82 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.27 123.02 1.49 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -179.59 -109.17 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -149.27 41.12 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.0 mt -58.54 131.53 51.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.906 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.0 m -136.98 132.14 33.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.344 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.635 ' HB3' HD12 ' A' ' 49' ' ' LEU . 37.2 t80 -90.16 127.38 36.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.458 HG21 ' CD1' ' A' ' 85' ' ' TYR . 71.1 p -63.03 -37.27 86.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.051 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.498 HD13 HD23 ' A' ' 49' ' ' LEU . 9.9 tp 49.64 -93.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.696 0.798 . . . . 0.0 112.161 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.465 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 5.4 m-85 -99.09 8.66 44.71 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.165 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -80.27 178.87 7.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.823 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.622 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 12.1 mm-40 -52.55 -54.91 37.41 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 52.1 Cg_exo -55.36 -37.65 94.48 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.671 1.581 . . . . 0.0 112.445 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.46 116.81 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.767 0.794 . . . . 0.0 112.878 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 54.01 58.06 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.741 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.21 162.56 39.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.005 -178.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.765 HD21 HG13 ' A' ' 135' ' ' VAL . 12.5 tp -101.73 151.37 22.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.464 0.174 . . . . 0.0 110.741 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.458 ' CD1' HG21 ' A' ' 75' ' ' THR . 18.4 p90 -155.82 -152.02 0.37 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 168.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.58 -167.5 24.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.99 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 6.3 tm0? -99.97 164.7 11.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.389 0.614 . . . . 0.0 111.608 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 88' ' ' LEU . 22.3 tp -155.41 135.14 12.68 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.675 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -133.96 -53.48 0.86 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.188 0.518 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.491 ' HA ' ' HA2' ' A' ' 115' ' ' GLY . 2.3 p -108.43 153.69 22.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.944 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.817 HD13 ' HE1' ' A' ' 66' ' ' PHE . 2.9 mm? -137.77 169.84 17.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.605 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 20.6 t -163.52 111.99 1.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.636 -175.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.694 ' HE2' HD23 ' A' ' 19' ' ' LEU . 3.4 m-30 -103.92 131.88 50.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.19 169.15 41.65 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.934 -1.126 . . . . 0.0 112.224 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -89.78 115.05 26.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.205 0.526 . . . . 0.0 111.374 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.54 112.14 0.64 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.625 170.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 67' ' ' VAL . 13.1 mt -89.39 160.26 16.91 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.474 0.654 . . . . 0.0 110.476 170.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 t -131.57 166.93 20.3 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.992 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.263 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.19 -174.61 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 CA--C 1.532 0.422 0 N-CA-C 114.275 0.836 . . . . 0.0 114.275 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.414 ' HE2' ' CA ' ' A' ' 43' ' ' GLY . 27.0 m-85 -68.22 164.15 21.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.435 -173.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 p -149.45 154.22 38.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.865 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.732 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -83.84 126.51 40.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -177.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -65.85 -50.95 62.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.129 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.9 t -112.62 85.6 7.58 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.46 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.71 106.28 1.44 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.637 2.892 . . . . 0.0 113.034 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -100.45 -140.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 1.055 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 38.8 t -62.01 143.62 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.691 0.757 . . . . 0.0 111.572 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.545 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 53.2 m -143.94 179.09 7.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.411 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.706 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.2 m-85 -137.57 150.24 47.32 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.058 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -162.31 131.89 2.65 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.353 175.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 106.6 16.03 15.43 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.794 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.484 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 11.8 mt -56.72 -44.18 81.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 51.63 50.58 18.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.63 0.728 . . . . 0.0 110.428 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 27.1 mt -109.15 118.87 37.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.894 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 13.1 p -116.64 133.08 56.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.313 . . . . 0.0 110.479 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 53.1 p -103.76 154.22 19.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.528 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 64.5 mt -82.06 165.94 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.575 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -58.84 -57.13 14.38 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -75.73 5.19 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.542 ' HB3' ' N ' ' A' ' 129' ' ' GLY . 31.3 mt-30 -80.03 57.24 2.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.74 102.32 0.49 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.847 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 81.13 -30.53 0.11 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.97 0.908 . . . . 0.0 111.553 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.471 ' HA ' HE21 ' A' ' 133' ' ' GLN . 8.6 t70 -81.23 -27.68 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.082 0.239 . . . . 0.0 111.357 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.542 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -56.09 128.14 44.94 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 28.0 m -56.48 -25.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -68.17 -48.53 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.639 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.4 t-160 -61.6 -38.75 88.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.819 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.591 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 21.1 mm-40 -56.21 -67.65 0.28 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.157 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 130' ' ' VAL . 17.7 m -58.05 -40.17 75.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.191 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.765 HG13 HD21 ' A' ' 84' ' ' LEU . 11.4 p -68.56 -47.37 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 121.289 -0.165 . . . . 0.0 111.083 -176.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.406 ' HD1' HG11 ' A' ' 135' ' ' VAL . 9.2 m-85 -72.26 -23.07 61.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.85 -55.59 23.71 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.676 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -48.29 -52.72 20.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.29 0.567 . . . . 0.0 110.747 176.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 1.111 ' HG2' HG13 ' A' ' 56' ' ' ILE . 51.9 mtp -54.53 -35.57 63.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.297 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.2 m -91.63 -1.99 57.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.829 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.56 44.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.92 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -109.73 134.33 52.12 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.46 0.304 . . . . 0.0 110.286 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.578 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 43.8 p -112.4 -11.29 13.68 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.404 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.14 -38.68 56.72 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.523 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.37 -38.0 68.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.693 -0.298 . . . . 0.0 111.021 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.586 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 45.2 tp -67.64 -38.63 84.12 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.859 ' HG2' HG21 ' A' ' 161' ' ' VAL . 67.6 mt-10 -55.93 -38.16 69.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.68 -34.71 58.21 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.12 0.486 . . . . 0.0 109.91 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.06 85.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.939 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.3 mt -55.92 -45.97 78.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.445 174.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -53.94 -16.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.76 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.34 46.51 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.11 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.594 HG22 ' HB3' ' A' ' 2' ' ' PHE . 3.8 mp -81.09 -47.01 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.83 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.548 HD13 HG11 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.99 -37.84 69.64 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.319 . . . . 0.0 111.498 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.71 -30.37 69.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.332 0.587 . . . . 0.0 110.014 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.459 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.0 m-85 -103.39 -9.74 19.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.1 20.55 25.41 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.824 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.459 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -105.51 -166.8 1.25 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.475 0.638 . . . . 0.0 110.915 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.8 m -159.74 179.28 8.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.859 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.0 p -56.61 -25.6 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.313 0.578 . . . . 0.0 110.965 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -89.64 33.65 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.124 -0.36 . . . . 0.0 111.637 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.632 ' HB3' HG21 ' A' ' 168' ' ' VAL . 18.7 t -101.93 150.62 23.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.9 m -72.8 133.55 44.54 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 119.003 -0.522 . . . . 0.0 111.649 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.66 ' CD1' HD12 ' A' ' 15' ' ' ILE . 3.4 m-30 -38.89 -53.97 1.67 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.23 -46.2 86.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.483 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -70.99 -35.85 72.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.739 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.728 HG22 HD11 ' A' ' 15' ' ' ILE . 37.1 t -62.4 -52.93 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.78 76.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.022 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 173' ' ' ALA . . . -64.78 -33.56 76.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.524 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.49 -32.63 62.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.227 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.822 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 31.0 p -85.15 -12.9 51.73 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.092 0.948 . . . . 0.0 109.611 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.831 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.895 0.379 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.866 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.6 t80 -80.49 158.85 25.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.174 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 p -173.9 165.3 4.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.307 0.575 . . . . 0.0 110.945 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.645 HG23 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.97 125.69 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.779 171.148 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.571 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 30.9 m-80 -101.75 49.4 0.86 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.746 0.784 . . . . 0.0 110.402 -176.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.959 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 26.1 p90 -74.42 148.48 41.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.589 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.7 t70 -63.27 106.62 0.91 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.7 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 10.2 t -39.25 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.841 1.338 . . . . 0.0 112.502 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 7' ' ' ASP . 13.5 t -173.7 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.967 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.528 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 85.5 m-85 -94.23 15.16 18.04 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.071 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.18 68.62 1.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.679 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.26 8.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 164' ' ' THR . 22.1 m-85 -92.57 146.88 23.33 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 122.163 0.185 . . . . 0.0 110.968 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 m -71.11 132.62 45.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.728 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -46.15 -53.31 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.569 0.622 . . . . 0.0 111.377 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.49 ' HB2' HG23 ' A' ' 161' ' ' VAL . 23.0 t-80 -61.07 -24.57 66.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.582 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.15 -44.82 28.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -71.12 -41.97 69.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.354 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 14.3 mt -56.33 -39.78 73.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.304 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -42.18 96.78 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.113 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 24' ' ' SER . 8.2 tt0 -61.89 -38.21 87.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 49.0 t90 -60.43 -46.36 90.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.867 175.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.83 -26.59 67.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.295 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 36.0 t -57.75 -55.51 33.88 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.038 0.447 . . . . 0.0 109.997 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.85 -32.39 73.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.603 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.467 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.0 t80 -61.78 -47.16 86.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.95 -30.67 76.37 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.284 -0.484 . . . . 0.0 113.766 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.27 109.0 8.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 60' ' ' ALA . 17.1 m -64.46 -29.45 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -94.88 1.5 55.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.851 0.358 . . . . 0.0 111.667 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -67.25 109.07 2.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -102.85 -177.63 3.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.467 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -155.41 121.05 5.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.4 -8.13 54.6 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.088 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.29 -5.88 32.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.382 0.61 . . . . 0.0 109.563 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.593 HG23 ' HA3' ' A' ' 96' ' ' GLY . 41.1 t -102.18 114.41 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.179 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -100.18 -73.55 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.52 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -57.14 8.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.069 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.48 73.52 0.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.064 0.935 . . . . 0.0 111.035 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 13.7 m-80 -84.58 135.03 34.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.456 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.423 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 69.2 m -74.86 -40.3 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.479 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 124.79 -124.97 5.56 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.447 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 59.79 2.96 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 61.3 m-85 60.6 -178.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.712 0.768 . . . . 0.0 112.976 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.503 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 36.9 t80 -142.02 -69.21 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.503 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.16 55.82 3.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.153 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 50' ' ' SER . . . 168.43 157.06 10.86 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.33 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.446 ' O ' HD22 ' A' ' 49' ' ' LEU . 4.0 m -82.06 -27.89 32.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.322 0.582 . . . . 0.0 109.896 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 48' ' ' SER . 6.8 mt -154.67 -40.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.452 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.774 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 10.4 p -116.04 148.25 40.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.839 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.8 -137.76 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.782 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 p -94.71 -57.92 2.33 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 54.2 tt0 -114.75 152.24 32.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.105 -167.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.685 ' CD1' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -145.12 94.77 2.58 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.723 0.773 . . . . 0.0 111.47 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.43 151.44 19.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.824 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.961 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.8 mm -146.45 129.42 8.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 123.197 0.599 . . . . 0.0 110.618 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.581 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.3 t -112.87 147.3 37.29 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 43.2 t -45.6 117.4 1.44 Allowed 'General case' 0 C--O 1.207 -1.163 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.535 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -12.93 56.52 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.977 -0.452 . . . . 0.0 110.843 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.417 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . . . -80.66 -60.73 2.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.834 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -115.5 -0.67 13.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.793 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.8 mt-30 33.77 42.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -173.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.444 HG11 ' N ' ' A' ' 64' ' ' THR . 7.3 p -121.83 -53.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.858 166.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.467 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 32.5 m -64.19 103.89 0.68 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.216 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.02 -176.95 3.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -169.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.768 ' CE1' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -159.82 120.15 3.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.267 -176.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 69.1 t -102.46 109.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.567 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.768 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . . . -97.18 151.62 19.63 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.56 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.29 139.56 6.52 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.014 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 -117.87 0.48 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.373 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.687 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 2.5 t-20 -145.91 73.15 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.685 HD13 ' CD1' ' A' ' 54' ' ' TYR . 16.4 mt -83.29 161.08 21.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.657 -164.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.585 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 52.8 m -155.75 121.57 5.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.481 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.908 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 44.1 t80 -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.421 0.629 . . . . 0.0 109.991 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.486 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . 13.0 p -81.87 47.61 1.12 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -171.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.908 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -60.02 -57.74 11.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.245 1.384 . . . . 0.0 111.987 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -89.92 1.72 55.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.508 0.67 . . . . 0.0 109.514 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.486 ' HB2' ' CA ' ' A' ' 75' ' ' THR . 29.7 m-80 -89.02 179.07 6.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.349 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.871 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 33.7 mm-40 -53.27 -67.8 0.54 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 51.6 Cg_exo -56.66 -28.16 73.89 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 121.666 1.578 . . . . 0.0 113.13 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.36 115.43 0.05 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.655 0.74 . . . . 0.0 112.64 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 54.04 51.36 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.277 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.712 HG21 ' CE1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -134.97 178.98 6.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.703 -174.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.404 ' H ' ' ND1' ' A' ' 132' ' ' HIS . 14.4 tp -125.75 142.23 51.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.67 ' HB2' ' HG ' ' A' ' 121' ' ' SER . 16.9 p90 -153.95 -159.53 0.98 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.93 -163.32 19.35 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.307 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.687 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 1.2 tm0? -93.36 165.94 12.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.788 0.804 . . . . 0.0 112.137 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 88' ' ' LEU . 25.3 tp -156.12 132.83 10.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.985 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -132.14 -45.0 0.93 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.262 0.553 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.52 134.39 46.06 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.526 HD13 ' HE1' ' A' ' 66' ' ' PHE . 3.1 mm? -108.13 175.55 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.903 169.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.631 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 12.6 t -167.22 103.78 0.53 Allowed 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.502 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.661 ' CE1' HD11 ' A' ' 138' ' ' LEU . 4.4 m-30 -95.87 145.19 25.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.666 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 177.04 170.92 40.07 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.906 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.8 114.63 26.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 111.594 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.593 ' HA3' HG23 ' A' ' 36' ' ' VAL . . . 85.01 107.44 0.65 Allowed Glycine 0 C--O 1.223 -0.558 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.781 169.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 105' ' ' TYR . 48.1 mt -86.59 155.77 20.31 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.231 0.539 . . . . 0.0 110.29 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.402 ' HA ' HD21 ' A' ' 40' ' ' ASN . 1.8 m -145.42 173.67 11.8 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.13 175.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.1 -125.34 8.23 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -172.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.595 ' HA3' ' CE1' ' A' ' 105' ' ' TYR . . . 58.03 49.0 79.11 Favored Glycine 0 C--N 1.322 -0.232 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.914 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.472 ' OD2' HG23 ' A' ' 102' ' ' THR . 19.6 t70 -144.81 -70.15 0.29 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.472 HG23 ' OD2' ' A' ' 101' ' ' ASP . 47.2 p -122.69 -8.31 8.48 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.561 174.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -121.91 154.19 60.83 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.407 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.503 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 25.6 Cg_exo -67.24 160.58 46.91 Favored 'Trans proline' 0 C--N 1.333 -0.266 0 C-N-CA 123.475 2.784 . . . . 0.0 111.452 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.595 ' CE1' ' HA3' ' A' ' 100' ' ' GLY . 48.3 m-85 -68.06 141.74 56.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.815 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.0 p -150.79 147.09 26.86 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.335 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.666 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.1 mp -79.42 130.17 36.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.109 0.48 . . . . 0.0 110.82 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.79 -44.48 93.2 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.156 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.92 82.82 2.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.8 111.21 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.523 2.815 . . . . 0.0 112.908 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 49.4 m-20 -104.48 -150.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.376 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.959 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 48.4 t -59.71 143.25 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.698 0.761 . . . . 0.0 111.572 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.571 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -140.74 178.83 7.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.339 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.593 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.8 m-85 -135.19 148.27 49.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -162.51 140.51 6.59 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.824 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.866 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 99.17 11.87 44.25 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.2 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.563 ' HA ' HD11 ' A' ' 153' ' ' ILE . 16.7 mt -57.98 -50.53 73.09 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 56.15 52.2 10.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.764 0.792 . . . . 0.0 110.519 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 23.7 mt -113.74 110.14 19.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.478 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.582 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 72.4 p -115.02 130.71 57.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.67 ' HG ' ' HB2' ' A' ' 85' ' ' TYR . 81.2 p -98.02 147.2 24.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.723 0.297 . . . . 0.0 110.493 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.61 171.32 14.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.855 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -49.62 -55.39 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.493 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.92 10.23 8.31 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.417 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 19.3 mm-40 -79.84 67.78 5.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.52 -103.61 0.01 OUTLIER Glycine 0 C--O 1.224 -0.519 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.434 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -83.41 -14.81 51.85 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.11 -0.641 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.498 ' HA ' HE21 ' A' ' 133' ' ' GLN . 17.3 t70 -87.43 -18.81 29.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 125' ' ' GLN . . . -65.25 121.42 20.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.54 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.0 m -49.57 -32.77 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.11 -41.6 92.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.27 0.486 . . . . 0.0 110.718 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.712 ' CE1' HG21 ' A' ' 83' ' ' THR . 4.9 t-160 -65.28 -37.84 88.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 109.85 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.54 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 6.8 mt-30 -65.41 -58.14 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.731 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 146' ' ' LEU . 24.9 m -58.31 -39.35 73.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.373 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.561 ' O ' ' HG3' ' A' ' 139' ' ' MET . 13.0 p -67.68 -50.04 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.755 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.433 ' N ' HG11 ' A' ' 135' ' ' VAL . 14.0 m-85 -71.01 -27.19 63.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.695 0.283 . . . . 0.0 110.823 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.98 -56.8 18.69 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.702 HD23 HD12 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -49.5 -50.4 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.145 0.578 . . . . 0.0 111.1 176.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.961 ' HG2' HG13 ' A' ' 56' ' ' ILE . 48.6 mtp -54.87 -33.15 61.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.41 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.2 m -94.1 -6.41 45.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.17 23.44 29.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.506 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -107.76 135.48 49.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 19' ' ' LEU . 37.4 p -117.94 10.16 13.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.798 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.484 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.03 -19.27 78.3 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.69 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.27 -36.02 14.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 0.0 110.647 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.702 HD12 HD23 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -67.34 -39.59 85.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.929 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.655 ' HB2' HG13 ' A' ' 161' ' ' VAL . 10.9 pt-20 -56.61 -35.25 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.82 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 -35.69 53.15 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.996 0.426 . . . . 0.0 109.964 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.46 82.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.615 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 96.3 mt -55.96 -42.06 75.67 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.88 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -54.65 -10.35 0.43 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.171 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.0 -39.85 53.12 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.411 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 117' ' ' LEU . 3.5 mp -85.52 -46.49 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 120.727 0.299 . . . . 0.0 110.436 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.61 HD13 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.28 -44.65 80.0 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.911 -177.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.63 -22.86 67.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.678 0.275 . . . . 0.0 111.514 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.12 -35.13 79.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.499 . . . . 0.0 110.019 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.444 ' HE2' HG21 ' A' ' 153' ' ' ILE . 34.5 m-85 -96.06 -14.68 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 99.19 24.11 10.69 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.756 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -104.4 -161.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.189 0.495 . . . . 0.0 110.377 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.408 ' H ' ' HB3' ' A' ' 159' ' ' LEU . 66.7 p -162.61 -179.94 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.819 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.655 HG13 ' HB2' ' A' ' 147' ' ' GLU . 9.1 p -59.06 -20.35 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.062 0.458 . . . . 0.0 111.392 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.87 13.52 12.46 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.048 -0.408 . . . . 0.0 111.022 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.62 ' HB3' HG21 ' A' ' 168' ' ' VAL . 8.5 t -84.01 148.7 26.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.7 m -72.81 149.44 43.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.988 -175.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.669 ' CE1' HD12 ' A' ' 15' ' ' ILE . 10.7 m-30 -53.19 -22.7 7.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.585 0.754 . . . . 0.0 111.46 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.46 -51.04 7.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.457 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -66.85 -43.63 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 163' ' ' SER . 3.2 t -55.58 -58.52 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.02 73.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.16 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 173' ' ' ALA . . . -66.84 -35.83 80.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.747 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -76.57 -30.86 57.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.385 0.612 . . . . 0.0 110.245 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.3 p -85.2 -15.26 44.23 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.92 0.867 . . . . 0.0 109.034 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . -70.48 -45.53 65.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.268 173.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 175' ' ' GLY . 7.8 p -170.51 -31.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.317 -175.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 171' ' ' ALA . . . 104.37 114.45 3.95 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -175.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.1 m -130.57 29.69 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.927 0.87 . . . . 0.0 110.235 -171.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -87.22 1.34 53.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.589 -171.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.217 -0.896 . . . . 0.0 109.98 -178.635 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 116' ' ' GLY . . . . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.031 0.443 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.752 ' O ' ' HB ' ' A' ' 172' ' ' THR . 44.4 t80 -87.88 148.77 24.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.435 -174.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -162.41 168.35 22.23 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.729 0.812 . . . . 0.0 109.221 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.639 HG21 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.9 128.19 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.654 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 25.3 m-80 -103.9 49.97 0.81 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 0.0 110.328 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.941 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 32.6 p90 -71.49 151.4 43.97 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.097 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 9' ' ' SER . 25.5 t70 -62.36 103.08 0.36 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.644 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 5.3 t -34.94 77.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.113 1.508 . . . . 0.0 112.974 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.4 t -173.35 -30.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.298 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 66.5 m-85 -95.74 19.81 10.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.004 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 59.2 2.31 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -172.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -166.32 16.9 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.554 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 26.4 m-85 -93.66 139.86 30.31 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.163 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 m -67.55 131.54 45.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 160.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.763 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.5 mm -45.65 -51.56 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 117.917 0.326 . . . . 0.0 111.499 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -56.14 -34.79 66.45 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.559 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.25 -53.35 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.394 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.469 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 73.6 t80 -68.86 -39.64 79.75 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.583 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.763 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 12.1 mt -56.69 -40.84 76.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.955 0.407 . . . . 0.0 110.244 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.62 -41.58 99.61 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.017 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -62.25 -39.85 94.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.631 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 44.8 t90 -59.16 -42.33 90.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.25 0.548 . . . . 0.0 110.202 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.38 -25.05 66.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.2 t -62.96 -55.78 22.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.024 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.3 -31.02 72.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.773 0.32 . . . . 0.0 111.073 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.555 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 32.1 t80 -58.85 -41.13 86.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.922 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.43 -18.64 78.46 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.433 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 90.33 2.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.414 0.626 . . . . 0.0 111.573 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' A' ' 60' ' ' ALA . 29.6 m -63.6 0.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -174.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -80.47 -20.21 44.25 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 52.9 t60 71.04 8.96 6.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.26 0.553 . . . . 0.0 112.188 169.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.9 p -87.62 133.7 33.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.302 0.572 . . . . 0.0 112.311 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.414 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 44.2 t-20 -168.36 123.76 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.267 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -6.78 56.3 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.419 -0.42 . . . . 0.0 114.064 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -112.98 -5.29 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.492 0.646 . . . . 0.0 111.534 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 63' ' ' VAL . 46.1 t -102.42 118.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.13 0.49 . . . . 0.0 111.743 -175.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.92 -62.83 1.39 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.46 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.91 -72.7 0.3 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.01 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 68.97 87.04 0.12 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.378 0.609 . . . . 0.0 112.247 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -83.72 154.38 23.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.86 175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -82.22 -37.65 25.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.406 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.29 170.73 39.3 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.154 -174.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.906 ' HA2' ' HE2' ' A' ' 105' ' ' TYR . . . -98.55 -111.67 3.12 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -168.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 55.96 64.96 1.57 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.952 0.882 . . . . 0.0 109.024 -164.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 52' ' ' SER . 2.2 t80 -73.12 -23.92 60.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.668 -173.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.84 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.95 -19.66 64.82 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.376 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.02 -145.59 8.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.453 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 m -75.04 -30.42 61.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.767 0.318 . . . . 0.0 110.958 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -166.43 40.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.284 0.564 . . . . 0.0 111.397 -175.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 p -164.67 177.65 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.35 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.84 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 106.49 -163.65 13.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.297 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 16.6 m -88.54 127.57 35.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 68' ' ' ALA . 5.3 tt0 80.21 105.72 0.07 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.178 171.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.414 ' CD2' HG23 ' A' ' 135' ' ' VAL . 2.0 t80 -102.05 101.6 11.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.329 172.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.526 ' H ' ' HA3' ' A' ' 43' ' ' GLY . . . -90.52 152.78 20.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.003 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 1.008 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.1 mm -147.18 132.86 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.318 0.647 . . . . 0.0 109.51 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 19.8 t -121.86 149.28 43.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 40.9 t -48.06 119.4 2.88 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.399 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -66.64 -10.3 44.66 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.821 -0.549 . . . . 0.0 111.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.434 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . . . -83.81 -49.87 8.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.674 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.571 ' HB2' ' HA ' ' A' ' 31' ' ' HIS . 39.2 p30 -127.76 -3.81 5.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.86 -172.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 58' ' ' SER . 63.7 mt-30 33.8 45.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.947 1.299 . . . . 0.0 114.168 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 36' ' ' VAL . 7.4 t -116.66 -63.38 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.669 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 21.6 m -61.84 102.59 0.28 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.337 -175.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.45 -178.43 3.38 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.54 -169.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.611 ' HE1' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -157.74 126.01 5.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.757 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 29.0 t -108.67 111.27 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 53' ' ' GLN . . . -90.29 107.69 19.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 0.0 111.03 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.86 117.91 5.36 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.852 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.67 -139.39 3.69 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.406 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.553 ' HB2' ' CB ' ' A' ' 87' ' ' GLN . 8.7 m-80 -136.24 47.74 2.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.027 0.918 . . . . 0.0 109.222 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 35.6 mt -70.31 149.92 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.639 -1.619 . . . . 0.0 112.015 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.4 ' HG1' ' C ' ' A' ' 72' ' ' LEU . 92.7 m -155.05 137.19 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.142 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.753 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 33.7 t80 -89.21 123.66 33.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.564 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 69.1 p -70.91 -32.55 69.52 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -171.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.753 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER 42.09 -92.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.836 0.854 . . . . 0.0 113.117 -168.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.528 ' H ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.63 7.29 46.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.718 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 33.8 m-80 -77.16 176.57 8.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.761 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 39.8 mt-10 -48.52 -63.13 1.7 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -170.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.761 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -55.65 -35.77 93.58 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.616 1.544 . . . . 0.0 112.433 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.63 128.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.894 0.746 . . . . 0.0 112.463 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 38.09 60.28 1.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.059 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.569 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -143.32 165.64 26.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.847 -174.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.676 HD21 HG13 ' A' ' 135' ' ' VAL . 11.7 tp -108.94 146.91 33.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 17.0 p90 -153.65 -160.7 1.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 85' ' ' TYR . . . 98.97 -166.56 21.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.929 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.678 HE22 ' HB2' ' A' ' 89' ' ' ASP . 17.8 tm0? -92.58 158.03 16.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.687 0.756 . . . . 0.0 111.906 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.56 ' CD2' HG21 ' A' ' 134' ' ' VAL . 57.1 tp -143.76 110.24 5.5 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.045 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.678 ' HB2' HE22 ' A' ' 87' ' ' GLN . 36.1 t70 -126.54 -28.82 2.98 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.882 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.488 ' O ' HD12 ' A' ' 91' ' ' LEU . 31.0 t -134.89 160.19 39.05 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.05 0.928 . . . . 0.0 112.327 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.611 HD13 ' HE1' ' A' ' 66' ' ' PHE . 3.0 mm? -144.46 163.7 33.04 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 19.9 t -162.82 106.93 1.1 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.163 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.631 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 2.4 m-30 -97.64 135.05 40.01 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.634 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.42 160.88 28.77 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.013 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.83 110.82 20.22 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.258 0.551 . . . . 0.0 110.734 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.96 110.51 2.36 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.801 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 105' ' ' TYR . 6.6 mt -83.89 155.14 23.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.486 . . . . 0.0 109.846 170.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 t -145.95 170.2 17.1 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.908 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.26 -133.9 13.52 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.536 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.9 32.93 31.26 Favored Glycine 0 C--N 1.313 -0.729 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.127 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.89 -102.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.194 0.521 . . . . 0.0 109.61 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 p -104.59 5.13 33.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.744 0.783 . . . . 0.0 109.496 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -129.57 167.75 19.01 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.315 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.25 172.56 10.91 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.173 2.582 . . . . 0.0 112.421 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.906 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 48.8 m-85 -75.8 165.19 25.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.404 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.6 p -147.77 139.76 24.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.996 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.713 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -81.61 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.624 -174.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.14 -48.16 77.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.053 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.75 88.37 7.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.87 93.9 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 123.142 2.561 . . . . 0.0 112.354 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 30.3 m-20 -93.45 -155.56 0.45 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.413 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.941 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 20.7 t -62.0 113.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.427 1.108 . . . . 0.0 112.422 -175.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.654 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 68.5 m -103.02 176.65 5.08 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.327 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.759 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.0 m-85 -137.07 141.28 42.39 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -156.45 128.92 2.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.155 -1.498 . . . . 0.0 113.047 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.698 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 111.38 10.0 20.68 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.25 174.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 89' ' ' ASP . 1.7 mm? -49.88 -53.04 28.3 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.063 0.945 . . . . 0.0 110.52 174.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.4 t30 53.68 47.62 23.38 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.58 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.4 mt -105.22 102.55 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.498 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.57 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 69.5 p -106.16 128.5 53.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.268 0.556 . . . . 0.0 110.851 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.7 t -108.71 119.16 38.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.467 ' N ' HD12 ' A' ' 122' ' ' LEU . 9.9 mp -59.14 167.49 1.71 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.297 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -51.65 -57.84 8.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.877 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.528 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -83.36 15.15 3.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -165.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -72.98 -31.09 64.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 66.18 -119.91 14.37 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.203 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.436 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 6.1 t-80 -88.77 -24.06 22.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.42 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.497 ' HA ' HE21 ' A' ' 133' ' ' GLN . 32.7 t70 -81.06 -21.49 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.822 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 125.99 40.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.281 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 134' ' ' VAL . 18.6 m -51.18 -32.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.3 -42.23 94.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.52 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.9 t-160 -65.05 -40.36 94.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.779 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.497 HE21 ' HA ' ' A' ' 128' ' ' ASP . 23.2 mm-40 -59.77 -65.31 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.926 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.674 HG13 ' HA ' ' A' ' 146' ' ' LEU . 27.1 m -55.86 -39.84 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.014 -174.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.676 HG13 HD21 ' A' ' 84' ' ' LEU . 8.3 p -69.68 -46.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.256 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.407 ' N ' HG11 ' A' ' 135' ' ' VAL . 12.2 m-85 -73.35 -24.77 60.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.54 -54.96 19.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.547 HD23 HD23 ' A' ' 146' ' ' LEU . 0.2 OUTLIER -48.7 -50.72 32.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.158 0.583 . . . . 0.0 110.82 176.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 1.008 ' HG2' HG13 ' A' ' 56' ' ' ILE . 41.5 mtp -52.72 -34.61 53.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.133 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m -90.99 -2.81 57.65 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 14.89 69.33 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.597 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -106.88 104.16 13.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.182 0.515 . . . . 0.0 110.302 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.602 HG23 ' HB3' ' A' ' 19' ' ' LEU . 3.5 p -92.16 11.86 24.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.481 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.19 -29.1 72.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.776 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.73 39.46 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.434 -0.451 . . . . 0.0 110.431 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.674 ' HA ' HG13 ' A' ' 134' ' ' VAL . 47.1 tp -68.39 -43.13 77.96 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.589 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.656 ' CB ' HG13 ' A' ' 161' ' ' VAL . 10.6 pt-20 -57.85 -31.08 66.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.658 0.266 . . . . 0.0 110.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -36.12 58.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.57 75.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.928 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 94.1 mt -55.45 -39.22 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.8 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -56.28 -10.19 0.83 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.451 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.35 -36.24 63.29 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.389 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.1 mp -84.4 -47.98 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 122.705 -0.291 . . . . 0.0 110.58 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.758 HD13 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.63 -43.09 75.86 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.8 -30.78 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.94 -31.84 72.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.137 0.494 . . . . 0.0 110.818 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -98.86 -6.11 29.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.299 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.38 39.31 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.308 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 mp -101.4 -167.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.1 p -167.85 175.41 6.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.286 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.656 HG13 ' CB ' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -61.71 -13.27 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.271 . . . . 0.0 111.669 172.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -89.73 10.62 22.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.956 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -87.17 -116.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.184 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.404 ' CG2' ' HA2' ' A' ' 12' ' ' GLY . 7.2 m -157.31 146.83 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.771 -174.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.672 ' CE1' HD12 ' A' ' 15' ' ' ILE . 6.7 m-30 -54.47 -45.26 73.12 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.455 0.302 . . . . 0.0 111.025 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.13 -41.1 90.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.656 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -66.78 -48.18 69.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.758 HG22 HD13 ' A' ' 154' ' ' LEU . 4.0 t -56.23 -54.95 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.686 0.279 . . . . 0.0 110.272 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.21 76.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.017 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.779 ' HB1' HG11 ' A' ' 176' ' ' VAL . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.278 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.414 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -75.4 -29.74 59.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.752 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 38.0 p -86.27 -11.84 51.19 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.06 0.933 . . . . 0.0 109.146 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . -68.76 -46.24 69.33 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.868 -1.514 . . . . 0.0 108.949 171.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 175' ' ' GLY . 9.5 p -167.87 -30.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.581 -177.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.557 ' N ' HG12 ' A' ' 174' ' ' VAL . . . 120.67 126.41 3.35 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.779 HG11 ' HB1' ' A' ' 170' ' ' ALA . 25.9 m -135.41 129.24 49.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.317 0.58 . . . . 0.0 111.157 -172.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -87.12 148.84 25.05 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.745 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.032 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.701 ' O ' ' HB ' ' A' ' 172' ' ' THR . 42.7 t80 -70.38 133.43 46.91 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.175 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -160.75 168.42 24.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.965 172.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.597 HG21 ' CD1' ' A' ' 165' ' ' PHE . 0.5 OUTLIER -88.19 130.17 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.482 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 44.5 m-20 -106.32 46.82 0.9 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.871 0.844 . . . . 0.0 110.814 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.986 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 20.4 p90 -70.56 145.4 50.82 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.261 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 9' ' ' SER . 32.7 t70 -63.82 104.84 0.73 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.347 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 p -25.15 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.726 1.61 . . . . 0.0 114.579 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ASP . 42.2 t -174.64 -32.07 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.26 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.596 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 74.7 m-85 -94.21 16.86 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.15 70.81 0.61 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.511 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.62 23.24 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.663 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 25.7 m-85 -107.77 141.36 39.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.522 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.55 129.59 38.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 161.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.713 HD11 HG22 ' A' ' 168' ' ' VAL . 5.0 mm -47.24 -43.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -170.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -63.2 -33.34 75.27 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.569 0.223 . . . . 0.0 111.316 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.28 -36.14 82.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 110.766 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.899 ' CE1' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -72.1 -48.12 46.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 175.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.862 HD22 ' CE2' ' A' ' 18' ' ' TYR . 15.9 mt -53.05 -46.54 68.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.774 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.2 -44.7 94.77 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.68 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -62.96 -43.46 98.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.652 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 55.6 t90 -58.69 -45.13 90.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.551 . . . . 0.0 109.916 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.4 -24.03 64.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.2 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -62.52 -53.2 58.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -34.35 78.04 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.488 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.2 t80 -56.8 -42.41 79.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.519 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.14 -21.41 79.21 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.239 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 7.3 t70 -75.96 104.03 6.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 111.0 -174.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.402 ' CG1' ' HB3' ' A' ' 60' ' ' ALA . 20.1 m -68.0 2.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -81.75 -11.04 59.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -168.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 85.9 t60 61.68 24.57 14.65 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.403 0.62 . . . . 0.0 111.551 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.7 p -90.38 130.86 36.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.512 0.672 . . . . 0.0 112.726 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -173.22 120.49 0.35 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.097 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.62 -6.77 63.42 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.996 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -118.37 3.88 11.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 117.628 0.714 . . . . 0.0 111.745 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.478 HG23 ' HA3' ' A' ' 96' ' ' GLY . 25.5 t -98.11 112.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.293 0.568 . . . . 0.0 112.378 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.78 -67.07 0.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.653 172.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -75.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.148 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.455 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 65.11 63.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.459 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.434 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 40.1 m-80 -86.23 147.99 25.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.365 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.495 ' HA ' ' CB ' ' A' ' 57' ' ' SER . 71.8 m -93.65 -39.11 10.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.997 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.72 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 114.3 -129.13 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.397 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.95 62.44 2.01 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 121.201 -0.524 . . . . 0.0 113.067 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 66.33 130.66 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.493 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 17.5 t80 -107.88 -24.65 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.269 172.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.48 19.8 8.28 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.132 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.76 -132.02 7.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.633 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -75.89 -52.18 10.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.543 0.211 . . . . 0.0 111.419 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.618 HD12 ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -164.44 21.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.1 p -161.62 156.65 23.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.82 -64.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.243 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.605 ' C ' ' HA2' ' A' ' 70' ' ' GLY . 23.1 t -148.77 -144.75 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 121.349 -0.14 . . . . 0.0 110.631 -170.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 12.3 mt-30 -43.93 141.75 1.56 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.806 0.842 . . . . 0.0 112.104 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' HB3' HD12 ' A' ' 72' ' ' LEU . 3.9 t80 -130.99 96.98 4.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.504 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.542 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -89.76 146.77 24.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.558 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 1.004 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.3 mm -145.12 121.1 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.564 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.719 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.1 t -104.73 165.97 10.7 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.436 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.691 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 33.4 t -61.13 152.78 27.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.09 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.9 p -101.53 -14.09 17.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.019 0.438 . . . . 0.0 110.115 168.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.402 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . . . -75.47 -54.5 6.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.293 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 31' ' ' HIS . 37.9 p30 -115.3 0.98 13.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.154 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.691 ' HA ' ' O ' ' A' ' 58' ' ' SER . 69.5 mt-30 30.0 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.455 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.8 p -128.64 -51.64 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.459 171.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 17.1 m -63.33 107.5 1.1 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.719 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -121.27 -178.22 3.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -170.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.725 ' HE1' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -156.37 131.78 9.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.869 -176.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 58.1 t -110.98 119.99 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.542 0.211 . . . . 0.0 110.694 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.78 14.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.949 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.619 ' O ' ' HG2' ' A' ' 53' ' ' GLN . . . -63.29 -99.3 0.01 OUTLIER Glycine 0 C--O 1.217 -0.921 0 N-CA-C 116.61 1.404 . . . . 0.0 116.61 -167.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.605 ' HA2' ' C ' ' A' ' 52' ' ' SER . . . -179.68 34.13 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 118.826 -1.654 . . . . 0.0 115.495 -170.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.652 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -146.39 27.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.756 1.278 . . . . 0.0 111.03 169.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.557 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 73.1 mt -79.05 144.6 34.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.973 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.9 m -144.38 124.33 13.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.383 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.618 ' HB3' HD12 ' A' ' 49' ' ' LEU . 58.3 t80 -82.07 123.09 28.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.846 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 80.7 p -61.4 -38.96 88.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.626 -171.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.409 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 11.5 tp 55.53 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 123.812 0.695 . . . . 0.0 111.337 -177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.409 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 18.9 m-85 -100.76 8.39 43.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.742 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.846 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 94.2 m-20 -76.44 179.03 6.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 111.536 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.757 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 6.0 mm-40 -51.4 -56.83 17.27 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.757 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -57.6 -37.3 97.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.754 1.636 . . . . 0.0 112.513 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.86 125.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.833 0.708 . . . . 0.0 112.372 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 47.53 58.82 4.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.11 169.05 20.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.333 -175.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.726 HD21 HG13 ' A' ' 135' ' ' VAL . 12.2 tp -108.81 138.8 44.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -157.01 139.01 14.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 166.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 72' ' ' LEU . . . -168.65 -131.2 1.27 Allowed Glycine 0 C--N 1.298 -1.542 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.187 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.675 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 1.8 tm0? -142.42 151.59 41.95 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 113.889 -1.155 . . . . 0.0 108.831 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.554 HD23 HD11 ' A' ' 91' ' ' LEU . 18.9 tp -138.99 116.25 11.11 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 16.6 t70 -110.89 -56.62 2.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.645 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.489 ' O ' HD12 ' A' ' 91' ' ' LEU . 4.9 p -107.74 155.07 20.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.323 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.725 HD13 ' HE1' ' A' ' 66' ' ' PHE . 3.0 mm? -141.15 160.52 39.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.638 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 58.0 m -149.76 111.33 4.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.675 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.689 ' HE2' HD23 ' A' ' 19' ' ' LEU . 3.9 m-30 -99.72 129.38 45.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.04 165.32 35.83 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.535 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -90.11 123.13 33.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.197 0.523 . . . . 0.0 111.618 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.478 ' HA3' HG23 ' A' ' 36' ' ' VAL . . . 82.76 110.04 0.47 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.469 171.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.542 HD11 ' HB1' ' A' ' 55' ' ' ALA . 77.0 mt -87.01 151.59 23.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.052 0.453 . . . . 0.0 109.979 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 p -131.19 154.04 48.81 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.998 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.29 23.91 53.04 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.673 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.29 52.05 4.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.641 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -94.22 -92.38 0.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.1 p -121.72 13.86 10.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.2 172.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 m -110.16 168.16 8.04 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.353 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.8 Cg_exo -72.8 142.65 35.8 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.222 2.615 . . . . 0.0 111.917 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.72 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 64.1 m-85 -67.74 150.7 48.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.322 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 97' ' ' LEU . 18.2 p -144.06 152.75 41.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.544 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.0 mp -85.98 119.08 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.643 0.259 . . . . 0.0 110.907 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.455 ' NE2' ' H ' ' A' ' 39' ' ' ALA . 41.7 mt-30 -65.04 -47.22 78.14 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.408 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 33.5 t -105.16 87.83 2.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 34.0 Cg_endo -63.25 100.7 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.372 2.715 . . . . 0.0 112.453 -176.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.475 ' OD2' HG23 ' A' ' 112' ' ' VAL . 10.1 t70 -106.1 -147.19 0.4 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.986 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 15.4 t -69.79 149.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.355 0.598 . . . . 0.0 111.892 -177.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.482 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 36.2 m -142.9 -177.49 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.123 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.706 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.0 m-85 -134.35 152.7 51.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.114 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.35 135.74 4.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.515 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.94 13.63 31.21 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.551 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 mt -55.41 -51.71 65.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.509 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 64.8 t30 53.4 43.26 31.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.208 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -106.29 128.8 54.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 171.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.675 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 51.2 p -131.17 139.04 49.68 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.983 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.5 p -98.55 151.44 20.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.864 0.364 . . . . 0.0 111.392 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.59 162.94 26.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -48.13 -55.56 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.7 11.35 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.433 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 15.0 mm100 -77.44 55.42 1.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 112.134 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 128' ' ' ASP . . . -64.24 104.33 0.88 Allowed Glycine 0 C--O 1.225 -0.422 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.526 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 74.95 -26.17 0.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.609 0.764 . . . . 0.0 111.35 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 126' ' ' GLY . 24.1 t70 -83.65 -23.21 31.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.091 0.472 . . . . 0.0 110.207 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -60.34 122.14 28.9 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.095 173.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.51 ' O ' HG21 ' A' ' 134' ' ' VAL . 22.9 m -51.52 -33.34 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 88' ' ' LEU . 12.5 m -64.83 -44.87 96.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.561 0.22 . . . . 0.0 110.958 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.536 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.5 t-160 -60.38 -40.42 90.79 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.423 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 32.6 mt-30 -59.09 -63.24 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.581 HG13 ' HA ' ' A' ' 146' ' ' LEU . 23.7 m -60.01 -40.49 83.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.022 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.726 HG13 HD21 ' A' ' 84' ' ' LEU . 10.7 p -68.99 -45.47 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.325 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.92 -22.44 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 0.0 110.601 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.9 -54.8 19.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.625 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -47.95 -52.17 20.71 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.344 0.658 . . . . 0.0 110.88 176.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 1.004 ' HG2' HG13 ' A' ' 56' ' ' ILE . 45.4 mtp -54.63 -33.64 60.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.392 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.5 t -89.67 -15.47 32.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.25 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.5 16.58 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.635 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.61 127.1 48.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.528 ' HB ' HD12 ' A' ' 19' ' ' LEU . 21.7 p -114.61 5.48 15.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.119 0.485 . . . . 0.0 110.979 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.48 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.99 -20.93 80.16 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.583 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.02 -35.45 21.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.581 ' HA ' HG13 ' A' ' 134' ' ' VAL . 36.1 tp -68.06 -40.93 82.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.492 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.642 ' HB2' HG13 ' A' ' 161' ' ' VAL . 11.8 pt-20 -56.67 -34.53 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.716 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -35.4 61.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.116 0.484 . . . . 0.0 110.053 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.21 -46.27 74.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.525 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 95.9 mt -55.26 -41.91 72.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.049 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -52.8 -14.32 0.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.331 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -72.87 -43.65 40.87 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.78 -175.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.411 HG21 ' HE2' ' A' ' 157' ' ' TYR . 3.8 mp -80.27 -43.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.285 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.488 ' HB3' ' C ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -59.18 -44.63 92.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.28 -25.73 67.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 111.389 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.09 -29.5 70.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.446 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 25.5 m-85 -100.47 -12.54 19.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.276 175.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 97.37 18.24 29.11 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.429 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.488 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -102.83 -163.07 0.96 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.421 0.611 . . . . 0.0 110.522 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.9 p -161.69 -176.66 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.974 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 147' ' ' GLU . 8.5 p -58.02 -23.16 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 111.034 174.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -88.77 18.39 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.295 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.706 ' HB3' HG21 ' A' ' 168' ' ' VAL . 16.6 t -83.76 143.42 30.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 168' ' ' VAL . 47.0 m -75.36 141.04 43.38 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.567 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.663 ' CE2' ' HB2' ' A' ' 13' ' ' TYR . 7.0 m-30 -39.82 -49.96 2.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.833 0.853 . . . . 0.0 113.187 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.19 -38.58 88.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.948 0.404 . . . . 0.0 110.742 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.478 HE21 ' HB ' ' A' ' 164' ' ' THR . 52.5 mt-30 -73.99 -38.95 63.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.289 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.713 HG22 HD11 ' A' ' 15' ' ' ILE . 17.9 t -62.07 -52.33 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 109.986 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.38 82.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.84 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.739 ' HB1' HG23 ' A' ' 176' ' ' VAL . . . -65.83 -35.35 80.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.74 -28.04 60.61 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.364 0.602 . . . . 0.0 110.638 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.701 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.8 p -89.96 -12.94 37.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.071 0.938 . . . . 0.0 109.594 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . -69.24 -36.81 77.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.512 173.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 175' ' ' GLY . 8.2 p -174.27 -30.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.302 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.562 ' N ' HG12 ' A' ' 174' ' ' VAL . . . 119.29 120.62 2.91 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.834 HG21 ' HG2' ' A' ' 177' ' ' GLN . 17.1 m -143.54 176.78 2.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.296 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.834 ' HG2' HG21 ' A' ' 176' ' ' VAL . 12.1 mm100 67.93 13.86 9.25 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.963 0.789 . . . . 0.0 112.445 174.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.081 179.113 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.025 0.44 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.818 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 17.0 t80 -113.81 160.66 18.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.177 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -173.7 160.53 3.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.221 0.534 . . . . 0.0 110.967 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.902 HG11 HD13 ' A' ' 15' ' ' ILE . 11.8 m -97.86 115.96 39.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.752 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.475 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 34.4 m-80 -96.45 59.32 1.82 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.623 -169.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.642 ' CE2' ' HA ' ' A' ' 8' ' ' SER . 38.9 p90 -74.23 149.7 40.69 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.049 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.5 t70 -62.73 94.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.642 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.5 p -24.99 72.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 114.92 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 20.7 t -173.79 -26.23 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.392 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.531 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 83.6 m-85 -90.04 10.24 24.94 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.931 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.2 69.23 1.09 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.974 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.61 21.83 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 164' ' ' THR . 21.8 m-85 -107.42 140.14 40.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.942 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m -68.89 133.24 47.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 162.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.902 HD13 HG11 ' A' ' 4' ' ' VAL . 6.3 mm -51.26 -47.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 118.134 0.424 . . . . 0.0 111.604 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -65.21 -25.22 67.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.947 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.43 -51.12 25.65 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.566 ' CE1' HG23 ' A' ' 112' ' ' VAL . 56.8 t80 -69.51 -49.2 56.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 16.3 mt -57.42 -38.99 75.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.029 0.442 . . . . 0.0 110.242 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.29 -41.01 94.76 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.86 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.84 -45.44 92.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.953 0.406 . . . . 0.0 110.988 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.734 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 9.3 t90 -52.69 -51.08 61.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.816 174.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.67 -28.92 68.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -57.79 -52.09 66.88 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -27.37 66.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.421 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.541 ' CE2' ' HE1' ' A' ' 66' ' ' PHE . 18.0 t80 -60.44 -49.9 75.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.54 0.209 . . . . 0.0 110.488 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.83 -28.26 73.7 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.254 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -73.25 103.9 4.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 110.962 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.477 HG12 ' HB3' ' A' ' 60' ' ' ALA . 27.9 m -63.04 -16.17 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.384 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -90.28 -13.59 34.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.935 0.398 . . . . 0.0 111.04 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -66.83 127.74 33.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.327 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.35 -176.08 4.34 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.364 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -158.44 125.14 4.79 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -10.32 62.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.065 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.77 -7.12 53.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.593 0.711 . . . . 0.0 109.293 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.526 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 23.4 t -94.91 120.42 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 m -92.7 -57.45 2.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.407 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.487 ' O ' ' HB1' ' A' ' 39' ' ' ALA . 4.5 t70 -98.44 -68.81 0.79 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.286 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 38' ' ' ASP . . . 79.92 81.25 0.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 124.972 1.42 . . . . 0.0 109.66 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.662 ' HB3' ' HE1' ' A' ' 105' ' ' TYR . 8.3 m-80 -78.51 135.74 37.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.256 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 60.2 p -76.56 -45.69 29.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.428 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.0 178.06 27.21 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 44' ' ' PHE . . . -167.56 -45.24 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 117.311 -2.376 . . . . 0.0 117.725 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.8 m-85 70.29 95.38 0.07 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.916 0.858 . . . . 0.0 109.543 -153.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -79.53 -17.42 54.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.55 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.36 17.58 37.82 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.939 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.08 -118.71 4.31 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.351 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.4 m -76.85 -54.35 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.769 0.318 . . . . 0.0 111.778 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -164.99 43.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.664 0.745 . . . . 0.0 110.781 -173.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 p -158.29 -178.32 7.2 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.356 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.86 -166.35 25.67 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.99 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -87.83 -39.1 15.13 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -117.77 155.24 30.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.48 0.657 . . . . 0.0 111.609 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -145.5 101.57 3.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.07 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.52 ' HB3' ' CD1' ' A' ' 97' ' ' LEU . . . -92.91 142.49 27.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.776 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.619 HG13 ' SD ' ' A' ' 139' ' ' MET . 31.7 mm -143.49 129.6 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 O-C-N 123.679 0.612 . . . . 0.0 109.945 177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 22.9 t -112.95 155.79 24.15 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.627 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 38.1 t -48.81 128.85 16.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.829 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 p -76.55 -14.88 59.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.171 0.51 . . . . 0.0 109.866 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.477 ' HB3' HG12 ' A' ' 29' ' ' VAL . . . -80.82 -60.06 2.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.891 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -116.33 1.52 13.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.053 0.454 . . . . 0.0 111.503 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.1 mm-40 39.0 36.24 0.15 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -175.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 64' ' ' THR . 13.9 p -124.08 -51.11 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.686 172.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.417 ' N ' HG11 ' A' ' 63' ' ' VAL . 38.1 m -64.54 102.98 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -120.62 175.51 5.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.299 0.571 . . . . 0.0 112.205 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.734 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -159.73 131.36 6.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.592 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.52 115.03 48.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.222 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.692 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -86.96 155.25 20.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.61 125.27 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.524 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -177.93 -104.19 0.18 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.628 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 2.4 t-20 -150.4 41.26 0.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.5 145.3 55.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.081 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.2 m -154.55 131.81 11.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.475 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.594 ' HB3' HD12 ' A' ' 49' ' ' LEU . 55.0 t80 -90.46 129.15 36.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.406 HG21 ' CD1' ' A' ' 85' ' ' TYR . 71.0 p -65.29 -35.81 82.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -172.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.509 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 8.8 tp 51.7 -96.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.689 0.796 . . . . 0.0 112.166 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.509 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 4.9 m-85 -101.58 7.78 42.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.103 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.75 178.44 6.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.938 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.75 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 41.0 mt-10 -48.35 -62.23 2.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -169.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.75 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 86.8 Cg_exo -50.73 -51.4 11.21 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.978 1.786 . . . . 0.0 112.992 175.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 71.68 130.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.882 0.739 . . . . 0.0 112.402 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 51.8 m80 54.49 49.91 17.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.268 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.624 HG21 ' HE1' ' A' ' 132' ' ' HIS . 0.6 OUTLIER -146.49 166.34 26.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 -175.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.658 ' CD2' HG13 ' A' ' 135' ' ' VAL . 13.9 tp -110.74 151.53 27.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.406 ' CD1' HG21 ' A' ' 75' ' ' THR . 18.6 p90 -153.49 -153.46 0.47 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 170.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.19 -144.46 17.35 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.199 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.696 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 24.7 tm0? -140.97 158.79 43.44 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.548 HD23 HD23 ' A' ' 91' ' ' LEU . 32.0 tp -144.22 135.15 25.21 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.525 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 19.0 t70 -133.02 -55.14 0.92 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.431 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.637 ' O ' HD22 ' A' ' 91' ' ' LEU . 5.7 p -108.31 158.33 17.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.515 -176.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 68' ' ' ALA . 2.4 mm? -140.23 156.89 46.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 172.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.556 ' HB3' HD13 ' A' ' 107' ' ' ILE . 3.7 m -147.09 106.02 3.85 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.285 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.607 ' HZ ' HD13 ' A' ' 146' ' ' LEU . 2.4 m-30 -91.97 147.64 22.81 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.623 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 173.36 163.56 27.2 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.781 173.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.0 117.98 29.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.336 0.589 . . . . 0.0 111.043 176.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 104.87 0.88 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.42 172.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.52 ' CD1' ' HB3' ' A' ' 55' ' ' ALA . 50.5 mt -88.93 161.12 16.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.263 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 t -146.96 168.47 21.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.42 32.55 84.58 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.699 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.636 ' HA3' ' CE1' ' A' ' 105' ' ' TYR . . . -87.41 19.58 31.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.829 -0.7 . . . . 0.0 114.33 -175.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.16 -79.93 0.37 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.353 0.577 . . . . 0.0 110.983 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 p -113.01 9.68 18.72 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.339 0.59 . . . . 0.0 110.819 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.53 168.27 13.57 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.944 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -77.55 151.14 28.67 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.286 2.657 . . . . 0.0 110.762 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.662 ' HE1' ' HB3' ' A' ' 40' ' ' ASN . 38.4 m-85 -65.38 144.25 57.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.584 0.707 . . . . 0.0 111.614 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 p -143.21 138.11 29.45 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.388 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.623 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.0 mp -79.62 123.83 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 78.2 mt-30 -64.58 -48.43 75.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.308 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.77 90.23 12.57 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.79 102.09 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.816 3.011 . . . . 0.0 113.919 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.6 m-20 -84.7 -164.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.716 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 84.5 t -63.28 138.02 23.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.824 0.821 . . . . 0.0 112.393 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.475 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 58.4 m -116.77 179.7 3.94 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.635 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.638 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 91.7 m-85 -143.56 153.16 42.28 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.26 134.09 3.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.636 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.818 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 103.89 15.67 21.54 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.308 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.415 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 22.6 mt -58.52 -45.74 88.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.644 0.722 . . . . 0.0 109.632 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.525 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 14.9 t30 59.98 19.0 8.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.436 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -92.36 132.08 37.03 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.559 0.695 . . . . 0.0 110.236 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.696 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 59.9 p -133.21 165.15 25.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.657 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.444 ' OG ' HG23 ' A' ' 131' ' ' VAL . 78.2 p -144.48 150.86 38.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.027 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.43 165.84 15.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.6 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -51.06 -56.3 13.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.995 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.548 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -81.77 15.79 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.95 -15.86 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.321 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 44.47 -123.83 5.35 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.705 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.415 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 1.4 t-80 -78.52 -20.14 51.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.441 ' HA ' HE21 ' A' ' 133' ' ' GLN . 17.0 t70 -85.17 -17.26 37.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -173.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.01 122.98 31.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.18 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.592 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.2 m -50.2 -33.62 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.444 HG23 ' OG ' ' A' ' 121' ' ' SER . 27.2 m -64.74 -41.25 91.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.624 ' HE1' HG21 ' A' ' 83' ' ' THR . 3.9 t-160 -64.0 -38.28 90.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.592 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 4.2 mm-40 -63.4 -62.77 1.46 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.59 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 130' ' ' VAL . 15.9 m -58.75 -37.1 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.264 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.658 HG13 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -66.35 -43.97 91.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.379 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.574 ' HD1' HG11 ' A' ' 135' ' ' VAL . 22.2 m-85 -71.94 -27.47 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.308 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -54.29 38.07 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 170.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.549 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.25 -60.62 2.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.544 0.688 . . . . 0.0 110.085 176.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.698 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 71.2 mtm -55.59 -25.97 41.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.463 -1.244 . . . . 0.0 114.071 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 m -94.09 -3.2 51.57 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.563 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.42 48.67 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.16 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -106.95 135.18 48.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.161 0.505 . . . . 0.0 110.616 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.7 p -111.75 8.5 20.66 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.52 ' O ' ' HG2' ' A' ' 147' ' ' GLU . . . -74.71 -42.94 30.43 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.553 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.62 -27.02 60.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.219 0.533 . . . . 0.0 109.688 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.607 HD13 ' HZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -73.74 -48.05 34.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.271 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.588 ' HB2' HG13 ' A' ' 161' ' ' VAL . 10.3 pt-20 -56.69 -36.16 69.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -38.28 69.09 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.187 0.518 . . . . 0.0 109.767 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.72 -47.35 75.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.1 mt -55.74 -46.47 77.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.517 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.93 -15.86 3.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.753 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.86 -39.94 58.59 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.623 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.0 mp -81.43 -51.12 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.281 175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.742 HD13 HG12 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -54.77 -41.93 71.09 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.77 -23.15 67.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.26 -24.11 63.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 110.106 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 9.2 m-85 -112.29 0.82 15.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.188 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 90.49 16.96 54.26 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.78 -0.646 . . . . 0.0 113.847 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 2.2 mm? -98.7 -170.88 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.627 0.713 . . . . 0.0 109.536 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 78.6 p -164.21 176.92 8.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.22 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.588 HG13 ' HB2' ' A' ' 147' ' ' GLU . 4.9 p -57.55 -26.45 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.083 0.468 . . . . 0.0 110.632 174.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -90.26 28.91 1.33 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.824 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 14' ' ' SER . 25.3 t -84.55 -134.62 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.661 ' HB ' HE21 ' A' ' 167' ' ' GLN . 98.6 m -158.25 142.39 15.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.645 ' CE1' HD12 ' A' ' 15' ' ' ILE . 10.9 m-30 -44.12 -49.76 8.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -173.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.69 -23.23 62.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.234 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.661 HE21 ' HB ' ' A' ' 164' ' ' THR . 49.8 mt-30 -84.26 -51.52 6.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.742 HG12 HD13 ' A' ' 154' ' ' LEU . 61.5 t -56.34 -57.03 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.255 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.17 69.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.72 84.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.782 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -73.28 -29.29 62.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.194 0.521 . . . . 0.0 110.81 -174.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.715 HG23 ' CD2' ' A' ' 2' ' ' PHE . 40.5 p -88.98 -21.1 23.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.851 0.834 . . . . 0.0 109.645 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.84 -46.28 45.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.973 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.442 ' C ' HG22 ' A' ' 176' ' ' VAL . 3.6 p -157.23 -10.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.538 -170.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.782 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -65.12 -20.85 67.48 Favored Glycine 0 CA--C 1.502 -0.723 0 CA-C-O 122.029 0.794 . . . . 0.0 112.015 176.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.461 HG13 ' CZ ' ' A' ' 157' ' ' TYR . 16.1 m -40.55 113.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 112.789 -1.706 . . . . 0.0 112.707 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 64.66 104.8 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.989 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.9 m80 . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.818 179.686 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.874 0.369 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.812 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 47.0 t80 -82.91 145.75 29.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.674 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -163.42 168.75 19.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.845 0.715 . . . . 0.0 109.094 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.51 HG13 ' HB2' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -88.26 122.59 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.472 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 63.9 m-20 -97.94 45.65 1.02 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.186 0.994 . . . . 0.0 110.366 -174.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.919 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -72.26 150.47 43.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.627 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 9' ' ' SER . 27.6 t70 -64.58 110.28 2.28 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.172 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.433 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.3 p -39.4 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.241 1.416 . . . . 0.0 113.338 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.7 t -170.84 -32.85 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.131 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.431 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 45.8 m-85 -89.44 18.39 5.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.587 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.39 76.82 0.92 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.619 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.27 -8.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.488 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 36.3 m-85 -73.5 133.58 43.66 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 122.825 -0.22 . . . . 0.0 110.478 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 17' ' ' ASP . 15.5 m -66.37 132.95 49.47 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 163.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.685 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 4.8 mm -46.78 -49.53 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 118.062 0.392 . . . . 0.0 111.697 -172.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.483 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 2.4 t-80 -58.48 -29.88 66.55 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.298 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' SER . 4.0 m-20 -68.2 -58.96 3.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.452 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -63.94 -45.56 88.67 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.661 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.804 ' HB3' HG23 ' A' ' 143' ' ' THR . 13.1 mt -57.13 -42.04 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.151 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.64 -40.4 97.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.08 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.08 -42.04 99.55 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 122.631 0.373 . . . . 0.0 111.354 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.4 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 39.9 t90 -60.35 -42.7 96.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.408 0.623 . . . . 0.0 109.724 176.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 141' ' ' GLY . . . -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.091 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.0 t -63.58 -54.38 36.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 p -64.34 -35.18 80.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.808 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 19.7 t80 -55.65 -42.93 75.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.213 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.98 -21.21 79.15 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.919 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 29.9 t70 -73.81 104.6 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.201 0.5 . . . . 0.0 111.374 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.435 HG12 ' HB3' ' A' ' 60' ' ' ALA . 24.9 m -67.27 -0.95 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.488 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 50.0 m-80 -81.42 -13.89 57.74 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.084 -0.385 . . . . 0.0 111.875 -171.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.565 ' CG ' ' H ' ' A' ' 32' ' ' THR . 8.9 t-160 55.68 -146.67 0.56 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.441 0.463 . . . . 0.0 110.26 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.565 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 27.0 p 57.5 138.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.225 1.41 . . . . 0.0 113.938 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.47 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t-20 -163.43 125.35 2.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.882 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.72 -13.56 63.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.001 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -111.13 15.68 21.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.706 HG22 ' NE2' ' A' ' 108' ' ' GLN . 0.5 OUTLIER -134.82 134.32 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -112.56 -74.69 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.043 0.449 . . . . 0.0 111.745 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.16 -67.0 0.5 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.513 -173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.38 80.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.754 0.659 . . . . 0.0 111.592 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 98' ' ' SER . 33.2 m-80 -79.79 157.76 26.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.449 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 58.0 m -93.26 -24.43 18.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -168.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.17 135.93 3.09 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.005 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.36 59.63 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.245 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.589 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 39.2 m-85 62.93 159.17 0.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.996 0.903 . . . . 0.0 112.553 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.856 ' HE1' ' HD3' ' A' ' 104' ' ' PRO . 5.3 t80 -126.72 -36.2 2.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.072 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.85 -21.83 58.84 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.21 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -138.87 4.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.467 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -77.08 -30.17 55.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.725 0.298 . . . . 0.0 110.912 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.589 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -164.25 27.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.604 -175.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -149.25 176.3 10.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.56 173.45 15.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.175 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 t -85.97 -3.17 58.87 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 28.6 tt0 -147.23 150.97 35.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.278 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -154.33 97.17 2.0 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 105' ' ' TYR . . . -91.72 155.69 18.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.702 HG21 ' HG2' ' A' ' 139' ' ' MET . 9.4 mm -150.76 146.81 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.551 0.741 . . . . 0.0 109.254 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 t -122.36 170.95 9.42 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 30.0 t -55.54 141.51 36.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.384 0.611 . . . . 0.0 111.403 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -85.92 -20.36 29.12 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.113 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.435 ' HB3' HG12 ' A' ' 29' ' ' VAL . . . -81.11 -54.08 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.6 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 34.4 p30 -119.64 -1.15 10.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 111.909 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.9 mm-40 42.11 38.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.506 HG11 ' N ' ' A' ' 64' ' ' THR . 11.7 p -122.78 -57.15 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 122.306 -0.247 . . . . 0.0 110.783 169.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.559 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 19.8 m -58.87 106.84 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 110.495 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -116.74 179.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.573 ' HZ ' HG21 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -157.42 133.43 9.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.753 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 22.4 t -115.05 114.18 45.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.264 -0.272 . . . . 0.0 110.684 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.559 ' O ' ' HG3' ' A' ' 53' ' ' GLN . . . -89.34 149.55 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.708 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.69 124.95 1.88 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.139 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.91 -115.5 0.46 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.438 ' HB3' ' CB ' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -148.38 48.62 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.2 mt -62.86 144.87 56.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.909 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -149.92 138.62 20.83 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.795 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.588 ' HB3' HD12 ' A' ' 49' ' ' LEU . 58.1 t80 -93.61 133.8 36.56 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.594 HG23 ' HB ' ' A' ' 83' ' ' THR . 31.9 p -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.525 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 8.2 tp 56.4 -94.45 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.079 0.552 . . . . 0.0 111.143 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.525 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 3.5 m-85 -98.57 -1.75 40.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.137 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -75.45 167.05 22.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.612 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 23.8 mm-40 -46.99 -60.08 4.4 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -165.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 99.7 Cg_exo -49.75 -38.27 46.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.769 1.646 . . . . 0.0 113.17 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 65.07 117.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.427 0.632 . . . . 0.0 112.617 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 56.7 60.16 3.2 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.512 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.805 HG22 ' HA2' ' A' ' 126' ' ' GLY . 26.5 m -149.3 153.36 37.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.147 -172.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.715 HD21 HG13 ' A' ' 135' ' ' VAL . 14.8 tp -101.12 148.05 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.424 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -156.05 -153.55 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.33 -167.31 24.81 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.258 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 12.5 tm0? -95.96 165.57 12.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.395 0.617 . . . . 0.0 111.594 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 88' ' ' LEU . 33.5 tp -152.85 136.71 16.22 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.007 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.03 -54.48 0.71 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.112 0.482 . . . . 0.0 110.716 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.452 ' C ' HD21 ' A' ' 91' ' ' LEU . 4.5 p -112.56 155.37 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -175.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 3.0 mm? -138.59 161.52 36.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 172.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.625 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 55.5 m -151.6 112.53 4.26 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 122.187 -0.321 . . . . 0.0 110.783 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.637 ' CE2' HD23 ' A' ' 19' ' ' LEU . 4.6 m-30 -99.77 139.13 35.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.58 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -179.79 163.86 31.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.522 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.43 132.79 34.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.129 0.464 . . . . 0.0 110.705 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.544 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . 68.23 112.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 174.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 40' ' ' ASN . 54.8 mt -87.04 156.36 19.78 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.199 -0.589 . . . . 0.0 109.953 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.417 ' HA ' HD21 ' A' ' 40' ' ' ASN . 10.1 t -150.8 -177.55 6.06 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.789 174.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.56 -109.76 3.69 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.914 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.55 55.29 26.18 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -80.94 -71.88 0.45 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.255 -0.473 . . . . 0.0 110.092 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.1 p -97.26 -27.57 14.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 169.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.641 ' N ' ' HD2' ' A' ' 104' ' ' PRO . 3.0 m 178.45 -55.39 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.216 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.856 ' HD3' ' HE1' ' A' ' 45' ' ' TYR . 7.2 Cg_endo -49.56 131.81 28.98 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.139 3.226 . . . . 0.0 114.522 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.523 ' CD2' ' HB1' ' A' ' 55' ' ' ALA . 50.4 m-85 -76.45 169.42 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.91 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 p -151.49 142.64 23.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.58 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.1 mp -84.31 120.46 35.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.706 ' NE2' HG22 ' A' ' 36' ' ' VAL . 20.0 mt-30 -65.45 -41.44 93.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.138 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.48 89.9 6.56 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.51 92.37 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.3 2.667 . . . . 0.0 112.49 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -99.32 -153.61 0.44 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.331 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.919 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -62.83 144.66 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.521 0.676 . . . . 0.0 111.549 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.472 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -136.6 179.31 6.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.589 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 95.6 m-85 -138.79 148.71 44.14 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.7 145.22 10.22 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.693 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.812 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.57 8.23 46.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.628 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.487 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 19.4 mt -56.73 -51.68 67.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.073 0.436 . . . . 0.0 109.947 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.403 ' HA ' ' NE2' ' A' ' 87' ' ' GLN . 63.0 t30 49.28 50.98 17.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.693 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 21.5 mt -106.8 107.62 18.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.704 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 17.9 p -105.82 131.07 53.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.4 t -103.73 141.96 35.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -74.22 169.45 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.582 HE22 HG22 ' A' ' 75' ' ' THR . 21.8 tp60 -58.96 -56.73 18.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.136 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.02 8.33 3.29 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.51 ' NE2' ' HA2' ' A' ' 129' ' ' GLY . 4.9 mm100 -77.04 52.86 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.892 175.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.805 ' HA2' HG22 ' A' ' 83' ' ' THR . . . -62.95 109.22 2.55 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.066 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.408 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 1.9 t-80 73.4 -40.16 0.46 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.137 0.975 . . . . 0.0 111.926 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.421 ' HA ' HE21 ' A' ' 133' ' ' GLN . 27.2 t70 -81.86 -11.03 59.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -176.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.51 ' HA2' ' NE2' ' A' ' 125' ' ' GLN . . . -64.37 125.73 32.03 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 170.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 134' ' ' VAL . 4.8 p -55.31 -29.4 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.9 -44.69 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.551 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.4 t-160 -62.49 -36.38 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.471 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.488 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 26.3 mt-30 -63.38 -63.73 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.885 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 146' ' ' LEU . 20.6 m -58.58 -39.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.807 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.715 HG13 HD21 ' A' ' 84' ' ' LEU . 10.1 p -68.03 -44.39 84.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.593 0.235 . . . . 0.0 110.784 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.451 ' HD1' HG11 ' A' ' 135' ' ' VAL . 9.7 m-85 -73.03 -31.37 64.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.577 0.227 . . . . 0.0 110.453 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.54 -53.22 45.63 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.635 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -50.47 -50.91 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.07 0.462 . . . . 0.0 110.568 175.265 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.702 ' HG2' HG21 ' A' ' 56' ' ' ILE . 55.7 mtp -57.72 -27.55 63.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.486 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m -95.45 -12.27 26.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.6 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . 88.75 29.01 19.84 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.868 -175.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -116.14 126.11 53.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.012 0.434 . . . . 0.0 110.725 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.804 HG23 ' HB3' ' A' ' 19' ' ' LEU . 20.1 p -111.4 15.22 21.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.794 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.12 -15.8 81.26 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.558 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.31 -32.2 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.095 0.474 . . . . 0.0 110.22 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.524 ' HA ' HG13 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -66.01 -37.6 86.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.669 ' HA ' ' CG1' ' A' ' 161' ' ' VAL . 11.8 pt-20 -54.45 -38.78 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.529 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -38.83 69.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.072 0.463 . . . . 0.0 110.251 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.48 72.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 90.8 mt -56.48 -42.67 78.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.156 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.8 -7.49 0.46 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.673 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.65 -38.64 61.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.526 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.78 -48.35 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.061 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.627 ' HB3' ' HB2' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -53.85 -37.4 63.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.62 -27.93 66.76 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.92 -29.5 69.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.472 0.653 . . . . 0.0 110.07 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.489 ' OH ' HG13 ' A' ' 176' ' ' VAL . 20.1 m-85 -106.55 -3.05 21.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.29 18.36 64.74 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.78 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.627 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 19.3 mt -95.2 -172.5 2.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.851 0.326 . . . . 0.0 111.0 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.5 p -166.69 -172.18 2.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.892 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.669 ' CG1' ' HA ' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -58.5 -25.53 28.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 176.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.416 ' HA ' ' HB3' ' A' ' 14' ' ' SER . 8.2 p30 -86.3 14.25 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.334 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.3 m -89.88 148.15 23.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 16.1 p -69.76 158.42 35.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.682 ' CE1' HD12 ' A' ' 15' ' ' ILE . 15.7 m-30 -54.47 -31.78 56.43 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.37 -62.17 1.86 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.938 174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.2 -48.39 80.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 154' ' ' LEU . 93.9 t -59.33 -55.54 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.58 0.229 . . . . 0.0 111.324 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.51 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -57.22 -48.02 79.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.21 81.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.735 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -76.5 -27.29 55.99 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.065 0.46 . . . . 0.0 111.144 -176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.783 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.5 p -91.95 -19.9 21.94 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.999 0.904 . . . . 0.0 109.981 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.83 -49.04 16.72 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.047 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.08 -10.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.451 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.735 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -67.21 -19.67 70.5 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-O 121.984 0.769 . . . . 0.0 111.241 175.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.489 HG13 ' OH ' ' A' ' 157' ' ' TYR . 16.1 m -50.94 78.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 112.665 -1.768 . . . . 0.0 112.845 171.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 175' ' ' GLY . 27.9 mt-30 -87.92 5.74 39.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.939 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 45.2 t60 . . . . . 0 C--O 1.249 1.05 0 O-C-N 123.856 0.723 . . . . 0.0 110.133 -178.735 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 121.016 0.436 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.781 ' O ' ' HB ' ' A' ' 172' ' ' THR . 28.5 t80 -68.22 153.99 42.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.124 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 p -169.37 159.29 8.59 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.93 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.538 HG12 HG13 ' A' ' 168' ' ' VAL . 25.6 m -93.43 114.36 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.257 174.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.0 m-80 -94.55 52.42 1.54 Allowed 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.934 0.873 . . . . 0.0 110.648 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.857 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -76.95 151.18 35.81 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.234 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 9' ' ' SER . 18.5 t70 -62.74 103.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.409 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.2 p -37.01 78.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 124.74 1.275 . . . . 0.0 113.464 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ASP . 22.9 t -174.63 -29.08 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.684 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.512 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 68.2 m-85 -93.67 15.15 16.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.286 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.516 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -69.22 70.55 0.47 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.57 -173.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -169.78 0.02 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.513 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 28.5 m-85 -86.25 136.02 33.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.73 -0.235 . . . . 0.0 110.411 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 163' ' ' SER . 19.7 m -68.99 134.5 49.56 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 160.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.617 HD12 ' CE1' ' A' ' 165' ' ' PHE . 5.1 mm -48.31 -48.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 118.389 0.54 . . . . 0.0 111.705 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.507 ' HD1' ' CD ' ' A' ' 147' ' ' GLU . 36.1 t60 -57.65 -30.86 65.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.628 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.0 -46.87 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.795 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.461 ' CE2' HG23 ' A' ' 112' ' ' VAL . 68.7 t80 -72.64 -46.13 55.53 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.906 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 14.6 mt -56.59 -34.2 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.288 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.69 -45.06 93.77 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.137 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -61.65 -41.37 97.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.858 0.361 . . . . 0.0 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.676 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 22.3 t90 -54.71 -51.72 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.638 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.41 63.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.052 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 t -61.5 -51.14 69.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.727 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -65.45 -32.12 73.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.759 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.48 ' HB2' HG22 ' A' ' 64' ' ' THR . 19.8 t80 -59.4 -37.2 77.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.848 0.356 . . . . 0.0 110.264 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.99 -18.41 77.71 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.292 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 25.1 t70 -75.57 93.29 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.185 0.517 . . . . 0.0 111.835 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.758 HG13 ' HB2' ' A' ' 60' ' ' ALA . 22.8 m -63.24 -3.14 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.768 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -88.0 -20.42 25.85 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -170.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.566 ' CG ' ' H ' ' A' ' 32' ' ' THR . 0.8 OUTLIER 57.91 -137.68 0.91 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.608 0.363 . . . . 0.0 111.209 172.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.566 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 56.2 p 63.52 128.64 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.764 1.625 . . . . 0.0 113.912 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -170.93 131.58 0.83 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.006 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.42 -9.28 61.0 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.454 ' OD1' HG22 ' A' ' 36' ' ' VAL . 9.8 p30 -104.83 -18.73 14.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.807 0.813 . . . . 0.0 110.718 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.463 HG21 HG21 ' A' ' 63' ' ' VAL . 49.3 t -87.72 114.04 25.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.376 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -101.24 -70.3 0.75 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.773 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.43 -73.19 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.848 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 69.18 86.5 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.784 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -80.89 141.58 34.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 51.5 m -71.81 -36.35 70.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.78 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 108.13 -123.09 6.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.584 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 64.18 2.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.898 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 60.56 -176.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.43 0.634 . . . . 0.0 112.708 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -144.61 -56.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.826 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.31 22.18 21.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.076 -173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.25 -179.47 40.84 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.453 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -81.48 -68.3 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 14.0 mt -76.56 -31.03 57.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.578 -176.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 11.0 p -147.9 163.74 35.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.558 -175.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.3 39.59 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.65 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.6 m 65.87 -60.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.517 0.727 . . . . 0.0 112.709 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -95.66 159.53 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.881 0.372 . . . . 0.0 111.072 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' HD2' HG23 ' A' ' 135' ' ' VAL . 1.5 t80 -153.32 99.22 2.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.858 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -93.12 144.96 24.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.433 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.664 HG13 ' HG2' ' A' ' 139' ' ' MET . 27.8 mm -146.25 127.65 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.036 0.446 . . . . 0.0 110.85 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 41' ' ' SER . 18.9 t -112.69 151.87 29.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.523 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 61' ' ' ASN . 47.0 t -49.99 136.05 19.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 112.079 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.74 27.57 3.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.296 0.569 . . . . 0.0 111.321 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.758 ' HB2' HG13 ' A' ' 29' ' ' VAL . . . -157.65 -33.39 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.991 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -103.33 -14.61 16.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.672 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.8 mm-40 31.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.748 -1.569 . . . . 0.0 115.213 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.518 ' HB ' ' CE1' ' A' ' 31' ' ' HIS . 10.4 p -138.21 -44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.269 169.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 26' ' ' PHE . 38.6 m -63.03 97.54 0.11 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -117.1 171.12 8.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.293 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.676 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -158.0 123.89 4.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.009 -178.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.2 t -105.56 102.57 14.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.886 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -85.43 154.58 21.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.033 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.96 127.99 2.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.777 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.11 -108.52 0.22 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -146.75 45.34 1.19 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.485 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 41.6 mt -64.26 124.75 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.279 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 31.6 m -137.35 119.13 15.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 47.1 t80 -68.36 122.94 19.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 82.7 p -63.7 -33.48 75.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.456 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 11.7 tp 52.3 -92.27 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.456 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 20.2 m-85 -98.91 0.1 43.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.738 -174.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.521 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 93.1 m-20 -73.18 170.34 15.17 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.954 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.595 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 10.9 mm-40 -48.94 -53.51 37.08 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 53.0 Cg_exo -56.83 -41.95 69.91 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.513 1.475 . . . . 0.0 112.221 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.95 130.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.77 0.795 . . . . 0.0 112.837 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 54.59 47.56 22.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.605 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.502 HG23 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -142.79 178.25 7.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.65 -174.123 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.881 HD21 HG13 ' A' ' 135' ' ' VAL . 18.1 tp -126.38 82.51 2.08 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -89.23 146.56 24.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 171.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 72' ' ' LEU . . . -168.09 178.31 41.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.401 -1.38 . . . . 0.0 114.006 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -97.65 167.7 10.8 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.595 ' HG ' HD12 ' A' ' 117' ' ' LEU . 27.9 tp -148.72 126.35 11.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.584 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.492 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 12.6 t70 -126.7 -48.9 1.51 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.172 0.51 . . . . 0.0 110.485 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.425 ' O ' HD22 ' A' ' 91' ' ' LEU . 19.4 p -132.81 158.92 41.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 122.005 0.907 . . . . 0.0 113.034 -173.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.1 mm? -134.9 169.11 17.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.772 -1.558 . . . . 0.0 106.878 174.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 19.8 t -163.06 99.38 0.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.819 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.632 ' CE1' HD11 ' A' ' 138' ' ' LEU . 1.2 m-30 -93.39 134.74 35.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.451 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -169.82 163.42 36.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 118.151 -1.976 . . . . 0.0 115.18 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.58 104.83 15.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.466 -0.867 . . . . 0.0 111.448 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 112.37 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.649 -1.159 . . . . 0.0 113.808 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 105' ' ' TYR . 46.7 mt -85.9 160.59 19.37 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.101 -0.646 . . . . 0.0 110.041 171.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 t -143.4 172.9 12.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.252 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.42 -123.55 6.29 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.2 21.61 75.77 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.571 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -87.4 -85.6 0.17 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -126.9 29.06 5.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.008 0.908 . . . . 0.0 108.883 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.5 p -141.46 161.0 54.84 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.65 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -65.19 156.42 63.06 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.534 2.822 . . . . 0.0 111.659 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.587 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 62.9 m-85 -73.63 149.08 42.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.366 -174.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 p -146.38 140.65 26.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.954 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.612 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.3 mp -78.63 133.26 30.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.92 -44.22 90.22 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.421 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.446 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 16.9 t -118.17 91.64 40.79 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 13.3 Cg_endo -56.66 101.91 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.234 2.622 . . . . 0.0 112.969 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -93.02 -162.39 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.924 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.857 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 41.3 t -60.11 128.69 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.333 1.063 . . . . 0.0 112.453 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.545 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 61.2 m -119.37 178.94 4.35 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.306 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 94.0 m-85 -140.42 146.35 38.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.29 140.44 6.64 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.704 -1.236 . . . . 0.0 112.402 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.51 12.84 37.06 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.996 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.595 HD12 ' HG ' ' A' ' 88' ' ' LEU . 48.5 mt -56.41 -53.92 51.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.492 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 52.7 t30 51.39 50.87 18.0 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.158 0.98 . . . . 0.0 110.257 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 19.4 mt -104.79 105.99 16.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.087 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.8 p -105.3 129.97 53.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.161 0.505 . . . . 0.0 110.617 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.81 ' HB3' HE22 ' A' ' 125' ' ' GLN . 74.7 m -103.73 165.91 10.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.418 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.525 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 44.4 mt -87.15 154.22 20.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.355 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -57.88 -60.0 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.828 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.559 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -77.0 17.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 1.099 ' HB3' ' HA ' ' A' ' 128' ' ' ASP . 26.9 mt-30 -74.67 -40.31 61.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 80' ' ' PRO . . . 83.47 -106.89 2.86 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.872 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.627 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 5.6 t-80 -68.01 -12.68 61.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 1.099 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 0.0 OUTLIER 78.49 172.5 0.18 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 156.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.417 ' N ' ' CG ' ' A' ' 128' ' ' ASP . . . -85.31 -35.69 11.85 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.314 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 134' ' ' VAL . 9.8 p -154.08 -40.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.547 HG23 ' OD2' ' A' ' 128' ' ' ASP . 13.6 m -67.17 -54.62 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.963 1.256 . . . . 0.0 112.697 -174.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.627 ' ND1' ' HA ' ' A' ' 127' ' ' HIS . 4.5 t-160 -58.67 -37.13 75.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -61.56 -65.91 0.62 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.502 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 130' ' ' VAL . 31.5 m -56.62 -39.29 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.035 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.881 HG13 HD21 ' A' ' 84' ' ' LEU . 10.0 p -67.96 -40.57 83.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -74.34 -30.68 62.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.32 79.97 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 173.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.632 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -49.42 -59.53 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.576 0.703 . . . . 0.0 109.566 174.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.664 ' HG2' HG13 ' A' ' 56' ' ' ILE . 71.8 mtm -55.97 -25.27 43.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.183 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -91.66 0.04 57.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.665 0.269 . . . . 0.0 111.502 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.08 29.49 64.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.232 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.76 121.93 43.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.467 . . . . 0.0 110.315 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.643 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 49.8 p -91.23 -16.96 26.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.022 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.38 -42.69 50.77 Favored Glycine 0 C--N 1.334 0.444 0 O-C-N 123.836 0.71 . . . . 0.0 113.477 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.75 -42.19 82.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.492 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -66.73 -39.76 88.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.96 ' HG2' HG21 ' A' ' 161' ' ' VAL . 52.5 mt-10 -54.13 -43.2 70.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.266 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -34.59 75.13 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.902 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.2 71.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.171 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 90.6 mt -54.2 -44.2 71.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.904 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -55.52 -8.87 0.41 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.359 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.75 -45.16 45.51 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.235 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.0 -45.92 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 120.645 0.259 . . . . 0.0 110.924 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.728 HD13 HG11 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -57.89 -42.95 85.73 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.0 -20.71 66.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.441 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.67 -33.14 75.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.363 0.601 . . . . 0.0 109.852 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.31 -5.65 29.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.018 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 88.42 17.36 57.27 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.991 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 17.3 mt -97.24 -174.28 2.9 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.938 0.369 . . . . 0.0 110.158 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -156.57 -176.77 6.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.96 HG21 ' HG2' ' A' ' 147' ' ' GLU . 11.9 p -56.99 -26.71 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.903 0.382 . . . . 0.0 111.707 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.53 30.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.06 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 14' ' ' SER . 13.7 t -98.62 147.76 24.49 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 168' ' ' VAL . 3.5 m -70.74 145.22 50.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.442 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.617 ' CE1' HD12 ' A' ' 15' ' ' ILE . 12.9 m-30 -47.98 -38.63 17.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 0.0 110.385 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.86 -54.02 47.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.18 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -63.57 -51.05 67.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.222 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.728 HG11 HD13 ' A' ' 154' ' ' LEU . 17.4 t -58.24 -55.91 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 O-C-N 123.019 0.2 . . . . 0.0 110.984 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.405 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . . . -53.54 -45.51 69.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.307 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.618 ' HB1' HG23 ' A' ' 176' ' ' VAL . . . -64.9 -36.51 84.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.205 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.09 -25.81 58.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.31 0.576 . . . . 0.0 110.496 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.781 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.1 p -88.97 -13.05 39.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.081 0.943 . . . . 0.0 109.556 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . -69.89 -33.34 72.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.944 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 175' ' ' GLY . 8.8 p -175.71 -29.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.317 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.589 ' N ' HG12 ' A' ' 174' ' ' VAL . . . 115.65 112.11 2.81 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.618 HG23 ' HB1' ' A' ' 170' ' ' ALA . 14.6 m -139.95 166.49 20.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.83 0.348 . . . . 0.0 111.391 -170.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -152.56 121.35 6.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.589 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.315 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.03 0.443 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.841 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 36.1 t80 -91.58 147.28 23.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.424 -176.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -166.0 166.87 17.02 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.879 0.737 . . . . 0.0 109.146 171.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.804 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -91.28 126.96 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.579 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 31.5 m-80 -104.25 56.2 0.72 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.834 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 53.8 p90 -69.14 152.25 45.36 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.62 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.0 67.67 0.15 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t 17.66 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 113.811 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -168.99 -28.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.489 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.566 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 82.9 m-85 -87.73 12.71 12.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.702 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA2' ' CB ' ' A' ' 165' ' ' PHE . . . -70.4 68.89 0.7 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.44 -172.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.66 19.74 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.488 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 27.6 m-85 -106.17 135.26 47.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.316 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' HIS . 1.8 m -74.74 67.93 1.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.675 HD12 ' CD1' ' A' ' 165' ' ' PHE . 3.4 mm 28.28 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 114.141 -172.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 14' ' ' SER . 11.5 t-160 -50.74 -29.16 10.72 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.673 0.389 . . . . 0.0 111.186 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -53.35 -62.73 1.46 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.881 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.414 ' HH ' ' CG ' ' A' ' 111' ' ' ASP . 84.5 t80 -66.95 -38.78 86.75 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.341 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.743 HD23 ' HE2' ' A' ' 93' ' ' PHE . 14.3 mt -54.31 -40.42 67.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.07 93.24 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.138 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -61.15 -38.49 86.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.989 0.516 . . . . 0.0 111.52 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.534 ' O ' HG22 ' A' ' 64' ' ' THR . 40.7 t90 -55.63 -45.06 77.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.957 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 26' ' ' PHE . . . -72.8 -13.69 61.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.909 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 t -63.54 -56.22 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.701 0.286 . . . . 0.0 110.536 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.6 p -65.2 -31.16 72.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' A' ' 62' ' ' GLN . 31.7 t80 -64.45 -28.17 69.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.876 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.25 75.71 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.795 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.586 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 32.6 t70 -78.51 165.64 23.51 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.462 0.631 . . . . 0.0 111.446 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.548 HG12 ' C ' ' A' ' 28' ' ' ASP . 29.1 m -142.02 14.88 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 112.144 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 31' ' ' HIS . 37.8 m-80 -83.06 -22.77 33.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 30' ' ' ASN . 41.9 t-80 79.66 62.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.925 0.89 . . . . 0.0 112.258 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.17 145.62 25.55 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.74 ' HB3' HG22 ' A' ' 36' ' ' VAL . 56.1 t-20 -166.29 127.26 1.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.152 171.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -1.51 19.98 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.46 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -115.02 6.81 15.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.838 HG23 HG21 ' A' ' 63' ' ' VAL . 12.6 t -87.55 114.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.271 0.558 . . . . 0.0 111.804 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.6 p -100.22 -73.9 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.284 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -89.24 -67.02 0.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 -172.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 74.14 74.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.656 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -86.71 156.09 20.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.783 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.5 m -96.84 -33.57 11.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.674 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 112.96 -135.8 12.95 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.932 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.601 ' HA2' ' HE1' ' A' ' 54' ' ' TYR . . . 80.99 74.61 1.13 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.753 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.564 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 46.0 m-85 66.11 -178.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.542 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 23.0 t80 -152.95 -71.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.247 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.04 45.45 3.3 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.203 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 170.69 36.51 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.808 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -76.04 -25.49 55.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.035 0.445 . . . . 0.0 110.113 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -167.79 32.33 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 p -158.86 166.9 30.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.205 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.81 -134.33 5.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.632 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.437 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 31.6 m -135.54 6.07 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.496 0.188 . . . . 0.0 110.918 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -141.61 143.33 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.318 . . . . 0.0 110.776 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.601 ' HE1' ' HA2' ' A' ' 43' ' ' GLY . 2.6 t80 -154.94 96.06 1.81 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -96.05 157.77 15.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.022 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 1.026 HG13 ' HG2' ' A' ' 139' ' ' MET . 11.6 mm -147.31 121.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 110.15 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.647 ' HG ' ' HB2' ' A' ' 65' ' ' ALA . 8.9 t -138.28 112.51 8.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.316 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.616 ' HB2' ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER 41.53 160.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 118.574 2.805 . . . . 0.0 118.574 -178.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.451 ' H ' ' NE2' ' A' ' 62' ' ' GLN . 20.7 p -132.06 13.39 4.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.726 -2.033 . . . . 0.0 109.915 163.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.04 -58.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.264 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.639 ' O ' HG12 ' A' ' 63' ' ' VAL . 7.2 t30 -146.1 -33.68 0.32 Allowed 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.616 ' C ' ' HB2' ' A' ' 58' ' ' SER . 0.5 OUTLIER -53.05 54.7 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 126.564 2.415 . . . . 0.0 113.457 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.838 HG21 HG23 ' A' ' 36' ' ' VAL . 1.4 p -66.4 -6.64 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 22' ' ' TRP . 92.9 m -53.14 112.05 0.8 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 110.099 -3.228 . . . . 0.0 107.366 161.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB2' ' HG ' ' A' ' 57' ' ' SER . . . -122.41 -179.39 4.18 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.35 -169.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.706 ' HZ ' HG21 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -160.3 121.64 3.09 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.813 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.6 112.82 41.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.269 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.628 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . . . -88.92 152.71 21.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 52' ' ' SER . . . -150.84 122.96 1.44 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.91 -110.16 0.26 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.571 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 2.7 t-20 -147.86 37.4 0.88 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.503 0.668 . . . . 0.0 109.235 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -59.24 139.92 56.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.787 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -149.62 134.39 17.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.722 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.61 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 58.4 t80 -84.61 127.44 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.58 HG22 ' NE2' ' A' ' 123' ' ' GLN . 44.5 p -62.55 -33.55 75.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.648 -170.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.464 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 9.6 tp 51.57 -95.53 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.954 0.784 . . . . 0.0 111.827 -176.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.464 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 5.3 m-85 -98.84 2.58 46.88 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -175.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -76.04 178.34 6.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.549 0.214 . . . . 0.0 111.206 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.803 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 19.6 mm-40 -47.51 -62.71 1.88 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -170.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.803 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 54.2 Cg_exo -55.35 -38.02 94.17 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.777 1.651 . . . . 0.0 112.873 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 66.63 122.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.837 0.827 . . . . 0.0 112.855 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 53.27 54.41 10.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.425 -1.261 . . . . 0.0 111.484 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -146.49 169.0 19.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.307 -176.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.628 HD21 HG13 ' A' ' 135' ' ' VAL . 11.2 tp -106.58 149.06 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.819 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 86' ' ' GLY . 20.0 p90 -156.45 -154.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.405 ' N ' ' CD2' ' A' ' 85' ' ' TYR . . . 99.03 -164.25 20.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.904 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 6.3 tm0? -99.98 164.51 11.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 111.59 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.463 ' HA ' HD12 ' A' ' 88' ' ' LEU . 30.4 tp -151.58 129.95 12.08 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.726 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.554 ' HA ' ' HB2' ' A' ' 117' ' ' LEU . 17.4 t70 -136.0 -60.22 0.73 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.387 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.419 ' C ' HD21 ' A' ' 91' ' ' LEU . 13.2 p -97.99 149.81 22.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.762 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.646 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.9 mm? -134.53 169.55 17.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 9.5 t -163.76 109.55 1.07 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.147 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.743 ' HE2' HD23 ' A' ' 19' ' ' LEU . 3.9 m-30 -97.77 140.43 32.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.648 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.97 172.01 42.8 Favored Glycine 0 C--N 1.314 -0.684 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.723 ' H ' HG11 ' A' ' 109' ' ' VAL . 24.9 m-20 -97.77 124.86 42.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 119.362 1.581 . . . . 0.0 111.414 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 63' ' ' VAL . . . 87.47 116.06 1.13 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.477 -0.783 . . . . 0.0 113.091 171.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.604 HD11 ' HB1' ' A' ' 55' ' ' ALA . 41.0 mt -86.55 153.75 21.59 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.12 168.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.8 t -138.59 168.8 18.99 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.45 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.33 -123.57 10.42 Favored Glycine 0 N--CA 1.443 -0.875 0 O-C-N 123.947 0.779 . . . . 0.0 111.65 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.04 29.68 74.89 Favored Glycine 0 C--N 1.318 -0.45 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.309 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -89.47 -88.76 0.16 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 p -112.68 4.81 17.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.83 0.824 . . . . 0.0 108.835 168.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -112.52 165.43 13.05 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.432 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.542 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.9 Cg_exo -73.15 167.49 27.21 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 123.155 2.57 . . . . 0.0 112.364 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.674 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 37.8 m-85 -71.85 151.62 43.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.361 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.9 p -149.07 143.95 26.37 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.681 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.648 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.5 mp -80.88 129.21 37.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.044 0.45 . . . . 0.0 110.857 -175.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.461 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 71.7 mt-30 -64.23 -59.07 4.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.578 176.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.723 HG11 ' H ' ' A' ' 95' ' ' ASP . 2.4 p -109.15 87.53 4.91 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 121.628 0.728 . . . . 0.0 110.017 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.09 122.71 10.55 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.95 2.433 . . . . 0.0 111.597 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.414 ' CG ' ' HH ' ' A' ' 18' ' ' TYR . 3.9 t0 -118.91 -143.27 0.36 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.834 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 19.4 t -61.16 115.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.338 1.066 . . . . 0.0 112.344 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 92' ' ' SER . 69.1 m -101.86 177.3 4.94 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.811 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.646 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 95.5 m-85 -138.56 149.62 45.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.57 141.67 7.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.807 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.841 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 102.02 11.83 35.95 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.704 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.554 ' HA ' HD11 ' A' ' 153' ' ' ILE . 16.8 mt -55.8 -46.73 77.94 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.343 0.572 . . . . 0.0 109.723 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 t30 49.46 45.61 23.81 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.022 0.915 . . . . 0.0 110.244 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 20.7 mt -108.6 115.82 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.015 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 38.8 p -111.2 132.64 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.283 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.41 ' HB2' HG23 ' A' ' 131' ' ' VAL . 41.5 m -101.76 147.97 25.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.28 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.4 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 69.9 mt -80.41 157.13 26.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.782 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.58 ' NE2' HG22 ' A' ' 75' ' ' THR . 19.0 tp60 -48.27 -54.41 13.78 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.488 0.493 . . . . 0.0 112.16 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.54 3.06 14.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -170.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.587 ' HB3' ' N ' ' A' ' 129' ' ' GLY . 37.2 mt-30 -78.86 58.16 2.29 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.014 0.435 . . . . 0.0 110.516 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.83 103.96 0.65 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.45 ' HA ' ' CG ' ' A' ' 132' ' ' HIS . 3.3 t-80 79.39 -29.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.845 0.858 . . . . 0.0 111.397 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.519 ' HA ' HE21 ' A' ' 133' ' ' GLN . 14.7 t70 -80.38 -30.43 37.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.543 0.211 . . . . 0.0 111.307 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.587 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -55.79 129.48 47.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.627 -0.796 . . . . 0.0 111.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.5 m -50.87 -33.21 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 132' ' ' HIS . 33.1 m -63.35 -47.16 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.796 0.331 . . . . 0.0 110.594 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.595 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.8 t-160 -63.5 -39.43 94.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.966 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.519 HE21 ' HA ' ' A' ' 128' ' ' ASP . 27.1 mm-40 -59.85 -64.7 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.4 t -53.89 -46.51 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.348 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.706 HG21 ' HZ ' ' A' ' 66' ' ' PHE . 11.0 p -65.86 -45.97 89.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.259 -175.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.409 ' HD1' HG11 ' A' ' 135' ' ' VAL . 12.5 m-85 -72.24 -27.5 62.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.818 0.342 . . . . 0.0 110.796 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.35 -53.29 33.44 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.518 ' HG ' ' CD1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -49.63 -49.59 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.1 0.56 . . . . 0.0 111.095 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 1.026 ' HG2' HG13 ' A' ' 56' ' ' ILE . 83.4 mtp -57.67 -30.75 65.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.034 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -91.3 -0.67 57.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.26 9.47 81.95 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.698 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -98.82 103.96 15.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.565 0.698 . . . . 0.0 110.79 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.475 ' HB ' HD12 ' A' ' 19' ' ' LEU . 2.8 p -89.48 2.42 54.58 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.069 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.529 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -62.78 -31.21 79.47 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.735 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.59 -33.29 64.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.557 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.4 OUTLIER -67.76 -33.6 75.17 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.612 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.918 ' HG2' HG21 ' A' ' 161' ' ' VAL . 46.1 mt-10 -52.91 -44.72 67.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -33.17 73.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.952 -175.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.57 64.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.32 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.2 mt -55.49 -45.37 77.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.831 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -58.64 -8.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.968 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.08 -41.68 26.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.035 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 117' ' ' LEU . 3.8 mp -86.51 -49.03 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.787 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.6 HD13 HG11 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -53.08 -40.93 64.42 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.67 -27.17 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.39 -34.22 77.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.227 0.537 . . . . 0.0 109.845 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.442 ' HE2' HG21 ' A' ' 153' ' ' ILE . 41.6 m-85 -95.63 -13.58 24.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.284 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 94.75 27.94 10.8 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.602 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.409 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -109.15 -166.98 1.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.135 0.468 . . . . 0.0 110.952 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.6 p -163.52 171.91 15.17 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.38 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.918 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.5 p -52.55 -36.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -88.82 40.22 0.96 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -88.9 -105.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.744 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 168' ' ' VAL . 15.6 m -163.05 146.91 11.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.675 ' CD1' HD12 ' A' ' 15' ' ' ILE . 6.1 m-30 -52.96 -42.35 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.353 0.524 . . . . 0.0 111.111 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.63 -52.22 33.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.853 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -59.74 -46.3 89.57 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -176.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.6 HG11 HD13 ' A' ' 154' ' ' LEU . 89.6 t -60.52 -56.67 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.491 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.472 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -54.36 -44.65 72.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 123.447 0.467 . . . . 0.0 110.993 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 173' ' ' ALA . . . -62.64 -40.87 98.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.647 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -74.49 -29.91 61.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.208 0.528 . . . . 0.0 110.57 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.686 HG23 ' CD2' ' A' ' 2' ' ' PHE . 38.3 p -85.74 -14.15 46.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.865 0.84 . . . . 0.0 109.624 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . -67.48 -42.77 82.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.653 173.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 176' ' ' VAL . 1.2 p 179.61 -28.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.599 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.647 ' HA2' ' HA ' ' A' ' 171' ' ' ALA . . . 140.44 -56.52 0.61 Allowed Glycine 0 CA--C 1.498 -1.02 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.635 175.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 174' ' ' VAL . 15.7 m 46.26 44.68 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.06 0.944 . . . . 0.0 113.389 169.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -141.76 152.63 43.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.223 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 83.3 t60 . . . . . 0 C--N 1.319 -0.732 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.588 177.196 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.87 0.366 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.801 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 t80 -86.62 149.63 24.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.98 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -172.22 167.51 5.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.62 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.704 HG11 ' HB ' ' A' ' 168' ' ' VAL . 0.2 OUTLIER -90.35 125.54 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.559 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 27.0 m-80 -101.82 48.84 0.87 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.729 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.99 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.0 p90 -70.5 150.04 46.56 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.735 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.8 t70 -62.06 105.35 0.57 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.619 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 4.4 p -37.52 74.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 125.082 1.489 . . . . 0.0 113.894 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.1 t -174.2 -25.62 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.341 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.494 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 96.0 m-85 -92.39 15.5 13.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.08 68.12 1.38 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.322 -173.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.45 22.85 0.16 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.557 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 45.3 m-85 -114.31 131.26 56.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.017 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 163' ' ' SER . 11.4 p -68.13 132.44 47.21 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 161.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.672 HD12 ' CE1' ' A' ' 165' ' ' PHE . 4.8 mm -46.56 -48.76 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -167.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -60.14 -30.37 69.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.648 0.261 . . . . 0.0 111.007 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.28 -49.17 58.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.371 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.453 ' HB2' ' CG ' ' A' ' 13' ' ' TYR . 72.0 t80 -70.72 -45.34 65.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.608 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.795 ' HB3' HG22 ' A' ' 143' ' ' THR . 12.0 mt -56.92 -44.4 82.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.18 94.81 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.975 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.432 ' O ' ' HB3' ' A' ' 24' ' ' SER . 3.7 tt0 -64.87 -43.34 93.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 122.89 0.476 . . . . 0.0 111.463 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -62.43 -42.21 99.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.919 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.14 67.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.791 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 25.1 t -62.23 -54.14 45.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -35.64 81.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.056 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 20.0 t80 -56.07 -39.43 72.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.346 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.89 -29.51 73.68 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.463 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' OD1' ' HB2' ' A' ' 30' ' ' ASN . 11.9 t70 -76.12 100.88 5.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.705 -176.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.404 ' HA ' ' HB3' ' A' ' 61' ' ' ASN . 35.4 m -65.99 -1.68 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.436 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 52.1 m-80 -84.87 -5.8 59.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -169.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.5 t60 56.05 92.48 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 168.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.1 p -142.21 134.65 27.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.941 0.4 . . . . 0.0 111.659 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -171.52 129.0 0.68 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.198 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.04 -7.49 76.54 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 114.446 0.538 . . . . 0.0 114.446 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -116.38 3.57 13.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.849 0.825 . . . . 0.0 111.684 -175.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.665 HG23 ' HA3' ' A' ' 96' ' ' GLY . 45.6 t -101.83 116.39 45.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 p -103.08 -76.11 0.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.295 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.89 -68.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.902 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.41 83.86 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.527 0.68 . . . . 0.0 111.972 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -83.88 137.86 33.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.956 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -74.62 -37.74 62.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.49 134.74 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.348 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.55 59.19 0.11 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.901 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 57.8 m-85 62.1 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.941 0.877 . . . . 0.0 113.326 -175.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.419 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 50.5 t80 -91.75 -13.24 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.768 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.807 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.58 -28.02 44.98 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.382 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.45 -118.6 0.75 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.899 -1.143 . . . . 0.0 113.084 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -76.62 -50.13 14.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 0.0 110.281 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -167.35 43.29 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.765 0.793 . . . . 0.0 109.782 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.648 ' HB3' ' HD1' ' A' ' 74' ' ' TYR . 20.9 p -154.03 -176.28 5.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.228 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.807 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 128.1 -172.43 19.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 t -92.95 -14.22 27.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.828 0.314 . . . . 0.0 111.265 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 14.9 tt0 -134.0 151.84 51.6 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.323 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.749 ' CD1' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -149.19 94.76 2.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.879 -173.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -94.82 153.16 17.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.861 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 1.014 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.0 mm -146.43 140.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 t -131.92 97.36 4.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.542 0.211 . . . . 0.0 110.517 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 33.1 t 18.48 115.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -19.5 65.89 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.425 -0.797 . . . . 0.0 110.472 171.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.02 -61.48 1.95 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.062 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 35.0 p30 -114.75 3.35 14.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.119 0.485 . . . . 0.0 111.59 -172.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 57' ' ' SER . 2.3 mm-40 39.79 38.26 0.43 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.447 HG11 ' N ' ' A' ' 64' ' ' THR . 9.1 p -129.37 -55.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.714 168.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.447 ' N ' HG11 ' A' ' 63' ' ' VAL . 4.5 m -58.0 101.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.243 0.544 . . . . 0.0 110.206 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -110.28 173.19 6.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -165.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.753 ' CE1' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -160.67 118.07 2.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.73 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 79.2 t -103.53 107.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.627 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . . . -91.12 157.14 17.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.91 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.11 135.62 4.95 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.201 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.34 -128.82 1.08 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.94 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -146.34 72.89 1.3 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 0.0 109.383 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.749 HD13 ' CD1' ' A' ' 54' ' ' TYR . 6.5 mt -92.14 166.93 12.39 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 122.377 1.084 . . . . 0.0 113.629 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.6 m -164.52 134.05 3.79 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 112.416 -2.175 . . . . 0.0 106.76 171.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.954 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 1.8 p90 -95.47 144.76 25.7 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 77.6 p -72.11 -68.4 0.47 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.954 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 13.4 tp 57.4 -87.55 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.018 0.927 . . . . 0.0 111.295 -169.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.402 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 21.8 m-85 -91.76 0.04 57.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.194 0.521 . . . . 0.0 110.897 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.493 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-80 -77.05 166.67 22.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.443 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.748 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 47.4 mm-40 -46.42 -61.54 2.56 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -168.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.748 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 77.2 Cg_exo -55.43 -40.42 85.61 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.935 1.756 . . . . 0.0 113.759 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 70.83 134.86 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.398 0.618 . . . . 0.0 112.483 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.4 m80 47.67 54.33 9.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.84 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.677 HG21 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -151.03 162.58 40.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.768 -171.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.459 ' H ' ' ND1' ' A' ' 132' ' ' HIS . 17.0 tp -108.83 156.02 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.974 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -158.21 -161.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.8 -159.04 22.81 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.26 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.3 tm0? -97.94 169.95 9.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.543 0.687 . . . . 0.0 112.742 -170.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.559 ' CD2' HG21 ' A' ' 134' ' ' VAL . 27.3 tp -155.34 135.51 13.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.53 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -134.94 -50.26 0.76 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.958 0.408 . . . . 0.0 111.28 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.498 ' O ' HD12 ' A' ' 91' ' ' LEU . 5.7 p -130.2 157.12 43.34 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -171.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.729 HD13 ' HE1' ' A' ' 66' ' ' PHE . 2.4 mm? -138.02 160.55 39.05 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 9.1 m -147.93 108.82 4.22 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 117.824 0.284 . . . . 0.0 110.951 176.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.63 ' CE1' HD11 ' A' ' 138' ' ' LEU . 4.6 m-30 -91.56 147.87 22.69 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.634 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.5 -152.33 11.35 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.732 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.413 ' O ' HG21 ' A' ' 109' ' ' VAL . 3.9 m-20 -134.57 126.97 30.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 110.742 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.665 ' HA3' HG23 ' A' ' 36' ' ' VAL . . . 76.2 110.09 0.12 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.836 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.0 mt -83.96 141.4 31.26 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.38 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -99.08 154.42 18.13 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.535 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.08 114.74 5.06 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.202 -166.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.48 -13.87 75.07 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 168.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.404 ' OD2' HG23 ' A' ' 102' ' ' THR . 26.9 t70 64.81 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.108 0.963 . . . . 0.0 111.118 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.404 HG23 ' OD2' ' A' ' 101' ' ' ASP . 76.3 p -99.42 -0.08 41.63 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.813 0.815 . . . . 0.0 109.213 176.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 m -113.87 166.18 11.95 Favored Pre-proline 0 N--CA 1.443 -0.819 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.171 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -64.27 152.05 82.92 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.983 2.455 . . . . 0.0 113.035 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -66.03 155.03 37.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.579 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 p -142.38 155.64 45.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.347 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.634 HG21 ' HA3' ' A' ' 94' ' ' GLY . 1.1 mp -89.1 122.76 40.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.414 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.98 -39.71 94.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.185 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 95' ' ' ASP . 1.9 t -112.0 88.16 9.75 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.487 170.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 36.0 Cg_endo -65.16 96.55 0.27 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.268 2.645 . . . . 0.0 112.838 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.464 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 33.1 m-20 -94.66 -154.47 0.42 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.264 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.99 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 46.6 t -58.31 138.5 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.707 0.765 . . . . 0.0 111.931 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.559 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 75.6 m -129.11 178.8 6.15 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.391 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.584 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 95.9 m-85 -138.82 146.79 41.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -160.58 142.06 7.86 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.921 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.801 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.22 11.15 40.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.411 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.415 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 26.3 mt -57.08 -50.5 72.59 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.0 t30 55.43 43.35 28.85 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.695 0.76 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.8 mt -106.11 112.56 25.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.381 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 34.5 p -107.04 130.84 54.6 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.815 0.341 . . . . 0.0 110.523 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.0 m -108.28 145.8 33.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.827 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -80.96 165.14 22.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.503 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -52.93 -61.1 2.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.583 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -79.66 14.61 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -168.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 34.8 mt-30 -77.15 -25.9 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.289 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 56.38 -118.1 10.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.221 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.461 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 4.7 t-80 -80.24 -22.76 41.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.537 0.335 . . . . 0.0 110.765 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.584 ' HA ' HE21 ' A' ' 133' ' ' GLN . 15.1 t70 -84.82 -19.63 32.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -59.45 126.59 42.63 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 174.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.61 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 18.2 m -52.69 -32.62 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.737 ' O ' HG22 ' A' ' 135' ' ' VAL . 18.1 m -63.63 -49.67 81.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.157 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.677 ' HE1' HG21 ' A' ' 83' ' ' THR . 4.8 t-160 -57.02 -41.25 78.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.035 0.445 . . . . 0.0 110.008 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.61 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 6.1 mm-40 -56.73 -63.97 1.03 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.31 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.559 HG21 ' CD2' ' A' ' 88' ' ' LEU . 16.1 m -56.63 -39.21 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.469 -172.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 131' ' ' VAL . 2.2 t -66.1 -57.81 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 CA-C-O 121.455 0.645 . . . . 0.0 110.061 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.34 -18.21 64.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.34 -56.23 7.04 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 167.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.63 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.92 -52.61 31.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.111 0.564 . . . . 0.0 111.226 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 1.014 ' HG2' HG13 ' A' ' 56' ' ' ILE . 50.7 mtp -55.82 -26.74 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.111 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.1 m -99.45 -6.53 27.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.752 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.36 32.14 20.45 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.244 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -121.11 130.59 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.795 HG22 ' HB3' ' A' ' 19' ' ' LEU . 53.9 p -108.15 2.03 22.62 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.78 -39.44 61.72 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 123.523 0.514 . . . . 0.0 114.04 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.76 -26.92 29.26 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.411 -0.464 . . . . 0.0 110.824 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -68.92 -51.02 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.676 ' HB3' HG21 ' A' ' 161' ' ' VAL . 5.0 pt-20 -58.0 -33.51 69.01 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.283 0.563 . . . . 0.0 110.181 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 28.0 m -67.67 -47.95 68.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.848 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.01 99.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.219 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 99.1 mt -55.58 -43.15 75.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.398 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -57.08 -9.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.331 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -75.39 -40.16 33.96 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.299 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.479 HG21 ' HE2' ' A' ' 157' ' ' TYR . 3.9 mp -86.47 -48.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.029 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.445 ' HB3' ' C ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -53.31 -41.51 65.73 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.66 -23.85 63.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.95 -28.97 62.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.1 m-85 -101.8 -7.37 22.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.105 0.479 . . . . 0.0 110.14 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.13 29.77 12.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.352 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.496 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 1.9 mm? -111.19 -165.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.34 0.57 . . . . 0.0 110.513 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 p -163.1 -178.91 6.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.069 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.676 HG21 ' HB3' ' A' ' 147' ' ' GLU . 9.7 p -57.5 -23.3 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 111.375 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.79 14.45 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.707 0.289 . . . . 0.0 111.716 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.667 ' HB3' HG22 ' A' ' 168' ' ' VAL . 12.8 t -88.96 143.68 26.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.61 ' O ' HG21 ' A' ' 168' ' ' VAL . 38.3 m -69.2 141.26 54.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.672 ' CE1' HD12 ' A' ' 15' ' ' ILE . 5.2 m-30 -38.24 -53.01 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.71 0.804 . . . . 0.0 112.739 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.53 -48.42 79.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.708 0.29 . . . . 0.0 110.224 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.478 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 1.7 mp0 -69.04 -5.33 21.23 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.704 ' HB ' HG11 ' A' ' 4' ' ' VAL . 34.0 t -96.31 -54.05 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.249 0.547 . . . . 0.0 109.819 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.0 -46.61 84.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.622 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.05 72.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.707 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.894 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -70.32 -35.83 73.88 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.533 0.682 . . . . 0.0 110.581 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.559 HG23 ' CD2' ' A' ' 2' ' ' PHE . 16.5 p -82.56 -18.97 39.51 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.993 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.06 -44.31 31.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.939 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.511 ' O ' HG22 ' A' ' 176' ' ' VAL . 4.3 p -176.18 6.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.5 0.667 . . . . 0.0 110.703 -172.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.894 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -86.89 91.15 1.72 Allowed Glycine 0 CA--C 1.499 -0.909 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.672 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 174' ' ' VAL . 5.5 m -145.16 30.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.654 0.74 . . . . 0.0 110.208 -168.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -154.0 70.5 0.82 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.366 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.033 -178.527 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 172' ' ' THR . . . . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.79 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 31.7 t80 59.26 156.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.032 0.833 . . . . 0.0 112.184 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -174.1 160.02 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.761 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.446 HG21 ' HB ' ' A' ' 168' ' ' VAL . 10.5 m -91.68 111.7 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.411 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 51.7 m-20 -94.62 50.18 1.31 Allowed 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.186 -167.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 1.06 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.6 p90 -67.58 149.03 50.63 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.547 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.3 t70 -62.16 100.06 0.16 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.454 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 8.4 m -30.14 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.827 1.651 . . . . 0.0 114.397 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.6 t -172.21 -31.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.098 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.573 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 81.9 m-85 -88.97 15.67 8.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.0 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.519 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.6 71.75 1.05 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.518 -172.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.45 5.73 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.511 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 32.2 m-85 -95.17 140.76 29.63 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.78 -0.21 . . . . 0.0 110.762 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -70.22 129.54 39.63 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 160.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.639 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 3.4 mm -44.89 -48.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -172.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 40.1 t-80 -57.13 -32.61 66.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.145 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.31 -51.52 23.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.24 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.431 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 57.6 t80 -68.13 -41.28 81.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.961 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.744 ' HB3' HG23 ' A' ' 143' ' ' THR . 17.0 mt -55.52 -41.13 72.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.874 0.369 . . . . 0.0 110.457 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.54 97.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.062 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -62.81 -40.53 97.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.757 0.423 . . . . 0.0 111.945 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -61.46 -43.64 98.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.59 -33.05 74.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.839 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.0 t -60.05 -51.77 68.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -68.25 -31.14 70.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.615 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 10.7 t80 -61.05 -52.78 63.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.231 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.41 -26.34 74.33 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.267 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -73.09 108.84 6.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 110.942 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.607 HG12 ' HB2' ' A' ' 60' ' ' ALA . 35.6 m -64.13 -14.36 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.062 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -90.43 -11.08 41.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.291 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.587 ' HB3' ' ND2' ' A' ' 61' ' ' ASN . 14.7 t-80 -71.53 114.41 9.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.976 0.417 . . . . 0.0 111.465 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.7 p -119.16 -176.06 3.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.515 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -158.66 119.95 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.46 56.0 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.979 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.8 1.5 37.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.571 0.7 . . . . 0.0 109.84 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.422 HG21 ' CG2' ' A' ' 63' ' ' VAL . 32.3 t -95.63 114.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.925 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 -71.5 0.66 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.725 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.86 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.518 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 66.89 74.29 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.021 0.915 . . . . 0.0 111.0 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.34 136.06 33.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.007 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.463 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 70.4 m -73.02 -38.0 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.283 -172.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.436 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 109.51 -135.87 13.17 Favored Glycine 0 C--N 1.317 -0.475 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.892 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.34 70.38 1.32 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.763 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.481 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 64.1 m-85 56.87 -171.36 0.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.494 0.317 . . . . 0.0 111.765 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 44' ' ' PHE . 29.3 t80 -178.4 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.329 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -80.76 7.95 57.24 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.853 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.06 -98.74 0.13 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.1 m -152.18 -63.15 0.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 1.9 mp -77.27 -44.07 31.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.557 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.576 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 17.7 p -140.33 170.12 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 158.57 45.0 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.212 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.1 m 68.33 -54.04 0.53 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.458 ' HG2' ' N ' ' A' ' 54' ' ' TYR . 7.7 tt0 -93.74 149.62 21.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.481 ' HD1' ' H ' ' A' ' 44' ' ' PHE . 2.3 t80 -147.96 103.36 3.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 146.6 23.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.366 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 1.08 HG13 ' HG2' ' A' ' 139' ' ' MET . 9.1 mm -146.52 122.06 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 92.5 p -106.23 158.77 16.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.378 174.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 42.0 t -51.46 139.39 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.292 0.568 . . . . 0.0 111.968 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -85.45 -19.44 31.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.425 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.607 ' HB2' HG12 ' A' ' 29' ' ' VAL . . . -81.04 -60.52 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.587 ' ND2' ' HB3' ' A' ' 31' ' ' HIS . 30.7 p30 -111.73 1.32 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.824 -174.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.63 ' HA ' ' O ' ' A' ' 58' ' ' SER . 2.9 mm-40 40.12 37.42 0.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.477 -1.238 . . . . 0.0 114.214 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.435 HG11 ' N ' ' A' ' 64' ' ' THR . 14.8 p -126.6 -51.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.921 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.435 ' N ' HG11 ' A' ' 63' ' ' VAL . 23.2 m -62.65 103.55 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.525 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -112.46 179.59 3.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.687 0.756 . . . . 0.0 112.924 -169.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.734 ' HE1' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -156.99 131.81 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.811 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.6 t -120.62 114.96 45.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.166 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.55 148.04 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.6 104.79 0.26 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.018 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.48 -92.29 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.194 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -147.92 30.14 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.482 0.641 . . . . 0.0 110.906 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 77.9 mt -59.24 143.73 48.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.34 0.591 . . . . 0.0 111.774 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 99.2 m -148.61 129.99 14.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.67 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.576 ' H ' ' HB3' ' A' ' 50' ' ' SER . 48.1 t80 -86.07 122.76 30.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 48.2 p -64.87 -41.29 95.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.623 -171.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.438 HD22 HD23 ' A' ' 49' ' ' LEU . 13.5 tp 51.08 -88.02 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.755 0.822 . . . . 0.0 111.978 -174.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.411 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 22.1 m-85 -95.08 -3.04 48.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.557 0.535 . . . . 0.0 111.711 -175.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.635 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 94.5 m-20 -75.51 -179.4 4.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.72 0.295 . . . . 0.0 111.623 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.872 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 32.7 mm-40 -45.83 -67.79 0.35 Allowed Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.872 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.9 Cg_exo -56.88 -36.6 99.01 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.415 1.41 . . . . 0.0 112.441 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 68.67 123.53 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.578 0.751 . . . . 0.0 112.247 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 60.35 59.99 2.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.992 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.789 HG22 ' HA2' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -143.88 166.34 25.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.074 -171.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.827 HD21 HG13 ' A' ' 135' ' ' VAL . 13.6 tp -119.23 144.18 46.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 7.9 p90 -158.15 -157.92 0.68 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 71' ' ' ASN . . . 95.04 -163.93 24.63 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.606 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.595 ' HG3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -103.43 172.96 6.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.529 HD13 HD11 ' A' ' 91' ' ' LEU . 1.5 pt? -139.62 -41.43 0.45 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.974 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HB2' ' OE1' ' A' ' 87' ' ' GLN . 37.2 t70 61.28 -58.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.685 1.194 . . . . 0.0 113.654 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 114' ' ' PHE . 8.0 m -136.29 135.26 38.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.902 0.858 . . . . 0.0 112.36 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.734 HD13 ' HE1' ' A' ' 66' ' ' PHE . 2.5 mm? -102.63 166.44 10.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.997 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.4 m -151.64 111.54 4.05 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 122.315 -0.241 . . . . 0.0 110.863 174.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.717 ' HE2' HD23 ' A' ' 19' ' ' LEU . 4.8 m-30 -97.62 141.56 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.612 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.28 164.71 31.83 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.015 172.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -87.08 120.83 28.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.159 0.504 . . . . 0.0 111.221 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.13 113.24 0.43 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.593 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' A' ' 105' ' ' TYR . 55.3 mt -89.03 153.89 20.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.582 . . . . 0.0 110.549 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -131.67 167.9 18.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.274 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.25 -130.49 10.35 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.07 8.42 86.89 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.482 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -91.69 -73.53 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.195 0.498 . . . . 0.0 110.388 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.1 p -126.69 -0.47 6.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.162 0.506 . . . . 0.0 110.69 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.71 156.99 79.04 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -67.15 175.67 5.46 Favored 'Trans proline' 0 C--N 1.33 -0.421 0 C-N-CA 123.739 2.959 . . . . 0.0 112.721 -172.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.436 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 52.5 m-85 -71.93 151.37 43.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.579 -174.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -146.59 152.58 39.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.868 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.612 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.3 mp -83.53 122.07 37.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.517 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.93 -48.45 74.07 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.424 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 21.5 t -112.51 87.55 9.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.404 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 24.5 Cg_endo -61.71 107.11 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.12 2.546 . . . . 0.0 112.639 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 12.1 m-20 -96.33 -148.73 0.31 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.293 174.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 1.06 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -61.22 143.54 14.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.632 0.73 . . . . 0.0 111.459 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.411 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 74.4 m -135.24 179.54 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.746 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.648 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.3 m-85 -139.04 146.04 40.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.36 141.71 7.62 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.632 -1.27 . . . . 0.0 112.396 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.22 11.59 41.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.761 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.508 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 14.6 mt -55.22 -49.21 72.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.3 t30 57.24 36.27 27.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.986 0.898 . . . . 0.0 109.588 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.538 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 19.2 mt -102.98 124.27 48.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.267 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.595 ' HB3' ' HG3' ' A' ' 87' ' ' GLN . 22.6 p -131.13 138.52 49.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.058 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.462 ' OG ' HG21 ' A' ' 131' ' ' VAL . 91.2 p -114.6 135.09 54.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 110.139 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 122' ' ' LEU . 8.4 mp -60.69 161.86 7.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.159 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -51.55 -56.32 14.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.41 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.06 17.25 4.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.402 ' OE1' ' HB2' ' A' ' 121' ' ' SER . 21.5 mt-30 -77.13 -37.06 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.533 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.789 ' HA2' HG22 ' A' ' 83' ' ' THR . . . 77.88 -124.4 6.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.337 174.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -78.91 -14.88 58.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.55 ' HA ' HE21 ' A' ' 133' ' ' GLN . 38.9 t70 -85.84 -16.11 39.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.872 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.56 125.2 30.74 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.216 -0.992 . . . . 0.0 110.641 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.544 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 23.9 m -52.8 -35.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.462 HG21 ' OG ' ' A' ' 121' ' ' SER . 25.5 m -65.18 -41.24 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.462 0.574 . . . . 0.0 110.48 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.468 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.2 t-160 -60.69 -38.38 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.545 0.688 . . . . 0.0 109.448 175.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.55 HE21 ' HA ' ' A' ' 128' ' ' ASP . 2.8 mt-30 -67.26 -60.62 2.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.868 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 130' ' ' VAL . 18.9 m -60.28 -37.92 75.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.807 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.827 HG13 HD21 ' A' ' 84' ' ' LEU . 8.9 p -68.3 -46.3 81.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.83 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.61 -30.28 66.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 110.198 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.31 -54.98 32.76 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.709 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -50.25 -47.76 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.016 0.527 . . . . 0.0 111.013 176.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 1.08 ' HG2' HG13 ' A' ' 56' ' ' ILE . 53.0 mtp -56.09 -33.59 65.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.822 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.9 m -91.55 -13.52 31.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.413 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.51 10.26 53.81 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.93 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.67 120.74 30.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.11 0.481 . . . . 0.0 110.969 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.744 HG23 ' HB3' ' A' ' 19' ' ' LEU . 17.3 p -108.5 9.15 27.55 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.606 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.12 -27.44 68.4 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.955 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.26 -30.31 23.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.991 0.424 . . . . 0.0 110.053 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -64.78 -47.91 76.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.035 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.565 ' HA ' HG13 ' A' ' 161' ' ' VAL . 1.5 pt-20 -55.15 -34.04 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.054 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.485 ' N ' ' HG3' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -75.1 -36.76 61.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.059 0.457 . . . . 0.0 109.8 -175.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.79 -47.15 69.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.527 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 98.3 mt -55.26 -43.49 74.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.048 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -55.29 -13.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.315 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.13 -37.65 55.38 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.39 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.582 HG22 ' HB3' ' A' ' 2' ' ' PHE . 3.2 mp -85.31 -46.26 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.724 HD13 HG12 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.74 -44.2 81.44 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.98 -24.73 67.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.99 -38.09 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.511 . . . . 0.0 110.219 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.569 ' CD1' HG13 ' A' ' 176' ' ' VAL . 13.7 m-85 -97.18 -7.71 31.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.91 16.63 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.379 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.531 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 1.9 mm? -110.85 -174.25 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.258 0.529 . . . . 0.0 110.335 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.5 p -165.39 -176.2 3.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.381 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' A' ' 147' ' ' GLU . 2.5 m -61.1 -13.15 6.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -88.75 4.49 47.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 168' ' ' VAL . 19.5 m -92.28 152.44 19.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.858 176.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.5 m -70.72 142.77 51.45 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.573 ' HD2' ' O ' ' A' ' 10' ' ' PHE . 4.1 m-30 -37.72 -64.38 0.4 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.386 0.674 . . . . 0.0 112.58 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.17 -40.85 82.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.112 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.57 -42.3 87.26 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.827 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.724 HG12 HD13 ' A' ' 154' ' ' LEU . 92.7 t -65.02 -52.02 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.33 78.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.727 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.34 83.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.611 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 1.009 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -68.63 -33.56 74.22 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.363 0.601 . . . . 0.0 110.864 -173.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.584 HG23 ' CD2' ' A' ' 2' ' ' PHE . 12.2 p -83.01 -25.2 32.43 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.009 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.05 -42.15 48.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.312 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.0 p -176.57 5.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 110.934 -171.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 1.009 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -76.1 -2.69 73.19 Favored Glycine 0 CA--C 1.503 -0.712 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.339 -173.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.569 HG13 ' CD1' ' A' ' 157' ' ' TYR . 19.8 m -49.96 73.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 125.919 1.688 . . . . 0.0 114.528 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -97.4 39.46 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.581 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 26.0 m170 . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.748 178.612 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.416 ' O ' ' HA3' ' A' ' 116' ' ' GLY . . . . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.937 0.398 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.822 ' O ' ' HB ' ' A' ' 172' ' ' THR . 38.7 t80 -93.8 149.69 21.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.335 -172.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.414 ' HG ' ' C ' ' A' ' 2' ' ' PHE . 10.0 m -161.51 163.35 30.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.394 0.678 . . . . 0.0 109.335 171.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.616 HG23 ' HD1' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.3 128.16 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.5 m-80 -105.35 49.57 0.8 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.625 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 1.055 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 25.5 p90 -73.18 152.84 40.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.547 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.2 t70 -62.15 100.71 0.18 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.463 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 22.3 t -35.46 75.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.665 1.586 . . . . 0.0 113.722 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.2 t -172.96 -30.64 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.859 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.469 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 53.7 m-85 -91.21 22.06 4.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.793 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.8 66.98 0.82 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.209 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -165.13 2.16 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.626 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 38.6 m-85 -83.23 141.8 31.62 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.5 m -71.44 138.08 48.77 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 159.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.731 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -47.01 -48.14 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 119.098 0.863 . . . . 0.0 110.842 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.533 ' HB2' HG11 ' A' ' 161' ' ' VAL . 44.4 t-80 -55.23 -32.23 62.13 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.74 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -65.46 -55.79 16.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.946 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 112' ' ' VAL . 83.2 t80 -66.59 -43.51 84.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.359 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 8.8 mt -55.88 -46.81 78.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.719 0.295 . . . . 0.0 110.573 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.52 -43.37 98.91 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.829 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.25 -43.01 99.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.578 0.351 . . . . 0.0 111.877 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 54.0 t90 -60.44 -43.55 96.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.04 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.85 71.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.481 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -62.4 -49.08 76.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 -28.18 67.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.59 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 38.6 t80 -62.25 -50.05 73.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.236 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -19.87 75.14 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.378 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.04 96.39 1.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.537 0.684 . . . . 0.0 110.906 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.485 ' CG1' ' HB3' ' A' ' 60' ' ' ALA . 16.8 m -62.23 -25.26 37.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -90.84 -7.62 51.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -66.18 127.42 32.09 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.159 0.504 . . . . 0.0 111.173 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.3 p -131.32 -176.19 3.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.828 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -160.57 118.12 2.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.835 0.35 . . . . 0.0 110.556 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 3.73 20.21 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.273 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -106.11 -0.62 24.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.496 . . . . 0.0 109.887 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.439 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 19.9 t -89.93 122.88 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.973 -177.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -92.37 -81.09 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.327 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -75.23 -62.1 1.67 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.755 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' HB1' ' CG1' ' A' ' 36' ' ' VAL . . . 66.78 80.63 0.21 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.622 -172.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -78.7 134.19 37.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.497 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.4 m -79.84 -31.77 40.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.146 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.65 -172.43 44.75 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' CA ' ' HE2' ' A' ' 105' ' ' TYR . . . -148.15 -83.36 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.858 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.62 60.97 2.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.744 0.783 . . . . 0.0 109.073 -158.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -84.22 71.72 10.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.617 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.607 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -157.97 -36.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.945 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.35 -125.14 0.97 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.253 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -73.51 -38.95 65.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.576 0.227 . . . . 0.0 111.524 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -168.73 28.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.375 0.607 . . . . 0.0 110.623 -175.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -154.04 175.97 12.78 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.549 -176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.607 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 149.83 -164.78 29.6 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.284 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -91.64 -18.54 23.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.661 0.267 . . . . 0.0 111.212 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 40.8 tt0 -135.9 147.63 48.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 111.216 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.12 108.51 3.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.114 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.83 155.39 17.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.466 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 1.111 HG13 ' HG2' ' A' ' 139' ' ' MET . 8.6 mm -148.8 137.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.887 0.742 . . . . 0.0 109.166 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 20.7 t -129.76 150.93 50.86 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.744 0.307 . . . . 0.0 110.38 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 30.0 t -50.55 122.37 7.04 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.733 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 p -83.04 40.77 0.72 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.673 0.749 . . . . 0.0 110.179 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.485 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . . . -146.52 -45.08 0.19 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.599 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -122.65 -1.83 8.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.18 0.514 . . . . 0.0 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.5 mt-30 31.59 41.42 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 p -127.91 -43.94 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.032 170.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 13.6 m -67.2 96.11 0.45 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -111.12 -179.9 3.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 112.346 -171.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.817 ' HE1' HD13 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -157.7 131.31 7.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.245 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 35.2 t -110.17 118.63 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . . . -94.12 149.9 20.82 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.27 123.02 1.49 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -179.59 -109.17 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -149.27 41.12 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.0 mt -58.54 131.53 51.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.906 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.0 m -136.98 132.14 33.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.344 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.635 ' HB3' HD12 ' A' ' 49' ' ' LEU . 37.2 t80 -90.16 127.38 36.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.458 HG21 ' CD1' ' A' ' 85' ' ' TYR . 71.1 p -63.03 -37.27 86.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.051 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.498 HD13 HD23 ' A' ' 49' ' ' LEU . 9.9 tp 49.64 -93.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.696 0.798 . . . . 0.0 112.161 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.465 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 5.4 m-85 -99.09 8.66 44.71 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.165 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -80.27 178.87 7.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.823 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.622 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 12.1 mm-40 -52.55 -54.91 37.41 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 52.1 Cg_exo -55.36 -37.65 94.48 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.671 1.581 . . . . 0.0 112.445 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.46 116.81 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.767 0.794 . . . . 0.0 112.878 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 54.01 58.06 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.741 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.21 162.56 39.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.005 -178.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.765 HD21 HG13 ' A' ' 135' ' ' VAL . 12.5 tp -101.73 151.37 22.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.464 0.174 . . . . 0.0 110.741 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.458 ' CD1' HG21 ' A' ' 75' ' ' THR . 18.4 p90 -155.82 -152.02 0.37 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 168.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.58 -167.5 24.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.99 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 6.3 tm0? -99.97 164.7 11.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.389 0.614 . . . . 0.0 111.608 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 88' ' ' LEU . 22.3 tp -155.41 135.14 12.68 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.675 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -133.96 -53.48 0.86 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.188 0.518 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.491 ' HA ' ' HA2' ' A' ' 115' ' ' GLY . 2.3 p -108.43 153.69 22.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.944 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.817 HD13 ' HE1' ' A' ' 66' ' ' PHE . 2.9 mm? -137.77 169.84 17.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.605 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 20.6 t -163.52 111.99 1.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.636 -175.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.694 ' HE2' HD23 ' A' ' 19' ' ' LEU . 3.4 m-30 -103.92 131.88 50.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.19 169.15 41.65 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.934 -1.126 . . . . 0.0 112.224 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -89.78 115.05 26.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.205 0.526 . . . . 0.0 111.374 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.54 112.14 0.64 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.625 170.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.447 HD11 HG22 ' A' ' 67' ' ' VAL . 13.1 mt -89.39 160.26 16.91 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.474 0.654 . . . . 0.0 110.476 170.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 t -131.57 166.93 20.3 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.992 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.455 ' C ' ' H ' ' A' ' 101' ' ' ASP . . . -99.23 127.75 9.35 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.19 -174.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.03 31.08 1.79 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 99' ' ' GLY . 29.6 t70 67.96 -90.29 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.999 0.919 . . . . 0.0 110.283 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.0 p -120.69 11.73 11.28 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.999 0.904 . . . . 0.0 108.835 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.405 ' HB3' ' CD ' ' A' ' 104' ' ' PRO . 9.1 m -117.17 167.46 10.8 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.44 175.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.405 ' CD ' ' HB3' ' A' ' 103' ' ' SER . 50.1 Cg_exo -60.47 163.88 14.28 Favored 'Trans proline' 0 C--N 1.329 -0.45 0 C-N-CA 123.147 2.564 . . . . 0.0 114.275 -171.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.414 ' HE2' ' CA ' ' A' ' 43' ' ' GLY . 27.0 m-85 -68.22 164.15 21.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.435 -173.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 p -149.45 154.22 38.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.865 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.732 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -83.84 126.51 40.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -177.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -65.85 -50.95 62.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.129 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.9 t -112.62 85.6 7.58 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.46 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.71 106.28 1.44 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.637 2.892 . . . . 0.0 113.034 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -100.45 -140.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 1.055 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 38.8 t -62.01 143.62 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.691 0.757 . . . . 0.0 111.572 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.545 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 53.2 m -143.94 179.09 7.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.411 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.706 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.2 m-85 -137.57 150.24 47.32 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.058 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.601 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -162.31 131.89 2.65 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.353 175.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 106.6 16.03 15.43 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.794 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.484 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 11.8 mt -56.72 -44.18 81.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 51.63 50.58 18.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.63 0.728 . . . . 0.0 110.428 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 27.1 mt -109.15 118.87 37.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.894 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 13.1 p -116.64 133.08 56.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.313 . . . . 0.0 110.479 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 53.1 p -103.76 154.22 19.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.528 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 64.5 mt -82.06 165.94 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.575 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -58.84 -57.13 14.38 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -75.73 5.19 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.542 ' HB3' ' N ' ' A' ' 129' ' ' GLY . 31.3 mt-30 -80.03 57.24 2.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.74 102.32 0.49 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.847 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 81.13 -30.53 0.11 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.97 0.908 . . . . 0.0 111.553 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.471 ' HA ' HE21 ' A' ' 133' ' ' GLN . 8.6 t70 -81.23 -27.68 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.082 0.239 . . . . 0.0 111.357 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.542 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -56.09 128.14 44.94 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 28.0 m -56.48 -25.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -68.17 -48.53 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.639 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.4 t-160 -61.6 -38.75 88.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.819 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.591 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 21.1 mm-40 -56.21 -67.65 0.28 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.157 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 130' ' ' VAL . 17.7 m -58.05 -40.17 75.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.191 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.765 HG13 HD21 ' A' ' 84' ' ' LEU . 11.4 p -68.56 -47.37 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 121.289 -0.165 . . . . 0.0 111.083 -176.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.406 ' HD1' HG11 ' A' ' 135' ' ' VAL . 9.2 m-85 -72.26 -23.07 61.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.85 -55.59 23.71 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.676 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -48.29 -52.72 20.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.29 0.567 . . . . 0.0 110.747 176.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 1.111 ' HG2' HG13 ' A' ' 56' ' ' ILE . 51.9 mtp -54.53 -35.57 63.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.297 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.2 m -91.63 -1.99 57.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.829 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.56 44.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.92 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -109.73 134.33 52.12 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.46 0.304 . . . . 0.0 110.286 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.578 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 43.8 p -112.4 -11.29 13.68 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.404 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.14 -38.68 56.72 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.523 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.37 -38.0 68.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.693 -0.298 . . . . 0.0 111.021 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.586 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 45.2 tp -67.64 -38.63 84.12 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.859 ' HG2' HG21 ' A' ' 161' ' ' VAL . 67.6 mt-10 -55.93 -38.16 69.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.68 -34.71 58.21 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.12 0.486 . . . . 0.0 109.91 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.06 85.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.939 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.3 mt -55.92 -45.97 78.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.445 174.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -53.94 -16.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.76 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.34 46.51 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.11 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.594 HG22 ' HB3' ' A' ' 2' ' ' PHE . 3.8 mp -81.09 -47.01 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.83 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.548 HD13 HG11 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.99 -37.84 69.64 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.319 . . . . 0.0 111.498 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.71 -30.37 69.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.332 0.587 . . . . 0.0 110.014 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.459 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.0 m-85 -103.39 -9.74 19.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.1 20.55 25.41 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.824 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.459 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -105.51 -166.8 1.25 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.475 0.638 . . . . 0.0 110.915 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.8 m -159.74 179.28 8.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.859 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.0 p -56.61 -25.6 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.313 0.578 . . . . 0.0 110.965 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -89.64 33.65 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.124 -0.36 . . . . 0.0 111.637 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.632 ' HB3' HG21 ' A' ' 168' ' ' VAL . 18.7 t -101.93 150.62 23.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.9 m -72.8 133.55 44.54 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 119.003 -0.522 . . . . 0.0 111.649 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.66 ' CD1' HD12 ' A' ' 15' ' ' ILE . 3.4 m-30 -38.89 -53.97 1.67 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.23 -46.2 86.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.483 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -70.99 -35.85 72.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.739 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.728 HG22 HD11 ' A' ' 15' ' ' ILE . 37.1 t -62.4 -52.93 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.78 76.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.022 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 173' ' ' ALA . . . -64.78 -33.56 76.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.524 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.457 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -74.49 -32.63 62.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.227 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.822 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 31.0 p -85.15 -12.9 51.73 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.092 0.948 . . . . 0.0 109.611 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 170' ' ' ALA . . . -68.85 -40.86 79.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.831 172.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.625 HG12 ' N ' ' A' ' 175' ' ' GLY . 7.3 p -170.61 -32.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.469 -177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.625 ' N ' HG12 ' A' ' 174' ' ' VAL . . . 115.57 113.1 2.86 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' A' ' 170' ' ' ALA . 16.3 m -129.01 147.16 33.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.985 -169.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 61.99 -174.65 0.14 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.598 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.5 p80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.132 178.779 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.865 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.6 t80 . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 p -173.9 165.3 4.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.307 0.575 . . . . 0.0 110.945 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.645 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.97 125.69 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.779 171.148 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.591 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 30.9 m-80 -101.75 49.4 0.86 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.746 0.784 . . . . 0.0 110.402 -176.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.982 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 26.1 p90 -74.42 148.48 41.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.589 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.7 t70 -63.27 106.62 0.91 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.715 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 10.2 t -39.25 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.841 1.338 . . . . 0.0 112.502 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 7' ' ' ASP . 13.5 t -173.7 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.967 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.526 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 85.5 m-85 -94.23 15.16 18.04 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.071 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.18 68.62 1.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.679 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -168.26 8.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 164' ' ' THR . 22.1 m-85 -92.57 146.88 23.33 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 122.163 0.185 . . . . 0.0 110.968 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 m -71.11 132.62 45.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.755 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -46.15 -53.31 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.569 0.622 . . . . 0.0 111.377 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.498 ' HB2' HG22 ' A' ' 161' ' ' VAL . 23.0 t-80 -61.07 -24.57 66.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.582 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.15 -44.82 28.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -71.12 -41.97 69.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.354 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.93 ' HB3' HG21 ' A' ' 143' ' ' THR . 14.3 mt -56.33 -39.78 73.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.304 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -42.18 96.78 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.113 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 24' ' ' SER . 8.2 tt0 -61.89 -38.21 87.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.534 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 49.0 t90 -60.43 -46.36 90.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.867 175.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 26' ' ' PHE . . . -65.83 -26.59 67.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.295 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.533 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 36.0 t -57.75 -55.51 33.88 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.038 0.447 . . . . 0.0 109.997 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.85 -32.39 73.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.603 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.476 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.0 t80 -61.78 -47.16 86.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.95 -30.67 76.37 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.284 -0.484 . . . . 0.0 113.766 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.27 109.0 8.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.661 HG12 ' HB1' ' A' ' 60' ' ' ALA . 17.1 m . . . . . 0 C--N 1.328 -0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.4 -8.13 54.6 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.088 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.29 -5.88 32.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.382 0.61 . . . . 0.0 109.563 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.499 HG21 HG23 ' A' ' 63' ' ' VAL . 41.1 t -102.18 114.41 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.179 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -100.18 -73.55 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.52 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -57.14 8.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.069 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.48 73.52 0.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.064 0.935 . . . . 0.0 111.035 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 7.5 m120 -84.58 135.03 34.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.456 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 69.2 m -74.86 -40.3 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 124.79 -124.97 5.56 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.447 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 59.79 2.96 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 61.3 m-85 60.6 -178.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.712 0.768 . . . . 0.0 112.976 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.502 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 36.9 t80 -142.02 -69.21 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.503 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.16 55.82 3.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.153 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 50' ' ' SER . . . 168.43 157.06 10.86 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.33 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.483 ' O ' HD23 ' A' ' 49' ' ' LEU . 4.0 m -82.06 -27.89 32.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.322 0.582 . . . . 0.0 109.896 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 48' ' ' SER . 6.8 mt -154.67 -40.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.452 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.771 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 10.4 p -116.04 148.25 40.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.839 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.8 -137.76 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.782 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 p -94.71 -57.92 2.33 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 54.2 tt0 -114.75 152.24 32.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.105 -167.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.736 ' CD1' HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -145.12 94.77 2.58 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.723 0.773 . . . . 0.0 111.47 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 97' ' ' LEU . . . -95.43 151.44 19.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.824 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.982 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.8 mm -146.45 129.42 8.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 123.197 0.599 . . . . 0.0 110.618 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.3 t -112.87 147.3 37.29 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 43.2 t -45.6 117.4 1.44 Allowed 'General case' 0 C--O 1.207 -1.163 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.535 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -12.93 56.52 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.977 -0.452 . . . . 0.0 110.843 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.661 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -80.66 -60.73 2.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.834 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -115.5 -0.67 13.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.793 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.8 mt-30 33.77 42.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -173.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.499 HG23 HG21 ' A' ' 36' ' ' VAL . 7.3 p -121.83 -53.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.858 166.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 32.5 m -64.19 103.89 0.68 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.216 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.02 -176.95 3.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -169.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.779 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -159.82 120.15 3.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.267 -176.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 69.1 t -102.46 109.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.567 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.779 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -97.18 151.62 19.63 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.56 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.29 139.56 6.52 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.014 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 -117.87 0.48 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.373 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.759 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 64.8 t30 -145.91 73.15 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 54' ' ' TYR . 16.4 mt -83.29 161.08 21.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.657 -164.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.59 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 52.8 m -155.75 121.57 5.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.481 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.922 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 44.1 t80 -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.421 0.629 . . . . 0.0 109.991 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.498 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . 13.0 p -81.87 47.61 1.12 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -171.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.922 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -60.02 -57.74 11.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.245 1.384 . . . . 0.0 111.987 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.402 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 11.5 m-30 -89.92 1.72 55.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.508 0.67 . . . . 0.0 109.514 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' HB2' ' CA ' ' A' ' 75' ' ' THR . 29.7 m-80 -89.02 179.07 6.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.349 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.906 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 33.7 mm-40 -53.27 -67.8 0.54 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 51.6 Cg_exo -56.66 -28.16 73.89 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 121.666 1.578 . . . . 0.0 113.13 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.36 115.43 0.05 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.655 0.74 . . . . 0.0 112.64 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 54.04 51.36 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.277 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.733 HG22 ' CE1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -134.97 178.98 6.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.703 -174.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.4 tp -125.75 142.23 51.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -153.95 -159.53 0.98 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.93 -163.32 19.35 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.307 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.759 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 1.2 tm0? -93.36 165.94 12.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.788 0.804 . . . . 0.0 112.137 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.423 HD13 ' OH ' ' A' ' 54' ' ' TYR . 25.3 tp -156.12 132.83 10.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.985 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -132.14 -45.0 0.93 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.262 0.553 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.52 134.39 46.06 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.535 HD12 ' HE1' ' A' ' 66' ' ' PHE . 3.1 mm? -108.13 175.55 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.903 169.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.67 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 12.6 t -167.22 103.78 0.53 Allowed 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.502 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.779 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.4 m-30 -95.87 145.19 25.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.78 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 177.04 170.92 40.07 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.906 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.8 114.63 26.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 111.594 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . 85.01 107.44 0.65 Allowed Glycine 0 C--O 1.223 -0.558 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.781 169.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 105' ' ' TYR . 48.1 mt -86.59 155.77 20.31 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.231 0.539 . . . . 0.0 110.29 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -145.42 173.67 11.8 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.13 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.155 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -172.843 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.502 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 25.6 Cg_exo . . . . . 0 N--CA 1.464 -0.241 0 N-CA-C 111.452 -0.249 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.474 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 48.3 m-85 -68.06 141.74 56.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.815 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.0 p -150.79 147.09 26.86 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.335 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.78 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.1 mp -79.42 130.17 36.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.109 0.48 . . . . 0.0 110.82 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.79 -44.48 93.2 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.156 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.92 82.82 2.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.8 111.21 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.523 2.815 . . . . 0.0 112.908 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 49.4 m-20 -104.48 -150.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.376 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.982 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 48.4 t -59.71 143.25 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.698 0.761 . . . . 0.0 111.572 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.591 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -140.74 178.83 7.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.339 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.516 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.8 m-85 -135.19 148.27 49.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -162.51 140.51 6.59 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.824 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.865 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 99.17 11.87 44.25 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.2 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.529 ' HA ' HD11 ' A' ' 153' ' ' ILE . 16.7 mt -57.98 -50.53 73.09 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 56.15 52.2 10.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.764 0.792 . . . . 0.0 110.519 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 23.7 mt -113.74 110.14 19.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.478 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.636 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 72.4 p -115.02 130.71 57.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 81.2 p -98.02 147.2 24.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.723 0.297 . . . . 0.0 110.493 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.61 171.32 14.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.855 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -49.62 -55.39 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.92 10.23 8.31 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.447 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 19.3 mm-40 -79.84 67.78 5.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.52 -103.61 0.01 OUTLIER Glycine 0 C--O 1.224 -0.519 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.434 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -83.41 -14.81 51.85 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.11 -0.641 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -87.43 -18.81 29.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 125' ' ' GLN . . . -65.25 121.42 20.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.569 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.0 m -49.57 -32.77 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.11 -41.6 92.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.27 0.486 . . . . 0.0 110.718 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.733 ' CE1' HG22 ' A' ' 83' ' ' THR . 4.9 t-160 -65.28 -37.84 88.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 109.85 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.569 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 2.1 mt-30 -65.41 -58.14 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.731 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 130' ' ' VAL . 24.9 m -58.31 -39.35 73.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.373 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.559 ' O ' ' HG3' ' A' ' 139' ' ' MET . 13.0 p -67.68 -50.04 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.755 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.427 ' HD1' HG13 ' A' ' 135' ' ' VAL . 14.0 m-85 -71.01 -27.19 63.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.695 0.283 . . . . 0.0 110.823 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.98 -56.8 18.69 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -49.5 -50.4 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.145 0.578 . . . . 0.0 111.1 176.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.982 ' HG2' HG13 ' A' ' 56' ' ' ILE . 48.6 mtp -54.87 -33.15 61.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.41 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.2 m -94.1 -6.41 45.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.17 23.44 29.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.506 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -107.76 135.48 49.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.93 HG21 ' HB3' ' A' ' 19' ' ' LEU . 37.4 p -117.94 10.16 13.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.798 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.498 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.03 -19.27 78.3 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.69 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.27 -36.02 14.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 0.0 110.647 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.726 HD12 HD21 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -67.34 -39.59 85.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.929 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.664 ' HB2' HG11 ' A' ' 161' ' ' VAL . 10.9 pt-20 -56.61 -35.25 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.82 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 -35.69 53.15 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.996 0.426 . . . . 0.0 109.964 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.46 82.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.615 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 96.3 mt -55.96 -42.06 75.67 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.88 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -54.65 -10.35 0.43 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.171 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.0 -39.85 53.12 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.411 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.5 mp -85.52 -46.49 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 120.727 0.299 . . . . 0.0 110.436 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.495 HD11 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.28 -44.65 80.0 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.911 -177.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.63 -22.86 67.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.678 0.275 . . . . 0.0 111.514 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.12 -35.13 79.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.499 . . . . 0.0 110.019 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.447 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 34.5 m-85 -96.06 -14.68 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 99.19 24.11 10.69 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.756 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.447 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -104.4 -161.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.189 0.495 . . . . 0.0 110.377 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 66.7 p -162.61 -179.94 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.819 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.664 HG11 ' HB2' ' A' ' 147' ' ' GLU . 9.1 p -59.06 -20.35 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.062 0.458 . . . . 0.0 111.392 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.87 13.52 12.46 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.048 -0.408 . . . . 0.0 111.022 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 168' ' ' VAL . 8.5 t -84.01 148.7 26.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.7 m -72.81 149.44 43.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.988 -175.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.686 ' CD1' HD13 ' A' ' 15' ' ' ILE . 10.7 m-30 -53.19 -22.7 7.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.585 0.754 . . . . 0.0 111.46 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.46 -51.04 7.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.457 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -66.85 -43.63 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.604 HG23 ' HB3' ' A' ' 163' ' ' SER . 3.2 t -55.58 -58.52 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.02 73.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.16 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -66.84 -35.83 80.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.57 -30.86 57.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.385 0.612 . . . . 0.0 110.245 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.3 p -85.2 -15.26 44.23 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.92 0.867 . . . . 0.0 109.034 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.268 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.76 ' O ' ' HB ' ' A' ' 172' ' ' THR . 44.4 t80 . . . . . 0 C--O 1.222 -0.395 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -162.41 168.35 22.23 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.729 0.812 . . . . 0.0 109.221 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.624 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.9 128.19 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.681 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 25.3 m-80 -103.9 49.97 0.81 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 0.0 110.328 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.936 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 32.6 p90 -71.49 151.4 43.97 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.097 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 9' ' ' SER . 25.5 t70 -62.36 103.08 0.36 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.665 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 5.3 t -34.94 77.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.113 1.508 . . . . 0.0 112.974 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.4 t -173.35 -30.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.298 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.573 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 66.5 m-85 -95.74 19.81 10.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.004 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 59.2 2.31 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -172.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.402 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -166.32 16.9 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.558 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 26.4 m-85 -93.66 139.86 30.31 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.163 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 m -67.55 131.54 45.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 160.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.782 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.5 mm -45.65 -51.56 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 117.917 0.326 . . . . 0.0 111.499 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -56.14 -34.79 66.45 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.559 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.25 -53.35 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.394 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.481 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 73.6 t80 -68.86 -39.64 79.75 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.583 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 12.1 mt -56.69 -40.84 76.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.955 0.407 . . . . 0.0 110.244 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.62 -41.58 99.61 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.017 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 24' ' ' SER . 6.0 tt0 -62.25 -39.85 94.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.641 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 44.8 t90 -59.16 -42.33 90.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.25 0.548 . . . . 0.0 110.202 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.38 -25.05 66.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 21.2 t -62.96 -55.78 22.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.024 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.3 -31.02 72.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.773 0.32 . . . . 0.0 111.073 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 32.1 t80 -58.85 -41.13 86.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.922 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.43 -18.64 78.46 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.433 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 90.33 2.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.414 0.626 . . . . 0.0 111.573 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.827 HG12 ' HB1' ' A' ' 60' ' ' ALA . 29.6 m . . . . . 0 C--N 1.324 -0.537 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 44.2 t-20 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -6.78 56.3 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.419 -0.42 . . . . 0.0 114.064 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -112.98 -5.29 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.492 0.646 . . . . 0.0 111.534 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.509 HG11 HG13 ' A' ' 63' ' ' VAL . 46.1 t -102.42 118.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.13 0.49 . . . . 0.0 111.743 -175.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.92 -62.83 1.39 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.46 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.91 -72.7 0.3 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.01 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 68.97 87.04 0.12 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.378 0.609 . . . . 0.0 112.247 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -83.72 154.38 23.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.86 175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -82.22 -37.65 25.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.406 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.29 170.73 39.3 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.154 -174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.912 ' HA2' ' HE2' ' A' ' 105' ' ' TYR . . . -98.55 -111.67 3.12 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -168.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 55.96 64.96 1.57 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.952 0.882 . . . . 0.0 109.024 -164.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 52' ' ' SER . 2.2 t80 -73.12 -23.92 60.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.668 -173.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.857 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.95 -19.66 64.82 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.376 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.02 -145.59 8.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.453 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 m -75.04 -30.42 61.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.767 0.318 . . . . 0.0 110.958 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -166.43 40.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.284 0.564 . . . . 0.0 111.397 -175.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 p -164.67 177.65 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.35 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.857 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 106.49 -163.65 13.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.297 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 16.6 m -88.54 127.57 35.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 68' ' ' ALA . 5.3 tt0 80.21 105.72 0.07 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.178 171.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -102.05 101.6 11.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.329 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.601 ' H ' ' HA3' ' A' ' 43' ' ' GLY . . . -90.52 152.78 20.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.003 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.026 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.1 mm -147.18 132.86 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.318 0.647 . . . . 0.0 109.51 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 19.8 t -121.86 149.28 43.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 40.9 t -48.06 119.4 2.88 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.399 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -66.64 -10.3 44.66 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.821 -0.549 . . . . 0.0 111.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.827 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -83.81 -49.87 8.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.674 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.411 ' O ' HG23 ' A' ' 63' ' ' VAL . 39.2 p30 -127.76 -3.81 5.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.86 -172.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 58' ' ' SER . 63.7 mt-30 33.8 45.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.947 1.299 . . . . 0.0 114.168 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.509 HG13 HG11 ' A' ' 36' ' ' VAL . 7.4 t -116.66 -63.38 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.669 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 21.6 m -61.84 102.59 0.28 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.337 -175.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.45 -178.43 3.38 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.54 -169.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.692 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -157.74 126.01 5.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.757 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 29.0 t -108.67 111.27 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 53' ' ' GLN . . . -90.29 107.69 19.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 0.0 111.03 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.86 117.91 5.36 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.852 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.67 -139.39 3.69 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.406 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 87' ' ' GLN . 8.7 m-80 -136.24 47.74 2.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.027 0.918 . . . . 0.0 109.222 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 35.6 mt -70.31 149.92 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.639 -1.619 . . . . 0.0 112.015 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.7 m -155.05 137.19 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.142 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 33.7 t80 -89.21 123.66 33.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.564 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.751 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 69.1 p -70.91 -32.55 69.52 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -171.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.745 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER 42.09 -92.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.836 0.854 . . . . 0.0 113.117 -168.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.518 ' H ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.63 7.29 46.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.751 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 33.8 m-80 -77.16 176.57 8.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.802 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 39.8 mt-10 -48.52 -63.13 1.7 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -170.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.802 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -55.65 -35.77 93.58 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.616 1.544 . . . . 0.0 112.433 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.63 128.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.894 0.746 . . . . 0.0 112.463 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 38.09 60.28 1.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.059 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -143.32 165.64 26.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.847 -174.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.761 HD23 HG11 ' A' ' 135' ' ' VAL . 11.7 tp -108.94 146.91 33.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 17.0 p90 -153.65 -160.7 1.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 85' ' ' TYR . . . 98.97 -166.56 21.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.929 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.683 HE22 ' HB2' ' A' ' 89' ' ' ASP . 17.8 tm0? -92.58 158.03 16.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.687 0.756 . . . . 0.0 111.906 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.567 ' CD2' HG21 ' A' ' 134' ' ' VAL . 57.1 tp -143.76 110.24 5.5 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.045 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.683 ' HB2' HE22 ' A' ' 87' ' ' GLN . 36.1 t70 -126.54 -28.82 2.98 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.882 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.498 ' O ' HD13 ' A' ' 91' ' ' LEU . 31.0 t -134.89 160.19 39.05 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.05 0.928 . . . . 0.0 112.327 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 3.0 mm? -144.46 163.7 33.04 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 19.9 t -162.82 106.93 1.1 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.163 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.781 ' CE2' HD22 ' A' ' 19' ' ' LEU . 2.4 m-30 -97.64 135.05 40.01 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.42 160.88 28.77 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.013 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.83 110.82 20.22 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.258 0.551 . . . . 0.0 110.734 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.96 110.51 2.36 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.801 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.523 HD21 HG22 ' A' ' 67' ' ' VAL . 6.6 mt -83.89 155.14 23.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.486 . . . . 0.0 109.846 170.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 t -145.95 170.2 17.1 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.908 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.536 -177.549 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 C--O 1.235 0.363 0 CA-C-O 121.07 0.363 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.912 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 48.8 m-85 -75.8 165.19 25.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.404 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.6 p -147.77 139.76 24.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.996 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.815 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -81.61 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.624 -174.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.14 -48.16 77.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.053 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.75 88.37 7.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.87 93.9 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 123.142 2.561 . . . . 0.0 112.354 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.456 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 30.3 m-20 -93.45 -155.56 0.45 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.413 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.936 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 20.7 t -62.0 113.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.427 1.108 . . . . 0.0 112.422 -175.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.681 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 68.5 m -103.02 176.65 5.08 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.327 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.723 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.0 m-85 -137.07 141.28 42.39 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -156.45 128.92 2.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.155 -1.498 . . . . 0.0 113.047 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 111.38 10.0 20.68 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.25 174.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.649 ' CD2' ' H ' ' A' ' 117' ' ' LEU . 1.7 mm? -49.88 -53.04 28.3 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.063 0.945 . . . . 0.0 110.52 174.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.4 t30 53.68 47.62 23.38 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.58 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.4 mt -105.22 102.55 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.498 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.627 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 69.5 p -106.16 128.5 53.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.268 0.556 . . . . 0.0 110.851 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.7 t -108.71 119.16 38.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 122' ' ' LEU . 9.9 mp -59.14 167.49 1.71 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.297 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -51.65 -57.84 8.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.877 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.582 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -83.36 15.15 3.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -165.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -72.98 -31.09 64.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 66.18 -119.91 14.37 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.203 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.45 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 6.1 t-80 -88.77 -24.06 22.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.42 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.551 ' HA ' HE21 ' A' ' 133' ' ' GLN . 32.7 t70 -81.06 -21.49 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.822 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 125.99 40.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.281 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 134' ' ' VAL . 18.6 m -51.18 -32.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.3 -42.23 94.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.556 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.9 t-160 -65.05 -40.36 94.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.779 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 128' ' ' ASP . 23.2 mm-40 -59.77 -65.31 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.926 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.567 HG21 ' CD2' ' A' ' 88' ' ' LEU . 27.1 m -55.86 -39.84 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.014 -174.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.761 HG11 HD23 ' A' ' 84' ' ' LEU . 8.3 p -69.68 -46.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.256 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -73.35 -24.77 60.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.54 -54.96 19.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.575 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -48.7 -50.72 32.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.158 0.583 . . . . 0.0 110.82 176.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' MET . . . . . 1.026 ' HG2' HG13 ' A' ' 56' ' ' ILE . 41.5 mtp -52.72 -34.61 53.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.133 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m -90.99 -2.81 57.65 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 14.89 69.33 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.597 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -106.88 104.16 13.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.182 0.515 . . . . 0.0 110.302 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 19' ' ' LEU . 3.5 p -92.16 11.86 24.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.481 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.19 -29.1 72.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.776 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.73 39.46 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.434 -0.451 . . . . 0.0 110.431 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.562 HD22 HD21 ' A' ' 138' ' ' LEU . 47.1 tp -68.39 -43.13 77.96 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.589 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.678 ' HB2' HG21 ' A' ' 161' ' ' VAL . 10.6 pt-20 -57.85 -31.08 66.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.658 0.266 . . . . 0.0 110.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -36.12 58.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.57 75.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.928 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.539 HD23 HD11 ' A' ' 117' ' ' LEU . 94.1 mt -55.45 -39.22 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.8 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -56.28 -10.19 0.83 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.451 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.35 -36.24 63.29 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.389 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.41 HG22 ' HE2' ' A' ' 157' ' ' TYR . 4.1 mp -84.4 -47.98 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 122.705 -0.291 . . . . 0.0 110.58 175.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.638 HD11 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.63 -43.09 75.86 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.418 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.8 -30.78 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.94 -31.84 72.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.137 0.494 . . . . 0.0 110.818 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.41 ' HE2' HG22 ' A' ' 153' ' ' ILE . 47.0 m-85 -98.86 -6.11 29.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.299 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.38 39.31 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.308 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 mp -101.4 -167.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.1 p -167.85 175.41 6.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.286 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -61.71 -13.27 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.271 . . . . 0.0 111.669 172.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -89.73 10.62 22.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.956 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -87.17 -116.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.184 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 7.2 m -157.31 146.83 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.771 -174.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.691 ' CD1' HD13 ' A' ' 15' ' ' ILE . 6.7 m-30 -54.47 -45.26 73.12 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.455 0.302 . . . . 0.0 111.025 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.13 -41.1 90.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.656 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -66.78 -48.18 69.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.638 HG22 HD11 ' A' ' 154' ' ' LEU . 4.0 t -56.23 -54.95 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.686 0.279 . . . . 0.0 110.272 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.21 76.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.017 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.278 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.74 59.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.76 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 38.0 p -86.27 -11.84 51.19 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.06 0.933 . . . . 0.0 109.146 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 N--CA 1.445 -0.71 0 CA-C-N 113.868 -1.514 . . . . 0.0 108.949 171.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.705 ' O ' ' HB ' ' A' ' 172' ' ' THR . 42.7 t80 . . . . . 0 CA--C 1.515 -0.394 0 CA-C-O 120.682 0.277 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -160.75 168.42 24.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.965 172.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' A' ' 165' ' ' PHE . 0.5 OUTLIER -88.19 130.17 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 113' ' ' SER . 44.5 m-20 -106.32 46.82 0.9 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.871 0.844 . . . . 0.0 110.814 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.962 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 20.4 p90 -70.56 145.4 50.82 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.261 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 9' ' ' SER . 32.7 t70 -63.82 104.84 0.73 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.347 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 p -25.15 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.726 1.61 . . . . 0.0 114.579 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ASP . 42.2 t -174.64 -32.07 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.26 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.596 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 74.7 m-85 -94.21 16.86 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.15 70.81 0.61 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.511 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.62 23.24 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.666 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 25.7 m-85 -107.77 141.36 39.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.522 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -72.55 129.59 38.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 161.071 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 168' ' ' VAL . 5.0 mm -47.24 -43.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -170.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -63.2 -33.34 75.27 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.569 0.223 . . . . 0.0 111.316 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.28 -36.14 82.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 110.766 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.895 ' CE1' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -72.1 -48.12 46.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 175.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.803 HD21 ' HZ ' ' A' ' 114' ' ' PHE . 15.9 mt -53.05 -46.54 68.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.774 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.2 -44.7 94.77 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.68 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -62.96 -43.46 98.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.661 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 55.6 t90 -58.69 -45.13 90.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.551 . . . . 0.0 109.916 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.4 -24.03 64.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.2 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -62.52 -53.2 58.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -34.35 78.04 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.491 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.2 t80 -56.8 -42.41 79.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.519 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.14 -21.41 79.21 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.239 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 7.3 t70 -75.96 104.03 6.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 111.0 -174.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.837 HG12 ' HB1' ' A' ' 60' ' ' ALA . 20.1 m . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.62 -6.77 63.42 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.996 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -118.37 3.88 11.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 117.628 0.714 . . . . 0.0 111.745 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 63' ' ' VAL . 25.5 t -98.11 112.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.293 0.568 . . . . 0.0 112.378 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.78 -67.07 0.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.653 172.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -75.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.148 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.523 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 65.11 63.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.459 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 16.0 m120 -86.23 147.99 25.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.365 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 57' ' ' SER . 71.8 m -93.65 -39.11 10.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.997 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 114.3 -129.13 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.397 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.95 62.44 2.01 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 121.201 -0.524 . . . . 0.0 113.067 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 66.33 130.66 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.488 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 17.5 t80 -107.88 -24.65 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.269 172.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.48 19.8 8.28 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.132 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.76 -132.02 7.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.633 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -75.89 -52.18 10.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.543 0.211 . . . . 0.0 111.419 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -164.44 21.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.1 p -161.62 156.65 23.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.82 -64.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.243 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.615 ' C ' ' HA2' ' A' ' 70' ' ' GLY . 23.1 t -148.77 -144.75 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 121.349 -0.14 . . . . 0.0 110.631 -170.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 51.1 mt-30 -43.93 141.75 1.56 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.806 0.842 . . . . 0.0 112.104 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.423 ' HB3' HD12 ' A' ' 72' ' ' LEU . 3.9 t80 -130.99 96.98 4.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.504 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -89.76 146.77 24.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.558 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.03 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.3 mm -145.12 121.1 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.564 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.1 t -104.73 165.97 10.7 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.436 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 33.4 t -61.13 152.78 27.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.09 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.9 p -101.53 -14.09 17.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.019 0.438 . . . . 0.0 110.115 168.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.837 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -75.47 -54.5 6.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.293 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 37.9 p30 -115.3 0.98 13.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.154 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 58' ' ' SER . 69.5 mt-30 30.0 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.8 p -128.64 -51.64 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.459 171.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 17.1 m -63.33 107.5 1.1 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.692 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -121.27 -178.22 3.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -170.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.779 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -156.37 131.78 9.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.869 -176.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 58.1 t -110.98 119.99 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.542 0.211 . . . . 0.0 110.694 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.78 14.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.949 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 53' ' ' GLN . . . -63.29 -99.3 0.01 OUTLIER Glycine 0 C--O 1.217 -0.921 0 N-CA-C 116.61 1.404 . . . . 0.0 116.61 -167.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.615 ' HA2' ' C ' ' A' ' 52' ' ' SER . . . -179.68 34.13 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 118.826 -1.654 . . . . 0.0 115.495 -170.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 1.5 t30 -146.39 27.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.756 1.278 . . . . 0.0 111.03 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.585 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 73.1 mt -79.05 144.6 34.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.973 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.9 m -144.38 124.33 13.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.383 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.549 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 58.3 t80 -82.07 123.09 28.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.866 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 80.7 p -61.4 -38.96 88.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.626 -171.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 tp 55.53 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 123.812 0.695 . . . . 0.0 111.337 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -100.76 8.39 43.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.742 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.866 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 12.4 m120 -76.44 179.03 6.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 111.536 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.776 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 6.0 mm-40 -51.4 -56.83 17.27 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -57.6 -37.3 97.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.754 1.636 . . . . 0.0 112.513 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.86 125.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.833 0.708 . . . . 0.0 112.372 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 47.53 58.82 4.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.11 169.05 20.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.333 -175.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.773 HD23 HG11 ' A' ' 135' ' ' VAL . 12.2 tp -108.81 138.8 44.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -157.01 139.01 14.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 166.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 72' ' ' LEU . . . -168.65 -131.2 1.27 Allowed Glycine 0 C--N 1.298 -1.542 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.187 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 1.8 tm0? -142.42 151.59 41.95 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 113.889 -1.155 . . . . 0.0 108.831 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.564 HD21 HD11 ' A' ' 91' ' ' LEU . 18.9 tp -138.99 116.25 11.11 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.574 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 16.6 t70 -110.89 -56.62 2.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.645 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.503 ' O ' HD13 ' A' ' 91' ' ' LEU . 4.9 p -107.74 155.07 20.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.323 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.721 HD12 ' HE1' ' A' ' 66' ' ' PHE . 3.0 mm? -141.15 160.52 39.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.663 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 58.0 m -149.76 111.33 4.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.675 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.75 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.9 m-30 -99.72 129.38 45.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.439 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.04 165.32 35.83 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.535 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -90.11 123.13 33.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.197 0.523 . . . . 0.0 111.618 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.76 110.04 0.47 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.469 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.538 HD11 ' HB1' ' A' ' 55' ' ' ALA . 77.0 mt -87.01 151.59 23.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.052 0.453 . . . . 0.0 109.979 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 p -131.19 154.04 48.81 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.998 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.673 174.036 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.8 Cg_exo . . . . . 0 N--CA 1.459 -0.507 0 CA-C-O 121.129 0.387 . . . . 0.0 111.917 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.725 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 64.1 m-85 -67.74 150.7 48.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.322 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' LEU . 18.2 p -144.06 152.75 41.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.544 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.661 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.0 mp -85.98 119.08 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.643 0.259 . . . . 0.0 110.907 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.523 ' NE2' ' H ' ' A' ' 39' ' ' ALA . 41.7 mt-30 -65.04 -47.22 78.14 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 33.5 t -105.16 87.83 2.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 34.0 Cg_endo -63.25 100.7 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.372 2.715 . . . . 0.0 112.453 -176.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.515 ' OD2' HG23 ' A' ' 112' ' ' VAL . 10.1 t70 -106.1 -147.19 0.4 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.962 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 15.4 t -69.79 149.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.355 0.598 . . . . 0.0 111.892 -177.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 5' ' ' ASN . 36.2 m -142.9 -177.49 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.123 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.803 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.0 m-85 -134.35 152.7 51.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.114 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.35 135.74 4.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.515 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.94 13.63 31.21 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.551 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.506 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 mt -55.41 -51.71 65.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.574 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 64.8 t30 53.4 43.26 31.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.208 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -106.29 128.8 54.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 171.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.693 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 51.2 p -131.17 139.04 49.68 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.983 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.5 p -98.55 151.44 20.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.864 0.364 . . . . 0.0 111.392 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.59 162.94 26.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -48.13 -55.56 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.54 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.7 11.35 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 15.0 mm100 -77.44 55.42 1.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 112.134 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 128' ' ' ASP . . . -64.24 104.33 0.88 Allowed Glycine 0 C--O 1.225 -0.422 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.526 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 132' ' ' HIS . 1.6 t-80 74.95 -26.17 0.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.609 0.764 . . . . 0.0 111.35 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 126' ' ' GLY . 24.1 t70 -83.65 -23.21 31.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.091 0.472 . . . . 0.0 110.207 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -60.34 122.14 28.9 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.095 173.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.516 ' O ' HG22 ' A' ' 134' ' ' VAL . 22.9 m -51.52 -33.34 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 86' ' ' GLY . 12.5 m -64.83 -44.87 96.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.561 0.22 . . . . 0.0 110.958 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.582 ' CD2' ' H ' ' A' ' 84' ' ' LEU . 1.5 t-80 -60.38 -40.42 90.79 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.443 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 9.1 mt-30 -59.09 -63.24 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 130' ' ' VAL . 23.7 m -60.01 -40.49 83.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.022 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.779 HG23 ' HZ ' ' A' ' 66' ' ' PHE . 10.7 p -68.99 -45.47 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.325 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.92 -22.44 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 0.0 110.601 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.9 -54.8 19.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.646 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -47.95 -52.17 20.71 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.344 0.658 . . . . 0.0 110.88 176.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' MET . . . . . 1.03 ' HG2' HG13 ' A' ' 56' ' ' ILE . 45.4 mtp -54.63 -33.64 60.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.392 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.5 t -89.67 -15.47 32.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.25 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.5 16.58 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.635 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.61 127.1 48.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.583 HG21 ' HB3' ' A' ' 19' ' ' LEU . 21.7 p -114.61 5.48 15.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.119 0.485 . . . . 0.0 110.979 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.494 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.99 -20.93 80.16 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.583 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.02 -35.45 21.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 36.1 tp -68.06 -40.93 82.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.492 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.633 ' HB2' HG11 ' A' ' 161' ' ' VAL . 11.8 pt-20 -56.67 -34.53 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.716 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -35.4 61.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.116 0.484 . . . . 0.0 110.053 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.21 -46.27 74.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.525 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 95.9 mt -55.26 -41.91 72.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.049 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -52.8 -14.32 0.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.331 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -72.87 -43.65 40.87 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.78 -175.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.411 HG22 ' HE2' ' A' ' 157' ' ' TYR . 3.8 mp -80.27 -43.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.285 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.714 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -59.18 -44.63 92.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.309 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.28 -25.73 67.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 111.389 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.09 -29.5 70.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.471 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 25.5 m-85 -100.47 -12.54 19.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.276 175.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 97.37 18.24 29.11 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.429 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.508 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -102.83 -163.07 0.96 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.421 0.611 . . . . 0.0 110.522 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.9 p -161.69 -176.66 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.974 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 147' ' ' GLU . 8.5 p -58.02 -23.16 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 111.034 174.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -88.77 18.39 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.295 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.703 ' HB3' HG22 ' A' ' 168' ' ' VAL . 16.6 t -83.76 143.42 30.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 168' ' ' VAL . 47.0 m -75.36 141.04 43.38 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.567 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 13' ' ' TYR . 7.0 m-30 -39.82 -49.96 2.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.833 0.853 . . . . 0.0 113.187 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.19 -38.58 88.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.948 0.404 . . . . 0.0 110.742 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -73.99 -38.95 63.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.289 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.714 HG13 HD11 ' A' ' 154' ' ' LEU . 17.9 t -62.07 -52.33 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 109.986 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.38 82.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.84 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -65.83 -35.35 80.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.74 -28.04 60.61 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.364 0.602 . . . . 0.0 110.638 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.705 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.8 p -89.96 -12.94 37.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.071 0.938 . . . . 0.0 109.594 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.512 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.814 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 17.0 t80 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -173.7 160.53 3.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.221 0.534 . . . . 0.0 110.967 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.674 HG11 HD12 ' A' ' 15' ' ' ILE . 11.8 m -97.86 115.96 39.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.752 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.496 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 34.4 m-80 -96.45 59.32 1.82 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.623 -169.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.679 ' CE2' ' HA ' ' A' ' 8' ' ' SER . 38.9 p90 -74.23 149.7 40.69 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.049 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.5 t70 -62.73 94.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.679 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.5 p -24.99 72.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 114.92 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 20.7 t -173.79 -26.23 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.392 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.531 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 83.6 m-85 -90.04 10.24 24.94 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.931 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.2 69.23 1.09 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.974 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.61 21.83 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 164' ' ' THR . 21.8 m-85 -107.42 140.14 40.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.942 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m -68.89 133.24 47.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 162.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.674 HD12 HG11 ' A' ' 4' ' ' VAL . 6.3 mm -51.26 -47.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 118.134 0.424 . . . . 0.0 111.604 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -65.21 -25.22 67.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.947 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.43 -51.12 25.65 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 56.8 t80 -69.51 -49.2 56.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' A' ' 93' ' ' PHE . 16.3 mt -57.42 -38.99 75.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.029 0.442 . . . . 0.0 110.242 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.29 -41.01 94.76 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.86 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.84 -45.44 92.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.953 0.406 . . . . 0.0 110.988 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.738 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 9.3 t90 -52.69 -51.08 61.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.816 174.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.67 -28.92 68.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -57.79 -52.09 66.88 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -27.37 66.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.421 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.542 ' CE2' ' HE1' ' A' ' 66' ' ' PHE . 18.0 t80 -60.44 -49.9 75.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.54 0.209 . . . . 0.0 110.488 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.83 -28.26 73.7 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.254 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -73.25 103.9 4.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 110.962 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.701 HG12 ' HB1' ' A' ' 60' ' ' ALA . 27.9 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.384 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 . . . . . 0 CA--C 1.522 -0.103 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -10.32 62.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.065 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -90.77 -7.12 53.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.593 0.711 . . . . 0.0 109.293 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.546 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 23.4 t -94.91 120.42 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 m -92.7 -57.45 2.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.407 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 4.5 t70 -98.44 -68.81 0.79 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.286 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' H ' HE22 ' A' ' 108' ' ' GLN . . . 79.92 81.25 0.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 124.972 1.42 . . . . 0.0 109.66 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.67 ' HB3' ' HE1' ' A' ' 105' ' ' TYR . 5.4 m120 -78.51 135.74 37.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.256 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 60.2 p -76.56 -45.69 29.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.428 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.0 178.06 27.21 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 44' ' ' PHE . . . -167.56 -45.24 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 117.311 -2.376 . . . . 0.0 117.725 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.8 m-85 70.29 95.38 0.07 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.916 0.858 . . . . 0.0 109.543 -153.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -79.53 -17.42 54.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.55 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.36 17.58 37.82 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.939 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.08 -118.71 4.31 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.351 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.4 m -76.85 -54.35 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.769 0.318 . . . . 0.0 111.778 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -164.99 43.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.664 0.745 . . . . 0.0 110.781 -173.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 p -158.29 -178.32 7.2 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.356 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.86 -166.35 25.67 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.99 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -87.83 -39.1 15.13 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' ALA . 77.9 mt-30 -117.77 155.24 30.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.48 0.657 . . . . 0.0 111.609 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -145.5 101.57 3.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.07 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 97' ' ' LEU . . . -92.91 142.49 27.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.776 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 139' ' ' MET . 31.7 mm -143.49 129.6 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 O-C-N 123.679 0.612 . . . . 0.0 109.945 177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.542 ' HB3' ' HA ' ' A' ' 41' ' ' SER . 22.9 t -112.95 155.79 24.15 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.627 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 38.1 t -48.81 128.85 16.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.829 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 p -76.55 -14.88 59.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.171 0.51 . . . . 0.0 109.866 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.701 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -80.82 -60.06 2.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.891 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -116.33 1.52 13.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.053 0.454 . . . . 0.0 111.503 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.1 mm-40 39.0 36.24 0.15 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -175.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 p -124.08 -51.11 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.686 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 m -64.54 102.98 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -120.62 175.51 5.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.299 0.571 . . . . 0.0 112.205 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -159.73 131.36 6.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.592 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 49.1 t -108.52 115.03 48.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.222 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -86.96 155.25 20.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.61 125.27 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.524 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -177.93 -104.19 0.18 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.694 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 64.4 t30 -150.4 41.26 0.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.5 145.3 55.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.081 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.2 m -154.55 131.81 11.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.475 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HB3' HD13 ' A' ' 49' ' ' LEU . 55.0 t80 -90.46 129.15 36.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.0 p -65.29 -35.81 82.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.529 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 8.8 tp 51.7 -96.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.689 0.796 . . . . 0.0 112.166 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.529 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 4.9 m-85 -101.58 7.78 42.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.103 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.75 178.44 6.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.938 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 41.0 mt-10 -48.35 -62.23 2.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -169.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.79 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 86.8 Cg_exo -50.73 -51.4 11.21 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.978 1.786 . . . . 0.0 112.992 175.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 71.68 130.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.882 0.739 . . . . 0.0 112.402 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 51.8 m80 54.49 49.91 17.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.268 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.652 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.6 OUTLIER -146.49 166.34 26.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 -175.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.668 ' CD2' HG11 ' A' ' 135' ' ' VAL . 13.9 tp -110.74 151.53 27.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -153.49 -153.46 0.47 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.19 -144.46 17.35 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.199 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.716 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 24.7 tm0? -140.97 158.79 43.44 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 91' ' ' LEU . 32.0 tp -144.22 135.15 25.21 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.565 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 19.0 t70 -133.02 -55.14 0.92 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.431 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.636 ' O ' HD22 ' A' ' 91' ' ' LEU . 5.7 p -108.31 158.33 17.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.515 -176.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 68' ' ' ALA . 2.4 mm? -140.23 156.89 46.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 172.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.511 ' HB3' HD11 ' A' ' 107' ' ' ILE . 3.7 m -147.09 106.02 3.85 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.285 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.67 ' CE2' HD22 ' A' ' 19' ' ' LEU . 2.4 m-30 -91.97 147.64 22.81 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.76 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 173.36 163.56 27.2 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.781 173.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.0 117.98 29.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.336 0.589 . . . . 0.0 111.043 176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 104.87 0.88 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.42 172.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.54 ' CD1' ' HB1' ' A' ' 55' ' ' ALA . 50.5 mt -88.93 161.12 16.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.263 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 t -146.96 168.47 21.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.517 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.699 175.416 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo . . . . . 0 N--CA 1.459 -0.519 0 N-CA-C 110.762 -0.515 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.67 ' HE1' ' HB3' ' A' ' 40' ' ' ASN . 38.4 m-85 -65.38 144.25 57.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.584 0.707 . . . . 0.0 111.614 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 p -143.21 138.11 29.45 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.388 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.76 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.0 mp -79.62 123.83 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.546 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 78.2 mt-30 -64.58 -48.43 75.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.308 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.77 90.23 12.57 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.79 102.09 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.816 3.011 . . . . 0.0 113.919 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.6 m-20 -84.7 -164.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.716 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 84.5 t -63.28 138.02 23.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.824 0.821 . . . . 0.0 112.393 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 58.4 m -116.77 179.7 3.94 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.635 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 91.7 m-85 -143.56 153.16 42.28 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.26 134.09 3.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.636 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.814 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 103.89 15.67 21.54 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.308 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.432 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 22.6 mt -58.52 -45.74 88.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.644 0.722 . . . . 0.0 109.632 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.565 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 14.9 t30 59.98 19.0 8.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.436 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -92.36 132.08 37.03 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.559 0.695 . . . . 0.0 110.236 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.716 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 59.9 p -133.21 165.15 25.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.657 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 131' ' ' VAL . 78.2 p -144.48 150.86 38.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.027 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.43 165.84 15.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.6 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -51.06 -56.3 13.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.995 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.597 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -81.77 15.79 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -74.95 -15.86 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.321 177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 44.47 -123.83 5.35 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.705 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.434 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 1.4 t-80 -78.52 -20.14 51.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HA ' HE21 ' A' ' 133' ' ' GLN . 17.0 t70 -85.17 -17.26 37.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.01 122.98 31.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.18 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.626 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.2 m -50.2 -33.62 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.45 HG22 ' OG ' ' A' ' 121' ' ' SER . 27.2 m -64.74 -41.25 91.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.652 ' HE1' HG22 ' A' ' 83' ' ' THR . 3.9 t-160 -64.0 -38.28 90.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.626 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 4.2 mm-40 -63.4 -62.77 1.46 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.59 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 130' ' ' VAL . 15.9 m -58.75 -37.1 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.264 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.668 HG11 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -66.35 -43.97 91.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.379 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.581 ' HD1' HG13 ' A' ' 135' ' ' VAL . 22.2 m-85 -71.94 -27.47 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.308 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -54.29 38.07 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 170.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.599 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.25 -60.62 2.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.544 0.688 . . . . 0.0 110.085 176.267 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.721 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 71.2 mtm -55.59 -25.97 41.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.463 -1.244 . . . . 0.0 114.071 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 m -94.09 -3.2 51.57 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.563 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.42 48.67 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.16 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -106.95 135.18 48.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.161 0.505 . . . . 0.0 110.616 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.418 HG21 ' HB3' ' A' ' 19' ' ' LEU . 23.7 p -111.75 8.5 20.66 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 147' ' ' GLU . . . -74.71 -42.94 30.43 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.553 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.62 -27.02 60.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.219 0.533 . . . . 0.0 109.688 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.619 HD11 ' HZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -73.74 -48.05 34.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.271 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.58 ' HB2' HG11 ' A' ' 161' ' ' VAL . 10.3 pt-20 -56.69 -36.16 69.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -38.28 69.09 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.187 0.518 . . . . 0.0 109.767 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.72 -47.35 75.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.427 ' O ' HD22 ' A' ' 154' ' ' LEU . 96.1 mt -55.74 -46.47 77.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.517 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.93 -15.86 3.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.753 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.86 -39.94 58.59 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.623 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.405 HG22 ' HE2' ' A' ' 157' ' ' TYR . 4.0 mp -81.43 -51.12 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.281 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.737 HD11 HG13 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -54.77 -41.93 71.09 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.77 -23.15 67.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.26 -24.11 63.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 110.106 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.517 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 9.2 m-85 -112.29 0.82 15.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.188 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 90.49 16.96 54.26 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.78 -0.646 . . . . 0.0 113.847 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 2.2 mm? -98.7 -170.88 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.627 0.713 . . . . 0.0 109.536 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 78.6 p -164.21 176.92 8.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.22 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.58 HG11 ' HB2' ' A' ' 147' ' ' GLU . 4.9 p -57.55 -26.45 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.083 0.468 . . . . 0.0 110.632 174.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -90.26 28.91 1.33 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.824 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 14' ' ' SER . 25.3 t -84.55 -134.62 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 98.6 m -158.25 142.39 15.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.58 ' CD1' HD13 ' A' ' 15' ' ' ILE . 10.9 m-30 -44.12 -49.76 8.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -173.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.69 -23.23 62.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.234 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -84.26 -51.52 6.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.737 HG13 HD11 ' A' ' 154' ' ' LEU . 61.5 t -56.34 -57.03 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.255 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.17 69.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.72 84.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.28 -29.29 62.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.194 0.521 . . . . 0.0 110.81 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.675 HG21 ' CD2' ' A' ' 2' ' ' PHE . 40.5 p -88.98 -21.1 23.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.851 0.834 . . . . 0.0 109.645 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.973 178.462 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.809 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 47.0 t80 . . . . . 0 C--O 1.224 -0.279 0 N-CA-C 110.674 -0.121 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -163.42 168.75 19.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.845 0.715 . . . . 0.0 109.094 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.595 HG13 ' HB2' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -88.26 122.59 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.496 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 63.9 m-20 -97.94 45.65 1.02 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.186 0.994 . . . . 0.0 110.366 -174.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.934 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -72.26 150.47 43.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.627 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 9' ' ' SER . 27.6 t70 -64.58 110.28 2.28 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.172 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.46 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.3 p -39.4 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.241 1.416 . . . . 0.0 113.338 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.7 t -170.84 -32.85 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.131 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.428 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 45.8 m-85 -89.44 18.39 5.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.6 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.39 76.82 0.92 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.619 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -174.27 -8.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.487 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 36.3 m-85 -73.5 133.58 43.66 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 122.825 -0.22 . . . . 0.0 110.478 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 17' ' ' ASP . 15.5 m -66.37 132.95 49.47 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 163.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.697 HD13 ' CD1' ' A' ' 165' ' ' PHE . 4.8 mm -46.78 -49.53 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 118.062 0.392 . . . . 0.0 111.697 -172.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.514 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 2.4 t-80 -58.48 -29.88 66.55 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.298 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' SER . 4.0 m-20 -68.2 -58.96 3.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.452 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HB2' ' CG ' ' A' ' 13' ' ' TYR . 59.5 t80 -63.94 -45.56 88.67 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.661 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.934 ' HB3' HG21 ' A' ' 143' ' ' THR . 13.1 mt -57.13 -42.04 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.151 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.64 -40.4 97.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.08 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.08 -42.04 99.55 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 122.631 0.373 . . . . 0.0 111.354 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 39.9 t90 -60.35 -42.7 96.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.408 0.623 . . . . 0.0 109.724 176.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.091 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.0 t -63.58 -54.38 36.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 p -64.34 -35.18 80.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.808 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 19.7 t80 -55.65 -42.93 75.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.213 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.98 -21.21 79.15 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.919 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 29.9 t70 -73.81 104.6 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.201 0.5 . . . . 0.0 111.374 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.655 HG12 ' HB1' ' A' ' 60' ' ' ALA . 24.9 m . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t-20 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.72 -13.56 63.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.001 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -111.13 15.68 21.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.727 HG22 ' NE2' ' A' ' 108' ' ' GLN . 0.5 OUTLIER -134.82 134.32 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -112.56 -74.69 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.043 0.449 . . . . 0.0 111.745 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.16 -67.0 0.5 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.513 -173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.38 80.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.754 0.659 . . . . 0.0 111.592 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 11.0 m120 -79.79 157.76 26.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.449 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 58.0 m -93.26 -24.43 18.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -168.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.17 135.93 3.09 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.005 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.36 59.63 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.245 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 39.2 m-85 62.93 159.17 0.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.996 0.903 . . . . 0.0 112.553 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.859 ' HE1' ' HD3' ' A' ' 104' ' ' PRO . 5.3 t80 -126.72 -36.2 2.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.072 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.85 -21.83 58.84 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.21 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -138.87 4.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.467 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -77.08 -30.17 55.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.725 0.298 . . . . 0.0 110.912 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.609 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -164.25 27.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.604 -175.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -149.25 176.3 10.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.56 173.45 15.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.175 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 t -85.97 -3.17 58.87 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 28.6 tt0 -147.23 150.97 35.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.278 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -154.33 97.17 2.0 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB3' ' CD2' ' A' ' 105' ' ' TYR . . . -91.72 155.69 18.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.713 HG21 ' HG2' ' A' ' 139' ' ' MET . 9.4 mm -150.76 146.81 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.551 0.741 . . . . 0.0 109.254 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 t -122.36 170.95 9.42 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 30.0 t -55.54 141.51 36.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.384 0.611 . . . . 0.0 111.403 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -85.92 -20.36 29.12 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.113 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.655 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.11 -54.08 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.6 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 34.4 p30 -119.64 -1.15 10.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 111.909 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.9 mm-40 42.11 38.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 36' ' ' VAL . 11.7 p -122.78 -57.15 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 122.306 -0.247 . . . . 0.0 110.783 169.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.557 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 19.8 m -58.87 106.84 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 110.495 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -116.74 179.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.712 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -157.42 133.43 9.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.753 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 22.4 t -115.05 114.18 45.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.264 -0.272 . . . . 0.0 110.684 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 53' ' ' GLN . . . -89.34 149.55 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.708 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.69 124.95 1.88 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.139 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.91 -115.5 0.46 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.449 ' HB3' ' CB ' ' A' ' 87' ' ' GLN . 13.9 t-20 -148.38 48.62 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.2 mt -62.86 144.87 56.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.909 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -149.92 138.62 20.83 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.795 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' A' ' 49' ' ' LEU . 58.1 t80 -93.61 133.8 36.56 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 80' ' ' PRO . 31.9 p -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.438 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 8.2 tp 56.4 -94.45 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.079 0.552 . . . . 0.0 111.143 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.438 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 3.5 m-85 -98.57 -1.75 40.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.137 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -75.45 167.05 22.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.647 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 23.8 mm-40 -46.99 -60.08 4.4 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -165.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HB2' HG21 ' A' ' 75' ' ' THR . 99.7 Cg_exo -49.75 -38.27 46.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.769 1.646 . . . . 0.0 113.17 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 65.07 117.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.427 0.632 . . . . 0.0 112.617 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 10.7 m-70 56.7 60.16 3.2 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.512 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.834 HG21 ' HA2' ' A' ' 126' ' ' GLY . 26.5 m -149.3 153.36 37.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.147 -172.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.746 HD23 HG11 ' A' ' 135' ' ' VAL . 14.8 tp -101.12 148.05 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.424 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -156.05 -153.55 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.33 -167.31 24.81 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.258 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.591 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 12.5 tm0? -95.96 165.57 12.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.395 0.617 . . . . 0.0 111.594 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.5 tp -152.85 136.71 16.22 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.007 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.03 -54.48 0.71 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.112 0.482 . . . . 0.0 110.716 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.453 ' C ' HD22 ' A' ' 91' ' ' LEU . 4.5 p -112.56 155.37 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -175.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 3.0 mm? -138.59 161.52 36.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 172.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.644 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 55.5 m -151.6 112.53 4.26 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 122.187 -0.321 . . . . 0.0 110.783 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.793 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.6 m-30 -99.77 139.13 35.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.605 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -179.79 163.86 31.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.522 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.43 132.79 34.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.129 0.464 . . . . 0.0 110.705 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . 68.23 112.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 174.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.441 HD11 ' HB1' ' A' ' 55' ' ' ALA . 54.8 mt -87.04 156.36 19.78 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.199 -0.589 . . . . 0.0 109.953 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.1 t -150.8 -177.55 6.06 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.789 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.914 175.505 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.859 ' HD3' ' HE1' ' A' ' 45' ' ' TYR . 7.2 Cg_endo . . . . . 0 C--O 1.234 0.313 0 N-CA-C 114.522 0.932 . . . . 0.0 114.522 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.644 ' CD2' ' HB3' ' A' ' 55' ' ' ALA . 50.4 m-85 -76.45 169.42 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.91 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 p -151.49 142.64 23.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.1 mp -84.31 120.46 35.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.727 ' NE2' HG22 ' A' ' 36' ' ' VAL . 20.0 mt-30 -65.45 -41.44 93.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.138 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.48 89.9 6.56 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.51 92.37 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.3 2.667 . . . . 0.0 112.49 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 72.9 m-20 -99.32 -153.61 0.44 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.331 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.934 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -62.83 144.66 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.521 0.676 . . . . 0.0 111.549 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -136.6 179.31 6.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 95.6 m-85 -138.79 148.71 44.14 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.7 145.22 10.22 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.693 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.809 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.57 8.23 46.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.628 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 19.4 mt -56.73 -51.68 67.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.073 0.436 . . . . 0.0 109.947 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.411 ' HA ' ' NE2' ' A' ' 87' ' ' GLN . 63.0 t30 49.28 50.98 17.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.693 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 21.5 mt -106.8 107.62 18.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.704 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.591 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 17.9 p -105.82 131.07 53.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.4 t -103.73 141.96 35.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -74.22 169.45 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.41 ' OE1' HG22 ' A' ' 75' ' ' THR . 5.6 tp-100 -58.96 -56.73 18.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.136 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.02 8.33 3.29 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.407 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 7.9 mm-40 -77.04 52.86 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.892 175.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.834 ' HA2' HG21 ' A' ' 83' ' ' THR . . . -62.95 109.22 2.55 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.066 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.629 ' HA ' ' CD2' ' A' ' 132' ' ' HIS . 1.9 t-80 73.4 -40.16 0.46 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.137 0.975 . . . . 0.0 111.926 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -81.86 -11.03 59.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 125' ' ' GLN . . . -64.37 125.73 32.03 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 170.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.512 ' O ' HG22 ' A' ' 134' ' ' VAL . 4.8 p -55.31 -29.4 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.9 -44.69 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.629 ' CD2' ' HA ' ' A' ' 127' ' ' HIS . 1.7 t-80 -62.49 -36.38 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.471 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.505 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 7.8 mt-30 -63.38 -63.73 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.885 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 130' ' ' VAL . 20.6 m -58.58 -39.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.807 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.746 HG11 HD23 ' A' ' 84' ' ' LEU . 10.1 p -68.03 -44.39 84.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.593 0.235 . . . . 0.0 110.784 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.457 ' HD1' HG13 ' A' ' 135' ' ' VAL . 9.7 m-85 -73.03 -31.37 64.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.577 0.227 . . . . 0.0 110.453 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.54 -53.22 45.63 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -50.47 -50.91 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.07 0.462 . . . . 0.0 110.568 175.265 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.713 ' HG2' HG21 ' A' ' 56' ' ' ILE . 55.7 mtp -57.72 -27.55 63.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.486 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m -95.45 -12.27 26.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.6 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.75 29.01 19.84 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.868 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -116.14 126.11 53.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.012 0.434 . . . . 0.0 110.725 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.934 HG21 ' HB3' ' A' ' 19' ' ' LEU . 20.1 p -111.4 15.22 21.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.794 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.12 -15.8 81.26 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.558 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.31 -32.2 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.095 0.474 . . . . 0.0 110.22 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.446 ' CD1' ' HZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -66.01 -37.6 86.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.669 ' HA ' ' CG1' ' A' ' 161' ' ' VAL . 11.8 pt-20 -54.45 -38.78 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.529 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -38.83 69.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.072 0.463 . . . . 0.0 110.251 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.48 72.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.432 ' O ' HD22 ' A' ' 154' ' ' LEU . 90.8 mt -56.48 -42.67 78.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.156 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.8 -7.49 0.46 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.673 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.65 -38.64 61.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.526 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.78 -48.35 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.061 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.629 ' HB3' ' HB2' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -53.85 -37.4 63.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.62 -27.93 66.76 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.92 -29.5 69.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.472 0.653 . . . . 0.0 110.07 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.442 ' HB2' ' HG ' ' A' ' 159' ' ' LEU . 20.1 m-85 -106.55 -3.05 21.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.29 18.36 64.74 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.78 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.629 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 19.3 mt -95.2 -172.5 2.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.851 0.326 . . . . 0.0 111.0 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.5 p -166.69 -172.18 2.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.892 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.669 ' CG1' ' HA ' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -58.5 -25.53 28.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 176.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 14' ' ' SER . 1.6 p-10 -86.3 14.25 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.334 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.3 m -89.88 148.15 23.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.1 p -69.76 158.42 35.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.697 ' CD1' HD13 ' A' ' 15' ' ' ILE . 15.7 m-30 -54.47 -31.78 56.43 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.37 -62.17 1.86 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.938 174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.2 -48.39 80.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.593 HG13 HD11 ' A' ' 154' ' ' LEU . 93.9 t -59.33 -55.54 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.58 0.229 . . . . 0.0 111.324 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.595 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -57.22 -48.02 79.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.21 81.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.5 -27.29 55.99 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.065 0.46 . . . . 0.0 111.144 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.792 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.5 p -91.95 -19.9 21.94 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.999 0.904 . . . . 0.0 109.981 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.869 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.047 177.418 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.79 ' O ' ' HB ' ' A' ' 172' ' ' THR . 28.5 t80 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.673 0.273 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 p -169.37 159.29 8.59 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.93 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' A' ' 169' ' ' ALA . 25.6 m -93.43 114.36 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.257 174.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.572 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.0 m-80 -94.55 52.42 1.54 Allowed 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.934 0.873 . . . . 0.0 110.648 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.844 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -76.95 151.18 35.81 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.234 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 9' ' ' SER . 18.5 t70 -62.74 103.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.2 p -37.01 78.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 124.74 1.275 . . . . 0.0 113.464 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ASP . 22.9 t -174.63 -29.08 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.684 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.51 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 68.2 m-85 -93.67 15.15 16.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.286 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -69.22 70.55 0.47 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.57 -173.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -169.78 0.02 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.516 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 28.5 m-85 -86.25 136.02 33.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.73 -0.235 . . . . 0.0 110.411 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 163' ' ' SER . 19.7 m -68.99 134.5 49.56 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 160.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.596 HD13 ' CD1' ' A' ' 165' ' ' PHE . 5.1 mm -48.31 -48.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 118.389 0.54 . . . . 0.0 111.705 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -57.65 -30.86 65.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.628 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.0 -46.87 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.795 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.42 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 68.7 t80 -72.64 -46.13 55.53 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.906 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.622 ' HB3' HG21 ' A' ' 143' ' ' THR . 14.6 mt -56.59 -34.2 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.288 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.69 -45.06 93.77 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.137 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -61.65 -41.37 97.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.858 0.361 . . . . 0.0 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.68 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 22.3 t90 -54.71 -51.72 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.638 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.41 63.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.052 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 t -61.5 -51.14 69.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.727 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -65.45 -32.12 73.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.759 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.686 ' HB2' HG21 ' A' ' 64' ' ' THR . 19.8 t80 -59.4 -37.2 77.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.848 0.356 . . . . 0.0 110.264 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.99 -18.41 77.71 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.292 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.603 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 25.1 t70 -75.57 93.29 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.185 0.517 . . . . 0.0 111.835 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.922 HG12 ' HB1' ' A' ' 60' ' ' ALA . 22.8 m . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.768 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.2 t30 . . . . . 0 N--CA 1.462 0.131 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.42 -9.28 61.0 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.548 ' ND2' HG21 ' A' ' 109' ' ' VAL . 9.8 p30 -104.83 -18.73 14.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.807 0.813 . . . . 0.0 110.718 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' A' ' 63' ' ' VAL . 49.3 t -87.72 114.04 25.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.376 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -101.24 -70.3 0.75 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.773 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.43 -73.19 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.848 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 69.18 86.5 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.784 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -80.89 141.58 34.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 51.5 m -71.81 -36.35 70.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.78 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 108.13 -123.09 6.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.584 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 64.18 2.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.898 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 60.56 -176.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.43 0.634 . . . . 0.0 112.708 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -144.61 -56.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.826 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.31 22.18 21.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.076 -173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.25 -179.47 40.84 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.453 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -81.48 -68.3 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 14.0 mt -76.56 -31.03 57.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.578 -176.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.54 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 11.0 p -147.9 163.74 35.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.558 -175.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.3 39.59 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.65 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.6 m 65.87 -60.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.517 0.727 . . . . 0.0 112.709 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -95.66 159.53 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.881 0.372 . . . . 0.0 111.072 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' HD2' HG21 ' A' ' 135' ' ' VAL . 1.5 t80 -153.32 99.22 2.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.858 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -93.12 144.96 24.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.433 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.676 HG13 ' HG2' ' A' ' 139' ' ' MET . 27.8 mm -146.25 127.65 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.036 0.446 . . . . 0.0 110.85 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 41' ' ' SER . 18.9 t -112.69 151.87 29.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.523 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.507 ' OG ' ' HB3' ' A' ' 61' ' ' ASN . 47.0 t -49.99 136.05 19.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 112.079 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.74 27.57 3.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.296 0.569 . . . . 0.0 111.321 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.922 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -157.65 -33.39 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.991 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.603 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -103.33 -14.61 16.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.672 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.8 mm-40 31.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.748 -1.569 . . . . 0.0 115.213 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.483 ' CG2' HG21 ' A' ' 36' ' ' VAL . 10.4 p -138.21 -44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.269 169.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 26' ' ' PHE . 38.6 m -63.03 97.54 0.11 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -117.1 171.12 8.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.293 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.68 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -158.0 123.89 4.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.009 -178.036 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.2 t -105.56 102.57 14.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.886 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -85.43 154.58 21.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.033 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.96 127.99 2.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.777 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.11 -108.52 0.22 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -146.75 45.34 1.19 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.511 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 41.6 mt -64.26 124.75 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.279 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 31.6 m -137.35 119.13 15.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.505 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 47.1 t80 -68.36 122.94 19.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 82.7 p -63.7 -33.48 75.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.448 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 11.7 tp 52.3 -92.27 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.448 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 20.2 m-85 -98.91 0.1 43.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.738 -174.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.547 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 93.1 m-20 -73.18 170.34 15.17 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.954 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.624 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 10.9 mm-40 -48.94 -53.51 37.08 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 53.0 Cg_exo -56.83 -41.95 69.91 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.513 1.475 . . . . 0.0 112.221 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.95 130.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.77 0.795 . . . . 0.0 112.837 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 54.59 47.56 22.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.605 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.515 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -142.79 178.25 7.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.65 -174.123 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 135' ' ' VAL . 18.1 tp -126.38 82.51 2.08 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -89.23 146.56 24.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 171.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.576 ' H ' HG21 ' A' ' 131' ' ' VAL . . . -168.09 178.31 41.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.401 -1.38 . . . . 0.0 114.006 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 11.4 tm0? -97.65 167.7 10.8 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.559 ' HG ' HD12 ' A' ' 117' ' ' LEU . 27.9 tp -148.72 126.35 11.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.584 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 12.6 t70 -126.7 -48.9 1.51 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.172 0.51 . . . . 0.0 110.485 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.461 ' O ' HD22 ' A' ' 91' ' ' LEU . 19.4 p -132.81 158.92 41.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 122.005 0.907 . . . . 0.0 113.034 -173.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.1 mm? -134.9 169.11 17.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.772 -1.558 . . . . 0.0 106.878 174.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 19.8 t -163.06 99.38 0.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.819 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.685 ' CE1' HD11 ' A' ' 138' ' ' LEU . 1.2 m-30 -93.39 134.74 35.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.505 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -169.82 163.42 36.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 118.151 -1.976 . . . . 0.0 115.18 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.58 104.83 15.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.466 -0.867 . . . . 0.0 111.448 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 112.37 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.649 -1.159 . . . . 0.0 113.808 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.503 HD13 ' HB3' ' A' ' 105' ' ' TYR . 46.7 mt -85.9 160.59 19.37 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.101 -0.646 . . . . 0.0 110.041 171.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 t -143.4 172.9 12.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.252 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.228 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -175.939 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo . . . . . 0 C--O 1.233 0.239 0 CA-C-O 120.947 0.311 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.587 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 62.9 m-85 -73.63 149.08 42.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.366 -174.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 p -146.38 140.65 26.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.954 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.716 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.3 mp -78.63 133.26 30.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.92 -44.22 90.22 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.421 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.548 HG21 ' ND2' ' A' ' 35' ' ' ASN . 16.9 t -118.17 91.64 40.79 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 13.3 Cg_endo -56.66 101.91 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.234 2.622 . . . . 0.0 112.969 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -93.02 -162.39 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.924 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.844 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 41.3 t -60.11 128.69 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.333 1.063 . . . . 0.0 112.453 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.572 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 61.2 m -119.37 178.94 4.35 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.306 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.532 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 94.0 m-85 -140.42 146.35 38.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.29 140.44 6.64 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.704 -1.236 . . . . 0.0 112.402 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.725 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.51 12.84 37.06 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.996 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.559 HD12 ' HG ' ' A' ' 88' ' ' LEU . 48.5 mt -56.41 -53.92 51.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.557 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 52.7 t30 51.39 50.87 18.0 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.158 0.98 . . . . 0.0 110.257 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 19.4 mt -104.79 105.99 16.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.087 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 9.8 p -105.3 129.97 53.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.161 0.505 . . . . 0.0 110.617 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.588 ' HB3' ' OE1' ' A' ' 125' ' ' GLN . 74.7 m -103.73 165.91 10.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.418 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.542 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 44.4 mt -87.15 154.22 20.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.355 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -57.88 -60.0 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.828 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.616 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -77.0 17.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 1.066 ' HB3' ' HA ' ' A' ' 128' ' ' ASP . 96.0 mt-30 -74.67 -40.31 61.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 80' ' ' PRO . . . 83.47 -106.89 2.86 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.872 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.606 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 5.6 t-80 -68.01 -12.68 61.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 1.066 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 0.0 OUTLIER 78.49 172.5 0.18 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 156.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.417 ' N ' ' CG ' ' A' ' 128' ' ' ASP . . . -85.31 -35.69 11.85 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.314 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.551 ' O ' HG22 ' A' ' 134' ' ' VAL . 9.8 p -154.08 -40.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.576 HG21 ' H ' ' A' ' 86' ' ' GLY . 13.6 m -67.17 -54.62 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.963 1.256 . . . . 0.0 112.697 -174.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.606 ' ND1' ' HA ' ' A' ' 127' ' ' HIS . 4.5 t-160 -58.67 -37.13 75.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.424 ' HG2' ' OD1' ' A' ' 128' ' ' ASP . 51.6 mm-40 -61.56 -65.91 0.62 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.502 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 130' ' ' VAL . 31.5 m -56.62 -39.29 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.035 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 84' ' ' LEU . 10.0 p -67.96 -40.57 83.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -74.34 -30.68 62.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.32 79.97 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 173.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.685 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -49.42 -59.53 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.576 0.703 . . . . 0.0 109.566 174.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.676 ' HG2' HG13 ' A' ' 56' ' ' ILE . 71.8 mtm -55.97 -25.27 43.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.183 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -91.66 0.04 57.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.665 0.269 . . . . 0.0 111.502 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.08 29.49 64.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.232 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.76 121.93 43.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.467 . . . . 0.0 110.315 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.641 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 49.8 p -91.23 -16.96 26.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.022 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.38 -42.69 50.77 Favored Glycine 0 C--N 1.334 0.444 0 O-C-N 123.836 0.71 . . . . 0.0 113.477 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.75 -42.19 82.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -66.73 -39.76 88.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.971 ' HG2' HG21 ' A' ' 161' ' ' VAL . 52.5 mt-10 -54.13 -43.2 70.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.266 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -34.59 75.13 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.902 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.2 71.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.171 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 90.6 mt -54.2 -44.2 71.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.904 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -55.52 -8.87 0.41 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.359 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.75 -45.16 45.51 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.235 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.0 -45.92 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 120.645 0.259 . . . . 0.0 110.924 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.797 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -57.89 -42.95 85.73 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.0 -20.71 66.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.441 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.67 -33.14 75.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.363 0.601 . . . . 0.0 109.852 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.31 -5.65 29.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.018 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 88.42 17.36 57.27 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.991 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 17.3 mt -97.24 -174.28 2.9 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.938 0.369 . . . . 0.0 110.158 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -156.57 -176.77 6.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.971 HG21 ' HG2' ' A' ' 147' ' ' GLU . 11.9 p -56.99 -26.71 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.903 0.382 . . . . 0.0 111.707 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.53 30.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.06 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 14' ' ' SER . 13.7 t -98.62 147.76 24.49 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 168' ' ' VAL . 3.5 m -70.74 145.22 50.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.442 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.596 ' CD1' HD13 ' A' ' 15' ' ' ILE . 12.9 m-30 -47.98 -38.63 17.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 0.0 110.385 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.86 -54.02 47.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.18 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -63.57 -51.05 67.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.222 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.797 HG13 HD11 ' A' ' 154' ' ' LEU . 17.4 t -58.24 -55.91 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 O-C-N 123.019 0.2 . . . . 0.0 110.984 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.455 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . . . -53.54 -45.51 69.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.307 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -64.9 -36.51 84.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.205 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.09 -25.81 58.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.31 0.576 . . . . 0.0 110.496 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.79 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.1 p -88.97 -13.05 39.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.081 0.943 . . . . 0.0 109.556 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.944 175.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.82 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 36.1 t80 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -166.0 166.87 17.02 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.879 0.737 . . . . 0.0 109.146 171.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.788 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -91.28 126.96 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.429 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.607 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 31.5 m-80 -104.25 56.2 0.72 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.862 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 53.8 p90 -69.14 152.25 45.36 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.62 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.0 67.67 0.15 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t 17.66 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 113.811 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -168.99 -28.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.489 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.564 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 82.9 m-85 -87.73 12.71 12.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.702 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 165' ' ' PHE . . . -70.4 68.89 0.7 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.44 -172.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.66 19.74 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 27.6 m-85 -106.17 135.26 47.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.316 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' HIS . 1.8 m -74.74 67.93 1.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.719 HD13 ' CD1' ' A' ' 165' ' ' PHE . 3.4 mm 28.28 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 114.141 -172.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.485 ' H ' HG22 ' A' ' 161' ' ' VAL . 11.5 t-160 -50.74 -29.16 10.72 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.673 0.389 . . . . 0.0 111.186 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -53.35 -62.73 1.46 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.881 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.421 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 84.5 t80 -66.95 -38.78 86.75 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.341 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.887 HD22 ' HE2' ' A' ' 93' ' ' PHE . 14.3 mt -54.31 -40.42 67.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.07 93.24 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.138 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 24' ' ' SER . 5.5 tt0 -61.15 -38.49 86.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.989 0.516 . . . . 0.0 111.52 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.488 ' O ' HG21 ' A' ' 64' ' ' THR . 40.7 t90 -55.63 -45.06 77.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.957 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 26' ' ' PHE . . . -72.8 -13.69 61.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.909 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 36.9 t -63.54 -56.22 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.701 0.286 . . . . 0.0 110.536 176.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.6 p -65.2 -31.16 72.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 62' ' ' GLN . 31.7 t80 -64.45 -28.17 69.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.876 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.25 75.71 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.795 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 32.6 t70 -78.51 165.64 23.51 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.462 0.631 . . . . 0.0 111.446 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.45 -0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 112.144 -174.396 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.877 ' HB3' HG23 ' A' ' 36' ' ' VAL . 56.1 t-20 . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -1.51 19.98 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.46 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -115.02 6.81 15.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.877 HG23 ' HB3' ' A' ' 33' ' ' ASN . 12.6 t -87.55 114.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.271 0.558 . . . . 0.0 111.804 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.6 p -100.22 -73.9 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.284 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -89.24 -67.02 0.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 -172.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.496 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 74.14 74.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.656 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -86.71 156.09 20.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.783 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.411 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 58.5 m -96.84 -33.57 11.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.675 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 112.96 -135.8 12.95 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.932 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.609 ' HA2' ' HE1' ' A' ' 54' ' ' TYR . . . 80.99 74.61 1.13 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.753 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.576 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 46.0 m-85 66.11 -178.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.54 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 23.0 t80 -152.95 -71.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.247 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.04 45.45 3.3 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.203 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 170.69 36.51 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.808 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -76.04 -25.49 55.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.035 0.445 . . . . 0.0 110.113 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -167.79 32.33 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 p -158.86 166.9 30.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.205 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.81 -134.33 5.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.632 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.447 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 31.6 m -135.54 6.07 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.496 0.188 . . . . 0.0 110.918 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -141.61 143.33 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.318 . . . . 0.0 110.776 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.609 ' HE1' ' HA2' ' A' ' 43' ' ' GLY . 2.6 t80 -154.94 96.06 1.81 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.595 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -96.05 157.77 15.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.022 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.009 HG13 ' HG2' ' A' ' 139' ' ' MET . 11.6 mm -147.31 121.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 110.15 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.54 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 8.9 t -138.28 112.51 8.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.316 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.632 ' HB2' ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER 41.53 160.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 118.574 2.805 . . . . 0.0 118.574 -178.069 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.421 ' H ' ' HG3' ' A' ' 62' ' ' GLN . 20.7 p -132.06 13.39 4.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.726 -2.033 . . . . 0.0 109.915 163.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.04 -58.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.264 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.628 ' O ' HG12 ' A' ' 63' ' ' VAL . 22.3 t-20 -146.1 -33.68 0.32 Allowed 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.656 ' HB3' ' HA ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -53.05 54.7 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 126.564 2.415 . . . . 0.0 113.457 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.802 HG21 HG22 ' A' ' 36' ' ' VAL . 1.4 p -66.4 -6.64 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.513 ' N ' ' C ' ' A' ' 62' ' ' GLN . 92.9 m -53.14 112.05 0.8 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 110.099 -3.228 . . . . 0.0 107.366 161.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.41 -179.39 4.18 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.35 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.849 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -160.3 121.64 3.09 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.813 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.6 112.82 41.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.269 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.634 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -88.92 152.71 21.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 52' ' ' SER . . . -150.84 122.96 1.44 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.91 -110.16 0.26 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.624 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 66.8 t30 -147.86 37.4 0.88 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.503 0.668 . . . . 0.0 109.235 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -59.24 139.92 56.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.787 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -149.62 134.39 17.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.722 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.622 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 58.4 t80 -84.61 127.44 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.5 p -62.55 -33.55 75.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.648 -170.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.469 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 9.6 tp 51.57 -95.53 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.954 0.784 . . . . 0.0 111.827 -176.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.469 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 5.3 m-85 -98.84 2.58 46.88 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -175.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -76.04 178.34 6.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.549 0.214 . . . . 0.0 111.206 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.826 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 19.6 mm-40 -47.51 -62.71 1.88 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -170.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 54.2 Cg_exo -55.35 -38.02 94.17 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.777 1.651 . . . . 0.0 112.873 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 66.63 122.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.837 0.827 . . . . 0.0 112.855 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 93.4 m-70 53.27 54.41 10.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.425 -1.261 . . . . 0.0 111.484 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -146.49 169.0 19.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.307 -176.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.672 HD23 HG11 ' A' ' 135' ' ' VAL . 11.2 tp -106.58 149.06 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.819 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 86' ' ' GLY . 20.0 p90 -156.45 -154.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.417 ' O ' HG11 ' A' ' 131' ' ' VAL . . . 99.03 -164.25 20.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.904 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 6.3 tm0? -99.98 164.51 11.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 111.59 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.51 ' CB ' HG12 ' A' ' 131' ' ' VAL . 30.4 tp -151.58 129.95 12.08 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.726 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 117' ' ' LEU . 17.4 t70 -136.0 -60.22 0.73 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.387 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.431 ' C ' HD22 ' A' ' 91' ' ' LEU . 13.2 p -97.99 149.81 22.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.762 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.66 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.9 mm? -134.53 169.55 17.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 9.5 t -163.76 109.55 1.07 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.147 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.887 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.9 m-30 -97.77 140.43 32.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.661 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.97 172.01 42.8 Favored Glycine 0 C--N 1.314 -0.684 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.85 ' H ' HG13 ' A' ' 109' ' ' VAL . 24.9 m-20 -97.77 124.86 42.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 119.362 1.581 . . . . 0.0 111.414 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 63' ' ' VAL . . . 87.47 116.06 1.13 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.477 -0.783 . . . . 0.0 113.091 171.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.595 HD11 ' HB1' ' A' ' 55' ' ' ALA . 41.0 mt -86.55 153.75 21.59 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.12 168.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.8 t -138.59 168.8 18.99 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.45 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.875 0 O-C-N 123.947 0.779 . . . . 0.0 111.65 -175.962 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.9 Cg_exo . . . . . 0 N--CA 1.463 -0.273 0 CA-C-O 121.196 0.415 . . . . 0.0 112.364 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.675 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 37.8 m-85 -71.85 151.62 43.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.361 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.9 p -149.07 143.95 26.37 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.681 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.674 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.5 mp -80.88 129.21 37.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.044 0.45 . . . . 0.0 110.857 -175.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.496 ' NE2' ' H ' ' A' ' 39' ' ' ALA . 71.7 mt-30 -64.23 -59.07 4.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.578 176.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.85 HG13 ' H ' ' A' ' 95' ' ' ASP . 2.4 p -109.15 87.53 4.91 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 121.628 0.728 . . . . 0.0 110.017 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 31.7 Cg_endo -65.09 122.71 10.55 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.95 2.433 . . . . 0.0 111.597 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 112' ' ' VAL . 3.9 t0 -118.91 -143.27 0.36 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.862 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 19.4 t -61.16 115.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.338 1.066 . . . . 0.0 112.344 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.607 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 69.1 m -101.86 177.3 4.94 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.811 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.66 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 95.5 m-85 -138.56 149.62 45.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.57 141.67 7.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.807 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.82 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 102.02 11.83 35.95 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.704 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 89' ' ' ASP . 16.8 mt -55.8 -46.73 77.94 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.343 0.572 . . . . 0.0 109.723 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 t30 49.46 45.61 23.81 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.022 0.915 . . . . 0.0 110.244 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 20.7 mt -108.6 115.82 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.015 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 38.8 p -111.2 132.64 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.283 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.5 m -101.76 147.97 25.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.28 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 69.9 mt -80.41 157.13 26.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.782 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -48.27 -54.41 13.78 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.488 0.493 . . . . 0.0 112.16 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.448 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -77.54 3.06 14.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -170.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.602 ' HB3' ' N ' ' A' ' 129' ' ' GLY . 37.2 mt-30 -78.86 58.16 2.29 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.014 0.435 . . . . 0.0 110.516 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.83 103.96 0.65 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.454 ' HA ' ' CG ' ' A' ' 132' ' ' HIS . 3.3 t-80 79.39 -29.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.845 0.858 . . . . 0.0 111.397 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -80.38 -30.43 37.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.543 0.211 . . . . 0.0 111.307 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.602 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -55.79 129.48 47.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.627 -0.796 . . . . 0.0 111.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.5 m -50.87 -33.21 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.51 HG12 ' CB ' ' A' ' 88' ' ' LEU . 33.1 m -63.35 -47.16 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.796 0.331 . . . . 0.0 110.594 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.65 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.8 t-160 -63.5 -39.43 94.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.966 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.435 HE21 ' HB3' ' A' ' 133' ' ' GLN . 2.7 mm100 -59.85 -64.7 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.4 t -53.89 -46.51 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.348 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.849 HG23 ' HZ ' ' A' ' 66' ' ' PHE . 11.0 p -65.86 -45.97 89.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.259 -175.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.414 ' HD1' HG13 ' A' ' 135' ' ' VAL . 12.5 m-85 -72.24 -27.5 62.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.818 0.342 . . . . 0.0 110.796 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.35 -53.29 33.44 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 146' ' ' LEU . 0.2 OUTLIER -49.63 -49.59 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.1 0.56 . . . . 0.0 111.095 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' MET . . . . . 1.009 ' HG2' HG13 ' A' ' 56' ' ' ILE . 83.4 mtp -57.67 -30.75 65.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.034 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -91.3 -0.67 57.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.401 ' HA2' ' CZ3' ' A' ' 22' ' ' TRP . . . 84.26 9.47 81.95 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.698 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -98.82 103.96 15.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.565 0.698 . . . . 0.0 110.79 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.461 ' CB ' ' HB3' ' A' ' 19' ' ' LEU . 2.8 p -89.48 2.42 54.58 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.069 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.542 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -62.78 -31.21 79.47 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.735 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.59 -33.29 64.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.557 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.4 OUTLIER -67.76 -33.6 75.17 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.612 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.921 ' HG2' HG21 ' A' ' 161' ' ' VAL . 46.1 mt-10 -52.91 -44.72 67.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -33.17 73.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.952 -175.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.57 64.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.32 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.2 mt -55.49 -45.37 77.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.831 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -58.64 -8.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.968 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.08 -41.68 26.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.035 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' A' ' 117' ' ' LEU . 3.8 mp -86.51 -49.03 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.787 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.942 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -53.08 -40.93 64.42 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.67 -27.17 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.39 -34.22 77.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.227 0.537 . . . . 0.0 109.845 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.464 ' HE2' HG22 ' A' ' 153' ' ' ILE . 41.6 m-85 -95.63 -13.58 24.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.284 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 94.75 27.94 10.8 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.602 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.427 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -109.15 -166.98 1.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.135 0.468 . . . . 0.0 110.952 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.6 p -163.52 171.91 15.17 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.38 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.921 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.5 p -52.55 -36.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -88.82 40.22 0.96 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -88.9 -105.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.744 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 168' ' ' VAL . 15.6 m -163.05 146.91 11.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.719 ' CD1' HD13 ' A' ' 15' ' ' ILE . 6.1 m-30 -52.96 -42.35 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.353 0.524 . . . . 0.0 111.111 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.63 -52.22 33.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.853 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -59.74 -46.3 89.57 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -176.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.942 HG13 HD11 ' A' ' 154' ' ' LEU . 89.6 t -60.52 -56.67 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.491 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.606 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -54.36 -44.65 72.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 123.447 0.467 . . . . 0.0 110.993 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -62.64 -40.87 98.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.49 -29.91 61.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.208 0.528 . . . . 0.0 110.57 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 38.3 p -85.74 -14.15 46.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.865 0.84 . . . . 0.0 109.624 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.653 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.796 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 t80 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.485 0.183 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -172.22 167.51 5.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.62 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.66 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -90.35 125.54 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.004 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.579 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 27.0 m-80 -101.82 48.84 0.87 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.729 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.0 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.0 p90 -70.5 150.04 46.56 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.735 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.8 t70 -62.06 105.35 0.57 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.646 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 4.4 p -37.52 74.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 125.082 1.489 . . . . 0.0 113.894 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.1 t -174.2 -25.62 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.341 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.494 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 96.0 m-85 -92.39 15.5 13.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.08 68.12 1.38 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.322 -173.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.45 22.85 0.16 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.562 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 45.3 m-85 -114.31 131.26 56.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.017 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 163' ' ' SER . 11.4 p -68.13 132.44 47.21 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 161.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 165' ' ' PHE . 4.8 mm -46.56 -48.76 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -167.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -60.14 -30.37 69.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.648 0.261 . . . . 0.0 111.007 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.28 -49.17 58.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.371 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.462 ' HB2' ' CG ' ' A' ' 13' ' ' TYR . 72.0 t80 -70.72 -45.34 65.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.608 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.784 HD22 ' CE2' ' A' ' 93' ' ' PHE . 12.0 mt -56.92 -44.4 82.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.18 94.81 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.975 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 24' ' ' SER . 3.7 tt0 -64.87 -43.34 93.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 122.89 0.476 . . . . 0.0 111.463 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -62.43 -42.21 99.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.919 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.14 67.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.791 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 25.1 t -62.23 -54.14 45.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -35.64 81.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.056 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.605 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 20.0 t80 -56.07 -39.43 72.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.346 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.89 -29.51 73.68 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.463 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 11.9 t70 -76.12 100.88 5.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.705 -176.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.716 HG12 ' HB1' ' A' ' 60' ' ' ALA . 35.4 m . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.04 -7.49 76.54 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 114.446 0.538 . . . . 0.0 114.446 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -116.38 3.57 13.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.849 0.825 . . . . 0.0 111.684 -175.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.537 HG22 ' HA3' ' A' ' 96' ' ' GLY . 45.6 t -101.83 116.39 45.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 p -103.08 -76.11 0.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.295 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.89 -68.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.902 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.41 83.86 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.527 0.68 . . . . 0.0 111.972 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -83.88 137.86 33.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.956 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -74.62 -37.74 62.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.49 134.74 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.348 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.55 59.19 0.11 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.901 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 57.8 m-85 62.1 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.941 0.877 . . . . 0.0 113.326 -175.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 50.5 t80 -91.75 -13.24 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.768 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.83 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.58 -28.02 44.98 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.382 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.45 -118.6 0.75 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.899 -1.143 . . . . 0.0 113.084 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -76.62 -50.13 14.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 0.0 110.281 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -167.35 43.29 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.765 0.793 . . . . 0.0 109.782 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.642 ' HB3' ' HD1' ' A' ' 74' ' ' TYR . 20.9 p -154.03 -176.28 5.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.228 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.83 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 128.1 -172.43 19.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 t -92.95 -14.22 27.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.828 0.314 . . . . 0.0 111.265 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 27.0 tt0 -134.0 151.84 51.6 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.323 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.777 ' CD1' HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -149.19 94.76 2.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.879 -173.539 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -94.82 153.16 17.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.861 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.042 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.0 mm -146.43 140.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 t -131.92 97.36 4.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.542 0.211 . . . . 0.0 110.517 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.605 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 33.1 t 18.48 115.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -19.5 65.89 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.425 -0.797 . . . . 0.0 110.472 171.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.716 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.02 -61.48 1.95 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.062 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 35.0 p30 -114.75 3.35 14.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.119 0.485 . . . . 0.0 111.59 -172.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 57' ' ' SER . 2.3 mm-40 39.79 38.26 0.43 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 64' ' ' THR . 9.1 p -129.37 -55.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.714 168.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 63' ' ' VAL . 4.5 m -58.0 101.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.243 0.544 . . . . 0.0 110.206 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -110.28 173.19 6.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -165.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.77 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -160.67 118.07 2.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.73 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 79.2 t -103.53 107.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.627 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.77 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -91.12 157.14 17.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.91 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.11 135.62 4.95 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.201 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.34 -128.82 1.08 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.94 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 1.6 t-20 -146.34 72.89 1.3 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 0.0 109.383 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 54' ' ' TYR . 6.5 mt -92.14 166.93 12.39 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 122.377 1.084 . . . . 0.0 113.629 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.6 m -164.52 134.05 3.79 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 112.416 -2.175 . . . . 0.0 106.76 171.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.958 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 1.8 p90 -95.47 144.76 25.7 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 77.6 p -72.11 -68.4 0.47 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.958 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 13.4 tp 57.4 -87.55 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.018 0.927 . . . . 0.0 111.295 -169.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 21.8 m-85 -91.76 0.04 57.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.194 0.521 . . . . 0.0 110.897 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.524 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-80 -77.05 166.67 22.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.443 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.769 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 47.4 mm-40 -46.42 -61.54 2.56 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -168.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 77.2 Cg_exo -55.43 -40.42 85.61 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.935 1.756 . . . . 0.0 113.759 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 70.83 134.86 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.398 0.618 . . . . 0.0 112.483 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.4 m80 47.67 54.33 9.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.84 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.683 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -151.03 162.58 40.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.768 -171.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.0 tp -108.83 156.02 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.974 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -158.21 -161.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.8 -159.04 22.81 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.26 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.3 tm0? -97.94 169.95 9.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.543 0.687 . . . . 0.0 112.742 -170.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.566 ' CD2' HG21 ' A' ' 134' ' ' VAL . 27.3 tp -155.34 135.51 13.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.53 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -134.94 -50.26 0.76 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.958 0.408 . . . . 0.0 111.28 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.508 ' O ' HD13 ' A' ' 91' ' ' LEU . 5.7 p -130.2 157.12 43.34 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -171.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.739 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.4 mm? -138.02 160.55 39.05 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 9.1 m -147.93 108.82 4.22 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 117.824 0.284 . . . . 0.0 110.951 176.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.784 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.6 m-30 -91.56 147.87 22.69 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.649 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.5 -152.33 11.35 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.732 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.57 126.97 30.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 110.742 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . 76.2 110.09 0.12 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.836 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.0 mt -83.96 141.4 31.26 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.38 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -99.08 154.42 18.13 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.535 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.048 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.202 -166.636 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo . . . . . 0 C--O 1.233 0.27 0 CA-C-O 121.279 0.45 . . . . 0.0 113.035 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -66.03 155.03 37.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.579 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 p -142.38 155.64 45.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.347 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 107' ' ' ILE . 1.1 mp -89.1 122.76 40.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.414 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.98 -39.71 94.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.185 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.0 88.16 9.75 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.487 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.16 96.55 0.27 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.268 2.645 . . . . 0.0 112.838 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 33.1 m-20 -94.66 -154.47 0.42 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.264 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.0 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 46.6 t -58.31 138.5 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.707 0.765 . . . . 0.0 111.931 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.579 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 75.6 m -129.11 178.8 6.15 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.391 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.535 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 95.9 m-85 -138.82 146.79 41.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -160.58 142.06 7.86 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.921 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.796 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.22 11.15 40.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.411 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.442 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 26.3 mt -57.08 -50.5 72.59 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.0 t30 55.43 43.35 28.85 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.695 0.76 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.8 mt -106.11 112.56 25.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.381 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 34.5 p -107.04 130.84 54.6 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.815 0.341 . . . . 0.0 110.523 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.498 ' HB2' HG22 ' A' ' 131' ' ' VAL . 26.0 m -108.28 145.8 33.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.827 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -80.96 165.14 22.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.503 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -52.93 -61.1 2.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.583 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.487 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -79.66 14.61 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -168.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.462 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 34.8 mt-30 -77.15 -25.9 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.289 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 56.38 -118.1 10.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.221 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.476 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 4.7 t-80 -80.24 -22.76 41.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.537 0.335 . . . . 0.0 110.765 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.82 -19.63 32.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -174.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.462 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -59.45 126.59 42.63 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 174.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.651 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 18.2 m -52.69 -32.62 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.76 ' O ' HG23 ' A' ' 135' ' ' VAL . 18.1 m -63.63 -49.67 81.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.157 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.683 ' HE1' HG22 ' A' ' 83' ' ' THR . 4.8 t-160 -57.02 -41.25 78.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.035 0.445 . . . . 0.0 110.008 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.651 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 0.2 OUTLIER -56.73 -63.97 1.03 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.31 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 88' ' ' LEU . 16.1 m -56.63 -39.21 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.469 -172.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 131' ' ' VAL . 2.2 t -66.1 -57.81 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 CA-C-O 121.455 0.645 . . . . 0.0 110.061 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.34 -18.21 64.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.34 -56.23 7.04 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 167.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.623 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.92 -52.61 31.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.111 0.564 . . . . 0.0 111.226 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' MET . . . . . 1.042 ' HG2' HG13 ' A' ' 56' ' ' ILE . 50.7 mtp -55.82 -26.74 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.111 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.1 m -99.45 -6.53 27.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.752 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.36 32.14 20.45 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.244 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -121.11 130.59 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.647 HG21 ' HB3' ' A' ' 19' ' ' LEU . 53.9 p -108.15 2.03 22.62 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.78 -39.44 61.72 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 123.523 0.514 . . . . 0.0 114.04 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.76 -26.92 29.26 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.411 -0.464 . . . . 0.0 110.824 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -68.92 -51.02 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.522 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.717 ' HB3' HG21 ' A' ' 161' ' ' VAL . 5.0 pt-20 -58.0 -33.51 69.01 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.283 0.563 . . . . 0.0 110.181 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 28.0 m -67.67 -47.95 68.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.848 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.01 99.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.219 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 99.1 mt -55.58 -43.15 75.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.398 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -57.08 -9.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.331 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -75.39 -40.16 33.96 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.299 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.482 HG22 ' HE2' ' A' ' 157' ' ' TYR . 3.9 mp -86.47 -48.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.029 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.613 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -53.31 -41.51 65.73 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.66 -23.85 63.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.95 -28.97 62.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.1 m-85 -101.8 -7.37 22.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.105 0.479 . . . . 0.0 110.14 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.13 29.77 12.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.352 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 1.9 mm? -111.19 -165.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.34 0.57 . . . . 0.0 110.513 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 p -163.1 -178.91 6.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.069 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 147' ' ' GLU . 9.7 p -57.5 -23.3 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 111.375 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.79 14.45 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.707 0.289 . . . . 0.0 111.716 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.661 ' HB3' HG22 ' A' ' 168' ' ' VAL . 12.8 t -88.96 143.68 26.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 168' ' ' VAL . 38.3 m -69.2 141.26 54.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.669 ' CD1' HD13 ' A' ' 15' ' ' ILE . 5.2 m-30 -38.24 -53.01 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.71 0.804 . . . . 0.0 112.739 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.53 -48.42 79.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.708 0.29 . . . . 0.0 110.224 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 1.7 mp0 -69.04 -5.33 21.23 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 163' ' ' SER . 34.0 t -96.31 -54.05 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.249 0.547 . . . . 0.0 109.819 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -58.0 -46.61 84.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.622 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.05 72.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.707 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 167' ' ' GLN . . . -70.32 -35.83 73.88 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.533 0.682 . . . . 0.0 110.581 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.517 HG21 ' CD2' ' A' ' 2' ' ' PHE . 16.5 p -82.56 -18.97 39.51 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.993 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.675 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.939 175.835 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.773 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 31.7 t80 . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.177 0.513 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -174.1 160.02 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.761 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.669 HG11 HD12 ' A' ' 15' ' ' ILE . 10.5 m -91.68 111.7 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.43 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 51.7 m-20 -94.62 50.18 1.31 Allowed 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.186 -167.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.101 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.6 p90 -67.58 149.03 50.63 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.547 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.3 t70 -62.16 100.06 0.16 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.515 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 8.4 m -30.14 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.827 1.651 . . . . 0.0 114.397 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.6 t -172.21 -31.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.098 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.573 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 81.9 m-85 -88.97 15.67 8.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.0 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.6 71.75 1.05 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.518 -172.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.45 5.73 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.515 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 32.2 m-85 -95.17 140.76 29.63 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.78 -0.21 . . . . 0.0 110.762 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -70.22 129.54 39.63 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 160.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.669 HD12 HG11 ' A' ' 4' ' ' VAL . 3.4 mm -44.89 -48.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -172.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 40.1 t-80 -57.13 -32.61 66.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.145 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.31 -51.52 23.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.24 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.443 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 57.6 t80 -68.13 -41.28 81.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.961 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.854 ' HB3' HG21 ' A' ' 143' ' ' THR . 17.0 mt -55.52 -41.13 72.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.874 0.369 . . . . 0.0 110.457 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.54 97.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.062 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -62.81 -40.53 97.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.757 0.423 . . . . 0.0 111.945 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -61.46 -43.64 98.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.59 -33.05 74.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.839 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.0 t -60.05 -51.77 68.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -68.25 -31.14 70.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.615 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 10.7 t80 -61.05 -52.78 63.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.231 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.41 -26.34 74.33 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.267 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -73.09 108.84 6.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 110.942 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.619 HG12 ' HB1' ' A' ' 60' ' ' ALA . 35.6 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.062 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.46 56.0 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.979 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.8 1.5 37.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.571 0.7 . . . . 0.0 109.84 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.456 HG21 ' CG2' ' A' ' 63' ' ' VAL . 32.3 t -95.63 114.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.925 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 -71.5 0.66 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.725 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.86 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.518 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 66.89 74.29 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.021 0.915 . . . . 0.0 111.0 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.34 136.06 33.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.007 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.473 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 70.4 m -73.02 -38.0 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.283 -172.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 109.51 -135.87 13.17 Favored Glycine 0 C--N 1.317 -0.475 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.892 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.34 70.38 1.32 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.763 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.545 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 64.1 m-85 56.87 -171.36 0.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.494 0.317 . . . . 0.0 111.765 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 44' ' ' PHE . 29.3 t80 -178.4 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.329 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -80.76 7.95 57.24 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.853 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.06 -98.74 0.13 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.1 m -152.18 -63.15 0.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 1.9 mp -77.27 -44.07 31.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.557 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.575 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 17.7 p -140.33 170.12 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 158.57 45.0 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.212 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.1 m 68.33 -54.04 0.53 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.464 ' HG2' ' N ' ' A' ' 54' ' ' TYR . 7.7 tt0 -93.74 149.62 21.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.545 ' HD1' ' H ' ' A' ' 44' ' ' PHE . 2.3 t80 -147.96 103.36 3.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 146.6 23.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.366 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.1 HG13 ' HG2' ' A' ' 139' ' ' MET . 9.1 mm -146.52 122.06 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 92.5 p -106.23 158.77 16.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.378 174.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 42.0 t -51.46 139.39 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.292 0.568 . . . . 0.0 111.968 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -85.45 -19.44 31.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.425 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.619 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.04 -60.52 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -111.73 1.32 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.824 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 58' ' ' SER . 2.9 mm-40 40.12 37.42 0.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.477 -1.238 . . . . 0.0 114.214 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.456 ' CG2' HG21 ' A' ' 36' ' ' VAL . 14.8 p -126.6 -51.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.921 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 23.2 m -62.65 103.55 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.525 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -112.46 179.59 3.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.687 0.756 . . . . 0.0 112.924 -169.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.741 ' HE1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -156.99 131.81 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.811 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 61.6 t -120.62 114.96 45.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.166 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.55 148.04 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.6 104.79 0.26 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.018 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.48 -92.29 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.194 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -147.92 30.14 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.482 0.641 . . . . 0.0 110.906 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 77.9 mt -59.24 143.73 48.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.34 0.591 . . . . 0.0 111.774 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 99.2 m -148.61 129.99 14.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.67 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.575 ' H ' ' HB3' ' A' ' 50' ' ' SER . 48.1 t80 -86.07 122.76 30.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 48.2 p -64.87 -41.29 95.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.623 -171.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.5 tp 51.08 -88.02 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.755 0.822 . . . . 0.0 111.978 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -95.08 -3.04 48.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.557 0.535 . . . . 0.0 111.711 -175.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.663 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 94.5 m-20 -75.51 -179.4 4.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.72 0.295 . . . . 0.0 111.623 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.912 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 32.7 mm-40 -45.83 -67.79 0.35 Allowed Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.912 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.9 Cg_exo -56.88 -36.6 99.01 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.415 1.41 . . . . 0.0 112.441 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 68.67 123.53 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.578 0.751 . . . . 0.0 112.247 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 60.35 59.99 2.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.992 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.809 HG21 ' HA2' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -143.88 166.34 25.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.074 -171.127 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.829 HD23 HG11 ' A' ' 135' ' ' VAL . 13.6 tp -119.23 144.18 46.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 7.9 p90 -158.15 -157.92 0.68 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 71' ' ' ASN . . . 95.04 -163.93 24.63 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.606 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.638 ' HG3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -103.43 172.96 6.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.714 HD23 ' H ' ' A' ' 89' ' ' ASP . 1.5 pt? -139.62 -41.43 0.45 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.974 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.714 ' H ' HD23 ' A' ' 88' ' ' LEU . 37.2 t70 61.28 -58.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.685 1.194 . . . . 0.0 113.654 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 114' ' ' PHE . 8.0 m -136.29 135.26 38.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.902 0.858 . . . . 0.0 112.36 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.741 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.5 mm? -102.63 166.44 10.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.997 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 22.4 m -151.64 111.54 4.05 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 122.315 -0.241 . . . . 0.0 110.863 174.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.839 ' HE2' HD22 ' A' ' 19' ' ' LEU . 4.8 m-30 -97.62 141.56 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.28 164.71 31.83 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.015 172.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -87.08 120.83 28.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.159 0.504 . . . . 0.0 111.221 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.13 113.24 0.43 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.593 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.3 mt -89.03 153.89 20.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.582 . . . . 0.0 110.549 172.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -131.67 167.9 18.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.274 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.095 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo . . . . . 0 N--CA 1.465 -0.191 0 CA-C-O 121.155 0.398 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 52.5 m-85 -71.93 151.37 43.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.579 -174.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -146.59 152.58 39.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.868 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.696 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.3 mp -83.53 122.07 37.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.517 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.93 -48.45 74.07 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 21.5 t -112.51 87.55 9.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.404 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 24.5 Cg_endo -61.71 107.11 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.12 2.546 . . . . 0.0 112.639 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 12.1 m-20 -96.33 -148.73 0.31 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.293 174.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.101 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -61.22 143.54 14.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.632 0.73 . . . . 0.0 111.459 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.43 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 74.4 m -135.24 179.54 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.746 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.591 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.3 m-85 -139.04 146.04 40.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.36 141.71 7.62 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.632 -1.27 . . . . 0.0 112.396 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.773 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.22 11.59 41.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.761 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.535 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 14.6 mt -55.22 -49.21 72.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.3 t30 57.24 36.27 27.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.986 0.898 . . . . 0.0 109.588 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.553 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 19.2 mt -102.98 124.27 48.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.267 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.638 ' HB3' ' HG3' ' A' ' 87' ' ' GLN . 22.6 p -131.13 138.52 49.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.058 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 131' ' ' VAL . 91.2 p -114.6 135.09 54.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 110.139 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 122' ' ' LEU . 8.4 mp -60.69 161.86 7.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.159 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -51.55 -56.32 14.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.41 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.06 17.25 4.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 121' ' ' SER . 21.5 mt-30 -77.13 -37.06 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.533 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.809 ' HA2' HG21 ' A' ' 83' ' ' THR . . . 77.88 -124.4 6.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.337 174.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -78.91 -14.88 58.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -85.84 -16.11 39.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.872 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.56 125.2 30.74 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.216 -0.992 . . . . 0.0 110.641 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.579 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 23.9 m -52.8 -35.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.635 HG22 ' OG ' ' A' ' 121' ' ' SER . 25.5 m -65.18 -41.24 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.462 0.574 . . . . 0.0 110.48 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.504 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.2 t-160 -60.69 -38.38 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.545 0.688 . . . . 0.0 109.448 175.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.579 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -67.26 -60.62 2.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.868 -177.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 130' ' ' VAL . 18.9 m -60.28 -37.92 75.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.807 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.829 HG11 HD23 ' A' ' 84' ' ' LEU . 8.9 p -68.3 -46.3 81.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.83 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.61 -30.28 66.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 110.198 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.31 -54.98 32.76 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.658 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -50.25 -47.76 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.016 0.527 . . . . 0.0 111.013 176.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' MET . . . . . 1.1 ' HG2' HG13 ' A' ' 56' ' ' ILE . 53.0 mtp -56.09 -33.59 65.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.822 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.9 m -91.55 -13.52 31.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.413 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.51 10.26 53.81 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.93 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.67 120.74 30.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.11 0.481 . . . . 0.0 110.969 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.854 HG21 ' HB3' ' A' ' 19' ' ' LEU . 17.3 p -108.5 9.15 27.55 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.606 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.12 -27.44 68.4 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.955 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.26 -30.31 23.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.991 0.424 . . . . 0.0 110.053 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -64.78 -47.91 76.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.035 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.575 ' HB2' HG21 ' A' ' 161' ' ' VAL . 1.5 pt-20 -55.15 -34.04 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.054 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.479 ' N ' ' HG3' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -75.1 -36.76 61.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.059 0.457 . . . . 0.0 109.8 -175.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.79 -47.15 69.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.527 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 98.3 mt -55.26 -43.49 74.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.048 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -55.29 -13.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.315 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.13 -37.65 55.38 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.39 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.2 mp -85.31 -46.26 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.744 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.74 -44.2 81.44 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.334 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.98 -24.73 67.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.99 -38.09 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.511 . . . . 0.0 110.219 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.532 ' HE2' HG22 ' A' ' 153' ' ' ILE . 13.7 m-85 -97.18 -7.71 31.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.91 16.63 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.379 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.548 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 1.9 mm? -110.85 -174.25 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.258 0.529 . . . . 0.0 110.335 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.5 p -165.39 -176.2 3.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.381 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 147' ' ' GLU . 2.5 m -61.1 -13.15 6.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -88.75 4.49 47.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.565 ' HB2' HG22 ' A' ' 168' ' ' VAL . 19.5 m -92.28 152.44 19.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.858 176.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.5 m -70.72 142.77 51.45 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.573 ' HD2' ' O ' ' A' ' 10' ' ' PHE . 4.1 m-30 -37.72 -64.38 0.4 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.386 0.674 . . . . 0.0 112.58 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.17 -40.85 82.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.112 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -66.57 -42.3 87.26 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.827 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.744 HG13 HD11 ' A' ' 154' ' ' LEU . 92.7 t -65.02 -52.02 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.33 78.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.727 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.34 83.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.611 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.63 -33.56 74.22 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.363 0.601 . . . . 0.0 110.864 -173.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.542 HG21 ' CD2' ' A' ' 2' ' ' PHE . 12.2 p -83.01 -25.2 32.43 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.009 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.312 179.898 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.835 ' O ' ' HB ' ' A' ' 172' ' ' THR . 38.7 t80 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.464 0.173 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.0 m -161.51 163.35 30.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.394 0.678 . . . . 0.0 109.335 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.582 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.3 128.16 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.353 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.5 m-80 -105.35 49.57 0.8 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.625 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 1.075 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 25.5 p90 -73.18 152.84 40.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.547 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.2 t70 -62.15 100.71 0.18 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.497 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 22.3 t -35.46 75.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.665 1.586 . . . . 0.0 113.722 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.2 t -172.96 -30.64 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.859 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.466 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 53.7 m-85 -91.21 22.06 4.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.793 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.8 66.98 0.82 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.209 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -165.13 2.16 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.629 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 38.6 m-85 -83.23 141.8 31.62 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.5 m -71.44 138.08 48.77 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 159.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.757 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -47.01 -48.14 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 119.098 0.863 . . . . 0.0 110.842 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.492 ' HB2' HG13 ' A' ' 161' ' ' VAL . 21.1 t60 -55.23 -32.23 62.13 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.74 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -65.46 -55.79 16.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.946 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 112' ' ' VAL . 83.2 t80 -66.59 -43.51 84.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.359 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.846 HD22 ' HE2' ' A' ' 93' ' ' PHE . 8.8 mt -55.88 -46.81 78.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.719 0.295 . . . . 0.0 110.573 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.52 -43.37 98.91 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.829 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.25 -43.01 99.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.578 0.351 . . . . 0.0 111.877 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.466 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 54.0 t90 -60.44 -43.55 96.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.04 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.85 71.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.481 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -62.4 -49.08 76.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 -28.18 67.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.59 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.403 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 38.6 t80 -62.25 -50.05 73.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.236 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -19.87 75.14 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.378 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.04 96.39 1.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.537 0.684 . . . . 0.0 110.906 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.851 HG12 ' HB1' ' A' ' 60' ' ' ALA . 16.8 m . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.489 ' HB3' HG23 ' A' ' 36' ' ' VAL . 36.2 t-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.835 0.35 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 3.73 20.21 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.273 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -106.11 -0.62 24.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.496 . . . . 0.0 109.887 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.489 HG23 ' HB3' ' A' ' 33' ' ' ASN . 19.9 t -89.93 122.88 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.973 -177.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -92.37 -81.09 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.327 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -75.23 -62.1 1.67 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.755 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.437 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . . . 66.78 80.63 0.21 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.622 -172.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -78.7 134.19 37.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.497 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.4 m -79.84 -31.77 40.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.146 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.65 -172.43 44.75 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.413 ' CA ' ' HE2' ' A' ' 105' ' ' TYR . . . -148.15 -83.36 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.858 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.62 60.97 2.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.744 0.783 . . . . 0.0 109.073 -158.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -84.22 71.72 10.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.617 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.635 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -157.97 -36.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.945 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.35 -125.14 0.97 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.253 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -73.51 -38.95 65.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.576 0.227 . . . . 0.0 111.524 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -168.73 28.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.375 0.607 . . . . 0.0 110.623 -175.436 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -154.04 175.97 12.78 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.549 -176.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.635 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 149.83 -164.78 29.6 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.284 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -91.64 -18.54 23.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.661 0.267 . . . . 0.0 111.212 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 40.8 tt0 -135.9 147.63 48.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 111.216 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.12 108.51 3.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.114 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.83 155.39 17.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.466 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.106 HG13 ' HG2' ' A' ' 139' ' ' MET . 8.6 mm -148.8 137.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.887 0.742 . . . . 0.0 109.166 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 20.7 t -129.76 150.93 50.86 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.744 0.307 . . . . 0.0 110.38 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 30.0 t -50.55 122.37 7.04 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.733 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 p -83.04 40.77 0.72 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.673 0.749 . . . . 0.0 110.179 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.851 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -146.52 -45.08 0.19 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.599 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -122.65 -1.83 8.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.18 0.514 . . . . 0.0 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.5 mt-30 31.59 41.42 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.437 HG23 HG21 ' A' ' 36' ' ' VAL . 14.5 p -127.91 -43.94 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.032 170.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 13.6 m -67.2 96.11 0.45 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -111.12 -179.9 3.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 112.346 -171.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.826 ' HE1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -157.7 131.31 7.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.245 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.637 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 35.2 t -110.17 118.63 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . . . -94.12 149.9 20.82 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.27 123.02 1.49 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -179.59 -109.17 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 22.6 t-20 -149.27 41.12 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.0 mt -58.54 131.53 51.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.906 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.0 m -136.98 132.14 33.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.344 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB3' HD13 ' A' ' 49' ' ' LEU . 37.2 t80 -90.16 127.38 36.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.1 p -63.03 -37.27 86.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.051 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.485 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 9.9 tp 49.64 -93.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.696 0.798 . . . . 0.0 112.161 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.485 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 5.4 m-85 -99.09 8.66 44.71 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.165 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -80.27 178.87 7.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.823 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.641 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 12.1 mm-40 -52.55 -54.91 37.41 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 52.1 Cg_exo -55.36 -37.65 94.48 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.671 1.581 . . . . 0.0 112.445 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.46 116.81 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.767 0.794 . . . . 0.0 112.878 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 54.01 58.06 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.741 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.21 162.56 39.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.005 -178.1 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.791 HD23 HG11 ' A' ' 135' ' ' VAL . 12.5 tp -101.73 151.37 22.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.464 0.174 . . . . 0.0 110.741 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -155.82 -152.02 0.37 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.58 -167.5 24.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.99 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 6.3 tm0? -99.97 164.7 11.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.389 0.614 . . . . 0.0 111.608 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.519 ' HB2' HG22 ' A' ' 131' ' ' VAL . 22.3 tp -155.41 135.14 12.68 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.675 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -133.96 -53.48 0.86 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.188 0.518 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 115' ' ' GLY . 2.3 p -108.43 153.69 22.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.944 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.826 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.9 mm? -137.77 169.84 17.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.637 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 20.6 t -163.52 111.99 1.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.636 -175.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.846 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.4 m-30 -103.92 131.88 50.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.19 169.15 41.65 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.934 -1.126 . . . . 0.0 112.224 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -89.78 115.05 26.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.205 0.526 . . . . 0.0 111.374 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.54 112.14 0.64 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.625 170.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 67' ' ' VAL . 13.1 mt -89.39 160.26 16.91 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.474 0.654 . . . . 0.0 110.476 170.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 t -131.57 166.93 20.3 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.992 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.263 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.19 -174.61 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 CA--C 1.532 0.422 0 N-CA-C 114.275 0.836 . . . . 0.0 114.275 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.413 ' HE2' ' CA ' ' A' ' 43' ' ' GLY . 27.0 m-85 -68.22 164.15 21.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.435 -173.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 p -149.45 154.22 38.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.865 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.829 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -83.84 126.51 40.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -177.392 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 46.3 mt-30 -65.85 -50.95 62.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.129 175.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.416 HG21 HD21 ' A' ' 33' ' ' ASN . 23.9 t -112.62 85.6 7.58 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.46 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.71 106.28 1.44 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.637 2.892 . . . . 0.0 113.034 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.522 ' OD1' HG23 ' A' ' 112' ' ' VAL . 4.2 t70 -100.45 -140.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.075 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 38.8 t -62.01 143.62 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.691 0.757 . . . . 0.0 111.572 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.567 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 53.2 m -143.94 179.09 7.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.411 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.631 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.2 m-85 -137.57 150.24 47.32 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.058 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -162.31 131.89 2.65 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.353 175.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.753 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 106.6 16.03 15.43 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.794 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.509 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 11.8 mt -56.72 -44.18 81.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 51.63 50.58 18.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.63 0.728 . . . . 0.0 110.428 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 27.1 mt -109.15 118.87 37.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.894 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 13.1 p -116.64 133.08 56.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.313 . . . . 0.0 110.479 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 53.1 p -103.76 154.22 19.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 64.5 mt -82.06 165.94 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.575 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -58.84 -57.13 14.38 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -75.73 5.19 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 122' ' ' LEU . 31.3 mt-30 -80.03 57.24 2.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.74 102.32 0.49 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.847 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.602 ' HA ' ' CD2' ' A' ' 132' ' ' HIS . 2.8 t-80 81.13 -30.53 0.11 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.97 0.908 . . . . 0.0 111.553 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.23 -27.68 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.082 0.239 . . . . 0.0 111.357 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -56.09 128.14 44.94 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.613 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 28.0 m -56.48 -25.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -68.17 -48.53 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.655 ' CD2' ' H ' ' A' ' 84' ' ' LEU . 1.6 t-80 -61.6 -38.75 88.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.819 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.613 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 2.0 mm100 -56.21 -67.65 0.28 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.157 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 130' ' ' VAL . 17.7 m -58.05 -40.17 75.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.191 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.791 HG11 HD23 ' A' ' 84' ' ' LEU . 11.4 p -68.56 -47.37 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 121.289 -0.165 . . . . 0.0 111.083 -176.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.416 ' HD1' HG13 ' A' ' 135' ' ' VAL . 9.2 m-85 -72.26 -23.07 61.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.85 -55.59 23.71 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.657 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -48.29 -52.72 20.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.29 0.567 . . . . 0.0 110.747 176.324 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' MET . . . . . 1.106 ' HG2' HG13 ' A' ' 56' ' ' ILE . 51.9 mtp -54.53 -35.57 63.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.297 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.2 m -91.63 -1.99 57.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.829 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.56 44.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.92 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -109.73 134.33 52.12 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.46 0.304 . . . . 0.0 110.286 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 19' ' ' LEU . 43.8 p -112.4 -11.29 13.68 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.404 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.14 -38.68 56.72 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.523 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.37 -38.0 68.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.693 -0.298 . . . . 0.0 111.021 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 45.2 tp -67.64 -38.63 84.12 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.858 ' HG2' HG21 ' A' ' 161' ' ' VAL . 67.6 mt-10 -55.93 -38.16 69.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.68 -34.71 58.21 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.12 0.486 . . . . 0.0 109.91 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.06 85.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.939 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.3 mt -55.92 -45.97 78.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.445 174.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -53.94 -16.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.76 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.34 46.51 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.11 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.608 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.8 mp -81.09 -47.01 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.83 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.99 -37.84 69.64 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.321 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.319 . . . . 0.0 111.498 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.71 -30.37 69.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.332 0.587 . . . . 0.0 110.014 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.481 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.0 m-85 -103.39 -9.74 19.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.1 20.55 25.41 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.824 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -105.51 -166.8 1.25 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.475 0.638 . . . . 0.0 110.915 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.8 m -159.74 179.28 8.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.858 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.0 p -56.61 -25.6 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.313 0.578 . . . . 0.0 110.965 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -89.64 33.65 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.124 -0.36 . . . . 0.0 111.637 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.633 ' HB3' HG22 ' A' ' 168' ' ' VAL . 18.7 t -101.93 150.62 23.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.9 m -72.8 133.55 44.54 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 119.003 -0.522 . . . . 0.0 111.649 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.685 ' CD1' HD13 ' A' ' 15' ' ' ILE . 3.4 m-30 -38.89 -53.97 1.67 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.23 -46.2 86.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.483 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -70.99 -35.85 72.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.739 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 154' ' ' LEU . 37.1 t -62.4 -52.93 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -55.31 -46.78 76.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.022 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -64.78 -33.56 76.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.524 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.49 -32.63 62.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.227 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.835 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 31.0 p -85.15 -12.9 51.73 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.092 0.948 . . . . 0.0 109.611 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.831 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.895 0.379 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.865 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.6 t80 -80.49 158.85 25.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.174 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 p -173.9 165.3 4.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.307 0.575 . . . . 0.0 110.945 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.645 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.97 125.69 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.779 171.148 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.591 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 30.9 m-80 -101.75 49.4 0.86 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.746 0.784 . . . . 0.0 110.402 -176.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.982 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 26.1 p90 -74.42 148.48 41.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.589 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.7 t70 -63.27 106.62 0.91 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.715 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 10.2 t -39.25 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.841 1.338 . . . . 0.0 112.502 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 7' ' ' ASP . 13.5 t -173.7 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.967 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.526 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 85.5 m-85 -94.23 15.16 18.04 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.071 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.18 68.62 1.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.679 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -168.26 8.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 164' ' ' THR . 22.1 m-85 -92.57 146.88 23.33 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 122.163 0.185 . . . . 0.0 110.968 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 m -71.11 132.62 45.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.755 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -46.15 -53.31 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.569 0.622 . . . . 0.0 111.377 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.498 ' HB2' HG22 ' A' ' 161' ' ' VAL . 23.0 t-80 -61.07 -24.57 66.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.582 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.15 -44.82 28.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -71.12 -41.97 69.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.354 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.93 ' HB3' HG21 ' A' ' 143' ' ' THR . 14.3 mt -56.33 -39.78 73.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.304 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -42.18 96.78 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.113 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 24' ' ' SER . 8.2 tt0 -61.89 -38.21 87.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.534 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 49.0 t90 -60.43 -46.36 90.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.867 175.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 26' ' ' PHE . . . -65.83 -26.59 67.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.295 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.533 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 36.0 t -57.75 -55.51 33.88 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.038 0.447 . . . . 0.0 109.997 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.85 -32.39 73.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.603 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.476 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.0 t80 -61.78 -47.16 86.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.95 -30.67 76.37 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.284 -0.484 . . . . 0.0 113.766 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.27 109.0 8.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.661 HG12 ' HB1' ' A' ' 60' ' ' ALA . 17.1 m -64.46 -29.45 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -94.88 1.5 55.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.851 0.358 . . . . 0.0 111.667 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -67.25 109.07 2.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -102.85 -177.63 3.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.467 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -155.41 121.05 5.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.4 -8.13 54.6 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.088 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.29 -5.88 32.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.382 0.61 . . . . 0.0 109.563 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.499 HG21 HG23 ' A' ' 63' ' ' VAL . 41.1 t -102.18 114.41 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.179 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -100.18 -73.55 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.52 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -57.14 8.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.069 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.48 73.52 0.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.064 0.935 . . . . 0.0 111.035 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 7.5 m120 -84.58 135.03 34.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.456 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 69.2 m -74.86 -40.3 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 124.79 -124.97 5.56 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.447 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 59.79 2.96 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 61.3 m-85 60.6 -178.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.712 0.768 . . . . 0.0 112.976 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.502 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 36.9 t80 -142.02 -69.21 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.503 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.16 55.82 3.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.153 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 50' ' ' SER . . . 168.43 157.06 10.86 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.33 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.483 ' O ' HD23 ' A' ' 49' ' ' LEU . 4.0 m -82.06 -27.89 32.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.322 0.582 . . . . 0.0 109.896 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 48' ' ' SER . 6.8 mt -154.67 -40.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.452 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.771 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 10.4 p -116.04 148.25 40.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.839 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.8 -137.76 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.782 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 p -94.71 -57.92 2.33 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 54.2 tt0 -114.75 152.24 32.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.105 -167.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.736 ' CD1' HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -145.12 94.77 2.58 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.723 0.773 . . . . 0.0 111.47 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 97' ' ' LEU . . . -95.43 151.44 19.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.824 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.982 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.8 mm -146.45 129.42 8.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 123.197 0.599 . . . . 0.0 110.618 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.3 t -112.87 147.3 37.29 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 43.2 t -45.6 117.4 1.44 Allowed 'General case' 0 C--O 1.207 -1.163 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.535 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -12.93 56.52 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.977 -0.452 . . . . 0.0 110.843 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.661 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -80.66 -60.73 2.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.834 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -115.5 -0.67 13.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.793 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.8 mt-30 33.77 42.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -173.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.499 HG23 HG21 ' A' ' 36' ' ' VAL . 7.3 p -121.83 -53.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.858 166.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 32.5 m -64.19 103.89 0.68 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.216 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.02 -176.95 3.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -169.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.779 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -159.82 120.15 3.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.267 -176.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 69.1 t -102.46 109.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.567 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.779 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -97.18 151.62 19.63 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.56 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.29 139.56 6.52 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.014 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 -117.87 0.48 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.373 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.759 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 64.8 t30 -145.91 73.15 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 54' ' ' TYR . 16.4 mt -83.29 161.08 21.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.657 -164.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.59 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 52.8 m -155.75 121.57 5.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.481 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.922 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 44.1 t80 -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.421 0.629 . . . . 0.0 109.991 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.498 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . 13.0 p -81.87 47.61 1.12 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -171.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.922 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -60.02 -57.74 11.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.245 1.384 . . . . 0.0 111.987 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.402 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 11.5 m-30 -89.92 1.72 55.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.508 0.67 . . . . 0.0 109.514 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' HB2' ' CA ' ' A' ' 75' ' ' THR . 29.7 m-80 -89.02 179.07 6.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.349 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.906 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 33.7 mm-40 -53.27 -67.8 0.54 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 51.6 Cg_exo -56.66 -28.16 73.89 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 121.666 1.578 . . . . 0.0 113.13 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.36 115.43 0.05 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.655 0.74 . . . . 0.0 112.64 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 54.04 51.36 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.277 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.733 HG22 ' CE1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -134.97 178.98 6.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.703 -174.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.4 tp -125.75 142.23 51.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -153.95 -159.53 0.98 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.93 -163.32 19.35 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.307 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.759 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 1.2 tm0? -93.36 165.94 12.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.788 0.804 . . . . 0.0 112.137 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.423 HD13 ' OH ' ' A' ' 54' ' ' TYR . 25.3 tp -156.12 132.83 10.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.985 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -132.14 -45.0 0.93 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.262 0.553 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.52 134.39 46.06 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.535 HD12 ' HE1' ' A' ' 66' ' ' PHE . 3.1 mm? -108.13 175.55 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.903 169.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.67 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 12.6 t -167.22 103.78 0.53 Allowed 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.502 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.779 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.4 m-30 -95.87 145.19 25.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.78 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 177.04 170.92 40.07 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.906 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.8 114.63 26.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 111.594 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . 85.01 107.44 0.65 Allowed Glycine 0 C--O 1.223 -0.558 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.781 169.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 105' ' ' TYR . 48.1 mt -86.59 155.77 20.31 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.231 0.539 . . . . 0.0 110.29 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -145.42 173.67 11.8 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.13 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.1 -125.34 8.23 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -172.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.61 ' HA3' ' CE1' ' A' ' 105' ' ' TYR . . . 58.03 49.0 79.11 Favored Glycine 0 C--N 1.322 -0.232 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.914 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.47 ' OD2' HG23 ' A' ' 102' ' ' THR . 19.6 t70 -144.81 -70.15 0.29 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.47 HG23 ' OD2' ' A' ' 101' ' ' ASP . 47.2 p -122.69 -8.31 8.48 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.561 174.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -121.91 154.19 60.83 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.407 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.502 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 25.6 Cg_exo -67.24 160.58 46.91 Favored 'Trans proline' 0 C--N 1.333 -0.266 0 C-N-CA 123.475 2.784 . . . . 0.0 111.452 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.61 ' CE1' ' HA3' ' A' ' 100' ' ' GLY . 48.3 m-85 -68.06 141.74 56.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.815 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.0 p -150.79 147.09 26.86 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.335 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.78 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.1 mp -79.42 130.17 36.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.109 0.48 . . . . 0.0 110.82 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.79 -44.48 93.2 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.156 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.92 82.82 2.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.8 111.21 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.523 2.815 . . . . 0.0 112.908 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 49.4 m-20 -104.48 -150.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.376 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.982 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 48.4 t -59.71 143.25 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.698 0.761 . . . . 0.0 111.572 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.591 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -140.74 178.83 7.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.339 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.516 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.8 m-85 -135.19 148.27 49.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -162.51 140.51 6.59 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.824 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.865 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 99.17 11.87 44.25 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.2 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.529 ' HA ' HD11 ' A' ' 153' ' ' ILE . 16.7 mt -57.98 -50.53 73.09 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 56.15 52.2 10.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.764 0.792 . . . . 0.0 110.519 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 23.7 mt -113.74 110.14 19.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.478 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.636 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 72.4 p -115.02 130.71 57.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 81.2 p -98.02 147.2 24.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.723 0.297 . . . . 0.0 110.493 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.61 171.32 14.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.855 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -49.62 -55.39 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.92 10.23 8.31 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.447 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 19.3 mm-40 -79.84 67.78 5.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.52 -103.61 0.01 OUTLIER Glycine 0 C--O 1.224 -0.519 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.434 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -83.41 -14.81 51.85 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.11 -0.641 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -87.43 -18.81 29.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 125' ' ' GLN . . . -65.25 121.42 20.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.569 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.0 m -49.57 -32.77 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.11 -41.6 92.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.27 0.486 . . . . 0.0 110.718 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.733 ' CE1' HG22 ' A' ' 83' ' ' THR . 4.9 t-160 -65.28 -37.84 88.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 109.85 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.569 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 2.1 mt-30 -65.41 -58.14 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.731 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 130' ' ' VAL . 24.9 m -58.31 -39.35 73.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.373 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.559 ' O ' ' HG3' ' A' ' 139' ' ' MET . 13.0 p -67.68 -50.04 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.755 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.427 ' HD1' HG13 ' A' ' 135' ' ' VAL . 14.0 m-85 -71.01 -27.19 63.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.695 0.283 . . . . 0.0 110.823 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.98 -56.8 18.69 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -49.5 -50.4 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.145 0.578 . . . . 0.0 111.1 176.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.982 ' HG2' HG13 ' A' ' 56' ' ' ILE . 48.6 mtp -54.87 -33.15 61.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.41 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.2 m -94.1 -6.41 45.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.17 23.44 29.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.506 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -107.76 135.48 49.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.93 HG21 ' HB3' ' A' ' 19' ' ' LEU . 37.4 p -117.94 10.16 13.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.798 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.498 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.03 -19.27 78.3 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.69 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.27 -36.02 14.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 0.0 110.647 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.726 HD12 HD21 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -67.34 -39.59 85.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.929 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.664 ' HB2' HG11 ' A' ' 161' ' ' VAL . 10.9 pt-20 -56.61 -35.25 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.82 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 -35.69 53.15 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.996 0.426 . . . . 0.0 109.964 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.46 82.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.615 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 96.3 mt -55.96 -42.06 75.67 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.88 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -54.65 -10.35 0.43 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.171 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.0 -39.85 53.12 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.411 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.5 mp -85.52 -46.49 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 120.727 0.299 . . . . 0.0 110.436 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.495 HD11 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.28 -44.65 80.0 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.911 -177.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.63 -22.86 67.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.678 0.275 . . . . 0.0 111.514 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.12 -35.13 79.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.499 . . . . 0.0 110.019 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.447 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 34.5 m-85 -96.06 -14.68 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 99.19 24.11 10.69 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.756 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.447 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -104.4 -161.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.189 0.495 . . . . 0.0 110.377 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 66.7 p -162.61 -179.94 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.819 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.664 HG11 ' HB2' ' A' ' 147' ' ' GLU . 9.1 p -59.06 -20.35 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.062 0.458 . . . . 0.0 111.392 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.87 13.52 12.46 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.048 -0.408 . . . . 0.0 111.022 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 168' ' ' VAL . 8.5 t -84.01 148.7 26.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.7 m -72.81 149.44 43.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.988 -175.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.686 ' CD1' HD13 ' A' ' 15' ' ' ILE . 10.7 m-30 -53.19 -22.7 7.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.585 0.754 . . . . 0.0 111.46 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.46 -51.04 7.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.457 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -66.85 -43.63 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.604 HG23 ' HB3' ' A' ' 163' ' ' SER . 3.2 t -55.58 -58.52 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.02 73.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.16 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -66.84 -35.83 80.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.76 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -76.57 -30.86 57.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.385 0.612 . . . . 0.0 110.245 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.3 p -85.2 -15.26 44.23 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.92 0.867 . . . . 0.0 109.034 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -70.48 -45.53 65.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.268 173.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.51 -31.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.317 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 171' ' ' ALA . . . 104.37 114.45 3.95 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -175.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.1 m -130.57 29.69 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.927 0.87 . . . . 0.0 110.235 -171.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -87.22 1.34 53.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.589 -171.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.217 -0.896 . . . . 0.0 109.98 -178.635 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 116' ' ' GLY . . . . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.031 0.443 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.76 ' O ' ' HB ' ' A' ' 172' ' ' THR . 44.4 t80 -87.88 148.77 24.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.435 -174.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -162.41 168.35 22.23 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.729 0.812 . . . . 0.0 109.221 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.624 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.9 128.19 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.681 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 25.3 m-80 -103.9 49.97 0.81 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 0.0 110.328 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.936 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 32.6 p90 -71.49 151.4 43.97 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.097 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 9' ' ' SER . 25.5 t70 -62.36 103.08 0.36 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.665 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 5.3 t -34.94 77.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.113 1.508 . . . . 0.0 112.974 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.4 t -173.35 -30.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.298 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.573 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 66.5 m-85 -95.74 19.81 10.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.004 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 59.2 2.31 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -172.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.402 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -166.32 16.9 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.558 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 26.4 m-85 -93.66 139.86 30.31 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.163 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 m -67.55 131.54 45.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 160.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.782 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.5 mm -45.65 -51.56 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 117.917 0.326 . . . . 0.0 111.499 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -56.14 -34.79 66.45 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.559 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.25 -53.35 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.394 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.481 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 73.6 t80 -68.86 -39.64 79.75 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.583 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 12.1 mt -56.69 -40.84 76.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.955 0.407 . . . . 0.0 110.244 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.62 -41.58 99.61 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.017 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 24' ' ' SER . 6.0 tt0 -62.25 -39.85 94.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.641 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 44.8 t90 -59.16 -42.33 90.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.25 0.548 . . . . 0.0 110.202 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.38 -25.05 66.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 21.2 t -62.96 -55.78 22.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.024 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.3 -31.02 72.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.773 0.32 . . . . 0.0 111.073 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 32.1 t80 -58.85 -41.13 86.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.922 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.43 -18.64 78.46 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.433 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 90.33 2.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.414 0.626 . . . . 0.0 111.573 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.827 HG12 ' HB1' ' A' ' 60' ' ' ALA . 29.6 m -63.6 0.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -174.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -80.47 -20.21 44.25 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 52.9 t60 71.04 8.96 6.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.26 0.553 . . . . 0.0 112.188 169.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.9 p -87.62 133.7 33.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.302 0.572 . . . . 0.0 112.311 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 44.2 t-20 -168.36 123.76 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.267 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -6.78 56.3 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.419 -0.42 . . . . 0.0 114.064 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -112.98 -5.29 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.492 0.646 . . . . 0.0 111.534 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.509 HG11 HG13 ' A' ' 63' ' ' VAL . 46.1 t -102.42 118.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.13 0.49 . . . . 0.0 111.743 -175.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.92 -62.83 1.39 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.46 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.91 -72.7 0.3 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.01 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 68.97 87.04 0.12 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.378 0.609 . . . . 0.0 112.247 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -83.72 154.38 23.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.86 175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -82.22 -37.65 25.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.406 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.29 170.73 39.3 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.154 -174.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.912 ' HA2' ' HE2' ' A' ' 105' ' ' TYR . . . -98.55 -111.67 3.12 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -168.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 55.96 64.96 1.57 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.952 0.882 . . . . 0.0 109.024 -164.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 52' ' ' SER . 2.2 t80 -73.12 -23.92 60.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.668 -173.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.857 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.95 -19.66 64.82 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.376 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.02 -145.59 8.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.453 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 m -75.04 -30.42 61.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.767 0.318 . . . . 0.0 110.958 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -166.43 40.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.284 0.564 . . . . 0.0 111.397 -175.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 p -164.67 177.65 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.35 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.857 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 106.49 -163.65 13.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.297 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 16.6 m -88.54 127.57 35.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 68' ' ' ALA . 5.3 tt0 80.21 105.72 0.07 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.178 171.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -102.05 101.6 11.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.329 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.601 ' H ' ' HA3' ' A' ' 43' ' ' GLY . . . -90.52 152.78 20.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.003 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.026 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.1 mm -147.18 132.86 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.318 0.647 . . . . 0.0 109.51 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 19.8 t -121.86 149.28 43.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 40.9 t -48.06 119.4 2.88 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.399 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -66.64 -10.3 44.66 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.821 -0.549 . . . . 0.0 111.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.827 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -83.81 -49.87 8.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.674 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 31' ' ' HIS . 39.2 p30 -127.76 -3.81 5.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.86 -172.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 58' ' ' SER . 63.7 mt-30 33.8 45.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.947 1.299 . . . . 0.0 114.168 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.509 HG13 HG11 ' A' ' 36' ' ' VAL . 7.4 t -116.66 -63.38 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.669 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 21.6 m -61.84 102.59 0.28 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.337 -175.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.45 -178.43 3.38 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.54 -169.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.692 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -157.74 126.01 5.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.757 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 29.0 t -108.67 111.27 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 53' ' ' GLN . . . -90.29 107.69 19.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 0.0 111.03 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.86 117.91 5.36 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.852 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.67 -139.39 3.69 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.406 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 87' ' ' GLN . 8.7 m-80 -136.24 47.74 2.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.027 0.918 . . . . 0.0 109.222 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 35.6 mt -70.31 149.92 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.639 -1.619 . . . . 0.0 112.015 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.7 m -155.05 137.19 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.142 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 33.7 t80 -89.21 123.66 33.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.564 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.751 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 69.1 p -70.91 -32.55 69.52 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -171.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.745 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER 42.09 -92.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.836 0.854 . . . . 0.0 113.117 -168.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.518 ' H ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.63 7.29 46.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.751 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 33.8 m-80 -77.16 176.57 8.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.802 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 39.8 mt-10 -48.52 -63.13 1.7 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -170.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.802 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -55.65 -35.77 93.58 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.616 1.544 . . . . 0.0 112.433 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.63 128.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.894 0.746 . . . . 0.0 112.463 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 38.09 60.28 1.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.059 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -143.32 165.64 26.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.847 -174.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.761 HD23 HG11 ' A' ' 135' ' ' VAL . 11.7 tp -108.94 146.91 33.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 17.0 p90 -153.65 -160.7 1.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 85' ' ' TYR . . . 98.97 -166.56 21.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.929 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.683 HE22 ' HB2' ' A' ' 89' ' ' ASP . 17.8 tm0? -92.58 158.03 16.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.687 0.756 . . . . 0.0 111.906 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.567 ' CD2' HG21 ' A' ' 134' ' ' VAL . 57.1 tp -143.76 110.24 5.5 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.045 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.683 ' HB2' HE22 ' A' ' 87' ' ' GLN . 36.1 t70 -126.54 -28.82 2.98 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.882 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.498 ' O ' HD13 ' A' ' 91' ' ' LEU . 31.0 t -134.89 160.19 39.05 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.05 0.928 . . . . 0.0 112.327 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 3.0 mm? -144.46 163.7 33.04 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 19.9 t -162.82 106.93 1.1 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.163 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.781 ' CE2' HD22 ' A' ' 19' ' ' LEU . 2.4 m-30 -97.64 135.05 40.01 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.42 160.88 28.77 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.013 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.83 110.82 20.22 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.258 0.551 . . . . 0.0 110.734 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.96 110.51 2.36 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.801 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.523 HD21 HG22 ' A' ' 67' ' ' VAL . 6.6 mt -83.89 155.14 23.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.486 . . . . 0.0 109.846 170.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 t -145.95 170.2 17.1 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.908 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.26 -133.9 13.52 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.536 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.9 32.93 31.26 Favored Glycine 0 C--N 1.313 -0.729 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.127 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.89 -102.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.194 0.521 . . . . 0.0 109.61 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 p -104.59 5.13 33.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.744 0.783 . . . . 0.0 109.496 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -129.57 167.75 19.01 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.315 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.25 172.56 10.91 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.173 2.582 . . . . 0.0 112.421 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.912 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 48.8 m-85 -75.8 165.19 25.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.404 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.6 p -147.77 139.76 24.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.996 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.815 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -81.61 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.624 -174.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.14 -48.16 77.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.053 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.75 88.37 7.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.87 93.9 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 123.142 2.561 . . . . 0.0 112.354 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.456 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 30.3 m-20 -93.45 -155.56 0.45 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.413 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.936 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 20.7 t -62.0 113.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.427 1.108 . . . . 0.0 112.422 -175.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.681 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 68.5 m -103.02 176.65 5.08 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.327 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.723 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.0 m-85 -137.07 141.28 42.39 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -156.45 128.92 2.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.155 -1.498 . . . . 0.0 113.047 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 111.38 10.0 20.68 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.25 174.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.649 ' CD2' ' H ' ' A' ' 117' ' ' LEU . 1.7 mm? -49.88 -53.04 28.3 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.063 0.945 . . . . 0.0 110.52 174.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.4 t30 53.68 47.62 23.38 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.58 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.4 mt -105.22 102.55 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.498 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.627 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 69.5 p -106.16 128.5 53.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.268 0.556 . . . . 0.0 110.851 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.7 t -108.71 119.16 38.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 122' ' ' LEU . 9.9 mp -59.14 167.49 1.71 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.297 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -51.65 -57.84 8.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.877 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.582 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -83.36 15.15 3.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -165.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -72.98 -31.09 64.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 66.18 -119.91 14.37 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.203 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.45 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 6.1 t-80 -88.77 -24.06 22.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.42 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.551 ' HA ' HE21 ' A' ' 133' ' ' GLN . 32.7 t70 -81.06 -21.49 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.822 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 125.99 40.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.281 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 134' ' ' VAL . 18.6 m -51.18 -32.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.3 -42.23 94.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.556 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.9 t-160 -65.05 -40.36 94.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.779 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 128' ' ' ASP . 23.2 mm-40 -59.77 -65.31 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.926 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.567 HG21 ' CD2' ' A' ' 88' ' ' LEU . 27.1 m -55.86 -39.84 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.014 -174.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.761 HG11 HD23 ' A' ' 84' ' ' LEU . 8.3 p -69.68 -46.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.256 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -73.35 -24.77 60.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.54 -54.96 19.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.575 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -48.7 -50.72 32.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.158 0.583 . . . . 0.0 110.82 176.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' MET . . . . . 1.026 ' HG2' HG13 ' A' ' 56' ' ' ILE . 41.5 mtp -52.72 -34.61 53.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.133 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m -90.99 -2.81 57.65 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 14.89 69.33 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.597 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -106.88 104.16 13.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.182 0.515 . . . . 0.0 110.302 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 19' ' ' LEU . 3.5 p -92.16 11.86 24.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.481 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.19 -29.1 72.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.776 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.73 39.46 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.434 -0.451 . . . . 0.0 110.431 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.562 HD22 HD21 ' A' ' 138' ' ' LEU . 47.1 tp -68.39 -43.13 77.96 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.589 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.678 ' HB2' HG21 ' A' ' 161' ' ' VAL . 10.6 pt-20 -57.85 -31.08 66.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.658 0.266 . . . . 0.0 110.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -36.12 58.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.57 75.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.928 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.539 HD23 HD11 ' A' ' 117' ' ' LEU . 94.1 mt -55.45 -39.22 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.8 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -56.28 -10.19 0.83 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.451 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.35 -36.24 63.29 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.389 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.41 HG22 ' HE2' ' A' ' 157' ' ' TYR . 4.1 mp -84.4 -47.98 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 122.705 -0.291 . . . . 0.0 110.58 175.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.638 HD11 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.63 -43.09 75.86 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.8 -30.78 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.94 -31.84 72.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.137 0.494 . . . . 0.0 110.818 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.41 ' HE2' HG22 ' A' ' 153' ' ' ILE . 47.0 m-85 -98.86 -6.11 29.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.299 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.38 39.31 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.308 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 mp -101.4 -167.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.1 p -167.85 175.41 6.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.286 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -61.71 -13.27 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.271 . . . . 0.0 111.669 172.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -89.73 10.62 22.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.956 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -87.17 -116.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.184 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 7.2 m -157.31 146.83 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.771 -174.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.691 ' CD1' HD13 ' A' ' 15' ' ' ILE . 6.7 m-30 -54.47 -45.26 73.12 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.455 0.302 . . . . 0.0 111.025 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.13 -41.1 90.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.656 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -66.78 -48.18 69.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.638 HG22 HD11 ' A' ' 154' ' ' LEU . 4.0 t -56.23 -54.95 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.686 0.279 . . . . 0.0 110.272 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.21 76.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.017 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.635 ' HB1' HG11 ' A' ' 176' ' ' VAL . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.278 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.419 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -75.4 -29.74 59.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.76 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 38.0 p -86.27 -11.84 51.19 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.06 0.933 . . . . 0.0 109.146 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -68.76 -46.24 69.33 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.868 -1.514 . . . . 0.0 108.949 171.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 p -167.87 -30.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.581 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 171' ' ' ALA . . . 120.67 126.41 3.35 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.635 HG11 ' HB1' ' A' ' 170' ' ' ALA . 25.9 m -135.41 129.24 49.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.317 0.58 . . . . 0.0 111.157 -172.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.405 ' CD ' ' H ' ' A' ' 177' ' ' GLN . 5.6 pm0 -87.12 148.84 25.05 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.745 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.032 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.705 ' O ' ' HB ' ' A' ' 172' ' ' THR . 42.7 t80 -70.38 133.43 46.91 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.175 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -160.75 168.42 24.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.965 172.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' A' ' 165' ' ' PHE . 0.5 OUTLIER -88.19 130.17 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 113' ' ' SER . 44.5 m-20 -106.32 46.82 0.9 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.871 0.844 . . . . 0.0 110.814 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.962 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 20.4 p90 -70.56 145.4 50.82 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.261 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 9' ' ' SER . 32.7 t70 -63.82 104.84 0.73 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.347 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 p -25.15 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.726 1.61 . . . . 0.0 114.579 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ASP . 42.2 t -174.64 -32.07 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.26 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.596 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 74.7 m-85 -94.21 16.86 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.15 70.81 0.61 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.511 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.62 23.24 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.666 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 25.7 m-85 -107.77 141.36 39.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.522 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -72.55 129.59 38.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 161.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 168' ' ' VAL . 5.0 mm -47.24 -43.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -170.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -63.2 -33.34 75.27 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.569 0.223 . . . . 0.0 111.316 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.28 -36.14 82.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 110.766 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.895 ' CE1' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -72.1 -48.12 46.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 175.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.803 HD21 ' HZ ' ' A' ' 114' ' ' PHE . 15.9 mt -53.05 -46.54 68.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.774 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.2 -44.7 94.77 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.68 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -62.96 -43.46 98.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.661 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 55.6 t90 -58.69 -45.13 90.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.551 . . . . 0.0 109.916 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.4 -24.03 64.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.2 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -62.52 -53.2 58.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -34.35 78.04 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.491 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.2 t80 -56.8 -42.41 79.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.519 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.14 -21.41 79.21 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.239 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 7.3 t70 -75.96 104.03 6.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 111.0 -174.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.837 HG12 ' HB1' ' A' ' 60' ' ' ALA . 20.1 m -68.0 2.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -81.75 -11.04 59.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -168.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.512 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 85.9 t60 61.68 24.57 14.65 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.403 0.62 . . . . 0.0 111.551 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.7 p -90.38 130.86 36.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.512 0.672 . . . . 0.0 112.726 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -173.22 120.49 0.35 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.097 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.62 -6.77 63.42 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.996 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -118.37 3.88 11.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 117.628 0.714 . . . . 0.0 111.745 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 63' ' ' VAL . 25.5 t -98.11 112.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.293 0.568 . . . . 0.0 112.378 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.78 -67.07 0.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.653 172.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -75.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.148 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.523 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 65.11 63.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.459 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 40.1 m-80 -86.23 147.99 25.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.365 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 57' ' ' SER . 71.8 m -93.65 -39.11 10.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.997 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 114.3 -129.13 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.397 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.95 62.44 2.01 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 121.201 -0.524 . . . . 0.0 113.067 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 66.33 130.66 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.488 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 17.5 t80 -107.88 -24.65 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.269 172.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.48 19.8 8.28 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.132 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.76 -132.02 7.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.633 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -75.89 -52.18 10.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.543 0.211 . . . . 0.0 111.419 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -164.44 21.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.1 p -161.62 156.65 23.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.82 -64.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.243 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.615 ' C ' ' HA2' ' A' ' 70' ' ' GLY . 23.1 t -148.77 -144.75 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 121.349 -0.14 . . . . 0.0 110.631 -170.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 51.1 mt-30 -43.93 141.75 1.56 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.806 0.842 . . . . 0.0 112.104 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.423 ' HB3' HD12 ' A' ' 72' ' ' LEU . 3.9 t80 -130.99 96.98 4.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.504 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -89.76 146.77 24.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.558 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.03 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.3 mm -145.12 121.1 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.564 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.1 t -104.73 165.97 10.7 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.436 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 33.4 t -61.13 152.78 27.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.09 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.9 p -101.53 -14.09 17.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.019 0.438 . . . . 0.0 110.115 168.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.837 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -75.47 -54.5 6.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.293 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.512 ' HB2' ' HA ' ' A' ' 31' ' ' HIS . 37.9 p30 -115.3 0.98 13.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.154 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 58' ' ' SER . 69.5 mt-30 30.0 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.8 p -128.64 -51.64 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.459 171.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 17.1 m -63.33 107.5 1.1 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.692 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -121.27 -178.22 3.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -170.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.779 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -156.37 131.78 9.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.869 -176.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 58.1 t -110.98 119.99 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.542 0.211 . . . . 0.0 110.694 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.78 14.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.949 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 53' ' ' GLN . . . -63.29 -99.3 0.01 OUTLIER Glycine 0 C--O 1.217 -0.921 0 N-CA-C 116.61 1.404 . . . . 0.0 116.61 -167.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.615 ' HA2' ' C ' ' A' ' 52' ' ' SER . . . -179.68 34.13 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 118.826 -1.654 . . . . 0.0 115.495 -170.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 1.5 t30 -146.39 27.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.756 1.278 . . . . 0.0 111.03 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.585 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 73.1 mt -79.05 144.6 34.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.973 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.9 m -144.38 124.33 13.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.383 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.549 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 58.3 t80 -82.07 123.09 28.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.866 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 80.7 p -61.4 -38.96 88.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.626 -171.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 tp 55.53 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 123.812 0.695 . . . . 0.0 111.337 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -100.76 8.39 43.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.742 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.866 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 12.4 m120 -76.44 179.03 6.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 111.536 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.776 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 6.0 mm-40 -51.4 -56.83 17.27 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -57.6 -37.3 97.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.754 1.636 . . . . 0.0 112.513 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.86 125.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.833 0.708 . . . . 0.0 112.372 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 47.53 58.82 4.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.11 169.05 20.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.333 -175.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.773 HD23 HG11 ' A' ' 135' ' ' VAL . 12.2 tp -108.81 138.8 44.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -157.01 139.01 14.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 166.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 72' ' ' LEU . . . -168.65 -131.2 1.27 Allowed Glycine 0 C--N 1.298 -1.542 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.187 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 1.8 tm0? -142.42 151.59 41.95 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 113.889 -1.155 . . . . 0.0 108.831 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.564 HD21 HD11 ' A' ' 91' ' ' LEU . 18.9 tp -138.99 116.25 11.11 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.574 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 16.6 t70 -110.89 -56.62 2.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.645 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.503 ' O ' HD13 ' A' ' 91' ' ' LEU . 4.9 p -107.74 155.07 20.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.323 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.721 HD12 ' HE1' ' A' ' 66' ' ' PHE . 3.0 mm? -141.15 160.52 39.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.663 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 58.0 m -149.76 111.33 4.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.675 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.75 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.9 m-30 -99.72 129.38 45.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.04 165.32 35.83 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.535 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -90.11 123.13 33.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.197 0.523 . . . . 0.0 111.618 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.76 110.04 0.47 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.469 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.538 HD11 ' HB1' ' A' ' 55' ' ' ALA . 77.0 mt -87.01 151.59 23.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.052 0.453 . . . . 0.0 109.979 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 p -131.19 154.04 48.81 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.998 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.29 23.91 53.04 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.673 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.29 52.05 4.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.641 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -94.22 -92.38 0.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.1 p -121.72 13.86 10.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.2 172.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 m -110.16 168.16 8.04 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.353 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.8 Cg_exo -72.8 142.65 35.8 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.222 2.615 . . . . 0.0 111.917 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.725 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 64.1 m-85 -67.74 150.7 48.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.322 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' LEU . 18.2 p -144.06 152.75 41.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.544 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.661 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.0 mp -85.98 119.08 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.643 0.259 . . . . 0.0 110.907 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.523 ' NE2' ' H ' ' A' ' 39' ' ' ALA . 41.7 mt-30 -65.04 -47.22 78.14 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 33.5 t -105.16 87.83 2.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 34.0 Cg_endo -63.25 100.7 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.372 2.715 . . . . 0.0 112.453 -176.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.515 ' OD2' HG23 ' A' ' 112' ' ' VAL . 10.1 t70 -106.1 -147.19 0.4 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.962 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 15.4 t -69.79 149.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.355 0.598 . . . . 0.0 111.892 -177.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 5' ' ' ASN . 36.2 m -142.9 -177.49 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.123 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.803 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.0 m-85 -134.35 152.7 51.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.114 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.35 135.74 4.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.515 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.94 13.63 31.21 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.551 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.506 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 mt -55.41 -51.71 65.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.574 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 64.8 t30 53.4 43.26 31.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.208 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -106.29 128.8 54.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 171.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.693 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 51.2 p -131.17 139.04 49.68 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.983 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.5 p -98.55 151.44 20.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.864 0.364 . . . . 0.0 111.392 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.59 162.94 26.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -48.13 -55.56 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.54 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.7 11.35 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 15.0 mm100 -77.44 55.42 1.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 112.134 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 128' ' ' ASP . . . -64.24 104.33 0.88 Allowed Glycine 0 C--O 1.225 -0.422 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.526 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.489 ' HA ' ' CD2' ' A' ' 132' ' ' HIS . 1.6 t-80 74.95 -26.17 0.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.609 0.764 . . . . 0.0 111.35 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 126' ' ' GLY . 24.1 t70 -83.65 -23.21 31.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.091 0.472 . . . . 0.0 110.207 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -60.34 122.14 28.9 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.095 173.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.516 ' O ' HG22 ' A' ' 134' ' ' VAL . 22.9 m -51.52 -33.34 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 86' ' ' GLY . 12.5 m -64.83 -44.87 96.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.561 0.22 . . . . 0.0 110.958 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.582 ' CD2' ' H ' ' A' ' 84' ' ' LEU . 1.5 t-80 -60.38 -40.42 90.79 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.443 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 9.1 mt-30 -59.09 -63.24 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 130' ' ' VAL . 23.7 m -60.01 -40.49 83.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.022 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.779 HG23 ' HZ ' ' A' ' 66' ' ' PHE . 10.7 p -68.99 -45.47 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.325 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.92 -22.44 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 0.0 110.601 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.9 -54.8 19.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.646 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -47.95 -52.17 20.71 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.344 0.658 . . . . 0.0 110.88 176.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' MET . . . . . 1.03 ' HG2' HG13 ' A' ' 56' ' ' ILE . 45.4 mtp -54.63 -33.64 60.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.392 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.5 t -89.67 -15.47 32.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.25 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.5 16.58 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.635 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.61 127.1 48.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.583 HG21 ' HB3' ' A' ' 19' ' ' LEU . 21.7 p -114.61 5.48 15.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.119 0.485 . . . . 0.0 110.979 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.494 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.99 -20.93 80.16 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.583 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.02 -35.45 21.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 36.1 tp -68.06 -40.93 82.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.492 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.633 ' HB2' HG11 ' A' ' 161' ' ' VAL . 11.8 pt-20 -56.67 -34.53 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.716 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -35.4 61.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.116 0.484 . . . . 0.0 110.053 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.21 -46.27 74.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.525 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 95.9 mt -55.26 -41.91 72.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.049 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -52.8 -14.32 0.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.331 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -72.87 -43.65 40.87 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.78 -175.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.411 HG22 ' HE2' ' A' ' 157' ' ' TYR . 3.8 mp -80.27 -43.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.285 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.714 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -59.18 -44.63 92.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.309 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.28 -25.73 67.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 111.389 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.09 -29.5 70.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.471 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 25.5 m-85 -100.47 -12.54 19.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.276 175.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 97.37 18.24 29.11 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.429 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.508 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -102.83 -163.07 0.96 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.421 0.611 . . . . 0.0 110.522 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.9 p -161.69 -176.66 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.974 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 147' ' ' GLU . 8.5 p -58.02 -23.16 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 111.034 174.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -88.77 18.39 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.295 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.703 ' HB3' HG22 ' A' ' 168' ' ' VAL . 16.6 t -83.76 143.42 30.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 168' ' ' VAL . 47.0 m -75.36 141.04 43.38 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.567 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 13' ' ' TYR . 7.0 m-30 -39.82 -49.96 2.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.833 0.853 . . . . 0.0 113.187 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.19 -38.58 88.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.948 0.404 . . . . 0.0 110.742 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.525 HE21 ' HB ' ' A' ' 164' ' ' THR . 52.5 mt-30 -73.99 -38.95 63.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.289 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.714 HG13 HD11 ' A' ' 154' ' ' LEU . 17.9 t -62.07 -52.33 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 109.986 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.38 82.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.84 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -65.83 -35.35 80.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.74 -28.04 60.61 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.364 0.602 . . . . 0.0 110.638 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.705 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.8 p -89.96 -12.94 37.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.071 0.938 . . . . 0.0 109.594 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -69.24 -36.81 77.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.512 173.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.2 p -174.27 -30.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.302 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 119.29 120.62 2.91 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.857 HG23 ' HG2' ' A' ' 177' ' ' GLN . 17.1 m -143.54 176.78 2.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.296 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.857 ' HG2' HG23 ' A' ' 176' ' ' VAL . 12.1 mm100 67.93 13.86 9.25 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.963 0.789 . . . . 0.0 112.445 174.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.081 179.113 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.025 0.44 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.814 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 17.0 t80 -113.81 160.66 18.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.177 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -173.7 160.53 3.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.221 0.534 . . . . 0.0 110.967 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.674 HG11 HD12 ' A' ' 15' ' ' ILE . 11.8 m -97.86 115.96 39.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.752 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.496 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 34.4 m-80 -96.45 59.32 1.82 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.623 -169.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.679 ' CE2' ' HA ' ' A' ' 8' ' ' SER . 38.9 p90 -74.23 149.7 40.69 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.049 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.5 t70 -62.73 94.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.679 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.5 p -24.99 72.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 114.92 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 20.7 t -173.79 -26.23 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.392 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.531 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 83.6 m-85 -90.04 10.24 24.94 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.931 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.2 69.23 1.09 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.974 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.61 21.83 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 164' ' ' THR . 21.8 m-85 -107.42 140.14 40.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.942 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m -68.89 133.24 47.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 162.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.674 HD12 HG11 ' A' ' 4' ' ' VAL . 6.3 mm -51.26 -47.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 118.134 0.424 . . . . 0.0 111.604 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -65.21 -25.22 67.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.947 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.43 -51.12 25.65 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 56.8 t80 -69.51 -49.2 56.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' A' ' 93' ' ' PHE . 16.3 mt -57.42 -38.99 75.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.029 0.442 . . . . 0.0 110.242 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.29 -41.01 94.76 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.86 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.84 -45.44 92.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.953 0.406 . . . . 0.0 110.988 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.738 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 9.3 t90 -52.69 -51.08 61.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.816 174.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.67 -28.92 68.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -57.79 -52.09 66.88 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -27.37 66.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.421 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.542 ' CE2' ' HE1' ' A' ' 66' ' ' PHE . 18.0 t80 -60.44 -49.9 75.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.54 0.209 . . . . 0.0 110.488 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.83 -28.26 73.7 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.254 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -73.25 103.9 4.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 110.962 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.701 HG12 ' HB1' ' A' ' 60' ' ' ALA . 27.9 m -63.04 -16.17 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.384 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -90.28 -13.59 34.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.935 0.398 . . . . 0.0 111.04 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -66.83 127.74 33.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.327 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.35 -176.08 4.34 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.364 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -158.44 125.14 4.79 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -10.32 62.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.065 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -90.77 -7.12 53.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.593 0.711 . . . . 0.0 109.293 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.546 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 23.4 t -94.91 120.42 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 m -92.7 -57.45 2.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.407 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 4.5 t70 -98.44 -68.81 0.79 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.286 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' H ' HE22 ' A' ' 108' ' ' GLN . . . 79.92 81.25 0.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 124.972 1.42 . . . . 0.0 109.66 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.67 ' HB3' ' HE1' ' A' ' 105' ' ' TYR . 5.4 m120 -78.51 135.74 37.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.256 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 60.2 p -76.56 -45.69 29.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.428 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.0 178.06 27.21 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 44' ' ' PHE . . . -167.56 -45.24 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 117.311 -2.376 . . . . 0.0 117.725 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.8 m-85 70.29 95.38 0.07 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.916 0.858 . . . . 0.0 109.543 -153.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -79.53 -17.42 54.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.55 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.36 17.58 37.82 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.939 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.08 -118.71 4.31 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.351 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.4 m -76.85 -54.35 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.769 0.318 . . . . 0.0 111.778 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -164.99 43.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.664 0.745 . . . . 0.0 110.781 -173.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 p -158.29 -178.32 7.2 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.356 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.86 -166.35 25.67 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.99 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -87.83 -39.1 15.13 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' ALA . 77.9 mt-30 -117.77 155.24 30.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.48 0.657 . . . . 0.0 111.609 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -145.5 101.57 3.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.07 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 97' ' ' LEU . . . -92.91 142.49 27.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.776 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 139' ' ' MET . 31.7 mm -143.49 129.6 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 O-C-N 123.679 0.612 . . . . 0.0 109.945 177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.542 ' HB3' ' HA ' ' A' ' 41' ' ' SER . 22.9 t -112.95 155.79 24.15 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.627 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 38.1 t -48.81 128.85 16.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.829 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 p -76.55 -14.88 59.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.171 0.51 . . . . 0.0 109.866 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.701 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -80.82 -60.06 2.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.891 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -116.33 1.52 13.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.053 0.454 . . . . 0.0 111.503 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.1 mm-40 39.0 36.24 0.15 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -175.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 p -124.08 -51.11 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.686 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 m -64.54 102.98 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -120.62 175.51 5.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.299 0.571 . . . . 0.0 112.205 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -159.73 131.36 6.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.592 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 49.1 t -108.52 115.03 48.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.222 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -86.96 155.25 20.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.61 125.27 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.524 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -177.93 -104.19 0.18 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.694 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 64.4 t30 -150.4 41.26 0.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.5 145.3 55.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.081 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.2 m -154.55 131.81 11.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.475 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HB3' HD13 ' A' ' 49' ' ' LEU . 55.0 t80 -90.46 129.15 36.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.0 p -65.29 -35.81 82.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.529 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 8.8 tp 51.7 -96.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.689 0.796 . . . . 0.0 112.166 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.529 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 4.9 m-85 -101.58 7.78 42.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.103 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.75 178.44 6.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.938 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 41.0 mt-10 -48.35 -62.23 2.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -169.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.79 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 86.8 Cg_exo -50.73 -51.4 11.21 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.978 1.786 . . . . 0.0 112.992 175.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 71.68 130.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.882 0.739 . . . . 0.0 112.402 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 51.8 m80 54.49 49.91 17.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.268 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.652 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.6 OUTLIER -146.49 166.34 26.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 -175.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.668 ' CD2' HG11 ' A' ' 135' ' ' VAL . 13.9 tp -110.74 151.53 27.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -153.49 -153.46 0.47 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.19 -144.46 17.35 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.199 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.716 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 24.7 tm0? -140.97 158.79 43.44 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 91' ' ' LEU . 32.0 tp -144.22 135.15 25.21 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.565 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 19.0 t70 -133.02 -55.14 0.92 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.431 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.636 ' O ' HD22 ' A' ' 91' ' ' LEU . 5.7 p -108.31 158.33 17.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.515 -176.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 68' ' ' ALA . 2.4 mm? -140.23 156.89 46.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 172.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.511 ' HB3' HD11 ' A' ' 107' ' ' ILE . 3.7 m -147.09 106.02 3.85 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.285 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.67 ' CE2' HD22 ' A' ' 19' ' ' LEU . 2.4 m-30 -91.97 147.64 22.81 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.76 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 173.36 163.56 27.2 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.781 173.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.0 117.98 29.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.336 0.589 . . . . 0.0 111.043 176.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 104.87 0.88 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.42 172.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.54 ' CD1' ' HB1' ' A' ' 55' ' ' ALA . 50.5 mt -88.93 161.12 16.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.263 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 t -146.96 168.47 21.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.42 32.55 84.58 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.699 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.65 ' HA3' ' CE1' ' A' ' 105' ' ' TYR . . . -87.41 19.58 31.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.829 -0.7 . . . . 0.0 114.33 -175.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.16 -79.93 0.37 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.353 0.577 . . . . 0.0 110.983 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 p -113.01 9.68 18.72 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.339 0.59 . . . . 0.0 110.819 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.53 168.27 13.57 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.944 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -77.55 151.14 28.67 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.286 2.657 . . . . 0.0 110.762 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.67 ' HE1' ' HB3' ' A' ' 40' ' ' ASN . 38.4 m-85 -65.38 144.25 57.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.584 0.707 . . . . 0.0 111.614 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 p -143.21 138.11 29.45 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.388 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.76 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.0 mp -79.62 123.83 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.546 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 78.2 mt-30 -64.58 -48.43 75.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.308 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.77 90.23 12.57 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.79 102.09 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.816 3.011 . . . . 0.0 113.919 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.6 m-20 -84.7 -164.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.716 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 84.5 t -63.28 138.02 23.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.824 0.821 . . . . 0.0 112.393 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 58.4 m -116.77 179.7 3.94 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.635 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 91.7 m-85 -143.56 153.16 42.28 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.26 134.09 3.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.636 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.814 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 103.89 15.67 21.54 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.308 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.432 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 22.6 mt -58.52 -45.74 88.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.644 0.722 . . . . 0.0 109.632 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.565 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 14.9 t30 59.98 19.0 8.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.436 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -92.36 132.08 37.03 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.559 0.695 . . . . 0.0 110.236 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.716 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 59.9 p -133.21 165.15 25.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.657 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 131' ' ' VAL . 78.2 p -144.48 150.86 38.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.027 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.43 165.84 15.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.6 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -51.06 -56.3 13.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.995 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.597 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -81.77 15.79 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -74.95 -15.86 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.321 177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 44.47 -123.83 5.35 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.705 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.434 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 1.4 t-80 -78.52 -20.14 51.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HA ' HE21 ' A' ' 133' ' ' GLN . 17.0 t70 -85.17 -17.26 37.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.01 122.98 31.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.18 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.626 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.2 m -50.2 -33.62 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.45 HG22 ' OG ' ' A' ' 121' ' ' SER . 27.2 m -64.74 -41.25 91.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.652 ' HE1' HG22 ' A' ' 83' ' ' THR . 3.9 t-160 -64.0 -38.28 90.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.626 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 4.2 mm-40 -63.4 -62.77 1.46 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.59 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 130' ' ' VAL . 15.9 m -58.75 -37.1 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.264 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.668 HG11 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -66.35 -43.97 91.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.379 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.581 ' HD1' HG13 ' A' ' 135' ' ' VAL . 22.2 m-85 -71.94 -27.47 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.308 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -54.29 38.07 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 170.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.599 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.25 -60.62 2.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.544 0.688 . . . . 0.0 110.085 176.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.721 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 71.2 mtm -55.59 -25.97 41.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.463 -1.244 . . . . 0.0 114.071 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 m -94.09 -3.2 51.57 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.563 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.42 48.67 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.16 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -106.95 135.18 48.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.161 0.505 . . . . 0.0 110.616 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.418 HG21 ' HB3' ' A' ' 19' ' ' LEU . 23.7 p -111.75 8.5 20.66 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 147' ' ' GLU . . . -74.71 -42.94 30.43 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.553 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.62 -27.02 60.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.219 0.533 . . . . 0.0 109.688 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.619 HD11 ' HZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -73.74 -48.05 34.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.271 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.58 ' HB2' HG11 ' A' ' 161' ' ' VAL . 10.3 pt-20 -56.69 -36.16 69.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -38.28 69.09 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.187 0.518 . . . . 0.0 109.767 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.72 -47.35 75.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.427 ' O ' HD22 ' A' ' 154' ' ' LEU . 96.1 mt -55.74 -46.47 77.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.517 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.93 -15.86 3.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.753 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.86 -39.94 58.59 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.623 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.405 HG22 ' HE2' ' A' ' 157' ' ' TYR . 4.0 mp -81.43 -51.12 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.281 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.737 HD11 HG13 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -54.77 -41.93 71.09 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.77 -23.15 67.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.26 -24.11 63.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 110.106 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.517 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 9.2 m-85 -112.29 0.82 15.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.188 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 90.49 16.96 54.26 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.78 -0.646 . . . . 0.0 113.847 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 2.2 mm? -98.7 -170.88 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.627 0.713 . . . . 0.0 109.536 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 78.6 p -164.21 176.92 8.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.22 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.58 HG11 ' HB2' ' A' ' 147' ' ' GLU . 4.9 p -57.55 -26.45 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.083 0.468 . . . . 0.0 110.632 174.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -90.26 28.91 1.33 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.824 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 14' ' ' SER . 25.3 t -84.55 -134.62 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 98.6 m -158.25 142.39 15.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.58 ' CD1' HD13 ' A' ' 15' ' ' ILE . 10.9 m-30 -44.12 -49.76 8.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -173.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.69 -23.23 62.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.234 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -84.26 -51.52 6.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.737 HG13 HD11 ' A' ' 154' ' ' LEU . 61.5 t -56.34 -57.03 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.255 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.17 69.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.72 84.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.795 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -73.28 -29.29 62.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.194 0.521 . . . . 0.0 110.81 -174.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.675 HG21 ' CD2' ' A' ' 2' ' ' PHE . 40.5 p -88.98 -21.1 23.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.851 0.834 . . . . 0.0 109.645 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.84 -46.28 45.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.973 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.419 ' H ' ' H ' ' A' ' 175' ' ' GLY . 3.6 p -157.23 -10.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.538 -170.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.795 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -65.12 -20.85 67.48 Favored Glycine 0 CA--C 1.502 -0.723 0 CA-C-O 122.029 0.794 . . . . 0.0 112.015 176.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.48 HG12 ' CZ ' ' A' ' 157' ' ' TYR . 16.1 m -40.55 113.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 112.789 -1.706 . . . . 0.0 112.707 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 64.66 104.8 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.989 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.9 m80 . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.818 179.686 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.874 0.369 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.809 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 47.0 t80 -82.91 145.75 29.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.674 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -163.42 168.75 19.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.845 0.715 . . . . 0.0 109.094 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.595 HG13 ' HB2' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -88.26 122.59 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.496 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 63.9 m-20 -97.94 45.65 1.02 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.186 0.994 . . . . 0.0 110.366 -174.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.934 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -72.26 150.47 43.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.627 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 9' ' ' SER . 27.6 t70 -64.58 110.28 2.28 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.172 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.46 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.3 p -39.4 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.241 1.416 . . . . 0.0 113.338 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.7 t -170.84 -32.85 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.131 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.428 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 45.8 m-85 -89.44 18.39 5.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.6 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.39 76.82 0.92 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.619 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -174.27 -8.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.487 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 36.3 m-85 -73.5 133.58 43.66 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 122.825 -0.22 . . . . 0.0 110.478 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 17' ' ' ASP . 15.5 m -66.37 132.95 49.47 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 163.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.697 HD13 ' CD1' ' A' ' 165' ' ' PHE . 4.8 mm -46.78 -49.53 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 118.062 0.392 . . . . 0.0 111.697 -172.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.514 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 2.4 t-80 -58.48 -29.88 66.55 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.298 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' SER . 4.0 m-20 -68.2 -58.96 3.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.452 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HB2' ' CG ' ' A' ' 13' ' ' TYR . 59.5 t80 -63.94 -45.56 88.67 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.661 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.934 ' HB3' HG21 ' A' ' 143' ' ' THR . 13.1 mt -57.13 -42.04 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.151 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.64 -40.4 97.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.08 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.08 -42.04 99.55 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 122.631 0.373 . . . . 0.0 111.354 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 39.9 t90 -60.35 -42.7 96.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.408 0.623 . . . . 0.0 109.724 176.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.091 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.0 t -63.58 -54.38 36.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 p -64.34 -35.18 80.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.808 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 19.7 t80 -55.65 -42.93 75.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.213 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.98 -21.21 79.15 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.919 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' OD2' ' HB2' ' A' ' 30' ' ' ASN . 29.9 t70 -73.81 104.6 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.201 0.5 . . . . 0.0 111.374 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.655 HG12 ' HB1' ' A' ' 60' ' ' ALA . 24.9 m -67.27 -0.95 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.499 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 50.0 m-80 -81.42 -13.89 57.74 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.084 -0.385 . . . . 0.0 111.875 -171.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.538 ' CG ' ' H ' ' A' ' 32' ' ' THR . 0.8 OUTLIER 55.68 -146.67 0.56 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.441 0.463 . . . . 0.0 110.26 175.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.538 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 27.0 p 57.5 138.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.225 1.41 . . . . 0.0 113.938 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t-20 -163.43 125.35 2.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.882 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.72 -13.56 63.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.001 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -111.13 15.68 21.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.727 HG22 ' NE2' ' A' ' 108' ' ' GLN . 0.5 OUTLIER -134.82 134.32 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -112.56 -74.69 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.043 0.449 . . . . 0.0 111.745 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.16 -67.0 0.5 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.513 -173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.38 80.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.754 0.659 . . . . 0.0 111.592 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 11.0 m120 -79.79 157.76 26.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.449 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 58.0 m -93.26 -24.43 18.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -168.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.17 135.93 3.09 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.005 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.36 59.63 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.245 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 39.2 m-85 62.93 159.17 0.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.996 0.903 . . . . 0.0 112.553 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.859 ' HE1' ' HD3' ' A' ' 104' ' ' PRO . 5.3 t80 -126.72 -36.2 2.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.072 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.85 -21.83 58.84 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.21 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -138.87 4.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.467 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -77.08 -30.17 55.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.725 0.298 . . . . 0.0 110.912 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.609 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -164.25 27.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.604 -175.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -149.25 176.3 10.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.56 173.45 15.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.175 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 t -85.97 -3.17 58.87 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 28.6 tt0 -147.23 150.97 35.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.278 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -154.33 97.17 2.0 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB3' ' CD2' ' A' ' 105' ' ' TYR . . . -91.72 155.69 18.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.713 HG21 ' HG2' ' A' ' 139' ' ' MET . 9.4 mm -150.76 146.81 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.551 0.741 . . . . 0.0 109.254 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 t -122.36 170.95 9.42 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 30.0 t -55.54 141.51 36.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.384 0.611 . . . . 0.0 111.403 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -85.92 -20.36 29.12 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.113 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.655 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.11 -54.08 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.6 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 34.4 p30 -119.64 -1.15 10.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 111.909 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.9 mm-40 42.11 38.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 31' ' ' HIS . 11.7 p -122.78 -57.15 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 122.306 -0.247 . . . . 0.0 110.783 169.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.557 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 19.8 m -58.87 106.84 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 110.495 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -116.74 179.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.712 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -157.42 133.43 9.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.753 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 22.4 t -115.05 114.18 45.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.264 -0.272 . . . . 0.0 110.684 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 53' ' ' GLN . . . -89.34 149.55 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.708 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.69 124.95 1.88 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.139 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.91 -115.5 0.46 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.449 ' HB3' ' CB ' ' A' ' 87' ' ' GLN . 13.9 t-20 -148.38 48.62 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.2 mt -62.86 144.87 56.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.909 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -149.92 138.62 20.83 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.795 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' A' ' 49' ' ' LEU . 58.1 t80 -93.61 133.8 36.56 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 80' ' ' PRO . 31.9 p -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.438 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 8.2 tp 56.4 -94.45 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.079 0.552 . . . . 0.0 111.143 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.438 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 3.5 m-85 -98.57 -1.75 40.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.137 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -75.45 167.05 22.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.647 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 23.8 mm-40 -46.99 -60.08 4.4 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -165.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HB2' HG21 ' A' ' 75' ' ' THR . 99.7 Cg_exo -49.75 -38.27 46.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.769 1.646 . . . . 0.0 113.17 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 65.07 117.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.427 0.632 . . . . 0.0 112.617 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 10.7 m-70 56.7 60.16 3.2 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.512 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.834 HG21 ' HA2' ' A' ' 126' ' ' GLY . 26.5 m -149.3 153.36 37.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.147 -172.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.746 HD23 HG11 ' A' ' 135' ' ' VAL . 14.8 tp -101.12 148.05 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.424 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -156.05 -153.55 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.33 -167.31 24.81 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.258 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.591 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 12.5 tm0? -95.96 165.57 12.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.395 0.617 . . . . 0.0 111.594 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.5 tp -152.85 136.71 16.22 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.007 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.03 -54.48 0.71 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.112 0.482 . . . . 0.0 110.716 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.453 ' C ' HD22 ' A' ' 91' ' ' LEU . 4.5 p -112.56 155.37 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -175.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 3.0 mm? -138.59 161.52 36.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 172.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.644 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 55.5 m -151.6 112.53 4.26 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 122.187 -0.321 . . . . 0.0 110.783 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.793 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.6 m-30 -99.77 139.13 35.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.605 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -179.79 163.86 31.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.522 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.43 132.79 34.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.129 0.464 . . . . 0.0 110.705 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . 68.23 112.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 174.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.441 HD11 ' HB1' ' A' ' 55' ' ' ALA . 54.8 mt -87.04 156.36 19.78 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.199 -0.589 . . . . 0.0 109.953 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.1 t -150.8 -177.55 6.06 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.789 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.56 -109.76 3.69 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.914 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.55 55.29 26.18 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -80.94 -71.88 0.45 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.255 -0.473 . . . . 0.0 110.092 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.1 p -97.26 -27.57 14.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 169.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.637 ' N ' ' HD2' ' A' ' 104' ' ' PRO . 3.0 m 178.45 -55.39 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.216 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.859 ' HD3' ' HE1' ' A' ' 45' ' ' TYR . 7.2 Cg_endo -49.56 131.81 28.98 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.139 3.226 . . . . 0.0 114.522 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.644 ' CD2' ' HB3' ' A' ' 55' ' ' ALA . 50.4 m-85 -76.45 169.42 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.91 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 p -151.49 142.64 23.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.1 mp -84.31 120.46 35.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.727 ' NE2' HG22 ' A' ' 36' ' ' VAL . 20.0 mt-30 -65.45 -41.44 93.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.138 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.48 89.9 6.56 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.51 92.37 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.3 2.667 . . . . 0.0 112.49 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 72.9 m-20 -99.32 -153.61 0.44 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.331 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.934 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -62.83 144.66 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.521 0.676 . . . . 0.0 111.549 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -136.6 179.31 6.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 95.6 m-85 -138.79 148.71 44.14 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.7 145.22 10.22 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.693 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.809 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.57 8.23 46.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.628 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 19.4 mt -56.73 -51.68 67.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.073 0.436 . . . . 0.0 109.947 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.411 ' HA ' ' NE2' ' A' ' 87' ' ' GLN . 63.0 t30 49.28 50.98 17.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.693 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 21.5 mt -106.8 107.62 18.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.704 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.591 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 17.9 p -105.82 131.07 53.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.4 t -103.73 141.96 35.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -74.22 169.45 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.41 ' OE1' HG22 ' A' ' 75' ' ' THR . 5.6 tp-100 -58.96 -56.73 18.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.136 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.02 8.33 3.29 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.407 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 7.9 mm-40 -77.04 52.86 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.892 175.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.834 ' HA2' HG21 ' A' ' 83' ' ' THR . . . -62.95 109.22 2.55 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.066 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.629 ' HA ' ' CD2' ' A' ' 132' ' ' HIS . 1.9 t-80 73.4 -40.16 0.46 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.137 0.975 . . . . 0.0 111.926 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -81.86 -11.03 59.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 125' ' ' GLN . . . -64.37 125.73 32.03 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 170.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.512 ' O ' HG22 ' A' ' 134' ' ' VAL . 4.8 p -55.31 -29.4 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.9 -44.69 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.629 ' CD2' ' HA ' ' A' ' 127' ' ' HIS . 1.7 t-80 -62.49 -36.38 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.471 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.505 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 7.8 mt-30 -63.38 -63.73 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.885 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 130' ' ' VAL . 20.6 m -58.58 -39.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.807 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.746 HG11 HD23 ' A' ' 84' ' ' LEU . 10.1 p -68.03 -44.39 84.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.593 0.235 . . . . 0.0 110.784 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.457 ' HD1' HG13 ' A' ' 135' ' ' VAL . 9.7 m-85 -73.03 -31.37 64.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.577 0.227 . . . . 0.0 110.453 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.54 -53.22 45.63 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -50.47 -50.91 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.07 0.462 . . . . 0.0 110.568 175.265 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.713 ' HG2' HG21 ' A' ' 56' ' ' ILE . 55.7 mtp -57.72 -27.55 63.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.486 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m -95.45 -12.27 26.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.6 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.75 29.01 19.84 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.868 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -116.14 126.11 53.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.012 0.434 . . . . 0.0 110.725 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.934 HG21 ' HB3' ' A' ' 19' ' ' LEU . 20.1 p -111.4 15.22 21.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.794 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.12 -15.8 81.26 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.558 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.31 -32.2 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.095 0.474 . . . . 0.0 110.22 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.446 ' CD1' ' HZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -66.01 -37.6 86.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.669 ' HA ' ' CG1' ' A' ' 161' ' ' VAL . 11.8 pt-20 -54.45 -38.78 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.529 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -38.83 69.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.072 0.463 . . . . 0.0 110.251 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.48 72.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.432 ' O ' HD22 ' A' ' 154' ' ' LEU . 90.8 mt -56.48 -42.67 78.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.156 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.8 -7.49 0.46 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.673 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.65 -38.64 61.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.526 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.78 -48.35 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.061 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.629 ' HB3' ' HB2' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -53.85 -37.4 63.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.62 -27.93 66.76 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.92 -29.5 69.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.472 0.653 . . . . 0.0 110.07 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.581 ' OH ' HG12 ' A' ' 176' ' ' VAL . 20.1 m-85 -106.55 -3.05 21.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.29 18.36 64.74 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.78 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.629 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 19.3 mt -95.2 -172.5 2.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.851 0.326 . . . . 0.0 111.0 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.5 p -166.69 -172.18 2.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.892 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.669 ' CG1' ' HA ' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -58.5 -25.53 28.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 176.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 14' ' ' SER . 1.6 p-10 -86.3 14.25 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.334 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.3 m -89.88 148.15 23.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.1 p -69.76 158.42 35.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.697 ' CD1' HD13 ' A' ' 15' ' ' ILE . 15.7 m-30 -54.47 -31.78 56.43 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.37 -62.17 1.86 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.938 174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.2 -48.39 80.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.593 HG13 HD11 ' A' ' 154' ' ' LEU . 93.9 t -59.33 -55.54 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.58 0.229 . . . . 0.0 111.324 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.595 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -57.22 -48.02 79.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.21 81.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.748 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -76.5 -27.29 55.99 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.065 0.46 . . . . 0.0 111.144 -176.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.792 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.5 p -91.95 -19.9 21.94 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.999 0.904 . . . . 0.0 109.981 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.83 -49.04 16.72 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.047 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.08 -10.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.451 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.748 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -67.21 -19.67 70.5 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-O 121.984 0.769 . . . . 0.0 111.241 175.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.581 HG12 ' OH ' ' A' ' 157' ' ' TYR . 16.1 m -50.94 78.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 112.665 -1.768 . . . . 0.0 112.845 171.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 175' ' ' GLY . 77.2 mt-30 -87.92 5.74 39.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.939 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 45.2 t60 . . . . . 0 C--O 1.249 1.05 0 O-C-N 123.856 0.723 . . . . 0.0 110.133 -178.735 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 121.016 0.436 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.79 ' O ' ' HB ' ' A' ' 172' ' ' THR . 28.5 t80 -68.22 153.99 42.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.124 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 p -169.37 159.29 8.59 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.93 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' A' ' 169' ' ' ALA . 25.6 m -93.43 114.36 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.257 174.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.572 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.0 m-80 -94.55 52.42 1.54 Allowed 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.934 0.873 . . . . 0.0 110.648 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.844 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -76.95 151.18 35.81 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.234 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 9' ' ' SER . 18.5 t70 -62.74 103.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.2 p -37.01 78.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 124.74 1.275 . . . . 0.0 113.464 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ASP . 22.9 t -174.63 -29.08 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.684 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.51 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 68.2 m-85 -93.67 15.15 16.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.286 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -69.22 70.55 0.47 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.57 -173.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -169.78 0.02 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.516 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 28.5 m-85 -86.25 136.02 33.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.73 -0.235 . . . . 0.0 110.411 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 163' ' ' SER . 19.7 m -68.99 134.5 49.56 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 160.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.596 HD13 ' CD1' ' A' ' 165' ' ' PHE . 5.1 mm -48.31 -48.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 118.389 0.54 . . . . 0.0 111.705 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -57.65 -30.86 65.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.628 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.0 -46.87 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.795 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.42 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 68.7 t80 -72.64 -46.13 55.53 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.906 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.622 ' HB3' HG21 ' A' ' 143' ' ' THR . 14.6 mt -56.59 -34.2 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.288 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.69 -45.06 93.77 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.137 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -61.65 -41.37 97.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.858 0.361 . . . . 0.0 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.68 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 22.3 t90 -54.71 -51.72 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.638 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.41 63.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.052 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 t -61.5 -51.14 69.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.727 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -65.45 -32.12 73.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.759 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.686 ' HB2' HG21 ' A' ' 64' ' ' THR . 19.8 t80 -59.4 -37.2 77.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.848 0.356 . . . . 0.0 110.264 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.99 -18.41 77.71 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.292 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.603 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 25.1 t70 -75.57 93.29 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.185 0.517 . . . . 0.0 111.835 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.922 HG12 ' HB1' ' A' ' 60' ' ' ALA . 22.8 m -63.24 -3.14 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.768 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -88.0 -20.42 25.85 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -170.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.573 ' CG ' ' H ' ' A' ' 32' ' ' THR . 0.8 OUTLIER 57.91 -137.68 0.91 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.608 0.363 . . . . 0.0 111.209 172.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.573 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 56.2 p 63.52 128.64 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.764 1.625 . . . . 0.0 113.912 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -170.93 131.58 0.83 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.006 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.42 -9.28 61.0 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.548 ' ND2' HG21 ' A' ' 109' ' ' VAL . 9.8 p30 -104.83 -18.73 14.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.807 0.813 . . . . 0.0 110.718 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' A' ' 63' ' ' VAL . 49.3 t -87.72 114.04 25.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.376 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -101.24 -70.3 0.75 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.773 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.43 -73.19 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.848 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 69.18 86.5 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.784 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -80.89 141.58 34.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 51.5 m -71.81 -36.35 70.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.78 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 108.13 -123.09 6.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.584 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 64.18 2.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.898 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 60.56 -176.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.43 0.634 . . . . 0.0 112.708 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -144.61 -56.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.826 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.31 22.18 21.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.076 -173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.25 -179.47 40.84 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.453 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -81.48 -68.3 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 14.0 mt -76.56 -31.03 57.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.578 -176.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.54 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 11.0 p -147.9 163.74 35.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.558 -175.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.3 39.59 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.65 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.6 m 65.87 -60.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.517 0.727 . . . . 0.0 112.709 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -95.66 159.53 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.881 0.372 . . . . 0.0 111.072 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' HD2' HG21 ' A' ' 135' ' ' VAL . 1.5 t80 -153.32 99.22 2.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.858 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -93.12 144.96 24.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.433 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.676 HG13 ' HG2' ' A' ' 139' ' ' MET . 27.8 mm -146.25 127.65 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.036 0.446 . . . . 0.0 110.85 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 41' ' ' SER . 18.9 t -112.69 151.87 29.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.523 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.507 ' OG ' ' HB3' ' A' ' 61' ' ' ASN . 47.0 t -49.99 136.05 19.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 112.079 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.74 27.57 3.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.296 0.569 . . . . 0.0 111.321 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.922 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -157.65 -33.39 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.991 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.603 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -103.33 -14.61 16.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.672 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.8 mm-40 31.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.748 -1.569 . . . . 0.0 115.213 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.534 ' HB ' ' CE1' ' A' ' 31' ' ' HIS . 10.4 p -138.21 -44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.269 169.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 26' ' ' PHE . 38.6 m -63.03 97.54 0.11 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -117.1 171.12 8.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.293 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.68 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -158.0 123.89 4.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.009 -178.036 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.2 t -105.56 102.57 14.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.886 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -85.43 154.58 21.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.033 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.96 127.99 2.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.777 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.11 -108.52 0.22 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -146.75 45.34 1.19 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.511 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 41.6 mt -64.26 124.75 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.279 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 31.6 m -137.35 119.13 15.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.505 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 47.1 t80 -68.36 122.94 19.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 82.7 p -63.7 -33.48 75.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.448 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 11.7 tp 52.3 -92.27 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.448 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 20.2 m-85 -98.91 0.1 43.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.738 -174.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.547 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 93.1 m-20 -73.18 170.34 15.17 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.954 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.624 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 10.9 mm-40 -48.94 -53.51 37.08 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 53.0 Cg_exo -56.83 -41.95 69.91 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.513 1.475 . . . . 0.0 112.221 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.95 130.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.77 0.795 . . . . 0.0 112.837 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 54.59 47.56 22.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.605 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.515 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -142.79 178.25 7.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.65 -174.123 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 135' ' ' VAL . 18.1 tp -126.38 82.51 2.08 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -89.23 146.56 24.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 171.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.576 ' H ' HG21 ' A' ' 131' ' ' VAL . . . -168.09 178.31 41.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.401 -1.38 . . . . 0.0 114.006 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 11.4 tm0? -97.65 167.7 10.8 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.559 ' HG ' HD12 ' A' ' 117' ' ' LEU . 27.9 tp -148.72 126.35 11.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.584 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 12.6 t70 -126.7 -48.9 1.51 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.172 0.51 . . . . 0.0 110.485 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.461 ' O ' HD22 ' A' ' 91' ' ' LEU . 19.4 p -132.81 158.92 41.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 122.005 0.907 . . . . 0.0 113.034 -173.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.1 mm? -134.9 169.11 17.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.772 -1.558 . . . . 0.0 106.878 174.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 19.8 t -163.06 99.38 0.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.819 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.685 ' CE1' HD11 ' A' ' 138' ' ' LEU . 1.2 m-30 -93.39 134.74 35.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.505 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -169.82 163.42 36.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 118.151 -1.976 . . . . 0.0 115.18 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.58 104.83 15.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.466 -0.867 . . . . 0.0 111.448 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 112.37 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.649 -1.159 . . . . 0.0 113.808 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD13 ' HB3' ' A' ' 105' ' ' TYR . 46.7 mt -85.9 160.59 19.37 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.101 -0.646 . . . . 0.0 110.041 171.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 t -143.4 172.9 12.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.252 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.42 -123.55 6.29 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.2 21.61 75.77 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.571 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -87.4 -85.6 0.17 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -126.9 29.06 5.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.008 0.908 . . . . 0.0 108.883 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.5 p -141.46 161.0 54.84 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.65 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -65.19 156.42 63.06 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.534 2.822 . . . . 0.0 111.659 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.587 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 62.9 m-85 -73.63 149.08 42.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.366 -174.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 p -146.38 140.65 26.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.954 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.716 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.3 mp -78.63 133.26 30.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.92 -44.22 90.22 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.421 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.548 HG21 ' ND2' ' A' ' 35' ' ' ASN . 16.9 t -118.17 91.64 40.79 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 13.3 Cg_endo -56.66 101.91 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.234 2.622 . . . . 0.0 112.969 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -93.02 -162.39 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.924 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.844 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 41.3 t -60.11 128.69 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.333 1.063 . . . . 0.0 112.453 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.572 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 61.2 m -119.37 178.94 4.35 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.306 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.532 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 94.0 m-85 -140.42 146.35 38.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.29 140.44 6.64 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.704 -1.236 . . . . 0.0 112.402 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.725 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.51 12.84 37.06 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.996 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.559 HD12 ' HG ' ' A' ' 88' ' ' LEU . 48.5 mt -56.41 -53.92 51.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.557 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 52.7 t30 51.39 50.87 18.0 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.158 0.98 . . . . 0.0 110.257 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 19.4 mt -104.79 105.99 16.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.087 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 9.8 p -105.3 129.97 53.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.161 0.505 . . . . 0.0 110.617 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.588 ' HB3' ' OE1' ' A' ' 125' ' ' GLN . 74.7 m -103.73 165.91 10.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.418 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.542 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 44.4 mt -87.15 154.22 20.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.355 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -57.88 -60.0 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.828 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.616 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -77.0 17.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 1.066 ' HB3' ' HA ' ' A' ' 128' ' ' ASP . 96.0 mt-30 -74.67 -40.31 61.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 80' ' ' PRO . . . 83.47 -106.89 2.86 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.872 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.606 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 5.6 t-80 -68.01 -12.68 61.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 1.066 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 0.0 OUTLIER 78.49 172.5 0.18 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 156.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.417 ' N ' ' CG ' ' A' ' 128' ' ' ASP . . . -85.31 -35.69 11.85 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.314 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.551 ' O ' HG22 ' A' ' 134' ' ' VAL . 9.8 p -154.08 -40.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.576 HG21 ' H ' ' A' ' 86' ' ' GLY . 13.6 m -67.17 -54.62 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.963 1.256 . . . . 0.0 112.697 -174.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.606 ' ND1' ' HA ' ' A' ' 127' ' ' HIS . 4.5 t-160 -58.67 -37.13 75.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.424 ' HG2' ' OD1' ' A' ' 128' ' ' ASP . 51.6 mm-40 -61.56 -65.91 0.62 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.502 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 130' ' ' VAL . 31.5 m -56.62 -39.29 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.035 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 84' ' ' LEU . 10.0 p -67.96 -40.57 83.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -74.34 -30.68 62.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.32 79.97 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 173.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.685 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -49.42 -59.53 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.576 0.703 . . . . 0.0 109.566 174.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.676 ' HG2' HG13 ' A' ' 56' ' ' ILE . 71.8 mtm -55.97 -25.27 43.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.183 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -91.66 0.04 57.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.665 0.269 . . . . 0.0 111.502 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.08 29.49 64.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.232 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.76 121.93 43.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.467 . . . . 0.0 110.315 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.641 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 49.8 p -91.23 -16.96 26.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.022 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.38 -42.69 50.77 Favored Glycine 0 C--N 1.334 0.444 0 O-C-N 123.836 0.71 . . . . 0.0 113.477 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.75 -42.19 82.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -66.73 -39.76 88.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.971 ' HG2' HG21 ' A' ' 161' ' ' VAL . 52.5 mt-10 -54.13 -43.2 70.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.266 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -34.59 75.13 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.902 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.2 71.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.171 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 90.6 mt -54.2 -44.2 71.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.904 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -55.52 -8.87 0.41 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.359 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.75 -45.16 45.51 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.235 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.0 -45.92 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 120.645 0.259 . . . . 0.0 110.924 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.797 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -57.89 -42.95 85.73 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.0 -20.71 66.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.441 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.67 -33.14 75.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.363 0.601 . . . . 0.0 109.852 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.31 -5.65 29.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.018 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 88.42 17.36 57.27 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.991 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 17.3 mt -97.24 -174.28 2.9 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.938 0.369 . . . . 0.0 110.158 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -156.57 -176.77 6.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.971 HG21 ' HG2' ' A' ' 147' ' ' GLU . 11.9 p -56.99 -26.71 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.903 0.382 . . . . 0.0 111.707 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.53 30.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.06 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 14' ' ' SER . 13.7 t -98.62 147.76 24.49 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 168' ' ' VAL . 3.5 m -70.74 145.22 50.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.442 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.596 ' CD1' HD13 ' A' ' 15' ' ' ILE . 12.9 m-30 -47.98 -38.63 17.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 0.0 110.385 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.86 -54.02 47.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.18 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -63.57 -51.05 67.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.222 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.797 HG13 HD11 ' A' ' 154' ' ' LEU . 17.4 t -58.24 -55.91 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 O-C-N 123.019 0.2 . . . . 0.0 110.984 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.455 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . . . -53.54 -45.51 69.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.307 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -64.9 -36.51 84.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.205 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.09 -25.81 58.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.31 0.576 . . . . 0.0 110.496 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.79 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.1 p -88.97 -13.05 39.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.081 0.943 . . . . 0.0 109.556 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -69.89 -33.34 72.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.944 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.8 p -175.71 -29.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.317 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 115.65 112.11 2.81 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.6 m -139.95 166.49 20.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.83 0.348 . . . . 0.0 111.391 -170.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -152.56 121.35 6.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.589 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.315 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.03 0.443 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.82 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 36.1 t80 -91.58 147.28 23.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.424 -176.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -166.0 166.87 17.02 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.879 0.737 . . . . 0.0 109.146 171.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.788 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -91.28 126.96 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.429 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.607 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 31.5 m-80 -104.25 56.2 0.72 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.862 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 53.8 p90 -69.14 152.25 45.36 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.62 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.0 67.67 0.15 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t 17.66 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 113.811 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -168.99 -28.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.489 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.564 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 82.9 m-85 -87.73 12.71 12.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.702 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 165' ' ' PHE . . . -70.4 68.89 0.7 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.44 -172.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.66 19.74 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 27.6 m-85 -106.17 135.26 47.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.316 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' HIS . 1.8 m -74.74 67.93 1.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.719 HD13 ' CD1' ' A' ' 165' ' ' PHE . 3.4 mm 28.28 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 114.141 -172.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.485 ' H ' HG22 ' A' ' 161' ' ' VAL . 11.5 t-160 -50.74 -29.16 10.72 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.673 0.389 . . . . 0.0 111.186 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -53.35 -62.73 1.46 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.881 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.421 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 84.5 t80 -66.95 -38.78 86.75 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.341 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.887 HD22 ' HE2' ' A' ' 93' ' ' PHE . 14.3 mt -54.31 -40.42 67.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.07 93.24 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.138 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 24' ' ' SER . 5.5 tt0 -61.15 -38.49 86.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.989 0.516 . . . . 0.0 111.52 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.488 ' O ' HG21 ' A' ' 64' ' ' THR . 40.7 t90 -55.63 -45.06 77.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.957 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 26' ' ' PHE . . . -72.8 -13.69 61.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.909 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 36.9 t -63.54 -56.22 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.701 0.286 . . . . 0.0 110.536 176.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.6 p -65.2 -31.16 72.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 62' ' ' GLN . 31.7 t80 -64.45 -28.17 69.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.876 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.25 75.71 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.795 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 32.6 t70 -78.51 165.64 23.51 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.462 0.631 . . . . 0.0 111.446 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.1 m -142.02 14.88 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 112.144 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' A' ' 31' ' ' HIS . 37.8 m-80 -83.06 -22.77 33.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.455 ' H ' ' HB2' ' A' ' 61' ' ' ASN . 41.9 t-80 79.66 62.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.925 0.89 . . . . 0.0 112.258 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.17 145.62 25.55 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.877 ' HB3' HG23 ' A' ' 36' ' ' VAL . 56.1 t-20 -166.29 127.26 1.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.152 171.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -1.51 19.98 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.46 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -115.02 6.81 15.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.877 HG23 ' HB3' ' A' ' 33' ' ' ASN . 12.6 t -87.55 114.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.271 0.558 . . . . 0.0 111.804 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.6 p -100.22 -73.9 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.284 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -89.24 -67.02 0.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 -172.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.496 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 74.14 74.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.656 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -86.71 156.09 20.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.783 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.411 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 58.5 m -96.84 -33.57 11.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.675 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 112.96 -135.8 12.95 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.932 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.609 ' HA2' ' HE1' ' A' ' 54' ' ' TYR . . . 80.99 74.61 1.13 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.753 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.576 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 46.0 m-85 66.11 -178.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.54 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 23.0 t80 -152.95 -71.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.247 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.04 45.45 3.3 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.203 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 170.69 36.51 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.808 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -76.04 -25.49 55.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.035 0.445 . . . . 0.0 110.113 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -167.79 32.33 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 p -158.86 166.9 30.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.205 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.81 -134.33 5.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.632 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.447 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 31.6 m -135.54 6.07 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.496 0.188 . . . . 0.0 110.918 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -141.61 143.33 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.318 . . . . 0.0 110.776 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.609 ' HE1' ' HA2' ' A' ' 43' ' ' GLY . 2.6 t80 -154.94 96.06 1.81 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.595 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -96.05 157.77 15.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.022 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.009 HG13 ' HG2' ' A' ' 139' ' ' MET . 11.6 mm -147.31 121.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 110.15 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.54 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 8.9 t -138.28 112.51 8.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.316 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.632 ' HB2' ' C ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER 41.53 160.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 118.574 2.805 . . . . 0.0 118.574 -178.069 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.421 ' H ' ' HG3' ' A' ' 62' ' ' GLN . 20.7 p -132.06 13.39 4.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.726 -2.033 . . . . 0.0 109.915 163.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.04 -58.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.264 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.628 ' O ' HG12 ' A' ' 63' ' ' VAL . 7.2 t30 -146.1 -33.68 0.32 Allowed 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.656 ' HB3' ' HA ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -53.05 54.7 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 126.564 2.415 . . . . 0.0 113.457 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.802 HG21 HG22 ' A' ' 36' ' ' VAL . 1.4 p -66.4 -6.64 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.513 ' N ' ' C ' ' A' ' 62' ' ' GLN . 92.9 m -53.14 112.05 0.8 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 110.099 -3.228 . . . . 0.0 107.366 161.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.41 -179.39 4.18 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.35 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.849 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -160.3 121.64 3.09 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.813 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.6 112.82 41.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.269 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.634 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -88.92 152.71 21.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 52' ' ' SER . . . -150.84 122.96 1.44 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.91 -110.16 0.26 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.624 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 66.8 t30 -147.86 37.4 0.88 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.503 0.668 . . . . 0.0 109.235 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -59.24 139.92 56.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.787 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -149.62 134.39 17.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.722 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.622 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 58.4 t80 -84.61 127.44 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.5 p -62.55 -33.55 75.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.648 -170.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.469 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 9.6 tp 51.57 -95.53 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.954 0.784 . . . . 0.0 111.827 -176.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.469 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 5.3 m-85 -98.84 2.58 46.88 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -175.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -76.04 178.34 6.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.549 0.214 . . . . 0.0 111.206 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.826 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 19.6 mm-40 -47.51 -62.71 1.88 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -170.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 54.2 Cg_exo -55.35 -38.02 94.17 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.777 1.651 . . . . 0.0 112.873 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 66.63 122.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.837 0.827 . . . . 0.0 112.855 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 93.4 m-70 53.27 54.41 10.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.425 -1.261 . . . . 0.0 111.484 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -146.49 169.0 19.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.307 -176.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.672 HD23 HG11 ' A' ' 135' ' ' VAL . 11.2 tp -106.58 149.06 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.819 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 86' ' ' GLY . 20.0 p90 -156.45 -154.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.417 ' O ' HG11 ' A' ' 131' ' ' VAL . . . 99.03 -164.25 20.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.904 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 6.3 tm0? -99.98 164.51 11.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 111.59 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.51 ' CB ' HG12 ' A' ' 131' ' ' VAL . 30.4 tp -151.58 129.95 12.08 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.726 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 117' ' ' LEU . 17.4 t70 -136.0 -60.22 0.73 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.387 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.431 ' C ' HD22 ' A' ' 91' ' ' LEU . 13.2 p -97.99 149.81 22.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.762 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.66 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.9 mm? -134.53 169.55 17.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 9.5 t -163.76 109.55 1.07 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.147 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.887 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.9 m-30 -97.77 140.43 32.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.661 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.97 172.01 42.8 Favored Glycine 0 C--N 1.314 -0.684 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.85 ' H ' HG13 ' A' ' 109' ' ' VAL . 24.9 m-20 -97.77 124.86 42.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 119.362 1.581 . . . . 0.0 111.414 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 63' ' ' VAL . . . 87.47 116.06 1.13 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.477 -0.783 . . . . 0.0 113.091 171.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.595 HD11 ' HB1' ' A' ' 55' ' ' ALA . 41.0 mt -86.55 153.75 21.59 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.12 168.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.8 t -138.59 168.8 18.99 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.45 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.33 -123.57 10.42 Favored Glycine 0 N--CA 1.443 -0.875 0 O-C-N 123.947 0.779 . . . . 0.0 111.65 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.04 29.68 74.89 Favored Glycine 0 C--N 1.318 -0.45 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.309 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -89.47 -88.76 0.16 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 p -112.68 4.81 17.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.83 0.824 . . . . 0.0 108.835 168.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -112.52 165.43 13.05 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.432 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.9 Cg_exo -73.15 167.49 27.21 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 123.155 2.57 . . . . 0.0 112.364 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.675 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 37.8 m-85 -71.85 151.62 43.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.361 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.9 p -149.07 143.95 26.37 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.681 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.674 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.5 mp -80.88 129.21 37.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.044 0.45 . . . . 0.0 110.857 -175.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.496 ' NE2' ' H ' ' A' ' 39' ' ' ALA . 71.7 mt-30 -64.23 -59.07 4.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.578 176.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.85 HG13 ' H ' ' A' ' 95' ' ' ASP . 2.4 p -109.15 87.53 4.91 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 121.628 0.728 . . . . 0.0 110.017 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 31.7 Cg_endo -65.09 122.71 10.55 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.95 2.433 . . . . 0.0 111.597 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 112' ' ' VAL . 3.9 t0 -118.91 -143.27 0.36 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.862 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 19.4 t -61.16 115.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.338 1.066 . . . . 0.0 112.344 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.607 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 69.1 m -101.86 177.3 4.94 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.811 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.66 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 95.5 m-85 -138.56 149.62 45.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.57 141.67 7.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.807 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.82 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 102.02 11.83 35.95 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.704 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 89' ' ' ASP . 16.8 mt -55.8 -46.73 77.94 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.343 0.572 . . . . 0.0 109.723 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 t30 49.46 45.61 23.81 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.022 0.915 . . . . 0.0 110.244 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 20.7 mt -108.6 115.82 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.015 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 38.8 p -111.2 132.64 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.283 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.5 m -101.76 147.97 25.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.28 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 69.9 mt -80.41 157.13 26.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.782 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -48.27 -54.41 13.78 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.488 0.493 . . . . 0.0 112.16 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.448 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -77.54 3.06 14.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -170.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.602 ' HB3' ' N ' ' A' ' 129' ' ' GLY . 37.2 mt-30 -78.86 58.16 2.29 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.014 0.435 . . . . 0.0 110.516 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.83 103.96 0.65 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.454 ' HA ' ' CG ' ' A' ' 132' ' ' HIS . 3.3 t-80 79.39 -29.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.845 0.858 . . . . 0.0 111.397 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -80.38 -30.43 37.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.543 0.211 . . . . 0.0 111.307 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.602 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -55.79 129.48 47.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.627 -0.796 . . . . 0.0 111.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.5 m -50.87 -33.21 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.51 HG12 ' CB ' ' A' ' 88' ' ' LEU . 33.1 m -63.35 -47.16 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.796 0.331 . . . . 0.0 110.594 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.65 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.8 t-160 -63.5 -39.43 94.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.966 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.435 HE21 ' HB3' ' A' ' 133' ' ' GLN . 2.7 mm100 -59.85 -64.7 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.4 t -53.89 -46.51 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.348 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.849 HG23 ' HZ ' ' A' ' 66' ' ' PHE . 11.0 p -65.86 -45.97 89.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.259 -175.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.414 ' HD1' HG13 ' A' ' 135' ' ' VAL . 12.5 m-85 -72.24 -27.5 62.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.818 0.342 . . . . 0.0 110.796 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.35 -53.29 33.44 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 146' ' ' LEU . 0.2 OUTLIER -49.63 -49.59 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.1 0.56 . . . . 0.0 111.095 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' MET . . . . . 1.009 ' HG2' HG13 ' A' ' 56' ' ' ILE . 83.4 mtp -57.67 -30.75 65.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.034 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -91.3 -0.67 57.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.401 ' HA2' ' CZ3' ' A' ' 22' ' ' TRP . . . 84.26 9.47 81.95 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.698 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -98.82 103.96 15.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.565 0.698 . . . . 0.0 110.79 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.461 ' CB ' ' HB3' ' A' ' 19' ' ' LEU . 2.8 p -89.48 2.42 54.58 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.069 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.542 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -62.78 -31.21 79.47 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.735 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.59 -33.29 64.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.557 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.4 OUTLIER -67.76 -33.6 75.17 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.612 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.921 ' HG2' HG21 ' A' ' 161' ' ' VAL . 46.1 mt-10 -52.91 -44.72 67.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -33.17 73.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.952 -175.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.57 64.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.32 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.2 mt -55.49 -45.37 77.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.831 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -58.64 -8.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.968 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.08 -41.68 26.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.035 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' A' ' 117' ' ' LEU . 3.8 mp -86.51 -49.03 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.787 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.942 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -53.08 -40.93 64.42 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.67 -27.17 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.39 -34.22 77.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.227 0.537 . . . . 0.0 109.845 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.464 ' HE2' HG22 ' A' ' 153' ' ' ILE . 41.6 m-85 -95.63 -13.58 24.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.284 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 94.75 27.94 10.8 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.602 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.427 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -109.15 -166.98 1.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.135 0.468 . . . . 0.0 110.952 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.6 p -163.52 171.91 15.17 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.38 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.921 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.5 p -52.55 -36.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -88.82 40.22 0.96 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -88.9 -105.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.744 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 168' ' ' VAL . 15.6 m -163.05 146.91 11.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.719 ' CD1' HD13 ' A' ' 15' ' ' ILE . 6.1 m-30 -52.96 -42.35 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.353 0.524 . . . . 0.0 111.111 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.63 -52.22 33.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.853 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -59.74 -46.3 89.57 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -176.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.942 HG13 HD11 ' A' ' 154' ' ' LEU . 89.6 t -60.52 -56.67 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.491 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.606 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -54.36 -44.65 72.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 123.447 0.467 . . . . 0.0 110.993 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.53 ' HB1' ' CG2' ' A' ' 176' ' ' VAL . . . -62.64 -40.87 98.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.648 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -74.49 -29.91 61.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.208 0.528 . . . . 0.0 110.57 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 38.3 p -85.74 -14.15 46.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.865 0.84 . . . . 0.0 109.624 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -67.48 -42.77 82.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.653 173.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.675 HG12 HG13 ' A' ' 176' ' ' VAL . 1.2 p 179.61 -28.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.599 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 171' ' ' ALA . . . 140.44 -56.52 0.61 Allowed Glycine 0 CA--C 1.498 -1.02 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.635 175.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.675 HG13 HG12 ' A' ' 174' ' ' VAL . 15.7 m 46.26 44.68 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.06 0.944 . . . . 0.0 113.389 169.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -141.76 152.63 43.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.223 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 83.3 t60 . . . . . 0 C--N 1.319 -0.732 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.588 177.196 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.87 0.366 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.796 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 t80 -86.62 149.63 24.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.98 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -172.22 167.51 5.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.62 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.66 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -90.35 125.54 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.004 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.579 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 27.0 m-80 -101.82 48.84 0.87 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.729 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.0 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.0 p90 -70.5 150.04 46.56 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.735 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.8 t70 -62.06 105.35 0.57 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.646 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 4.4 p -37.52 74.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 125.082 1.489 . . . . 0.0 113.894 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.1 t -174.2 -25.62 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.341 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.494 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 96.0 m-85 -92.39 15.5 13.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.08 68.12 1.38 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.322 -173.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.45 22.85 0.16 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.562 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 45.3 m-85 -114.31 131.26 56.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.017 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 163' ' ' SER . 11.4 p -68.13 132.44 47.21 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 161.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 165' ' ' PHE . 4.8 mm -46.56 -48.76 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -167.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -60.14 -30.37 69.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.648 0.261 . . . . 0.0 111.007 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.28 -49.17 58.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.371 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' HB2' ' CG ' ' A' ' 13' ' ' TYR . 72.0 t80 -70.72 -45.34 65.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.608 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.784 HD22 ' CE2' ' A' ' 93' ' ' PHE . 12.0 mt -56.92 -44.4 82.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.18 94.81 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.975 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 24' ' ' SER . 3.7 tt0 -64.87 -43.34 93.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 122.89 0.476 . . . . 0.0 111.463 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -62.43 -42.21 99.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.919 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.14 67.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.791 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 25.1 t -62.23 -54.14 45.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -35.64 81.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.056 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.605 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 20.0 t80 -56.07 -39.43 72.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.346 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.89 -29.51 73.68 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.463 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 11.9 t70 -76.12 100.88 5.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.705 -176.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.716 HG12 ' HB1' ' A' ' 60' ' ' ALA . 35.4 m -65.99 -1.68 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.426 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 52.1 m-80 -84.87 -5.8 59.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -169.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.5 t60 56.05 92.48 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 168.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.1 p -142.21 134.65 27.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.941 0.4 . . . . 0.0 111.659 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -171.52 129.0 0.68 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.198 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.04 -7.49 76.54 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 114.446 0.538 . . . . 0.0 114.446 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -116.38 3.57 13.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.849 0.825 . . . . 0.0 111.684 -175.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.537 HG22 ' HA3' ' A' ' 96' ' ' GLY . 45.6 t -101.83 116.39 45.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 p -103.08 -76.11 0.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.295 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.89 -68.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.902 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.41 83.86 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.527 0.68 . . . . 0.0 111.972 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -83.88 137.86 33.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.956 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -74.62 -37.74 62.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.49 134.74 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.348 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.55 59.19 0.11 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.901 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 57.8 m-85 62.1 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.941 0.877 . . . . 0.0 113.326 -175.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 50.5 t80 -91.75 -13.24 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.768 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.83 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.58 -28.02 44.98 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.382 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.45 -118.6 0.75 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.899 -1.143 . . . . 0.0 113.084 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -76.62 -50.13 14.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 0.0 110.281 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -167.35 43.29 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.765 0.793 . . . . 0.0 109.782 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.642 ' HB3' ' HD1' ' A' ' 74' ' ' TYR . 20.9 p -154.03 -176.28 5.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.228 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.83 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 128.1 -172.43 19.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 t -92.95 -14.22 27.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.828 0.314 . . . . 0.0 111.265 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 27.0 tt0 -134.0 151.84 51.6 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.323 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.777 ' CD1' HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -149.19 94.76 2.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.879 -173.539 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -94.82 153.16 17.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.861 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.042 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.0 mm -146.43 140.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 t -131.92 97.36 4.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.542 0.211 . . . . 0.0 110.517 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.605 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 33.1 t 18.48 115.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -19.5 65.89 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.425 -0.797 . . . . 0.0 110.472 171.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.716 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.02 -61.48 1.95 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.062 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 35.0 p30 -114.75 3.35 14.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.119 0.485 . . . . 0.0 111.59 -172.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 57' ' ' SER . 2.3 mm-40 39.79 38.26 0.43 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 64' ' ' THR . 9.1 p -129.37 -55.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.714 168.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 63' ' ' VAL . 4.5 m -58.0 101.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.243 0.544 . . . . 0.0 110.206 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -110.28 173.19 6.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -165.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.77 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -160.67 118.07 2.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.73 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 79.2 t -103.53 107.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.627 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.77 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -91.12 157.14 17.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.91 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.11 135.62 4.95 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.201 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.34 -128.82 1.08 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.94 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 1.6 t-20 -146.34 72.89 1.3 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 0.0 109.383 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 54' ' ' TYR . 6.5 mt -92.14 166.93 12.39 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 122.377 1.084 . . . . 0.0 113.629 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.6 m -164.52 134.05 3.79 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 112.416 -2.175 . . . . 0.0 106.76 171.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.958 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 1.8 p90 -95.47 144.76 25.7 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 77.6 p -72.11 -68.4 0.47 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.958 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 13.4 tp 57.4 -87.55 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.018 0.927 . . . . 0.0 111.295 -169.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.442 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 21.8 m-85 -91.76 0.04 57.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.194 0.521 . . . . 0.0 110.897 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.524 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-80 -77.05 166.67 22.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.443 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.769 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 47.4 mm-40 -46.42 -61.54 2.56 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -168.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 77.2 Cg_exo -55.43 -40.42 85.61 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.935 1.756 . . . . 0.0 113.759 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 70.83 134.86 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.398 0.618 . . . . 0.0 112.483 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.4 m80 47.67 54.33 9.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.84 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.683 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -151.03 162.58 40.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.768 -171.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.0 tp -108.83 156.02 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.974 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -158.21 -161.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.8 -159.04 22.81 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.26 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.3 tm0? -97.94 169.95 9.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.543 0.687 . . . . 0.0 112.742 -170.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.566 ' CD2' HG21 ' A' ' 134' ' ' VAL . 27.3 tp -155.34 135.51 13.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.53 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -134.94 -50.26 0.76 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.958 0.408 . . . . 0.0 111.28 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.508 ' O ' HD13 ' A' ' 91' ' ' LEU . 5.7 p -130.2 157.12 43.34 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -171.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.739 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.4 mm? -138.02 160.55 39.05 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 9.1 m -147.93 108.82 4.22 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 117.824 0.284 . . . . 0.0 110.951 176.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.784 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.6 m-30 -91.56 147.87 22.69 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.649 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.5 -152.33 11.35 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.732 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.57 126.97 30.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 110.742 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . 76.2 110.09 0.12 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.836 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.0 mt -83.96 141.4 31.26 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.38 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -99.08 154.42 18.13 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.535 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.08 114.74 5.06 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.202 -166.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.48 -13.87 75.07 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 168.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.41 ' OD2' HG23 ' A' ' 102' ' ' THR . 26.9 t70 64.81 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.108 0.963 . . . . 0.0 111.118 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.41 HG23 ' OD2' ' A' ' 101' ' ' ASP . 76.3 p -99.42 -0.08 41.63 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.813 0.815 . . . . 0.0 109.213 176.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 m -113.87 166.18 11.95 Favored Pre-proline 0 N--CA 1.443 -0.819 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.171 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -64.27 152.05 82.92 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.983 2.455 . . . . 0.0 113.035 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -66.03 155.03 37.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.579 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 p -142.38 155.64 45.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.347 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 107' ' ' ILE . 1.1 mp -89.1 122.76 40.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.414 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.98 -39.71 94.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.185 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.0 88.16 9.75 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.487 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.16 96.55 0.27 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.268 2.645 . . . . 0.0 112.838 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 33.1 m-20 -94.66 -154.47 0.42 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.264 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.0 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 46.6 t -58.31 138.5 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.707 0.765 . . . . 0.0 111.931 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.579 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 75.6 m -129.11 178.8 6.15 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.391 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.535 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 95.9 m-85 -138.82 146.79 41.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -160.58 142.06 7.86 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.921 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.796 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.22 11.15 40.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.411 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.442 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 26.3 mt -57.08 -50.5 72.59 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.0 t30 55.43 43.35 28.85 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.695 0.76 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.8 mt -106.11 112.56 25.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.381 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 34.5 p -107.04 130.84 54.6 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.815 0.341 . . . . 0.0 110.523 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.498 ' HB2' HG22 ' A' ' 131' ' ' VAL . 26.0 m -108.28 145.8 33.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.827 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -80.96 165.14 22.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.503 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -52.93 -61.1 2.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.583 -177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.487 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -79.66 14.61 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -168.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.462 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 34.8 mt-30 -77.15 -25.9 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.289 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 56.38 -118.1 10.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.221 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.476 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 4.7 t-80 -80.24 -22.76 41.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.537 0.335 . . . . 0.0 110.765 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -84.82 -19.63 32.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -174.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.462 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -59.45 126.59 42.63 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 174.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.651 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 18.2 m -52.69 -32.62 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.76 ' O ' HG23 ' A' ' 135' ' ' VAL . 18.1 m -63.63 -49.67 81.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.157 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.683 ' HE1' HG22 ' A' ' 83' ' ' THR . 4.8 t-160 -57.02 -41.25 78.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.035 0.445 . . . . 0.0 110.008 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.651 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 0.2 OUTLIER -56.73 -63.97 1.03 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.31 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 88' ' ' LEU . 16.1 m -56.63 -39.21 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.469 -172.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 131' ' ' VAL . 2.2 t -66.1 -57.81 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 CA-C-O 121.455 0.645 . . . . 0.0 110.061 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.34 -18.21 64.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.34 -56.23 7.04 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 167.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.623 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.92 -52.61 31.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.111 0.564 . . . . 0.0 111.226 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' MET . . . . . 1.042 ' HG2' HG13 ' A' ' 56' ' ' ILE . 50.7 mtp -55.82 -26.74 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.111 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.1 m -99.45 -6.53 27.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.752 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.36 32.14 20.45 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.244 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -121.11 130.59 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.647 HG21 ' HB3' ' A' ' 19' ' ' LEU . 53.9 p -108.15 2.03 22.62 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.78 -39.44 61.72 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 123.523 0.514 . . . . 0.0 114.04 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.76 -26.92 29.26 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.411 -0.464 . . . . 0.0 110.824 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -68.92 -51.02 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.522 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.717 ' HB3' HG21 ' A' ' 161' ' ' VAL . 5.0 pt-20 -58.0 -33.51 69.01 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.283 0.563 . . . . 0.0 110.181 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 28.0 m -67.67 -47.95 68.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.848 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.01 99.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.219 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 99.1 mt -55.58 -43.15 75.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.398 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -57.08 -9.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.331 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -75.39 -40.16 33.96 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.299 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.482 HG22 ' HE2' ' A' ' 157' ' ' TYR . 3.9 mp -86.47 -48.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.029 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.613 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -53.31 -41.51 65.73 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.66 -23.85 63.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.95 -28.97 62.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.1 m-85 -101.8 -7.37 22.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.105 0.479 . . . . 0.0 110.14 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.13 29.77 12.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.352 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 1.9 mm? -111.19 -165.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.34 0.57 . . . . 0.0 110.513 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 p -163.1 -178.91 6.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.069 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 147' ' ' GLU . 9.7 p -57.5 -23.3 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 111.375 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.79 14.45 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.707 0.289 . . . . 0.0 111.716 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.661 ' HB3' HG22 ' A' ' 168' ' ' VAL . 12.8 t -88.96 143.68 26.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 168' ' ' VAL . 38.3 m -69.2 141.26 54.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.669 ' CD1' HD13 ' A' ' 15' ' ' ILE . 5.2 m-30 -38.24 -53.01 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.71 0.804 . . . . 0.0 112.739 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.53 -48.42 79.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.708 0.29 . . . . 0.0 110.224 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 1.7 mp0 -69.04 -5.33 21.23 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 163' ' ' SER . 34.0 t -96.31 -54.05 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.249 0.547 . . . . 0.0 109.819 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -58.0 -46.61 84.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.622 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.05 72.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.707 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.884 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -70.32 -35.83 73.88 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.533 0.682 . . . . 0.0 110.581 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.517 HG21 ' CD2' ' A' ' 2' ' ' PHE . 16.5 p -82.56 -18.97 39.51 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.993 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.06 -44.31 31.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.939 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 176' ' ' VAL . 4.3 p -176.18 6.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.5 0.667 . . . . 0.0 110.703 -172.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.884 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -86.89 91.15 1.72 Allowed Glycine 0 CA--C 1.499 -0.909 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.672 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 174' ' ' VAL . 5.5 m -145.16 30.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.654 0.74 . . . . 0.0 110.208 -168.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -154.0 70.5 0.82 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.366 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.033 -178.527 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 172' ' ' THR . . . . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.773 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 31.7 t80 59.26 156.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.032 0.833 . . . . 0.0 112.184 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -174.1 160.02 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.761 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.669 HG11 HD12 ' A' ' 15' ' ' ILE . 10.5 m -91.68 111.7 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.43 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 51.7 m-20 -94.62 50.18 1.31 Allowed 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.186 -167.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.101 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.6 p90 -67.58 149.03 50.63 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.547 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.3 t70 -62.16 100.06 0.16 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.515 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 8.4 m -30.14 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.827 1.651 . . . . 0.0 114.397 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.6 t -172.21 -31.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.098 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.573 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 81.9 m-85 -88.97 15.67 8.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.0 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.6 71.75 1.05 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.518 -172.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.45 5.73 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.515 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 32.2 m-85 -95.17 140.76 29.63 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.78 -0.21 . . . . 0.0 110.762 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -70.22 129.54 39.63 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 160.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.669 HD12 HG11 ' A' ' 4' ' ' VAL . 3.4 mm -44.89 -48.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -172.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 40.1 t-80 -57.13 -32.61 66.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.145 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.31 -51.52 23.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.24 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.443 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 57.6 t80 -68.13 -41.28 81.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.961 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.854 ' HB3' HG21 ' A' ' 143' ' ' THR . 17.0 mt -55.52 -41.13 72.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.874 0.369 . . . . 0.0 110.457 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.54 97.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.062 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -62.81 -40.53 97.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.757 0.423 . . . . 0.0 111.945 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -61.46 -43.64 98.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.59 -33.05 74.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.839 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.0 t -60.05 -51.77 68.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -68.25 -31.14 70.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.615 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 10.7 t80 -61.05 -52.78 63.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.231 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.41 -26.34 74.33 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.267 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -73.09 108.84 6.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 110.942 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.619 HG12 ' HB1' ' A' ' 60' ' ' ALA . 35.6 m -64.13 -14.36 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.062 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -90.43 -11.08 41.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.291 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.596 ' HB3' ' ND2' ' A' ' 61' ' ' ASN . 14.7 t-80 -71.53 114.41 9.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.976 0.417 . . . . 0.0 111.465 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.7 p -119.16 -176.06 3.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.515 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -158.66 119.95 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.46 56.0 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.979 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.8 1.5 37.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.571 0.7 . . . . 0.0 109.84 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.456 HG21 ' CG2' ' A' ' 63' ' ' VAL . 32.3 t -95.63 114.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.925 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 -71.5 0.66 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.725 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.86 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.518 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 66.89 74.29 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.021 0.915 . . . . 0.0 111.0 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.34 136.06 33.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.007 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.473 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 70.4 m -73.02 -38.0 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.283 -172.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 109.51 -135.87 13.17 Favored Glycine 0 C--N 1.317 -0.475 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.892 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.34 70.38 1.32 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.763 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.545 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 64.1 m-85 56.87 -171.36 0.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.494 0.317 . . . . 0.0 111.765 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 44' ' ' PHE . 29.3 t80 -178.4 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.329 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -80.76 7.95 57.24 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.853 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.06 -98.74 0.13 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.1 m -152.18 -63.15 0.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 1.9 mp -77.27 -44.07 31.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.557 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.575 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 17.7 p -140.33 170.12 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 158.57 45.0 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.212 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.1 m 68.33 -54.04 0.53 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.464 ' HG2' ' N ' ' A' ' 54' ' ' TYR . 7.7 tt0 -93.74 149.62 21.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.545 ' HD1' ' H ' ' A' ' 44' ' ' PHE . 2.3 t80 -147.96 103.36 3.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 146.6 23.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.366 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.1 HG13 ' HG2' ' A' ' 139' ' ' MET . 9.1 mm -146.52 122.06 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 92.5 p -106.23 158.77 16.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.378 174.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 42.0 t -51.46 139.39 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.292 0.568 . . . . 0.0 111.968 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -85.45 -19.44 31.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.425 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.619 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.04 -60.52 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.596 ' ND2' ' HB3' ' A' ' 31' ' ' HIS . 30.7 p30 -111.73 1.32 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.824 -174.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 58' ' ' SER . 2.9 mm-40 40.12 37.42 0.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.477 -1.238 . . . . 0.0 114.214 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.456 ' CG2' HG21 ' A' ' 36' ' ' VAL . 14.8 p -126.6 -51.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.921 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 23.2 m -62.65 103.55 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.525 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -112.46 179.59 3.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.687 0.756 . . . . 0.0 112.924 -169.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.741 ' HE1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -156.99 131.81 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.811 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 61.6 t -120.62 114.96 45.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.166 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.55 148.04 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.6 104.79 0.26 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.018 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.48 -92.29 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.194 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -147.92 30.14 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.482 0.641 . . . . 0.0 110.906 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 77.9 mt -59.24 143.73 48.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.34 0.591 . . . . 0.0 111.774 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 99.2 m -148.61 129.99 14.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.67 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.575 ' H ' ' HB3' ' A' ' 50' ' ' SER . 48.1 t80 -86.07 122.76 30.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 48.2 p -64.87 -41.29 95.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.623 -171.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.5 tp 51.08 -88.02 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.755 0.822 . . . . 0.0 111.978 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -95.08 -3.04 48.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.557 0.535 . . . . 0.0 111.711 -175.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.663 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 94.5 m-20 -75.51 -179.4 4.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.72 0.295 . . . . 0.0 111.623 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.912 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 32.7 mm-40 -45.83 -67.79 0.35 Allowed Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.912 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.9 Cg_exo -56.88 -36.6 99.01 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.415 1.41 . . . . 0.0 112.441 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 68.67 123.53 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.578 0.751 . . . . 0.0 112.247 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 60.35 59.99 2.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.992 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.809 HG21 ' HA2' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -143.88 166.34 25.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.074 -171.127 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.829 HD23 HG11 ' A' ' 135' ' ' VAL . 13.6 tp -119.23 144.18 46.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 7.9 p90 -158.15 -157.92 0.68 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 71' ' ' ASN . . . 95.04 -163.93 24.63 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.606 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.638 ' HG3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -103.43 172.96 6.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.714 HD23 ' H ' ' A' ' 89' ' ' ASP . 1.5 pt? -139.62 -41.43 0.45 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.974 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.714 ' H ' HD23 ' A' ' 88' ' ' LEU . 37.2 t70 61.28 -58.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.685 1.194 . . . . 0.0 113.654 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 114' ' ' PHE . 8.0 m -136.29 135.26 38.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.902 0.858 . . . . 0.0 112.36 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.741 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.5 mm? -102.63 166.44 10.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.997 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 22.4 m -151.64 111.54 4.05 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 122.315 -0.241 . . . . 0.0 110.863 174.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.839 ' HE2' HD22 ' A' ' 19' ' ' LEU . 4.8 m-30 -97.62 141.56 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.28 164.71 31.83 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.015 172.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -87.08 120.83 28.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.159 0.504 . . . . 0.0 111.221 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.13 113.24 0.43 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.593 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.3 mt -89.03 153.89 20.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.582 . . . . 0.0 110.549 172.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -131.67 167.9 18.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.274 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.25 -130.49 10.35 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.07 8.42 86.89 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.482 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -91.69 -73.53 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.195 0.498 . . . . 0.0 110.388 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.1 p -126.69 -0.47 6.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.162 0.506 . . . . 0.0 110.69 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.71 156.99 79.04 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -67.15 175.67 5.46 Favored 'Trans proline' 0 C--N 1.33 -0.421 0 C-N-CA 123.739 2.959 . . . . 0.0 112.721 -172.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.437 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 52.5 m-85 -71.93 151.37 43.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.579 -174.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -146.59 152.58 39.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.868 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.696 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.3 mp -83.53 122.07 37.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.517 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.93 -48.45 74.07 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 21.5 t -112.51 87.55 9.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.404 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 24.5 Cg_endo -61.71 107.11 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.12 2.546 . . . . 0.0 112.639 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 12.1 m-20 -96.33 -148.73 0.31 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.293 174.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.101 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -61.22 143.54 14.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.632 0.73 . . . . 0.0 111.459 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.43 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 74.4 m -135.24 179.54 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.746 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.591 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.3 m-85 -139.04 146.04 40.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.36 141.71 7.62 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.632 -1.27 . . . . 0.0 112.396 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.773 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.22 11.59 41.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.761 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.535 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 14.6 mt -55.22 -49.21 72.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.3 t30 57.24 36.27 27.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.986 0.898 . . . . 0.0 109.588 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.553 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 19.2 mt -102.98 124.27 48.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.267 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.638 ' HB3' ' HG3' ' A' ' 87' ' ' GLN . 22.6 p -131.13 138.52 49.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.058 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 131' ' ' VAL . 91.2 p -114.6 135.09 54.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 110.139 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 122' ' ' LEU . 8.4 mp -60.69 161.86 7.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.159 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -51.55 -56.32 14.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.41 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.06 17.25 4.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 121' ' ' SER . 21.5 mt-30 -77.13 -37.06 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.533 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.809 ' HA2' HG21 ' A' ' 83' ' ' THR . . . 77.88 -124.4 6.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.337 174.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -78.91 -14.88 58.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -85.84 -16.11 39.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.872 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.56 125.2 30.74 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.216 -0.992 . . . . 0.0 110.641 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.579 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 23.9 m -52.8 -35.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.635 HG22 ' OG ' ' A' ' 121' ' ' SER . 25.5 m -65.18 -41.24 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.462 0.574 . . . . 0.0 110.48 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.504 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.2 t-160 -60.69 -38.38 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.545 0.688 . . . . 0.0 109.448 175.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.579 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 0.0 OUTLIER -67.26 -60.62 2.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.868 -177.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 130' ' ' VAL . 18.9 m -60.28 -37.92 75.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.807 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.829 HG11 HD23 ' A' ' 84' ' ' LEU . 8.9 p -68.3 -46.3 81.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.83 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.61 -30.28 66.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 110.198 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.31 -54.98 32.76 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.658 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -50.25 -47.76 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.016 0.527 . . . . 0.0 111.013 176.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' MET . . . . . 1.1 ' HG2' HG13 ' A' ' 56' ' ' ILE . 53.0 mtp -56.09 -33.59 65.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.822 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.9 m -91.55 -13.52 31.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.413 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.51 10.26 53.81 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.93 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.67 120.74 30.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.11 0.481 . . . . 0.0 110.969 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.854 HG21 ' HB3' ' A' ' 19' ' ' LEU . 17.3 p -108.5 9.15 27.55 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.606 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.12 -27.44 68.4 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.955 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.26 -30.31 23.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.991 0.424 . . . . 0.0 110.053 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -64.78 -47.91 76.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.035 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.575 ' HB2' HG21 ' A' ' 161' ' ' VAL . 1.5 pt-20 -55.15 -34.04 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.054 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.479 ' N ' ' HG3' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -75.1 -36.76 61.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.059 0.457 . . . . 0.0 109.8 -175.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.79 -47.15 69.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.527 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 98.3 mt -55.26 -43.49 74.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.048 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -55.29 -13.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.315 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.13 -37.65 55.38 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.39 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.2 mp -85.31 -46.26 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.744 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.74 -44.2 81.44 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.98 -24.73 67.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.99 -38.09 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.511 . . . . 0.0 110.219 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.536 ' CD1' HG12 ' A' ' 176' ' ' VAL . 13.7 m-85 -97.18 -7.71 31.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.91 16.63 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.379 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.548 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 1.9 mm? -110.85 -174.25 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.258 0.529 . . . . 0.0 110.335 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.5 p -165.39 -176.2 3.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.381 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 147' ' ' GLU . 2.5 m -61.1 -13.15 6.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -88.75 4.49 47.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.565 ' HB2' HG22 ' A' ' 168' ' ' VAL . 19.5 m -92.28 152.44 19.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.858 176.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.5 m -70.72 142.77 51.45 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.573 ' HD2' ' O ' ' A' ' 10' ' ' PHE . 4.1 m-30 -37.72 -64.38 0.4 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.386 0.674 . . . . 0.0 112.58 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.17 -40.85 82.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.112 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -66.57 -42.3 87.26 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.827 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.744 HG13 HD11 ' A' ' 154' ' ' LEU . 92.7 t -65.02 -52.02 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.33 78.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.727 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.34 83.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.611 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 1.011 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -68.63 -33.56 74.22 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.363 0.601 . . . . 0.0 110.864 -173.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.542 HG21 ' CD2' ' A' ' 2' ' ' PHE . 12.2 p -83.01 -25.2 32.43 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.009 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.05 -42.15 48.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.312 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.414 ' H ' ' H ' ' A' ' 175' ' ' GLY . 4.0 p -176.57 5.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 110.934 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 1.011 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -76.1 -2.69 73.19 Favored Glycine 0 CA--C 1.503 -0.712 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.339 -173.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.536 HG12 ' CD1' ' A' ' 157' ' ' TYR . 19.8 m -49.96 73.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 125.919 1.688 . . . . 0.0 114.528 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -97.4 39.46 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.581 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 26.0 m170 . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.748 178.612 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.433 ' O ' ' HA3' ' A' ' 116' ' ' GLY . . . . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.937 0.398 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.835 ' O ' ' HB ' ' A' ' 172' ' ' THR . 38.7 t80 -93.8 149.69 21.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.335 -172.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.0 m -161.51 163.35 30.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.394 0.678 . . . . 0.0 109.335 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.582 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.3 128.16 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.353 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.5 m-80 -105.35 49.57 0.8 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.625 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 1.075 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 25.5 p90 -73.18 152.84 40.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.547 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.2 t70 -62.15 100.71 0.18 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.497 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 22.3 t -35.46 75.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.665 1.586 . . . . 0.0 113.722 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.2 t -172.96 -30.64 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.859 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.466 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 53.7 m-85 -91.21 22.06 4.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.793 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.8 66.98 0.82 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.209 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -165.13 2.16 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.629 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 38.6 m-85 -83.23 141.8 31.62 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.5 m -71.44 138.08 48.77 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 159.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.757 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -47.01 -48.14 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 119.098 0.863 . . . . 0.0 110.842 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.492 ' HB2' HG13 ' A' ' 161' ' ' VAL . 21.1 t60 -55.23 -32.23 62.13 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.74 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -65.46 -55.79 16.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.946 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 112' ' ' VAL . 83.2 t80 -66.59 -43.51 84.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.359 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.846 HD22 ' HE2' ' A' ' 93' ' ' PHE . 8.8 mt -55.88 -46.81 78.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.719 0.295 . . . . 0.0 110.573 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.52 -43.37 98.91 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.829 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.25 -43.01 99.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.578 0.351 . . . . 0.0 111.877 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.466 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 54.0 t90 -60.44 -43.55 96.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.04 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.85 71.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.481 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -62.4 -49.08 76.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 -28.18 67.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.59 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.403 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 38.6 t80 -62.25 -50.05 73.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.236 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -19.87 75.14 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.378 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.04 96.39 1.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.537 0.684 . . . . 0.0 110.906 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG12 ' HB1' ' A' ' 60' ' ' ALA . 16.8 m -62.23 -25.26 37.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -90.84 -7.62 51.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -66.18 127.42 32.09 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.159 0.504 . . . . 0.0 111.173 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.3 p -131.32 -176.19 3.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.828 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.489 ' HB3' HG23 ' A' ' 36' ' ' VAL . 36.2 t-20 -160.57 118.12 2.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.835 0.35 . . . . 0.0 110.556 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 3.73 20.21 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.273 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -106.11 -0.62 24.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.496 . . . . 0.0 109.887 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.489 HG23 ' HB3' ' A' ' 33' ' ' ASN . 19.9 t -89.93 122.88 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.973 -177.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -92.37 -81.09 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.327 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -75.23 -62.1 1.67 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.755 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.437 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . . . 66.78 80.63 0.21 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.622 -172.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -78.7 134.19 37.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.497 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.4 m -79.84 -31.77 40.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.146 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.65 -172.43 44.75 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.413 ' CA ' ' HE2' ' A' ' 105' ' ' TYR . . . -148.15 -83.36 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.858 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.62 60.97 2.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.744 0.783 . . . . 0.0 109.073 -158.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -84.22 71.72 10.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.617 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.635 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -157.97 -36.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.945 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.35 -125.14 0.97 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.253 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -73.51 -38.95 65.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.576 0.227 . . . . 0.0 111.524 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -168.73 28.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.375 0.607 . . . . 0.0 110.623 -175.436 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -154.04 175.97 12.78 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.549 -176.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.635 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 149.83 -164.78 29.6 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.284 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -91.64 -18.54 23.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.661 0.267 . . . . 0.0 111.212 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 40.8 tt0 -135.9 147.63 48.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 111.216 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.12 108.51 3.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.114 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.83 155.39 17.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.466 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.106 HG13 ' HG2' ' A' ' 139' ' ' MET . 8.6 mm -148.8 137.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.887 0.742 . . . . 0.0 109.166 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 20.7 t -129.76 150.93 50.86 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.744 0.307 . . . . 0.0 110.38 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 30.0 t -50.55 122.37 7.04 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.733 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 p -83.04 40.77 0.72 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.673 0.749 . . . . 0.0 110.179 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.851 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -146.52 -45.08 0.19 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.599 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -122.65 -1.83 8.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.18 0.514 . . . . 0.0 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.5 mt-30 31.59 41.42 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.437 HG23 HG21 ' A' ' 36' ' ' VAL . 14.5 p -127.91 -43.94 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.032 170.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 13.6 m -67.2 96.11 0.45 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -111.12 -179.9 3.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 112.346 -171.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.826 ' HE1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -157.7 131.31 7.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.245 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.637 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 35.2 t -110.17 118.63 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . . . -94.12 149.9 20.82 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.27 123.02 1.49 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -179.59 -109.17 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 22.6 t-20 -149.27 41.12 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.0 mt -58.54 131.53 51.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.906 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.0 m -136.98 132.14 33.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.344 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB3' HD13 ' A' ' 49' ' ' LEU . 37.2 t80 -90.16 127.38 36.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.1 p -63.03 -37.27 86.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.051 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.485 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 9.9 tp 49.64 -93.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.696 0.798 . . . . 0.0 112.161 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.485 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 5.4 m-85 -99.09 8.66 44.71 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.165 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -80.27 178.87 7.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.823 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.641 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 12.1 mm-40 -52.55 -54.91 37.41 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 52.1 Cg_exo -55.36 -37.65 94.48 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.671 1.581 . . . . 0.0 112.445 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.46 116.81 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.767 0.794 . . . . 0.0 112.878 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 54.01 58.06 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.741 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.21 162.56 39.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.005 -178.1 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.791 HD23 HG11 ' A' ' 135' ' ' VAL . 12.5 tp -101.73 151.37 22.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.464 0.174 . . . . 0.0 110.741 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -155.82 -152.02 0.37 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.58 -167.5 24.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.99 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 6.3 tm0? -99.97 164.7 11.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.389 0.614 . . . . 0.0 111.608 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.519 ' HB2' HG22 ' A' ' 131' ' ' VAL . 22.3 tp -155.41 135.14 12.68 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.675 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -133.96 -53.48 0.86 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.188 0.518 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 115' ' ' GLY . 2.3 p -108.43 153.69 22.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.944 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.826 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.9 mm? -137.77 169.84 17.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.637 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 20.6 t -163.52 111.99 1.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.636 -175.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.846 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.4 m-30 -103.92 131.88 50.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.19 169.15 41.65 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.934 -1.126 . . . . 0.0 112.224 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -89.78 115.05 26.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.205 0.526 . . . . 0.0 111.374 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.54 112.14 0.64 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.625 170.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 67' ' ' VAL . 13.1 mt -89.39 160.26 16.91 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.474 0.654 . . . . 0.0 110.476 170.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 t -131.57 166.93 20.3 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.992 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 101' ' ' ASP . . . -99.23 127.75 9.35 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.19 -174.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.03 31.08 1.79 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 99' ' ' GLY . 29.6 t70 67.96 -90.29 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.999 0.919 . . . . 0.0 110.283 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.0 p -120.69 11.73 11.28 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.999 0.904 . . . . 0.0 108.835 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.412 ' HB3' ' CD ' ' A' ' 104' ' ' PRO . 9.1 m -117.17 167.46 10.8 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.44 175.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 103' ' ' SER . 50.1 Cg_exo -60.47 163.88 14.28 Favored 'Trans proline' 0 C--N 1.329 -0.45 0 C-N-CA 123.147 2.564 . . . . 0.0 114.275 -171.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.413 ' HE2' ' CA ' ' A' ' 43' ' ' GLY . 27.0 m-85 -68.22 164.15 21.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.435 -173.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 p -149.45 154.22 38.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.865 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.829 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -83.84 126.51 40.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -177.392 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 46.3 mt-30 -65.85 -50.95 62.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.129 175.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.416 HG21 HD21 ' A' ' 33' ' ' ASN . 23.9 t -112.62 85.6 7.58 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.46 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.71 106.28 1.44 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.637 2.892 . . . . 0.0 113.034 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.522 ' OD1' HG23 ' A' ' 112' ' ' VAL . 4.2 t70 -100.45 -140.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.075 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 38.8 t -62.01 143.62 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.691 0.757 . . . . 0.0 111.572 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.567 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 53.2 m -143.94 179.09 7.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.411 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.631 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.2 m-85 -137.57 150.24 47.32 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.058 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -162.31 131.89 2.65 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.353 175.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.753 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 106.6 16.03 15.43 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.794 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.509 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 11.8 mt -56.72 -44.18 81.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 51.63 50.58 18.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.63 0.728 . . . . 0.0 110.428 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 27.1 mt -109.15 118.87 37.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.894 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 13.1 p -116.64 133.08 56.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.313 . . . . 0.0 110.479 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 53.1 p -103.76 154.22 19.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 64.5 mt -82.06 165.94 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.575 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -58.84 -57.13 14.38 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -75.73 5.19 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 122' ' ' LEU . 31.3 mt-30 -80.03 57.24 2.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.74 102.32 0.49 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.847 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.602 ' HA ' ' CD2' ' A' ' 132' ' ' HIS . 2.8 t-80 81.13 -30.53 0.11 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.97 0.908 . . . . 0.0 111.553 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.23 -27.68 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.082 0.239 . . . . 0.0 111.357 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -56.09 128.14 44.94 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.613 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 28.0 m -56.48 -25.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -68.17 -48.53 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.655 ' CD2' ' H ' ' A' ' 84' ' ' LEU . 1.6 t-80 -61.6 -38.75 88.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.819 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.613 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 2.0 mm100 -56.21 -67.65 0.28 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.157 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 130' ' ' VAL . 17.7 m -58.05 -40.17 75.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.191 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.791 HG11 HD23 ' A' ' 84' ' ' LEU . 11.4 p -68.56 -47.37 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 121.289 -0.165 . . . . 0.0 111.083 -176.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.416 ' HD1' HG13 ' A' ' 135' ' ' VAL . 9.2 m-85 -72.26 -23.07 61.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.85 -55.59 23.71 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.657 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -48.29 -52.72 20.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.29 0.567 . . . . 0.0 110.747 176.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' MET . . . . . 1.106 ' HG2' HG13 ' A' ' 56' ' ' ILE . 51.9 mtp -54.53 -35.57 63.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.297 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.2 m -91.63 -1.99 57.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.829 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.56 44.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.92 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -109.73 134.33 52.12 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.46 0.304 . . . . 0.0 110.286 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 19' ' ' LEU . 43.8 p -112.4 -11.29 13.68 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.404 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.14 -38.68 56.72 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.523 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.37 -38.0 68.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.693 -0.298 . . . . 0.0 111.021 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 45.2 tp -67.64 -38.63 84.12 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.858 ' HG2' HG21 ' A' ' 161' ' ' VAL . 67.6 mt-10 -55.93 -38.16 69.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.68 -34.71 58.21 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.12 0.486 . . . . 0.0 109.91 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.06 85.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.939 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.3 mt -55.92 -45.97 78.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.445 174.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -53.94 -16.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.76 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.34 46.51 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.11 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.608 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.8 mp -81.09 -47.01 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.83 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.99 -37.84 69.64 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.321 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.319 . . . . 0.0 111.498 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.71 -30.37 69.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.332 0.587 . . . . 0.0 110.014 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.481 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.0 m-85 -103.39 -9.74 19.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.1 20.55 25.41 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.824 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -105.51 -166.8 1.25 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.475 0.638 . . . . 0.0 110.915 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.8 m -159.74 179.28 8.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.858 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.0 p -56.61 -25.6 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.313 0.578 . . . . 0.0 110.965 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -89.64 33.65 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.124 -0.36 . . . . 0.0 111.637 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.633 ' HB3' HG22 ' A' ' 168' ' ' VAL . 18.7 t -101.93 150.62 23.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.9 m -72.8 133.55 44.54 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 119.003 -0.522 . . . . 0.0 111.649 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.685 ' CD1' HD13 ' A' ' 15' ' ' ILE . 3.4 m-30 -38.89 -53.97 1.67 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.23 -46.2 86.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.483 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -70.99 -35.85 72.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.739 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 154' ' ' LEU . 37.1 t -62.4 -52.93 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -55.31 -46.78 76.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.022 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -64.78 -33.56 76.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.524 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.462 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -74.49 -32.63 62.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.227 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.835 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 31.0 p -85.15 -12.9 51.73 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.092 0.948 . . . . 0.0 109.611 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -68.85 -40.86 79.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.831 172.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.3 p -170.61 -32.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.469 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 171' ' ' ALA . . . 115.57 113.1 2.86 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.01 147.16 33.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.985 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 61.99 -174.65 0.14 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.598 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.5 p80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.132 178.779 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.865 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.6 t80 . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 p -173.9 165.3 4.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.307 0.575 . . . . 0.0 110.945 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.645 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.97 125.69 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.779 171.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.591 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 30.9 m-80 -101.75 49.4 0.86 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.746 0.784 . . . . 0.0 110.402 -176.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.982 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 26.1 p90 -74.42 148.48 41.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.589 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.7 t70 -63.27 106.62 0.91 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.715 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 10.2 t -39.25 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.841 1.338 . . . . 0.0 112.502 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 7' ' ' ASP . 13.5 t -173.7 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.967 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.526 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 85.5 m-85 -94.23 15.16 18.04 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.071 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.18 68.62 1.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.679 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -168.26 8.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 164' ' ' THR . 22.1 m-85 -92.57 146.88 23.33 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 122.163 0.185 . . . . 0.0 110.968 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 m -71.11 132.62 45.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.755 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -46.15 -53.31 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.569 0.622 . . . . 0.0 111.377 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.498 ' HB2' HG22 ' A' ' 161' ' ' VAL . 23.0 t-80 -61.07 -24.57 66.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.582 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.15 -44.82 28.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -71.12 -41.97 69.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.354 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.93 ' HB3' HG21 ' A' ' 143' ' ' THR . 14.3 mt -56.33 -39.78 73.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.304 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -42.18 96.78 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.113 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 24' ' ' SER . 8.2 tt0 -61.89 -38.21 87.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.534 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 49.0 t90 -60.43 -46.36 90.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.867 175.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 26' ' ' PHE . . . -65.83 -26.59 67.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.295 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.533 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 36.0 t -57.75 -55.51 33.88 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.038 0.447 . . . . 0.0 109.997 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.85 -32.39 73.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.603 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.476 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.0 t80 -61.78 -47.16 86.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.95 -30.67 76.37 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.284 -0.484 . . . . 0.0 113.766 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.27 109.0 8.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.661 HG12 ' HB1' ' A' ' 60' ' ' ALA . 17.1 m . . . . . 0 C--N 1.328 -0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.4 -8.13 54.6 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.088 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.29 -5.88 32.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.382 0.61 . . . . 0.0 109.563 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.499 HG21 HG23 ' A' ' 63' ' ' VAL . 41.1 t -102.18 114.41 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.179 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -100.18 -73.55 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.52 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -57.14 8.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.069 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.48 73.52 0.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.064 0.935 . . . . 0.0 111.035 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 98' ' ' SER . 13.7 m-80 -84.58 135.03 34.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.456 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 69.2 m -74.86 -40.3 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 124.79 -124.97 5.56 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.447 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 59.79 2.96 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 61.3 m-85 60.6 -178.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.712 0.768 . . . . 0.0 112.976 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.502 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 36.9 t80 -142.02 -69.21 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.503 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.16 55.82 3.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.153 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 50' ' ' SER . . . 168.43 157.06 10.86 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.33 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.483 ' O ' HD23 ' A' ' 49' ' ' LEU . 4.0 m -82.06 -27.89 32.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.322 0.582 . . . . 0.0 109.896 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 48' ' ' SER . 6.8 mt -154.67 -40.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.452 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.771 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 10.4 p -116.04 148.25 40.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.839 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.8 -137.76 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.782 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 p -94.71 -57.92 2.33 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 54.2 tt0 -114.75 152.24 32.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.105 -167.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.736 ' CD1' HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -145.12 94.77 2.58 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.723 0.773 . . . . 0.0 111.47 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 97' ' ' LEU . . . -95.43 151.44 19.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.824 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.982 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.8 mm -146.45 129.42 8.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 123.197 0.599 . . . . 0.0 110.618 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.3 t -112.87 147.3 37.29 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 43.2 t -45.6 117.4 1.44 Allowed 'General case' 0 C--O 1.207 -1.163 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.535 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -12.93 56.52 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.977 -0.452 . . . . 0.0 110.843 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.661 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -80.66 -60.73 2.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.834 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -115.5 -0.67 13.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.793 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.8 mt-30 33.77 42.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -173.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.499 HG23 HG21 ' A' ' 36' ' ' VAL . 7.3 p -121.83 -53.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.858 166.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 32.5 m -64.19 103.89 0.68 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.216 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.02 -176.95 3.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -169.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.779 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -159.82 120.15 3.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.267 -176.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 69.1 t -102.46 109.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.567 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.779 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -97.18 151.62 19.63 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.56 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.29 139.56 6.52 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.014 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 -117.87 0.48 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.373 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.759 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 2.5 t-20 -145.91 73.15 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 54' ' ' TYR . 16.4 mt -83.29 161.08 21.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.657 -164.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.59 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 52.8 m -155.75 121.57 5.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.481 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.922 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 44.1 t80 -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.421 0.629 . . . . 0.0 109.991 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.498 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . 13.0 p -81.87 47.61 1.12 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -171.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.922 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -60.02 -57.74 11.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.245 1.384 . . . . 0.0 111.987 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.402 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 11.5 m-30 -89.92 1.72 55.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.508 0.67 . . . . 0.0 109.514 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' HB2' ' CA ' ' A' ' 75' ' ' THR . 29.7 m-80 -89.02 179.07 6.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.349 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.906 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 33.7 mm-40 -53.27 -67.8 0.54 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 51.6 Cg_exo -56.66 -28.16 73.89 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 121.666 1.578 . . . . 0.0 113.13 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.36 115.43 0.05 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.655 0.74 . . . . 0.0 112.64 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 54.04 51.36 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.277 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.733 HG22 ' CE1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -134.97 178.98 6.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.703 -174.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.4 tp -125.75 142.23 51.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -153.95 -159.53 0.98 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.93 -163.32 19.35 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.307 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.759 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 1.2 tm0? -93.36 165.94 12.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.788 0.804 . . . . 0.0 112.137 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.423 HD13 ' OH ' ' A' ' 54' ' ' TYR . 25.3 tp -156.12 132.83 10.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.985 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -132.14 -45.0 0.93 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.262 0.553 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.52 134.39 46.06 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.535 HD12 ' HE1' ' A' ' 66' ' ' PHE . 3.1 mm? -108.13 175.55 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.903 169.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.67 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 12.6 t -167.22 103.78 0.53 Allowed 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.502 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.779 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.4 m-30 -95.87 145.19 25.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.78 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 177.04 170.92 40.07 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.906 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.8 114.63 26.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 111.594 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . 85.01 107.44 0.65 Allowed Glycine 0 C--O 1.223 -0.558 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.781 169.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 105' ' ' TYR . 48.1 mt -86.59 155.77 20.31 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.231 0.539 . . . . 0.0 110.29 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.446 ' HA ' HD22 ' A' ' 40' ' ' ASN . 1.8 m -145.42 173.67 11.8 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.13 175.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.155 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -172.843 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.502 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 25.6 Cg_exo . . . . . 0 N--CA 1.464 -0.241 0 N-CA-C 111.452 -0.249 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.474 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 48.3 m-85 -68.06 141.74 56.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.815 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.0 p -150.79 147.09 26.86 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.335 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.78 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.1 mp -79.42 130.17 36.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.109 0.48 . . . . 0.0 110.82 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.79 -44.48 93.2 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.156 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.92 82.82 2.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.8 111.21 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.523 2.815 . . . . 0.0 112.908 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 49.4 m-20 -104.48 -150.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.376 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.982 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 48.4 t -59.71 143.25 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.698 0.761 . . . . 0.0 111.572 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.591 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -140.74 178.83 7.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.339 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.516 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.8 m-85 -135.19 148.27 49.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -162.51 140.51 6.59 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.824 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.865 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 99.17 11.87 44.25 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.2 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.529 ' HA ' HD11 ' A' ' 153' ' ' ILE . 16.7 mt -57.98 -50.53 73.09 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 56.15 52.2 10.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.764 0.792 . . . . 0.0 110.519 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 23.7 mt -113.74 110.14 19.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.478 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.636 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 72.4 p -115.02 130.71 57.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 81.2 p -98.02 147.2 24.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.723 0.297 . . . . 0.0 110.493 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.61 171.32 14.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.855 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -49.62 -55.39 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.92 10.23 8.31 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.447 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 19.3 mm-40 -79.84 67.78 5.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.52 -103.61 0.01 OUTLIER Glycine 0 C--O 1.224 -0.519 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.434 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -83.41 -14.81 51.85 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.11 -0.641 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.559 ' HA ' HE21 ' A' ' 133' ' ' GLN . 17.3 t70 -87.43 -18.81 29.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 125' ' ' GLN . . . -65.25 121.42 20.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.569 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.0 m -49.57 -32.77 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.11 -41.6 92.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.27 0.486 . . . . 0.0 110.718 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.733 ' CE1' HG22 ' A' ' 83' ' ' THR . 4.9 t-160 -65.28 -37.84 88.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 109.85 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.569 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 6.8 mt-30 -65.41 -58.14 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.731 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 130' ' ' VAL . 24.9 m -58.31 -39.35 73.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.373 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.559 ' O ' ' HG3' ' A' ' 139' ' ' MET . 13.0 p -67.68 -50.04 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.755 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.427 ' HD1' HG13 ' A' ' 135' ' ' VAL . 14.0 m-85 -71.01 -27.19 63.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.695 0.283 . . . . 0.0 110.823 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.98 -56.8 18.69 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -49.5 -50.4 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.145 0.578 . . . . 0.0 111.1 176.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.982 ' HG2' HG13 ' A' ' 56' ' ' ILE . 48.6 mtp -54.87 -33.15 61.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.41 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.2 m -94.1 -6.41 45.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.17 23.44 29.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.506 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -107.76 135.48 49.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.93 HG21 ' HB3' ' A' ' 19' ' ' LEU . 37.4 p -117.94 10.16 13.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.798 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.498 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.03 -19.27 78.3 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.69 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.27 -36.02 14.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 0.0 110.647 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.726 HD12 HD21 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -67.34 -39.59 85.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.929 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.664 ' HB2' HG11 ' A' ' 161' ' ' VAL . 10.9 pt-20 -56.61 -35.25 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.82 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 -35.69 53.15 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.996 0.426 . . . . 0.0 109.964 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.46 82.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.615 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 96.3 mt -55.96 -42.06 75.67 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.88 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -54.65 -10.35 0.43 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.171 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.0 -39.85 53.12 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.411 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.5 mp -85.52 -46.49 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 120.727 0.299 . . . . 0.0 110.436 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.495 HD11 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.28 -44.65 80.0 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.911 -177.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.63 -22.86 67.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.678 0.275 . . . . 0.0 111.514 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.12 -35.13 79.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.499 . . . . 0.0 110.019 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.447 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 34.5 m-85 -96.06 -14.68 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 99.19 24.11 10.69 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.756 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.447 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -104.4 -161.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.189 0.495 . . . . 0.0 110.377 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 66.7 p -162.61 -179.94 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.819 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.664 HG11 ' HB2' ' A' ' 147' ' ' GLU . 9.1 p -59.06 -20.35 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.062 0.458 . . . . 0.0 111.392 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.87 13.52 12.46 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.048 -0.408 . . . . 0.0 111.022 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 168' ' ' VAL . 8.5 t -84.01 148.7 26.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.7 m -72.81 149.44 43.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.988 -175.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.686 ' CD1' HD13 ' A' ' 15' ' ' ILE . 10.7 m-30 -53.19 -22.7 7.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.585 0.754 . . . . 0.0 111.46 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.46 -51.04 7.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.457 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -66.85 -43.63 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.604 HG23 ' HB3' ' A' ' 163' ' ' SER . 3.2 t -55.58 -58.52 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.02 73.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.16 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -66.84 -35.83 80.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.57 -30.86 57.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.385 0.612 . . . . 0.0 110.245 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.3 p -85.2 -15.26 44.23 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.92 0.867 . . . . 0.0 109.034 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 N--CA 1.446 -0.636 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.268 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.76 ' O ' ' HB ' ' A' ' 172' ' ' THR . 44.4 t80 . . . . . 0 C--O 1.222 -0.395 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -162.41 168.35 22.23 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.729 0.812 . . . . 0.0 109.221 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.624 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.9 128.19 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.681 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 25.3 m-80 -103.9 49.97 0.81 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 0.0 110.328 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.936 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 32.6 p90 -71.49 151.4 43.97 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.097 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 9' ' ' SER . 25.5 t70 -62.36 103.08 0.36 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.665 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 5.3 t -34.94 77.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.113 1.508 . . . . 0.0 112.974 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.4 t -173.35 -30.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.298 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.573 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 66.5 m-85 -95.74 19.81 10.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.004 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 59.2 2.31 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -172.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.402 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -166.32 16.9 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.558 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 26.4 m-85 -93.66 139.86 30.31 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.163 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 m -67.55 131.54 45.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 160.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.782 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.5 mm -45.65 -51.56 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 117.917 0.326 . . . . 0.0 111.499 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -56.14 -34.79 66.45 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.559 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.25 -53.35 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.394 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.481 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 73.6 t80 -68.86 -39.64 79.75 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.583 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 12.1 mt -56.69 -40.84 76.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.955 0.407 . . . . 0.0 110.244 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.62 -41.58 99.61 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.017 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 24' ' ' SER . 6.0 tt0 -62.25 -39.85 94.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.641 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 44.8 t90 -59.16 -42.33 90.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.25 0.548 . . . . 0.0 110.202 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.38 -25.05 66.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 21.2 t -62.96 -55.78 22.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.024 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.3 -31.02 72.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.773 0.32 . . . . 0.0 111.073 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 32.1 t80 -58.85 -41.13 86.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.922 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.43 -18.64 78.46 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.433 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 90.33 2.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.414 0.626 . . . . 0.0 111.573 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.827 HG12 ' HB1' ' A' ' 60' ' ' ALA . 29.6 m . . . . . 0 C--N 1.324 -0.537 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 44.2 t-20 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -6.78 56.3 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.419 -0.42 . . . . 0.0 114.064 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -112.98 -5.29 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.492 0.646 . . . . 0.0 111.534 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.509 HG11 HG13 ' A' ' 63' ' ' VAL . 46.1 t -102.42 118.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.13 0.49 . . . . 0.0 111.743 -175.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.92 -62.83 1.39 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.46 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.91 -72.7 0.3 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.01 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 68.97 87.04 0.12 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.378 0.609 . . . . 0.0 112.247 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -83.72 154.38 23.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.86 175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -82.22 -37.65 25.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.406 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.29 170.73 39.3 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.154 -174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.912 ' HA2' ' HE2' ' A' ' 105' ' ' TYR . . . -98.55 -111.67 3.12 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -168.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 55.96 64.96 1.57 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.952 0.882 . . . . 0.0 109.024 -164.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 52' ' ' SER . 2.2 t80 -73.12 -23.92 60.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.668 -173.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.857 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.95 -19.66 64.82 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.376 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.02 -145.59 8.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.453 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 m -75.04 -30.42 61.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.767 0.318 . . . . 0.0 110.958 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -166.43 40.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.284 0.564 . . . . 0.0 111.397 -175.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 p -164.67 177.65 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.35 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.857 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 106.49 -163.65 13.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.297 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 16.6 m -88.54 127.57 35.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 68' ' ' ALA . 5.3 tt0 80.21 105.72 0.07 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.178 171.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -102.05 101.6 11.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.329 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.601 ' H ' ' HA3' ' A' ' 43' ' ' GLY . . . -90.52 152.78 20.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.003 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.026 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.1 mm -147.18 132.86 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.318 0.647 . . . . 0.0 109.51 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 19.8 t -121.86 149.28 43.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 40.9 t -48.06 119.4 2.88 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.399 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -66.64 -10.3 44.66 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.821 -0.549 . . . . 0.0 111.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.827 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -83.81 -49.87 8.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.674 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.411 ' O ' HG23 ' A' ' 63' ' ' VAL . 39.2 p30 -127.76 -3.81 5.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.86 -172.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 58' ' ' SER . 63.7 mt-30 33.8 45.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.947 1.299 . . . . 0.0 114.168 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.509 HG13 HG11 ' A' ' 36' ' ' VAL . 7.4 t -116.66 -63.38 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.669 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 21.6 m -61.84 102.59 0.28 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.337 -175.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.45 -178.43 3.38 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.54 -169.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.692 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -157.74 126.01 5.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.757 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 29.0 t -108.67 111.27 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 53' ' ' GLN . . . -90.29 107.69 19.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 0.0 111.03 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.86 117.91 5.36 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.852 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.67 -139.39 3.69 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.406 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 87' ' ' GLN . 8.7 m-80 -136.24 47.74 2.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.027 0.918 . . . . 0.0 109.222 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 35.6 mt -70.31 149.92 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.639 -1.619 . . . . 0.0 112.015 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.7 m -155.05 137.19 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.142 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 33.7 t80 -89.21 123.66 33.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.564 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.751 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 69.1 p -70.91 -32.55 69.52 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -171.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.745 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER 42.09 -92.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.836 0.854 . . . . 0.0 113.117 -168.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.518 ' H ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.63 7.29 46.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.751 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 33.8 m-80 -77.16 176.57 8.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.802 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 39.8 mt-10 -48.52 -63.13 1.7 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -170.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.802 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -55.65 -35.77 93.58 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.616 1.544 . . . . 0.0 112.433 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.63 128.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.894 0.746 . . . . 0.0 112.463 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 38.09 60.28 1.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.059 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -143.32 165.64 26.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.847 -174.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.761 HD23 HG11 ' A' ' 135' ' ' VAL . 11.7 tp -108.94 146.91 33.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 17.0 p90 -153.65 -160.7 1.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 85' ' ' TYR . . . 98.97 -166.56 21.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.929 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.683 HE22 ' HB2' ' A' ' 89' ' ' ASP . 17.8 tm0? -92.58 158.03 16.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.687 0.756 . . . . 0.0 111.906 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.567 ' CD2' HG21 ' A' ' 134' ' ' VAL . 57.1 tp -143.76 110.24 5.5 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.045 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.683 ' HB2' HE22 ' A' ' 87' ' ' GLN . 36.1 t70 -126.54 -28.82 2.98 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.882 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.498 ' O ' HD13 ' A' ' 91' ' ' LEU . 31.0 t -134.89 160.19 39.05 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.05 0.928 . . . . 0.0 112.327 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 3.0 mm? -144.46 163.7 33.04 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 19.9 t -162.82 106.93 1.1 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.163 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.781 ' CE2' HD22 ' A' ' 19' ' ' LEU . 2.4 m-30 -97.64 135.05 40.01 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.42 160.88 28.77 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.013 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.83 110.82 20.22 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.258 0.551 . . . . 0.0 110.734 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.96 110.51 2.36 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.801 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.523 HD21 HG22 ' A' ' 67' ' ' VAL . 6.6 mt -83.89 155.14 23.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.486 . . . . 0.0 109.846 170.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 t -145.95 170.2 17.1 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.908 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.536 -177.549 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 C--O 1.235 0.363 0 CA-C-O 121.07 0.363 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.912 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 48.8 m-85 -75.8 165.19 25.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.404 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.6 p -147.77 139.76 24.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.996 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.815 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -81.61 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.624 -174.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.14 -48.16 77.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.053 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.75 88.37 7.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.87 93.9 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 123.142 2.561 . . . . 0.0 112.354 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.456 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 30.3 m-20 -93.45 -155.56 0.45 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.413 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.936 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 20.7 t -62.0 113.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.427 1.108 . . . . 0.0 112.422 -175.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.681 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 68.5 m -103.02 176.65 5.08 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.327 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.723 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.0 m-85 -137.07 141.28 42.39 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -156.45 128.92 2.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.155 -1.498 . . . . 0.0 113.047 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 111.38 10.0 20.68 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.25 174.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.649 ' CD2' ' H ' ' A' ' 117' ' ' LEU . 1.7 mm? -49.88 -53.04 28.3 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.063 0.945 . . . . 0.0 110.52 174.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.4 t30 53.68 47.62 23.38 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.58 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.4 mt -105.22 102.55 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.498 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.627 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 69.5 p -106.16 128.5 53.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.268 0.556 . . . . 0.0 110.851 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.7 t -108.71 119.16 38.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 122' ' ' LEU . 9.9 mp -59.14 167.49 1.71 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.297 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -51.65 -57.84 8.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.877 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.582 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -83.36 15.15 3.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -165.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -72.98 -31.09 64.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 66.18 -119.91 14.37 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.203 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.45 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 6.1 t-80 -88.77 -24.06 22.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.42 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.551 ' HA ' HE21 ' A' ' 133' ' ' GLN . 32.7 t70 -81.06 -21.49 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.822 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 125.99 40.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.281 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 134' ' ' VAL . 18.6 m -51.18 -32.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.3 -42.23 94.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.556 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.9 t-160 -65.05 -40.36 94.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.779 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 128' ' ' ASP . 23.2 mm-40 -59.77 -65.31 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.926 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.567 HG21 ' CD2' ' A' ' 88' ' ' LEU . 27.1 m -55.86 -39.84 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.014 -174.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.761 HG11 HD23 ' A' ' 84' ' ' LEU . 8.3 p -69.68 -46.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.256 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -73.35 -24.77 60.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.54 -54.96 19.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.575 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -48.7 -50.72 32.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.158 0.583 . . . . 0.0 110.82 176.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 1.026 ' HG2' HG13 ' A' ' 56' ' ' ILE . 41.5 mtp -52.72 -34.61 53.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.133 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m -90.99 -2.81 57.65 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 14.89 69.33 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.597 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -106.88 104.16 13.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.182 0.515 . . . . 0.0 110.302 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 19' ' ' LEU . 3.5 p -92.16 11.86 24.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.481 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.19 -29.1 72.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.776 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.73 39.46 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.434 -0.451 . . . . 0.0 110.431 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.562 HD22 HD21 ' A' ' 138' ' ' LEU . 47.1 tp -68.39 -43.13 77.96 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.589 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.678 ' HB2' HG21 ' A' ' 161' ' ' VAL . 10.6 pt-20 -57.85 -31.08 66.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.658 0.266 . . . . 0.0 110.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -36.12 58.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.57 75.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.928 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.539 HD23 HD11 ' A' ' 117' ' ' LEU . 94.1 mt -55.45 -39.22 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.8 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -56.28 -10.19 0.83 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.451 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.35 -36.24 63.29 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.389 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.41 HG22 ' HE2' ' A' ' 157' ' ' TYR . 4.1 mp -84.4 -47.98 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 122.705 -0.291 . . . . 0.0 110.58 175.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.638 HD11 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.63 -43.09 75.86 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.8 -30.78 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.94 -31.84 72.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.137 0.494 . . . . 0.0 110.818 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.41 ' HE2' HG22 ' A' ' 153' ' ' ILE . 47.0 m-85 -98.86 -6.11 29.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.299 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.38 39.31 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.308 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 mp -101.4 -167.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.1 p -167.85 175.41 6.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.286 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -61.71 -13.27 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.271 . . . . 0.0 111.669 172.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -89.73 10.62 22.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.956 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -87.17 -116.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.184 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 7.2 m -157.31 146.83 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.771 -174.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.691 ' CD1' HD13 ' A' ' 15' ' ' ILE . 6.7 m-30 -54.47 -45.26 73.12 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.455 0.302 . . . . 0.0 111.025 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.13 -41.1 90.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.656 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -66.78 -48.18 69.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.638 HG22 HD11 ' A' ' 154' ' ' LEU . 4.0 t -56.23 -54.95 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.686 0.279 . . . . 0.0 110.272 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.21 76.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.017 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.278 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.74 59.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.76 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 38.0 p -86.27 -11.84 51.19 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.06 0.933 . . . . 0.0 109.146 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 N--CA 1.445 -0.71 0 CA-C-N 113.868 -1.514 . . . . 0.0 108.949 171.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.705 ' O ' ' HB ' ' A' ' 172' ' ' THR . 42.7 t80 . . . . . 0 CA--C 1.515 -0.394 0 CA-C-O 120.682 0.277 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -160.75 168.42 24.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.965 172.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' A' ' 165' ' ' PHE . 0.5 OUTLIER -88.19 130.17 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 113' ' ' SER . 44.5 m-20 -106.32 46.82 0.9 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.871 0.844 . . . . 0.0 110.814 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.962 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 20.4 p90 -70.56 145.4 50.82 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.261 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 9' ' ' SER . 32.7 t70 -63.82 104.84 0.73 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.347 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 p -25.15 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.726 1.61 . . . . 0.0 114.579 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ASP . 42.2 t -174.64 -32.07 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.26 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.596 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 74.7 m-85 -94.21 16.86 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.15 70.81 0.61 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.511 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.62 23.24 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.666 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 25.7 m-85 -107.77 141.36 39.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.522 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -72.55 129.59 38.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 161.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 168' ' ' VAL . 5.0 mm -47.24 -43.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -170.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -63.2 -33.34 75.27 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.569 0.223 . . . . 0.0 111.316 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.28 -36.14 82.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 110.766 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.895 ' CE1' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -72.1 -48.12 46.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 175.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.803 HD21 ' HZ ' ' A' ' 114' ' ' PHE . 15.9 mt -53.05 -46.54 68.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.774 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.2 -44.7 94.77 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.68 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -62.96 -43.46 98.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.661 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 55.6 t90 -58.69 -45.13 90.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.551 . . . . 0.0 109.916 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.4 -24.03 64.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.2 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -62.52 -53.2 58.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -34.35 78.04 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.491 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.2 t80 -56.8 -42.41 79.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.519 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.14 -21.41 79.21 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.239 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 7.3 t70 -75.96 104.03 6.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 111.0 -174.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.837 HG12 ' HB1' ' A' ' 60' ' ' ALA . 20.1 m . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.62 -6.77 63.42 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.996 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -118.37 3.88 11.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 117.628 0.714 . . . . 0.0 111.745 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 63' ' ' VAL . 25.5 t -98.11 112.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.293 0.568 . . . . 0.0 112.378 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.78 -67.07 0.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.653 172.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -75.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.148 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.523 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 65.11 63.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.459 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 40.1 m-80 -86.23 147.99 25.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.365 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 57' ' ' SER . 71.8 m -93.65 -39.11 10.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.997 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 114.3 -129.13 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.397 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.95 62.44 2.01 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 121.201 -0.524 . . . . 0.0 113.067 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 66.33 130.66 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.488 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 17.5 t80 -107.88 -24.65 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.269 172.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.48 19.8 8.28 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.132 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.76 -132.02 7.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.633 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -75.89 -52.18 10.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.543 0.211 . . . . 0.0 111.419 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -164.44 21.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.1 p -161.62 156.65 23.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.82 -64.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.243 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.615 ' C ' ' HA2' ' A' ' 70' ' ' GLY . 23.1 t -148.77 -144.75 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 121.349 -0.14 . . . . 0.0 110.631 -170.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 12.3 mt-30 -43.93 141.75 1.56 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.806 0.842 . . . . 0.0 112.104 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.423 ' HB3' HD12 ' A' ' 72' ' ' LEU . 3.9 t80 -130.99 96.98 4.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.504 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -89.76 146.77 24.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.558 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.03 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.3 mm -145.12 121.1 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.564 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.1 t -104.73 165.97 10.7 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.436 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 33.4 t -61.13 152.78 27.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.09 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.9 p -101.53 -14.09 17.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.019 0.438 . . . . 0.0 110.115 168.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.837 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -75.47 -54.5 6.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.293 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 37.9 p30 -115.3 0.98 13.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.154 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 58' ' ' SER . 69.5 mt-30 30.0 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.8 p -128.64 -51.64 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.459 171.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 17.1 m -63.33 107.5 1.1 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.692 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -121.27 -178.22 3.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -170.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.779 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -156.37 131.78 9.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.869 -176.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 58.1 t -110.98 119.99 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.542 0.211 . . . . 0.0 110.694 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.78 14.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.949 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 53' ' ' GLN . . . -63.29 -99.3 0.01 OUTLIER Glycine 0 C--O 1.217 -0.921 0 N-CA-C 116.61 1.404 . . . . 0.0 116.61 -167.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.615 ' HA2' ' C ' ' A' ' 52' ' ' SER . . . -179.68 34.13 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 118.826 -1.654 . . . . 0.0 115.495 -170.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -146.39 27.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.756 1.278 . . . . 0.0 111.03 169.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.585 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 73.1 mt -79.05 144.6 34.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.973 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.9 m -144.38 124.33 13.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.383 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.549 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 58.3 t80 -82.07 123.09 28.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.866 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 80.7 p -61.4 -38.96 88.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.626 -171.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 tp 55.53 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 123.812 0.695 . . . . 0.0 111.337 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -100.76 8.39 43.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.742 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.866 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 94.2 m-20 -76.44 179.03 6.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 111.536 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.776 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 6.0 mm-40 -51.4 -56.83 17.27 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -57.6 -37.3 97.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.754 1.636 . . . . 0.0 112.513 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.86 125.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.833 0.708 . . . . 0.0 112.372 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 47.53 58.82 4.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.11 169.05 20.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.333 -175.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.773 HD23 HG11 ' A' ' 135' ' ' VAL . 12.2 tp -108.81 138.8 44.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -157.01 139.01 14.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 166.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 72' ' ' LEU . . . -168.65 -131.2 1.27 Allowed Glycine 0 C--N 1.298 -1.542 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.187 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 1.8 tm0? -142.42 151.59 41.95 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 113.889 -1.155 . . . . 0.0 108.831 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.564 HD21 HD11 ' A' ' 91' ' ' LEU . 18.9 tp -138.99 116.25 11.11 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.574 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 16.6 t70 -110.89 -56.62 2.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.645 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.503 ' O ' HD13 ' A' ' 91' ' ' LEU . 4.9 p -107.74 155.07 20.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.323 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.721 HD12 ' HE1' ' A' ' 66' ' ' PHE . 3.0 mm? -141.15 160.52 39.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.663 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 58.0 m -149.76 111.33 4.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.675 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.75 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.9 m-30 -99.72 129.38 45.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.439 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.04 165.32 35.83 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.535 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -90.11 123.13 33.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.197 0.523 . . . . 0.0 111.618 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.76 110.04 0.47 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.469 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.538 HD11 ' HB1' ' A' ' 55' ' ' ALA . 77.0 mt -87.01 151.59 23.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.052 0.453 . . . . 0.0 109.979 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 p -131.19 154.04 48.81 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.998 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.673 174.036 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.8 Cg_exo . . . . . 0 N--CA 1.459 -0.507 0 CA-C-O 121.129 0.387 . . . . 0.0 111.917 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.725 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 64.1 m-85 -67.74 150.7 48.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.322 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' LEU . 18.2 p -144.06 152.75 41.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.544 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.661 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.0 mp -85.98 119.08 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.643 0.259 . . . . 0.0 110.907 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.523 ' NE2' ' H ' ' A' ' 39' ' ' ALA . 41.7 mt-30 -65.04 -47.22 78.14 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 33.5 t -105.16 87.83 2.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 34.0 Cg_endo -63.25 100.7 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.372 2.715 . . . . 0.0 112.453 -176.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.515 ' OD2' HG23 ' A' ' 112' ' ' VAL . 10.1 t70 -106.1 -147.19 0.4 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.962 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 15.4 t -69.79 149.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.355 0.598 . . . . 0.0 111.892 -177.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 5' ' ' ASN . 36.2 m -142.9 -177.49 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.123 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.803 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.0 m-85 -134.35 152.7 51.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.114 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.35 135.74 4.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.515 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.94 13.63 31.21 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.551 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.506 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 mt -55.41 -51.71 65.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.574 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 64.8 t30 53.4 43.26 31.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.208 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -106.29 128.8 54.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 171.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.693 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 51.2 p -131.17 139.04 49.68 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.983 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.5 p -98.55 151.44 20.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.864 0.364 . . . . 0.0 111.392 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.59 162.94 26.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -48.13 -55.56 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.54 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.7 11.35 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 15.0 mm100 -77.44 55.42 1.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 112.134 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 128' ' ' ASP . . . -64.24 104.33 0.88 Allowed Glycine 0 C--O 1.225 -0.422 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.526 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 74.95 -26.17 0.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.609 0.764 . . . . 0.0 111.35 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 126' ' ' GLY . 24.1 t70 -83.65 -23.21 31.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.091 0.472 . . . . 0.0 110.207 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -60.34 122.14 28.9 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.095 173.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.516 ' O ' HG22 ' A' ' 134' ' ' VAL . 22.9 m -51.52 -33.34 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 86' ' ' GLY . 12.5 m -64.83 -44.87 96.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.561 0.22 . . . . 0.0 110.958 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.583 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.5 t-160 -60.38 -40.42 90.79 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.443 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 32.6 mt-30 -59.09 -63.24 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 130' ' ' VAL . 23.7 m -60.01 -40.49 83.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.022 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.779 HG23 ' HZ ' ' A' ' 66' ' ' PHE . 10.7 p -68.99 -45.47 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.325 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.92 -22.44 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 0.0 110.601 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.9 -54.8 19.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.646 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -47.95 -52.17 20.71 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.344 0.658 . . . . 0.0 110.88 176.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 1.03 ' HG2' HG13 ' A' ' 56' ' ' ILE . 45.4 mtp -54.63 -33.64 60.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.392 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.5 t -89.67 -15.47 32.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.25 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.5 16.58 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.635 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.61 127.1 48.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.583 HG21 ' HB3' ' A' ' 19' ' ' LEU . 21.7 p -114.61 5.48 15.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.119 0.485 . . . . 0.0 110.979 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.494 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.99 -20.93 80.16 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.583 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.02 -35.45 21.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 36.1 tp -68.06 -40.93 82.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.492 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.633 ' HB2' HG11 ' A' ' 161' ' ' VAL . 11.8 pt-20 -56.67 -34.53 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.716 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -35.4 61.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.116 0.484 . . . . 0.0 110.053 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.21 -46.27 74.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.525 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 95.9 mt -55.26 -41.91 72.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.049 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -52.8 -14.32 0.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.331 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -72.87 -43.65 40.87 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.78 -175.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.411 HG22 ' HE2' ' A' ' 157' ' ' TYR . 3.8 mp -80.27 -43.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.285 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.714 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -59.18 -44.63 92.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.28 -25.73 67.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 111.389 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.09 -29.5 70.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.471 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 25.5 m-85 -100.47 -12.54 19.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.276 175.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 97.37 18.24 29.11 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.429 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.508 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -102.83 -163.07 0.96 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.421 0.611 . . . . 0.0 110.522 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.9 p -161.69 -176.66 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.974 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 147' ' ' GLU . 8.5 p -58.02 -23.16 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 111.034 174.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -88.77 18.39 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.295 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.703 ' HB3' HG22 ' A' ' 168' ' ' VAL . 16.6 t -83.76 143.42 30.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 168' ' ' VAL . 47.0 m -75.36 141.04 43.38 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.567 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 13' ' ' TYR . 7.0 m-30 -39.82 -49.96 2.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.833 0.853 . . . . 0.0 113.187 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.19 -38.58 88.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.948 0.404 . . . . 0.0 110.742 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.525 HE21 ' HB ' ' A' ' 164' ' ' THR . 52.5 mt-30 -73.99 -38.95 63.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.289 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.714 HG13 HD11 ' A' ' 154' ' ' LEU . 17.9 t -62.07 -52.33 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 109.986 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.38 82.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.84 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -65.83 -35.35 80.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.74 -28.04 60.61 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.364 0.602 . . . . 0.0 110.638 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.705 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.8 p -89.96 -12.94 37.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.071 0.938 . . . . 0.0 109.594 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.512 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.814 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 17.0 t80 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -173.7 160.53 3.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.221 0.534 . . . . 0.0 110.967 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.674 HG11 HD12 ' A' ' 15' ' ' ILE . 11.8 m -97.86 115.96 39.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.752 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.496 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 34.4 m-80 -96.45 59.32 1.82 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.623 -169.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.679 ' CE2' ' HA ' ' A' ' 8' ' ' SER . 38.9 p90 -74.23 149.7 40.69 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.049 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.5 t70 -62.73 94.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.679 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.5 p -24.99 72.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 114.92 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 20.7 t -173.79 -26.23 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.392 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.531 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 83.6 m-85 -90.04 10.24 24.94 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.931 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.2 69.23 1.09 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.974 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.61 21.83 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 164' ' ' THR . 21.8 m-85 -107.42 140.14 40.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.942 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m -68.89 133.24 47.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 162.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.674 HD12 HG11 ' A' ' 4' ' ' VAL . 6.3 mm -51.26 -47.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 118.134 0.424 . . . . 0.0 111.604 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -65.21 -25.22 67.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.947 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.43 -51.12 25.65 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 56.8 t80 -69.51 -49.2 56.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' A' ' 93' ' ' PHE . 16.3 mt -57.42 -38.99 75.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.029 0.442 . . . . 0.0 110.242 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.29 -41.01 94.76 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.86 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.84 -45.44 92.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.953 0.406 . . . . 0.0 110.988 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.738 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 9.3 t90 -52.69 -51.08 61.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.816 174.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.67 -28.92 68.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -57.79 -52.09 66.88 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -27.37 66.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.421 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.542 ' CE2' ' HE1' ' A' ' 66' ' ' PHE . 18.0 t80 -60.44 -49.9 75.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.54 0.209 . . . . 0.0 110.488 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.83 -28.26 73.7 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.254 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -73.25 103.9 4.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 110.962 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.701 HG12 ' HB1' ' A' ' 60' ' ' ALA . 27.9 m . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.384 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 . . . . . 0 CA--C 1.522 -0.103 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -10.32 62.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.065 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.77 -7.12 53.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.593 0.711 . . . . 0.0 109.293 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.546 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 23.4 t -94.91 120.42 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 m -92.7 -57.45 2.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.407 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 4.5 t70 -98.44 -68.81 0.79 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.286 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' H ' HE22 ' A' ' 108' ' ' GLN . . . 79.92 81.25 0.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 124.972 1.42 . . . . 0.0 109.66 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.67 ' HB3' ' HE1' ' A' ' 105' ' ' TYR . 8.3 m-80 -78.51 135.74 37.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.256 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 60.2 p -76.56 -45.69 29.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.428 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.0 178.06 27.21 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 44' ' ' PHE . . . -167.56 -45.24 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 117.311 -2.376 . . . . 0.0 117.725 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.8 m-85 70.29 95.38 0.07 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.916 0.858 . . . . 0.0 109.543 -153.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -79.53 -17.42 54.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.55 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.36 17.58 37.82 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.939 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.08 -118.71 4.31 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.351 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.4 m -76.85 -54.35 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.769 0.318 . . . . 0.0 111.778 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -164.99 43.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.664 0.745 . . . . 0.0 110.781 -173.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 p -158.29 -178.32 7.2 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.356 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.86 -166.35 25.67 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.99 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -87.83 -39.1 15.13 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' ALA . 27.2 mt-30 -117.77 155.24 30.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.48 0.657 . . . . 0.0 111.609 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -145.5 101.57 3.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.07 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 97' ' ' LEU . . . -92.91 142.49 27.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.776 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 139' ' ' MET . 31.7 mm -143.49 129.6 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 O-C-N 123.679 0.612 . . . . 0.0 109.945 177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.542 ' HB3' ' HA ' ' A' ' 41' ' ' SER . 22.9 t -112.95 155.79 24.15 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.627 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 38.1 t -48.81 128.85 16.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.829 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 p -76.55 -14.88 59.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.171 0.51 . . . . 0.0 109.866 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.701 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -80.82 -60.06 2.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.891 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -116.33 1.52 13.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.053 0.454 . . . . 0.0 111.503 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.1 mm-40 39.0 36.24 0.15 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -175.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 p -124.08 -51.11 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.686 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 m -64.54 102.98 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -120.62 175.51 5.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.299 0.571 . . . . 0.0 112.205 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -159.73 131.36 6.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.592 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 49.1 t -108.52 115.03 48.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.222 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -86.96 155.25 20.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.61 125.27 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.524 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -177.93 -104.19 0.18 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.694 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 2.4 t-20 -150.4 41.26 0.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.5 145.3 55.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.081 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.2 m -154.55 131.81 11.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.475 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HB3' HD13 ' A' ' 49' ' ' LEU . 55.0 t80 -90.46 129.15 36.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.608 HG22 HE22 ' A' ' 123' ' ' GLN . 71.0 p -65.29 -35.81 82.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -172.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.529 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 8.8 tp 51.7 -96.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.689 0.796 . . . . 0.0 112.166 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.529 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 4.9 m-85 -101.58 7.78 42.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.103 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.75 178.44 6.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.938 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 41.0 mt-10 -48.35 -62.23 2.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -169.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.79 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 86.8 Cg_exo -50.73 -51.4 11.21 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.978 1.786 . . . . 0.0 112.992 175.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 71.68 130.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.882 0.739 . . . . 0.0 112.402 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 51.8 m80 54.49 49.91 17.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.268 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.652 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.6 OUTLIER -146.49 166.34 26.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 -175.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.668 ' CD2' HG11 ' A' ' 135' ' ' VAL . 13.9 tp -110.74 151.53 27.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -153.49 -153.46 0.47 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.19 -144.46 17.35 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.199 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.716 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 24.7 tm0? -140.97 158.79 43.44 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 91' ' ' LEU . 32.0 tp -144.22 135.15 25.21 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.565 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 19.0 t70 -133.02 -55.14 0.92 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.431 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.636 ' O ' HD22 ' A' ' 91' ' ' LEU . 5.7 p -108.31 158.33 17.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.515 -176.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 68' ' ' ALA . 2.4 mm? -140.23 156.89 46.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 172.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.511 ' HB3' HD11 ' A' ' 107' ' ' ILE . 3.7 m -147.09 106.02 3.85 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.285 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.67 ' CE2' HD22 ' A' ' 19' ' ' LEU . 2.4 m-30 -91.97 147.64 22.81 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.76 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 173.36 163.56 27.2 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.781 173.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.0 117.98 29.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.336 0.589 . . . . 0.0 111.043 176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 104.87 0.88 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.42 172.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.54 ' CD1' ' HB1' ' A' ' 55' ' ' ALA . 50.5 mt -88.93 161.12 16.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.263 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 t -146.96 168.47 21.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.517 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.699 175.416 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo . . . . . 0 N--CA 1.459 -0.519 0 N-CA-C 110.762 -0.515 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.67 ' HE1' ' HB3' ' A' ' 40' ' ' ASN . 38.4 m-85 -65.38 144.25 57.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.584 0.707 . . . . 0.0 111.614 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 p -143.21 138.11 29.45 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.388 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.76 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.0 mp -79.62 123.83 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.546 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 78.2 mt-30 -64.58 -48.43 75.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.308 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.77 90.23 12.57 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.79 102.09 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.816 3.011 . . . . 0.0 113.919 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.6 m-20 -84.7 -164.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.716 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 84.5 t -63.28 138.02 23.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.824 0.821 . . . . 0.0 112.393 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 58.4 m -116.77 179.7 3.94 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.635 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 91.7 m-85 -143.56 153.16 42.28 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.26 134.09 3.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.636 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.814 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 103.89 15.67 21.54 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.308 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.432 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 22.6 mt -58.52 -45.74 88.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.644 0.722 . . . . 0.0 109.632 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.565 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 14.9 t30 59.98 19.0 8.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.436 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -92.36 132.08 37.03 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.559 0.695 . . . . 0.0 110.236 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.716 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 59.9 p -133.21 165.15 25.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.657 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 131' ' ' VAL . 78.2 p -144.48 150.86 38.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.027 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.43 165.84 15.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.6 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.608 HE22 HG22 ' A' ' 75' ' ' THR . 19.6 tp60 -51.06 -56.3 13.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.995 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.597 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -81.77 15.79 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.95 -15.86 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.321 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 44.47 -123.83 5.35 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.705 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.434 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 1.4 t-80 -78.52 -20.14 51.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HA ' HE21 ' A' ' 133' ' ' GLN . 17.0 t70 -85.17 -17.26 37.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.01 122.98 31.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.18 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.626 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.2 m -50.2 -33.62 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.45 HG22 ' OG ' ' A' ' 121' ' ' SER . 27.2 m -64.74 -41.25 91.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.652 ' HE1' HG22 ' A' ' 83' ' ' THR . 3.9 t-160 -64.0 -38.28 90.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.626 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 4.2 mm-40 -63.4 -62.77 1.46 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.59 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 130' ' ' VAL . 15.9 m -58.75 -37.1 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.264 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.668 HG11 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -66.35 -43.97 91.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.379 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.581 ' HD1' HG13 ' A' ' 135' ' ' VAL . 22.2 m-85 -71.94 -27.47 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.308 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -54.29 38.07 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 170.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.599 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.25 -60.62 2.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.544 0.688 . . . . 0.0 110.085 176.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.721 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 71.2 mtm -55.59 -25.97 41.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.463 -1.244 . . . . 0.0 114.071 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 m -94.09 -3.2 51.57 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.563 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.42 48.67 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.16 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -106.95 135.18 48.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.161 0.505 . . . . 0.0 110.616 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.418 HG21 ' HB3' ' A' ' 19' ' ' LEU . 23.7 p -111.75 8.5 20.66 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 147' ' ' GLU . . . -74.71 -42.94 30.43 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.553 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.62 -27.02 60.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.219 0.533 . . . . 0.0 109.688 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.619 HD11 ' HZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -73.74 -48.05 34.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.271 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.58 ' HB2' HG11 ' A' ' 161' ' ' VAL . 10.3 pt-20 -56.69 -36.16 69.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -38.28 69.09 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.187 0.518 . . . . 0.0 109.767 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.72 -47.35 75.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.427 ' O ' HD22 ' A' ' 154' ' ' LEU . 96.1 mt -55.74 -46.47 77.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.517 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.93 -15.86 3.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.753 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.86 -39.94 58.59 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.623 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.405 HG22 ' HE2' ' A' ' 157' ' ' TYR . 4.0 mp -81.43 -51.12 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.281 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.737 HD11 HG13 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -54.77 -41.93 71.09 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.77 -23.15 67.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.26 -24.11 63.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 110.106 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.517 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 9.2 m-85 -112.29 0.82 15.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.188 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 90.49 16.96 54.26 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.78 -0.646 . . . . 0.0 113.847 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 2.2 mm? -98.7 -170.88 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.627 0.713 . . . . 0.0 109.536 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 78.6 p -164.21 176.92 8.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.22 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.58 HG11 ' HB2' ' A' ' 147' ' ' GLU . 4.9 p -57.55 -26.45 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.083 0.468 . . . . 0.0 110.632 174.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -90.26 28.91 1.33 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.824 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 14' ' ' SER . 25.3 t -84.55 -134.62 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.684 ' HB ' HE21 ' A' ' 167' ' ' GLN . 98.6 m -158.25 142.39 15.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.58 ' CD1' HD13 ' A' ' 15' ' ' ILE . 10.9 m-30 -44.12 -49.76 8.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -173.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.69 -23.23 62.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.234 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.684 HE21 ' HB ' ' A' ' 164' ' ' THR . 49.8 mt-30 -84.26 -51.52 6.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.737 HG13 HD11 ' A' ' 154' ' ' LEU . 61.5 t -56.34 -57.03 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.255 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.17 69.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.72 84.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.28 -29.29 62.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.194 0.521 . . . . 0.0 110.81 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.675 HG21 ' CD2' ' A' ' 2' ' ' PHE . 40.5 p -88.98 -21.1 23.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.851 0.834 . . . . 0.0 109.645 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.563 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.973 178.462 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.809 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 47.0 t80 . . . . . 0 C--O 1.224 -0.279 0 N-CA-C 110.674 -0.121 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -163.42 168.75 19.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.845 0.715 . . . . 0.0 109.094 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.595 HG13 ' HB2' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -88.26 122.59 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.496 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 63.9 m-20 -97.94 45.65 1.02 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.186 0.994 . . . . 0.0 110.366 -174.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.934 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -72.26 150.47 43.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.627 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 9' ' ' SER . 27.6 t70 -64.58 110.28 2.28 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.172 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.46 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.3 p -39.4 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.241 1.416 . . . . 0.0 113.338 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.7 t -170.84 -32.85 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.131 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.428 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 45.8 m-85 -89.44 18.39 5.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.6 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.39 76.82 0.92 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.619 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -174.27 -8.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.487 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 36.3 m-85 -73.5 133.58 43.66 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 122.825 -0.22 . . . . 0.0 110.478 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 17' ' ' ASP . 15.5 m -66.37 132.95 49.47 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 163.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.697 HD13 ' CD1' ' A' ' 165' ' ' PHE . 4.8 mm -46.78 -49.53 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 118.062 0.392 . . . . 0.0 111.697 -172.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.514 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 2.4 t-80 -58.48 -29.88 66.55 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.298 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' SER . 4.0 m-20 -68.2 -58.96 3.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.452 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HB2' ' CG ' ' A' ' 13' ' ' TYR . 59.5 t80 -63.94 -45.56 88.67 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.661 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.934 ' HB3' HG21 ' A' ' 143' ' ' THR . 13.1 mt -57.13 -42.04 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.151 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.64 -40.4 97.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.08 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.08 -42.04 99.55 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 122.631 0.373 . . . . 0.0 111.354 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 39.9 t90 -60.35 -42.7 96.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.408 0.623 . . . . 0.0 109.724 176.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.091 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.0 t -63.58 -54.38 36.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 p -64.34 -35.18 80.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.808 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 19.7 t80 -55.65 -42.93 75.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.213 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.98 -21.21 79.15 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.919 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 29.9 t70 -73.81 104.6 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.201 0.5 . . . . 0.0 111.374 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.655 HG12 ' HB1' ' A' ' 60' ' ' ALA . 24.9 m . . . . . 0 C--N 1.324 -0.536 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t-20 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.72 -13.56 63.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.001 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -111.13 15.68 21.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.727 HG22 ' NE2' ' A' ' 108' ' ' GLN . 0.5 OUTLIER -134.82 134.32 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -112.56 -74.69 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.043 0.449 . . . . 0.0 111.745 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.16 -67.0 0.5 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.513 -173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.38 80.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.754 0.659 . . . . 0.0 111.592 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 98' ' ' SER . 33.2 m-80 -79.79 157.76 26.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.449 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 58.0 m -93.26 -24.43 18.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -168.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.17 135.93 3.09 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.005 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.36 59.63 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.245 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 39.2 m-85 62.93 159.17 0.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.996 0.903 . . . . 0.0 112.553 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.859 ' HE1' ' HD3' ' A' ' 104' ' ' PRO . 5.3 t80 -126.72 -36.2 2.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.072 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.85 -21.83 58.84 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.21 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -138.87 4.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.467 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -77.08 -30.17 55.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.725 0.298 . . . . 0.0 110.912 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.609 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -164.25 27.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.604 -175.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -149.25 176.3 10.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.56 173.45 15.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.175 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 t -85.97 -3.17 58.87 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 28.6 tt0 -147.23 150.97 35.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.278 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -154.33 97.17 2.0 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB3' ' CD2' ' A' ' 105' ' ' TYR . . . -91.72 155.69 18.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.713 HG21 ' HG2' ' A' ' 139' ' ' MET . 9.4 mm -150.76 146.81 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.551 0.741 . . . . 0.0 109.254 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 t -122.36 170.95 9.42 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 30.0 t -55.54 141.51 36.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.384 0.611 . . . . 0.0 111.403 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -85.92 -20.36 29.12 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.113 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.655 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.11 -54.08 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.6 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 34.4 p30 -119.64 -1.15 10.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 111.909 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.9 mm-40 42.11 38.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 36' ' ' VAL . 11.7 p -122.78 -57.15 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 122.306 -0.247 . . . . 0.0 110.783 169.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.557 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 19.8 m -58.87 106.84 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 110.495 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -116.74 179.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.712 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -157.42 133.43 9.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.753 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 22.4 t -115.05 114.18 45.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.264 -0.272 . . . . 0.0 110.684 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 53' ' ' GLN . . . -89.34 149.55 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.708 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.69 124.95 1.88 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.139 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.91 -115.5 0.46 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.449 ' HB3' ' CB ' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -148.38 48.62 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.2 mt -62.86 144.87 56.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.909 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -149.92 138.62 20.83 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.795 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' A' ' 49' ' ' LEU . 58.1 t80 -93.61 133.8 36.56 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.764 HG22 HE22 ' A' ' 123' ' ' GLN . 31.9 p -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.438 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 8.2 tp 56.4 -94.45 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.079 0.552 . . . . 0.0 111.143 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.438 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 3.5 m-85 -98.57 -1.75 40.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.137 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -75.45 167.05 22.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.647 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 23.8 mm-40 -46.99 -60.08 4.4 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -165.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HB2' HG21 ' A' ' 75' ' ' THR . 99.7 Cg_exo -49.75 -38.27 46.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.769 1.646 . . . . 0.0 113.17 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 65.07 117.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.427 0.632 . . . . 0.0 112.617 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 10.7 m-70 56.7 60.16 3.2 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.512 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.834 HG21 ' HA2' ' A' ' 126' ' ' GLY . 26.5 m -149.3 153.36 37.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.147 -172.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.746 HD23 HG11 ' A' ' 135' ' ' VAL . 14.8 tp -101.12 148.05 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.424 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -156.05 -153.55 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.33 -167.31 24.81 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.258 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.591 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 12.5 tm0? -95.96 165.57 12.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.395 0.617 . . . . 0.0 111.594 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.5 tp -152.85 136.71 16.22 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.007 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.03 -54.48 0.71 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.112 0.482 . . . . 0.0 110.716 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.453 ' C ' HD22 ' A' ' 91' ' ' LEU . 4.5 p -112.56 155.37 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -175.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 3.0 mm? -138.59 161.52 36.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 172.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.644 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 55.5 m -151.6 112.53 4.26 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 122.187 -0.321 . . . . 0.0 110.783 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.793 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.6 m-30 -99.77 139.13 35.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.605 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -179.79 163.86 31.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.522 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.43 132.79 34.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.129 0.464 . . . . 0.0 110.705 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.529 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . 68.23 112.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 174.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.441 HD11 ' HB1' ' A' ' 55' ' ' ALA . 54.8 mt -87.04 156.36 19.78 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.199 -0.589 . . . . 0.0 109.953 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.447 ' HA ' HD22 ' A' ' 40' ' ' ASN . 10.1 t -150.8 -177.55 6.06 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.789 174.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.914 175.505 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.859 ' HD3' ' HE1' ' A' ' 45' ' ' TYR . 7.2 Cg_endo . . . . . 0 C--O 1.234 0.313 0 N-CA-C 114.522 0.932 . . . . 0.0 114.522 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.644 ' CD2' ' HB3' ' A' ' 55' ' ' ALA . 50.4 m-85 -76.45 169.42 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.91 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 p -151.49 142.64 23.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.1 mp -84.31 120.46 35.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.727 ' NE2' HG22 ' A' ' 36' ' ' VAL . 20.0 mt-30 -65.45 -41.44 93.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.138 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.48 89.9 6.56 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.51 92.37 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.3 2.667 . . . . 0.0 112.49 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 72.9 m-20 -99.32 -153.61 0.44 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.331 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.934 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -62.83 144.66 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.521 0.676 . . . . 0.0 111.549 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -136.6 179.31 6.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 95.6 m-85 -138.79 148.71 44.14 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.7 145.22 10.22 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.693 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.809 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.57 8.23 46.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.628 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 19.4 mt -56.73 -51.68 67.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.073 0.436 . . . . 0.0 109.947 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.411 ' HA ' ' NE2' ' A' ' 87' ' ' GLN . 63.0 t30 49.28 50.98 17.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.693 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 21.5 mt -106.8 107.62 18.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.704 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.591 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 17.9 p -105.82 131.07 53.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.4 t -103.73 141.96 35.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -74.22 169.45 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.764 HE22 HG22 ' A' ' 75' ' ' THR . 21.8 tp60 -58.96 -56.73 18.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.136 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.02 8.33 3.29 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.525 ' NE2' ' HA2' ' A' ' 129' ' ' GLY . 4.9 mm100 -77.04 52.86 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.892 175.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.834 ' HA2' HG21 ' A' ' 83' ' ' THR . . . -62.95 109.22 2.55 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.066 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.429 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 1.9 t-80 73.4 -40.16 0.46 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.137 0.975 . . . . 0.0 111.926 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HA ' HE21 ' A' ' 133' ' ' GLN . 27.2 t70 -81.86 -11.03 59.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.525 ' HA2' ' NE2' ' A' ' 125' ' ' GLN . . . -64.37 125.73 32.03 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 170.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.512 ' O ' HG22 ' A' ' 134' ' ' VAL . 4.8 p -55.31 -29.4 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.9 -44.69 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.594 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.4 t-160 -62.49 -36.38 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.471 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.505 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 26.3 mt-30 -63.38 -63.73 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.885 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 130' ' ' VAL . 20.6 m -58.58 -39.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.807 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.746 HG11 HD23 ' A' ' 84' ' ' LEU . 10.1 p -68.03 -44.39 84.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.593 0.235 . . . . 0.0 110.784 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.457 ' HD1' HG13 ' A' ' 135' ' ' VAL . 9.7 m-85 -73.03 -31.37 64.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.577 0.227 . . . . 0.0 110.453 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.54 -53.22 45.63 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -50.47 -50.91 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.07 0.462 . . . . 0.0 110.568 175.265 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.713 ' HG2' HG21 ' A' ' 56' ' ' ILE . 55.7 mtp -57.72 -27.55 63.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.486 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m -95.45 -12.27 26.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.6 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.75 29.01 19.84 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.868 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -116.14 126.11 53.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.012 0.434 . . . . 0.0 110.725 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.934 HG21 ' HB3' ' A' ' 19' ' ' LEU . 20.1 p -111.4 15.22 21.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.794 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.12 -15.8 81.26 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.558 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.31 -32.2 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.095 0.474 . . . . 0.0 110.22 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.446 ' CD1' ' HZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -66.01 -37.6 86.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.669 ' HA ' ' CG1' ' A' ' 161' ' ' VAL . 11.8 pt-20 -54.45 -38.78 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.529 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -38.83 69.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.072 0.463 . . . . 0.0 110.251 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.48 72.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.432 ' O ' HD22 ' A' ' 154' ' ' LEU . 90.8 mt -56.48 -42.67 78.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.156 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.8 -7.49 0.46 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.673 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.65 -38.64 61.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.526 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.78 -48.35 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.061 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.629 ' HB3' ' HB2' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -53.85 -37.4 63.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.62 -27.93 66.76 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.92 -29.5 69.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.472 0.653 . . . . 0.0 110.07 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.442 ' HB2' ' HG ' ' A' ' 159' ' ' LEU . 20.1 m-85 -106.55 -3.05 21.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.29 18.36 64.74 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.78 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.629 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 19.3 mt -95.2 -172.5 2.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.851 0.326 . . . . 0.0 111.0 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.5 p -166.69 -172.18 2.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.892 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.669 ' CG1' ' HA ' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -58.5 -25.53 28.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 176.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 14' ' ' SER . 8.2 p30 -86.3 14.25 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.334 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.3 m -89.88 148.15 23.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.1 p -69.76 158.42 35.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.697 ' CD1' HD13 ' A' ' 15' ' ' ILE . 15.7 m-30 -54.47 -31.78 56.43 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.37 -62.17 1.86 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.938 174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.2 -48.39 80.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.593 HG13 HD11 ' A' ' 154' ' ' LEU . 93.9 t -59.33 -55.54 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.58 0.229 . . . . 0.0 111.324 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.595 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -57.22 -48.02 79.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.21 81.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.5 -27.29 55.99 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.065 0.46 . . . . 0.0 111.144 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.792 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.5 p -91.95 -19.9 21.94 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.999 0.904 . . . . 0.0 109.981 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.869 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.047 177.418 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.79 ' O ' ' HB ' ' A' ' 172' ' ' THR . 28.5 t80 . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.673 0.273 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 p -169.37 159.29 8.59 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.93 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' A' ' 169' ' ' ALA . 25.6 m -93.43 114.36 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.257 174.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.572 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.0 m-80 -94.55 52.42 1.54 Allowed 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.934 0.873 . . . . 0.0 110.648 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.844 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -76.95 151.18 35.81 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.234 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 9' ' ' SER . 18.5 t70 -62.74 103.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.2 p -37.01 78.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 124.74 1.275 . . . . 0.0 113.464 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ASP . 22.9 t -174.63 -29.08 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.684 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.51 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 68.2 m-85 -93.67 15.15 16.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.286 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -69.22 70.55 0.47 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.57 -173.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -169.78 0.02 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.516 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 28.5 m-85 -86.25 136.02 33.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.73 -0.235 . . . . 0.0 110.411 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 163' ' ' SER . 19.7 m -68.99 134.5 49.56 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 160.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.596 HD13 ' CD1' ' A' ' 165' ' ' PHE . 5.1 mm -48.31 -48.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 118.389 0.54 . . . . 0.0 111.705 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -57.65 -30.86 65.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.628 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.0 -46.87 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.795 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.42 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 68.7 t80 -72.64 -46.13 55.53 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.906 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.622 ' HB3' HG21 ' A' ' 143' ' ' THR . 14.6 mt -56.59 -34.2 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.288 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.69 -45.06 93.77 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.137 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -61.65 -41.37 97.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.858 0.361 . . . . 0.0 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.68 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 22.3 t90 -54.71 -51.72 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.638 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.41 63.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.052 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 t -61.5 -51.14 69.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.727 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -65.45 -32.12 73.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.759 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.686 ' HB2' HG21 ' A' ' 64' ' ' THR . 19.8 t80 -59.4 -37.2 77.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.848 0.356 . . . . 0.0 110.264 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.99 -18.41 77.71 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.292 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.603 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 25.1 t70 -75.57 93.29 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.185 0.517 . . . . 0.0 111.835 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.922 HG12 ' HB1' ' A' ' 60' ' ' ALA . 22.8 m . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.768 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.2 t30 . . . . . 0 N--CA 1.462 0.131 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.42 -9.28 61.0 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.548 ' ND2' HG21 ' A' ' 109' ' ' VAL . 9.8 p30 -104.83 -18.73 14.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.807 0.813 . . . . 0.0 110.718 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' A' ' 63' ' ' VAL . 49.3 t -87.72 114.04 25.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.376 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -101.24 -70.3 0.75 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.773 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.43 -73.19 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.848 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 69.18 86.5 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.784 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -80.89 141.58 34.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 51.5 m -71.81 -36.35 70.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.78 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 108.13 -123.09 6.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.584 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 64.18 2.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.898 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 60.56 -176.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.43 0.634 . . . . 0.0 112.708 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -144.61 -56.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.826 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.31 22.18 21.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.076 -173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.25 -179.47 40.84 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.453 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -81.48 -68.3 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 14.0 mt -76.56 -31.03 57.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.578 -176.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.54 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 11.0 p -147.9 163.74 35.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.558 -175.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.3 39.59 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.65 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.6 m 65.87 -60.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.517 0.727 . . . . 0.0 112.709 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -95.66 159.53 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.881 0.372 . . . . 0.0 111.072 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' HD2' HG21 ' A' ' 135' ' ' VAL . 1.5 t80 -153.32 99.22 2.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.858 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -93.12 144.96 24.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.433 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.676 HG13 ' HG2' ' A' ' 139' ' ' MET . 27.8 mm -146.25 127.65 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.036 0.446 . . . . 0.0 110.85 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 41' ' ' SER . 18.9 t -112.69 151.87 29.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.523 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.507 ' OG ' ' HB3' ' A' ' 61' ' ' ASN . 47.0 t -49.99 136.05 19.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 112.079 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.74 27.57 3.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.296 0.569 . . . . 0.0 111.321 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.922 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -157.65 -33.39 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.991 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.603 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -103.33 -14.61 16.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.672 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.8 mm-40 31.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.748 -1.569 . . . . 0.0 115.213 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.483 ' CG2' HG21 ' A' ' 36' ' ' VAL . 10.4 p -138.21 -44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.269 169.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 26' ' ' PHE . 38.6 m -63.03 97.54 0.11 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -117.1 171.12 8.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.293 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.68 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -158.0 123.89 4.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.009 -178.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.2 t -105.56 102.57 14.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.886 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -85.43 154.58 21.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.033 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.96 127.99 2.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.777 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.11 -108.52 0.22 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -146.75 45.34 1.19 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.511 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 41.6 mt -64.26 124.75 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.279 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 31.6 m -137.35 119.13 15.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.505 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 47.1 t80 -68.36 122.94 19.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.597 HG22 HE22 ' A' ' 123' ' ' GLN . 82.7 p -63.7 -33.48 75.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.448 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 11.7 tp 52.3 -92.27 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.448 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 20.2 m-85 -98.91 0.1 43.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.738 -174.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.547 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 93.1 m-20 -73.18 170.34 15.17 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.954 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.624 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 10.9 mm-40 -48.94 -53.51 37.08 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 53.0 Cg_exo -56.83 -41.95 69.91 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.513 1.475 . . . . 0.0 112.221 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.95 130.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.77 0.795 . . . . 0.0 112.837 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 54.59 47.56 22.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.605 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.515 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -142.79 178.25 7.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.65 -174.123 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 135' ' ' VAL . 18.1 tp -126.38 82.51 2.08 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -89.23 146.56 24.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 171.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.576 ' H ' HG21 ' A' ' 131' ' ' VAL . . . -168.09 178.31 41.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.401 -1.38 . . . . 0.0 114.006 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 11.4 tm0? -97.65 167.7 10.8 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.559 ' HG ' HD12 ' A' ' 117' ' ' LEU . 27.9 tp -148.72 126.35 11.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.584 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 12.6 t70 -126.7 -48.9 1.51 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.172 0.51 . . . . 0.0 110.485 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.461 ' O ' HD22 ' A' ' 91' ' ' LEU . 19.4 p -132.81 158.92 41.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 122.005 0.907 . . . . 0.0 113.034 -173.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.1 mm? -134.9 169.11 17.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.772 -1.558 . . . . 0.0 106.878 174.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 19.8 t -163.06 99.38 0.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.819 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.685 ' CE1' HD11 ' A' ' 138' ' ' LEU . 1.2 m-30 -93.39 134.74 35.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.505 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -169.82 163.42 36.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 118.151 -1.976 . . . . 0.0 115.18 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.58 104.83 15.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.466 -0.867 . . . . 0.0 111.448 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 112.37 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.649 -1.159 . . . . 0.0 113.808 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.503 HD13 ' HB3' ' A' ' 105' ' ' TYR . 46.7 mt -85.9 160.59 19.37 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.101 -0.646 . . . . 0.0 110.041 171.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 t -143.4 172.9 12.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.252 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.228 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -175.939 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo . . . . . 0 C--O 1.233 0.239 0 CA-C-O 120.947 0.311 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.587 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 62.9 m-85 -73.63 149.08 42.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.366 -174.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 p -146.38 140.65 26.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.954 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.716 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.3 mp -78.63 133.26 30.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.92 -44.22 90.22 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.421 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.548 HG21 ' ND2' ' A' ' 35' ' ' ASN . 16.9 t -118.17 91.64 40.79 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 13.3 Cg_endo -56.66 101.91 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.234 2.622 . . . . 0.0 112.969 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -93.02 -162.39 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.924 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.844 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 41.3 t -60.11 128.69 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.333 1.063 . . . . 0.0 112.453 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.572 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 61.2 m -119.37 178.94 4.35 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.306 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.532 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 94.0 m-85 -140.42 146.35 38.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.29 140.44 6.64 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.704 -1.236 . . . . 0.0 112.402 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.725 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.51 12.84 37.06 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.996 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.559 HD12 ' HG ' ' A' ' 88' ' ' LEU . 48.5 mt -56.41 -53.92 51.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.557 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 52.7 t30 51.39 50.87 18.0 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.158 0.98 . . . . 0.0 110.257 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 19.4 mt -104.79 105.99 16.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.087 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 9.8 p -105.3 129.97 53.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.161 0.505 . . . . 0.0 110.617 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.883 ' HB3' HE22 ' A' ' 125' ' ' GLN . 74.7 m -103.73 165.91 10.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.418 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.542 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 44.4 mt -87.15 154.22 20.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.355 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.597 HE22 HG22 ' A' ' 75' ' ' THR . 17.7 tp60 -57.88 -60.0 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.828 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.616 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -77.0 17.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 1.066 ' HB3' ' HA ' ' A' ' 128' ' ' ASP . 26.9 mt-30 -74.67 -40.31 61.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 80' ' ' PRO . . . 83.47 -106.89 2.86 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.872 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.606 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 5.6 t-80 -68.01 -12.68 61.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 1.066 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 0.0 OUTLIER 78.49 172.5 0.18 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 156.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.417 ' N ' ' CG ' ' A' ' 128' ' ' ASP . . . -85.31 -35.69 11.85 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.314 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.551 ' O ' HG22 ' A' ' 134' ' ' VAL . 9.8 p -154.08 -40.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.576 HG21 ' H ' ' A' ' 86' ' ' GLY . 13.6 m -67.17 -54.62 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.963 1.256 . . . . 0.0 112.697 -174.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.606 ' ND1' ' HA ' ' A' ' 127' ' ' HIS . 4.5 t-160 -58.67 -37.13 75.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.424 ' HG2' ' OD1' ' A' ' 128' ' ' ASP . 51.6 mm-40 -61.56 -65.91 0.62 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.502 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 130' ' ' VAL . 31.5 m -56.62 -39.29 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.035 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 84' ' ' LEU . 10.0 p -67.96 -40.57 83.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -74.34 -30.68 62.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.32 79.97 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 173.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.685 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -49.42 -59.53 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.576 0.703 . . . . 0.0 109.566 174.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.676 ' HG2' HG13 ' A' ' 56' ' ' ILE . 71.8 mtm -55.97 -25.27 43.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.183 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -91.66 0.04 57.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.665 0.269 . . . . 0.0 111.502 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.08 29.49 64.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.232 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.76 121.93 43.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.467 . . . . 0.0 110.315 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.641 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 49.8 p -91.23 -16.96 26.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.022 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.38 -42.69 50.77 Favored Glycine 0 C--N 1.334 0.444 0 O-C-N 123.836 0.71 . . . . 0.0 113.477 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.75 -42.19 82.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -66.73 -39.76 88.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.971 ' HG2' HG21 ' A' ' 161' ' ' VAL . 52.5 mt-10 -54.13 -43.2 70.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.266 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -34.59 75.13 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.902 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.2 71.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.171 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 90.6 mt -54.2 -44.2 71.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.904 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -55.52 -8.87 0.41 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.359 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.75 -45.16 45.51 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.235 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.0 -45.92 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 120.645 0.259 . . . . 0.0 110.924 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.797 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -57.89 -42.95 85.73 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.0 -20.71 66.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.441 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.67 -33.14 75.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.363 0.601 . . . . 0.0 109.852 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.31 -5.65 29.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.018 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 88.42 17.36 57.27 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.991 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 17.3 mt -97.24 -174.28 2.9 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.938 0.369 . . . . 0.0 110.158 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -156.57 -176.77 6.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.971 HG21 ' HG2' ' A' ' 147' ' ' GLU . 11.9 p -56.99 -26.71 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.903 0.382 . . . . 0.0 111.707 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.53 30.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.06 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 14' ' ' SER . 13.7 t -98.62 147.76 24.49 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 168' ' ' VAL . 3.5 m -70.74 145.22 50.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.442 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.596 ' CD1' HD13 ' A' ' 15' ' ' ILE . 12.9 m-30 -47.98 -38.63 17.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 0.0 110.385 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.86 -54.02 47.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.18 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -63.57 -51.05 67.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.222 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.797 HG13 HD11 ' A' ' 154' ' ' LEU . 17.4 t -58.24 -55.91 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 O-C-N 123.019 0.2 . . . . 0.0 110.984 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.455 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . . . -53.54 -45.51 69.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.307 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -64.9 -36.51 84.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.205 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.09 -25.81 58.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.31 0.576 . . . . 0.0 110.496 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.79 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.1 p -88.97 -13.05 39.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.081 0.943 . . . . 0.0 109.556 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.944 175.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.82 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 36.1 t80 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -166.0 166.87 17.02 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.879 0.737 . . . . 0.0 109.146 171.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.788 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -91.28 126.96 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.607 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 31.5 m-80 -104.25 56.2 0.72 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.862 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 53.8 p90 -69.14 152.25 45.36 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.62 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.0 67.67 0.15 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t 17.66 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 113.811 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -168.99 -28.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.489 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.564 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 82.9 m-85 -87.73 12.71 12.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.702 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 165' ' ' PHE . . . -70.4 68.89 0.7 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.44 -172.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.66 19.74 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 27.6 m-85 -106.17 135.26 47.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.316 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' HIS . 1.8 m -74.74 67.93 1.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.719 HD13 ' CD1' ' A' ' 165' ' ' PHE . 3.4 mm 28.28 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 114.141 -172.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.485 ' H ' HG22 ' A' ' 161' ' ' VAL . 11.5 t-160 -50.74 -29.16 10.72 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.673 0.389 . . . . 0.0 111.186 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -53.35 -62.73 1.46 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.881 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.421 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 84.5 t80 -66.95 -38.78 86.75 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.341 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.887 HD22 ' HE2' ' A' ' 93' ' ' PHE . 14.3 mt -54.31 -40.42 67.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.07 93.24 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.138 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 24' ' ' SER . 5.5 tt0 -61.15 -38.49 86.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.989 0.516 . . . . 0.0 111.52 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.488 ' O ' HG21 ' A' ' 64' ' ' THR . 40.7 t90 -55.63 -45.06 77.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.957 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 26' ' ' PHE . . . -72.8 -13.69 61.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.909 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 36.9 t -63.54 -56.22 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.701 0.286 . . . . 0.0 110.536 176.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.6 p -65.2 -31.16 72.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 62' ' ' GLN . 31.7 t80 -64.45 -28.17 69.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.876 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.25 75.71 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.795 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 32.6 t70 -78.51 165.64 23.51 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.462 0.631 . . . . 0.0 111.446 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.45 -0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 112.144 -174.396 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.877 ' HB3' HG23 ' A' ' 36' ' ' VAL . 56.1 t-20 . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -1.51 19.98 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.46 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -115.02 6.81 15.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.877 HG23 ' HB3' ' A' ' 33' ' ' ASN . 12.6 t -87.55 114.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.271 0.558 . . . . 0.0 111.804 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.6 p -100.22 -73.9 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.284 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -89.24 -67.02 0.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 -172.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.496 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 74.14 74.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.656 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -86.71 156.09 20.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.783 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.411 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 58.5 m -96.84 -33.57 11.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.675 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 112.96 -135.8 12.95 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.932 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.609 ' HA2' ' HE1' ' A' ' 54' ' ' TYR . . . 80.99 74.61 1.13 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.753 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.576 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 46.0 m-85 66.11 -178.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.54 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 23.0 t80 -152.95 -71.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.247 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.04 45.45 3.3 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.203 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 170.69 36.51 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.808 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -76.04 -25.49 55.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.035 0.445 . . . . 0.0 110.113 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -167.79 32.33 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 p -158.86 166.9 30.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.205 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.81 -134.33 5.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.632 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.447 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 31.6 m -135.54 6.07 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.496 0.188 . . . . 0.0 110.918 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -141.61 143.33 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.318 . . . . 0.0 110.776 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.609 ' HE1' ' HA2' ' A' ' 43' ' ' GLY . 2.6 t80 -154.94 96.06 1.81 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.595 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -96.05 157.77 15.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.022 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.009 HG13 ' HG2' ' A' ' 139' ' ' MET . 11.6 mm -147.31 121.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 110.15 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.54 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 8.9 t -138.28 112.51 8.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.316 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.702 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER 41.53 160.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 118.574 2.805 . . . . 0.0 118.574 -178.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.421 ' H ' ' HG3' ' A' ' 62' ' ' GLN . 20.7 p -132.06 13.39 4.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.726 -2.033 . . . . 0.0 109.915 163.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.04 -58.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.264 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.628 ' O ' HG12 ' A' ' 63' ' ' VAL . 7.2 t30 -146.1 -33.68 0.32 Allowed 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.702 HE21 ' HA ' ' A' ' 58' ' ' SER . 0.5 OUTLIER -53.05 54.7 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 126.564 2.415 . . . . 0.0 113.457 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.802 HG21 HG22 ' A' ' 36' ' ' VAL . 1.4 p -66.4 -6.64 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.513 ' N ' ' C ' ' A' ' 62' ' ' GLN . 92.9 m -53.14 112.05 0.8 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 110.099 -3.228 . . . . 0.0 107.366 161.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.41 -179.39 4.18 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.35 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.849 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -160.3 121.64 3.09 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.813 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.6 112.82 41.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.269 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.634 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -88.92 152.71 21.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 52' ' ' SER . . . -150.84 122.96 1.44 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.91 -110.16 0.26 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.624 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 2.7 t-20 -147.86 37.4 0.88 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.503 0.668 . . . . 0.0 109.235 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -59.24 139.92 56.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.787 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -149.62 134.39 17.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.722 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.622 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 58.4 t80 -84.61 127.44 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.637 HG22 HE22 ' A' ' 123' ' ' GLN . 44.5 p -62.55 -33.55 75.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.648 -170.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.469 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 9.6 tp 51.57 -95.53 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.954 0.784 . . . . 0.0 111.827 -176.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.469 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 5.3 m-85 -98.84 2.58 46.88 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -175.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -76.04 178.34 6.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.549 0.214 . . . . 0.0 111.206 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.826 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 19.6 mm-40 -47.51 -62.71 1.88 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -170.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 54.2 Cg_exo -55.35 -38.02 94.17 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.777 1.651 . . . . 0.0 112.873 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 66.63 122.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.837 0.827 . . . . 0.0 112.855 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 93.4 m-70 53.27 54.41 10.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.425 -1.261 . . . . 0.0 111.484 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -146.49 169.0 19.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.307 -176.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.672 HD23 HG11 ' A' ' 135' ' ' VAL . 11.2 tp -106.58 149.06 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.819 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 86' ' ' GLY . 20.0 p90 -156.45 -154.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.417 ' O ' HG11 ' A' ' 131' ' ' VAL . . . 99.03 -164.25 20.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.904 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 6.3 tm0? -99.98 164.51 11.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 111.59 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.51 ' CB ' HG12 ' A' ' 131' ' ' VAL . 30.4 tp -151.58 129.95 12.08 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.726 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 117' ' ' LEU . 17.4 t70 -136.0 -60.22 0.73 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.387 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.431 ' C ' HD22 ' A' ' 91' ' ' LEU . 13.2 p -97.99 149.81 22.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.762 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.66 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.9 mm? -134.53 169.55 17.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 9.5 t -163.76 109.55 1.07 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.147 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.887 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.9 m-30 -97.77 140.43 32.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.661 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.97 172.01 42.8 Favored Glycine 0 C--N 1.314 -0.684 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.85 ' H ' HG13 ' A' ' 109' ' ' VAL . 24.9 m-20 -97.77 124.86 42.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 119.362 1.581 . . . . 0.0 111.414 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 63' ' ' VAL . . . 87.47 116.06 1.13 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.477 -0.783 . . . . 0.0 113.091 171.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.595 HD11 ' HB1' ' A' ' 55' ' ' ALA . 41.0 mt -86.55 153.75 21.59 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.12 168.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.8 t -138.59 168.8 18.99 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.45 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.875 0 O-C-N 123.947 0.779 . . . . 0.0 111.65 -175.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.9 Cg_exo . . . . . 0 N--CA 1.463 -0.273 0 CA-C-O 121.196 0.415 . . . . 0.0 112.364 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.675 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 37.8 m-85 -71.85 151.62 43.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.361 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.9 p -149.07 143.95 26.37 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.681 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.674 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.5 mp -80.88 129.21 37.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.044 0.45 . . . . 0.0 110.857 -175.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.496 ' NE2' ' H ' ' A' ' 39' ' ' ALA . 71.7 mt-30 -64.23 -59.07 4.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.578 176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.85 HG13 ' H ' ' A' ' 95' ' ' ASP . 2.4 p -109.15 87.53 4.91 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 121.628 0.728 . . . . 0.0 110.017 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 31.7 Cg_endo -65.09 122.71 10.55 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.95 2.433 . . . . 0.0 111.597 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 112' ' ' VAL . 3.9 t0 -118.91 -143.27 0.36 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.862 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 19.4 t -61.16 115.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.338 1.066 . . . . 0.0 112.344 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.607 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 69.1 m -101.86 177.3 4.94 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.811 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.66 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 95.5 m-85 -138.56 149.62 45.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.57 141.67 7.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.807 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.82 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 102.02 11.83 35.95 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.704 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 89' ' ' ASP . 16.8 mt -55.8 -46.73 77.94 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.343 0.572 . . . . 0.0 109.723 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 t30 49.46 45.61 23.81 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.022 0.915 . . . . 0.0 110.244 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 20.7 mt -108.6 115.82 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.015 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 38.8 p -111.2 132.64 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.283 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.5 m -101.76 147.97 25.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.28 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 69.9 mt -80.41 157.13 26.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.782 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.637 HE22 HG22 ' A' ' 75' ' ' THR . 19.0 tp60 -48.27 -54.41 13.78 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.488 0.493 . . . . 0.0 112.16 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.448 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -77.54 3.06 14.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -170.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.602 ' HB3' ' N ' ' A' ' 129' ' ' GLY . 37.2 mt-30 -78.86 58.16 2.29 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.014 0.435 . . . . 0.0 110.516 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.83 103.96 0.65 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.454 ' HA ' ' CG ' ' A' ' 132' ' ' HIS . 3.3 t-80 79.39 -29.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.845 0.858 . . . . 0.0 111.397 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.588 ' HA ' HE21 ' A' ' 133' ' ' GLN . 14.7 t70 -80.38 -30.43 37.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.543 0.211 . . . . 0.0 111.307 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.602 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -55.79 129.48 47.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.627 -0.796 . . . . 0.0 111.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.5 m -50.87 -33.21 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.51 HG12 ' CB ' ' A' ' 88' ' ' LEU . 33.1 m -63.35 -47.16 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.796 0.331 . . . . 0.0 110.594 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.65 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.8 t-160 -63.5 -39.43 94.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.966 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.588 HE21 ' HA ' ' A' ' 128' ' ' ASP . 27.1 mm-40 -59.85 -64.7 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.4 t -53.89 -46.51 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.348 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.849 HG23 ' HZ ' ' A' ' 66' ' ' PHE . 11.0 p -65.86 -45.97 89.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.259 -175.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.414 ' HD1' HG13 ' A' ' 135' ' ' VAL . 12.5 m-85 -72.24 -27.5 62.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.818 0.342 . . . . 0.0 110.796 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.35 -53.29 33.44 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 146' ' ' LEU . 0.2 OUTLIER -49.63 -49.59 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.1 0.56 . . . . 0.0 111.095 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 1.009 ' HG2' HG13 ' A' ' 56' ' ' ILE . 83.4 mtp -57.67 -30.75 65.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.034 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -91.3 -0.67 57.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.401 ' HA2' ' CZ3' ' A' ' 22' ' ' TRP . . . 84.26 9.47 81.95 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.698 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -98.82 103.96 15.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.565 0.698 . . . . 0.0 110.79 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.461 ' CB ' ' HB3' ' A' ' 19' ' ' LEU . 2.8 p -89.48 2.42 54.58 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.069 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.542 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -62.78 -31.21 79.47 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.735 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.59 -33.29 64.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.557 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.4 OUTLIER -67.76 -33.6 75.17 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.612 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.921 ' HG2' HG21 ' A' ' 161' ' ' VAL . 46.1 mt-10 -52.91 -44.72 67.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -33.17 73.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.952 -175.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.57 64.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.32 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.2 mt -55.49 -45.37 77.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.831 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -58.64 -8.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.968 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.08 -41.68 26.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.035 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' A' ' 117' ' ' LEU . 3.8 mp -86.51 -49.03 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.787 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.942 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -53.08 -40.93 64.42 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.67 -27.17 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.39 -34.22 77.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.227 0.537 . . . . 0.0 109.845 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.464 ' HE2' HG22 ' A' ' 153' ' ' ILE . 41.6 m-85 -95.63 -13.58 24.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.284 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 94.75 27.94 10.8 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.602 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.427 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -109.15 -166.98 1.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.135 0.468 . . . . 0.0 110.952 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.6 p -163.52 171.91 15.17 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.38 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.921 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.5 p -52.55 -36.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -88.82 40.22 0.96 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -88.9 -105.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.744 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 168' ' ' VAL . 15.6 m -163.05 146.91 11.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.719 ' CD1' HD13 ' A' ' 15' ' ' ILE . 6.1 m-30 -52.96 -42.35 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.353 0.524 . . . . 0.0 111.111 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.63 -52.22 33.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.853 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -59.74 -46.3 89.57 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -176.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.942 HG13 HD11 ' A' ' 154' ' ' LEU . 89.6 t -60.52 -56.67 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.491 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.606 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -54.36 -44.65 72.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 123.447 0.467 . . . . 0.0 110.993 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -62.64 -40.87 98.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.49 -29.91 61.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.208 0.528 . . . . 0.0 110.57 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 38.3 p -85.74 -14.15 46.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.865 0.84 . . . . 0.0 109.624 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.574 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.653 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.796 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 t80 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.485 0.183 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -172.22 167.51 5.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.62 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.66 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -90.35 125.54 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.579 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 27.0 m-80 -101.82 48.84 0.87 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.729 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 1.0 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.0 p90 -70.5 150.04 46.56 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.735 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.8 t70 -62.06 105.35 0.57 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.646 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 4.4 p -37.52 74.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 125.082 1.489 . . . . 0.0 113.894 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.1 t -174.2 -25.62 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.341 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.494 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 96.0 m-85 -92.39 15.5 13.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.08 68.12 1.38 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.322 -173.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.45 22.85 0.16 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.562 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 45.3 m-85 -114.31 131.26 56.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.017 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 163' ' ' SER . 11.4 p -68.13 132.44 47.21 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 161.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 165' ' ' PHE . 4.8 mm -46.56 -48.76 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -167.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -60.14 -30.37 69.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.648 0.261 . . . . 0.0 111.007 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.28 -49.17 58.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.371 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.462 ' HB2' ' CG ' ' A' ' 13' ' ' TYR . 72.0 t80 -70.72 -45.34 65.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.608 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.784 HD22 ' CE2' ' A' ' 93' ' ' PHE . 12.0 mt -56.92 -44.4 82.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.18 94.81 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.975 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 24' ' ' SER . 3.7 tt0 -64.87 -43.34 93.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 122.89 0.476 . . . . 0.0 111.463 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -62.43 -42.21 99.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.919 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.14 67.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.791 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 25.1 t -62.23 -54.14 45.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -35.64 81.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.056 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.605 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 20.0 t80 -56.07 -39.43 72.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.346 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.89 -29.51 73.68 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.463 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 11.9 t70 -76.12 100.88 5.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.705 -176.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.716 HG12 ' HB1' ' A' ' 60' ' ' ALA . 35.4 m . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.04 -7.49 76.54 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 114.446 0.538 . . . . 0.0 114.446 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -116.38 3.57 13.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.849 0.825 . . . . 0.0 111.684 -175.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.537 HG22 ' HA3' ' A' ' 96' ' ' GLY . 45.6 t -101.83 116.39 45.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 p -103.08 -76.11 0.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.295 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.89 -68.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.902 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.41 83.86 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.527 0.68 . . . . 0.0 111.972 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -83.88 137.86 33.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.956 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -74.62 -37.74 62.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.49 134.74 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.348 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.55 59.19 0.11 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.901 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 57.8 m-85 62.1 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.941 0.877 . . . . 0.0 113.326 -175.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 50.5 t80 -91.75 -13.24 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.768 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.83 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.58 -28.02 44.98 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.382 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.45 -118.6 0.75 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.899 -1.143 . . . . 0.0 113.084 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -76.62 -50.13 14.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 0.0 110.281 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -167.35 43.29 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.765 0.793 . . . . 0.0 109.782 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.642 ' HB3' ' HD1' ' A' ' 74' ' ' TYR . 20.9 p -154.03 -176.28 5.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.228 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.83 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 128.1 -172.43 19.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 t -92.95 -14.22 27.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.828 0.314 . . . . 0.0 111.265 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 14.9 tt0 -134.0 151.84 51.6 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.323 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.777 ' CD1' HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -149.19 94.76 2.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.879 -173.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -94.82 153.16 17.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.861 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.042 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.0 mm -146.43 140.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 t -131.92 97.36 4.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.542 0.211 . . . . 0.0 110.517 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.605 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 33.1 t 18.48 115.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -19.5 65.89 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.425 -0.797 . . . . 0.0 110.472 171.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.716 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.02 -61.48 1.95 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.062 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 35.0 p30 -114.75 3.35 14.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.119 0.485 . . . . 0.0 111.59 -172.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 57' ' ' SER . 2.3 mm-40 39.79 38.26 0.43 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 64' ' ' THR . 9.1 p -129.37 -55.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.714 168.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 63' ' ' VAL . 4.5 m -58.0 101.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.243 0.544 . . . . 0.0 110.206 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -110.28 173.19 6.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -165.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.77 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -160.67 118.07 2.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.73 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 79.2 t -103.53 107.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.627 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.77 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -91.12 157.14 17.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.91 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.11 135.62 4.95 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.201 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.34 -128.82 1.08 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.94 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 1.6 t-20 -146.34 72.89 1.3 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 0.0 109.383 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 54' ' ' TYR . 6.5 mt -92.14 166.93 12.39 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 122.377 1.084 . . . . 0.0 113.629 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.6 m -164.52 134.05 3.79 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 112.416 -2.175 . . . . 0.0 106.76 171.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.958 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 1.8 p90 -95.47 144.76 25.7 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.681 HG22 HE22 ' A' ' 123' ' ' GLN . 77.6 p -72.11 -68.4 0.47 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.958 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 13.4 tp 57.4 -87.55 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.018 0.927 . . . . 0.0 111.295 -169.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 21.8 m-85 -91.76 0.04 57.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.194 0.521 . . . . 0.0 110.897 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.524 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-80 -77.05 166.67 22.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.443 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.769 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 47.4 mm-40 -46.42 -61.54 2.56 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -168.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 77.2 Cg_exo -55.43 -40.42 85.61 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.935 1.756 . . . . 0.0 113.759 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 70.83 134.86 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.398 0.618 . . . . 0.0 112.483 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.4 m80 47.67 54.33 9.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.84 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.683 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -151.03 162.58 40.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.768 -171.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.0 tp -108.83 156.02 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.974 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -158.21 -161.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.8 -159.04 22.81 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.26 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.3 tm0? -97.94 169.95 9.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.543 0.687 . . . . 0.0 112.742 -170.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.566 ' CD2' HG21 ' A' ' 134' ' ' VAL . 27.3 tp -155.34 135.51 13.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.53 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -134.94 -50.26 0.76 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.958 0.408 . . . . 0.0 111.28 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.508 ' O ' HD13 ' A' ' 91' ' ' LEU . 5.7 p -130.2 157.12 43.34 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -171.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.739 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.4 mm? -138.02 160.55 39.05 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 9.1 m -147.93 108.82 4.22 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 117.824 0.284 . . . . 0.0 110.951 176.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.784 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.6 m-30 -91.56 147.87 22.69 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.649 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.5 -152.33 11.35 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.732 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.57 126.97 30.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 110.742 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . 76.2 110.09 0.12 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.836 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.0 mt -83.96 141.4 31.26 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.38 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -99.08 154.42 18.13 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.535 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.048 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.202 -166.636 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo . . . . . 0 C--O 1.233 0.27 0 CA-C-O 121.279 0.45 . . . . 0.0 113.035 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -66.03 155.03 37.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.579 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 p -142.38 155.64 45.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.347 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 107' ' ' ILE . 1.1 mp -89.1 122.76 40.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.414 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.98 -39.71 94.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.185 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.0 88.16 9.75 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.487 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.16 96.55 0.27 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.268 2.645 . . . . 0.0 112.838 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 33.1 m-20 -94.66 -154.47 0.42 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.264 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.0 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 46.6 t -58.31 138.5 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.707 0.765 . . . . 0.0 111.931 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.579 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 75.6 m -129.11 178.8 6.15 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.391 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.535 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 95.9 m-85 -138.82 146.79 41.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -160.58 142.06 7.86 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.921 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.796 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.22 11.15 40.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.411 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.442 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 26.3 mt -57.08 -50.5 72.59 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.0 t30 55.43 43.35 28.85 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.695 0.76 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.8 mt -106.11 112.56 25.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.381 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 34.5 p -107.04 130.84 54.6 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.815 0.341 . . . . 0.0 110.523 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.498 ' HB2' HG22 ' A' ' 131' ' ' VAL . 26.0 m -108.28 145.8 33.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.827 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -80.96 165.14 22.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.503 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.681 HE22 HG22 ' A' ' 75' ' ' THR . 17.8 tp60 -52.93 -61.1 2.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.583 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.487 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -79.66 14.61 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -168.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.462 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 34.8 mt-30 -77.15 -25.9 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.289 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 56.38 -118.1 10.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.221 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.476 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 4.7 t-80 -80.24 -22.76 41.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.537 0.335 . . . . 0.0 110.765 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.643 ' HA ' HE21 ' A' ' 133' ' ' GLN . 15.1 t70 -84.82 -19.63 32.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.462 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -59.45 126.59 42.63 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 174.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.651 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 18.2 m -52.69 -32.62 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.76 ' O ' HG23 ' A' ' 135' ' ' VAL . 18.1 m -63.63 -49.67 81.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.157 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.683 ' HE1' HG22 ' A' ' 83' ' ' THR . 4.8 t-160 -57.02 -41.25 78.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.035 0.445 . . . . 0.0 110.008 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.651 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 6.1 mm-40 -56.73 -63.97 1.03 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.31 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 88' ' ' LEU . 16.1 m -56.63 -39.21 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.469 -172.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 131' ' ' VAL . 2.2 t -66.1 -57.81 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 CA-C-O 121.455 0.645 . . . . 0.0 110.061 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.34 -18.21 64.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.34 -56.23 7.04 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 167.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.623 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.92 -52.61 31.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.111 0.564 . . . . 0.0 111.226 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 1.042 ' HG2' HG13 ' A' ' 56' ' ' ILE . 50.7 mtp -55.82 -26.74 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.111 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.1 m -99.45 -6.53 27.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.752 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.36 32.14 20.45 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.244 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -121.11 130.59 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.647 HG21 ' HB3' ' A' ' 19' ' ' LEU . 53.9 p -108.15 2.03 22.62 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.78 -39.44 61.72 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 123.523 0.514 . . . . 0.0 114.04 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.76 -26.92 29.26 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.411 -0.464 . . . . 0.0 110.824 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -68.92 -51.02 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.717 ' HB3' HG21 ' A' ' 161' ' ' VAL . 5.0 pt-20 -58.0 -33.51 69.01 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.283 0.563 . . . . 0.0 110.181 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 28.0 m -67.67 -47.95 68.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.848 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.01 99.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.219 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 99.1 mt -55.58 -43.15 75.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.398 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -57.08 -9.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.331 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -75.39 -40.16 33.96 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.299 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.482 HG22 ' HE2' ' A' ' 157' ' ' TYR . 3.9 mp -86.47 -48.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.029 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.613 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -53.31 -41.51 65.73 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.66 -23.85 63.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.95 -28.97 62.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.1 m-85 -101.8 -7.37 22.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.105 0.479 . . . . 0.0 110.14 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.13 29.77 12.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.352 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 1.9 mm? -111.19 -165.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.34 0.57 . . . . 0.0 110.513 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 p -163.1 -178.91 6.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.069 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 147' ' ' GLU . 9.7 p -57.5 -23.3 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 111.375 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.79 14.45 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.707 0.289 . . . . 0.0 111.716 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.661 ' HB3' HG22 ' A' ' 168' ' ' VAL . 12.8 t -88.96 143.68 26.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 168' ' ' VAL . 38.3 m -69.2 141.26 54.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.669 ' CD1' HD13 ' A' ' 15' ' ' ILE . 5.2 m-30 -38.24 -53.01 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.71 0.804 . . . . 0.0 112.739 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.53 -48.42 79.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.708 0.29 . . . . 0.0 110.224 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 1.7 mp0 -69.04 -5.33 21.23 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 163' ' ' SER . 34.0 t -96.31 -54.05 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.249 0.547 . . . . 0.0 109.819 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -58.0 -46.61 84.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.622 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.05 72.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.707 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 167' ' ' GLN . . . -70.32 -35.83 73.88 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.533 0.682 . . . . 0.0 110.581 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.517 HG21 ' CD2' ' A' ' 2' ' ' PHE . 16.5 p -82.56 -18.97 39.51 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.993 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.675 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.939 175.835 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.773 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 31.7 t80 . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.177 0.513 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -174.1 160.02 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.761 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.669 HG11 HD12 ' A' ' 15' ' ' ILE . 10.5 m -91.68 111.7 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.43 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 51.7 m-20 -94.62 50.18 1.31 Allowed 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.186 -167.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 1.101 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.6 p90 -67.58 149.03 50.63 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.547 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.3 t70 -62.16 100.06 0.16 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.515 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 8.4 m -30.14 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.827 1.651 . . . . 0.0 114.397 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.6 t -172.21 -31.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.098 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.573 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 81.9 m-85 -88.97 15.67 8.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.0 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.6 71.75 1.05 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.518 -172.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.45 5.73 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.515 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 32.2 m-85 -95.17 140.76 29.63 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.78 -0.21 . . . . 0.0 110.762 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -70.22 129.54 39.63 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 160.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.669 HD12 HG11 ' A' ' 4' ' ' VAL . 3.4 mm -44.89 -48.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -172.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 40.1 t-80 -57.13 -32.61 66.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.145 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.31 -51.52 23.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.24 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.443 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 57.6 t80 -68.13 -41.28 81.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.961 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.854 ' HB3' HG21 ' A' ' 143' ' ' THR . 17.0 mt -55.52 -41.13 72.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.874 0.369 . . . . 0.0 110.457 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.54 97.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.062 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -62.81 -40.53 97.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.757 0.423 . . . . 0.0 111.945 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -61.46 -43.64 98.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.59 -33.05 74.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.839 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.0 t -60.05 -51.77 68.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -68.25 -31.14 70.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.615 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 10.7 t80 -61.05 -52.78 63.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.231 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.41 -26.34 74.33 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.267 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -73.09 108.84 6.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 110.942 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.619 HG12 ' HB1' ' A' ' 60' ' ' ALA . 35.6 m . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.062 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.46 56.0 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.979 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.8 1.5 37.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.571 0.7 . . . . 0.0 109.84 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.456 HG21 ' CG2' ' A' ' 63' ' ' VAL . 32.3 t -95.63 114.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.925 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 -71.5 0.66 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.725 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.86 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.518 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 66.89 74.29 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.021 0.915 . . . . 0.0 111.0 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.34 136.06 33.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.007 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.473 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 70.4 m -73.02 -38.0 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.283 -172.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 109.51 -135.87 13.17 Favored Glycine 0 C--N 1.317 -0.475 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.892 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.34 70.38 1.32 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.763 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.545 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 64.1 m-85 56.87 -171.36 0.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.494 0.317 . . . . 0.0 111.765 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 44' ' ' PHE . 29.3 t80 -178.4 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.329 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -80.76 7.95 57.24 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.853 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.06 -98.74 0.13 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.1 m -152.18 -63.15 0.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 1.9 mp -77.27 -44.07 31.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.557 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.575 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 17.7 p -140.33 170.12 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 158.57 45.0 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.212 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.1 m 68.33 -54.04 0.53 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.464 ' HG2' ' N ' ' A' ' 54' ' ' TYR . 7.7 tt0 -93.74 149.62 21.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.545 ' HD1' ' H ' ' A' ' 44' ' ' PHE . 2.3 t80 -147.96 103.36 3.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 146.6 23.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.366 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.1 HG13 ' HG2' ' A' ' 139' ' ' MET . 9.1 mm -146.52 122.06 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 92.5 p -106.23 158.77 16.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.378 174.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 42.0 t -51.46 139.39 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.292 0.568 . . . . 0.0 111.968 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -85.45 -19.44 31.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.425 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.619 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.04 -60.52 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -111.73 1.32 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.824 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 58' ' ' SER . 2.9 mm-40 40.12 37.42 0.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.477 -1.238 . . . . 0.0 114.214 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.456 ' CG2' HG21 ' A' ' 36' ' ' VAL . 14.8 p -126.6 -51.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.921 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 23.2 m -62.65 103.55 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.525 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -112.46 179.59 3.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.687 0.756 . . . . 0.0 112.924 -169.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.741 ' HE1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -156.99 131.81 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.811 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 61.6 t -120.62 114.96 45.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.166 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.55 148.04 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.6 104.79 0.26 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.018 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.48 -92.29 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.194 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -147.92 30.14 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.482 0.641 . . . . 0.0 110.906 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 77.9 mt -59.24 143.73 48.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.34 0.591 . . . . 0.0 111.774 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 99.2 m -148.61 129.99 14.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.67 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.575 ' H ' ' HB3' ' A' ' 50' ' ' SER . 48.1 t80 -86.07 122.76 30.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 48.2 p -64.87 -41.29 95.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.623 -171.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.5 tp 51.08 -88.02 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.755 0.822 . . . . 0.0 111.978 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -95.08 -3.04 48.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.557 0.535 . . . . 0.0 111.711 -175.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.663 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 94.5 m-20 -75.51 -179.4 4.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.72 0.295 . . . . 0.0 111.623 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.912 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 32.7 mm-40 -45.83 -67.79 0.35 Allowed Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.912 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.9 Cg_exo -56.88 -36.6 99.01 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.415 1.41 . . . . 0.0 112.441 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 68.67 123.53 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.578 0.751 . . . . 0.0 112.247 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 60.35 59.99 2.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.992 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.809 HG21 ' HA2' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -143.88 166.34 25.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.074 -171.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.829 HD23 HG11 ' A' ' 135' ' ' VAL . 13.6 tp -119.23 144.18 46.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 7.9 p90 -158.15 -157.92 0.68 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 71' ' ' ASN . . . 95.04 -163.93 24.63 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.606 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.638 ' HG3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -103.43 172.96 6.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.714 HD23 ' H ' ' A' ' 89' ' ' ASP . 1.5 pt? -139.62 -41.43 0.45 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.974 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.714 ' H ' HD23 ' A' ' 88' ' ' LEU . 37.2 t70 61.28 -58.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.685 1.194 . . . . 0.0 113.654 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 114' ' ' PHE . 8.0 m -136.29 135.26 38.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.902 0.858 . . . . 0.0 112.36 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.741 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.5 mm? -102.63 166.44 10.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.997 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 22.4 m -151.64 111.54 4.05 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 122.315 -0.241 . . . . 0.0 110.863 174.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.839 ' HE2' HD22 ' A' ' 19' ' ' LEU . 4.8 m-30 -97.62 141.56 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.28 164.71 31.83 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.015 172.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -87.08 120.83 28.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.159 0.504 . . . . 0.0 111.221 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.13 113.24 0.43 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.593 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.3 mt -89.03 153.89 20.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.582 . . . . 0.0 110.549 172.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -131.67 167.9 18.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.274 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.095 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo . . . . . 0 N--CA 1.465 -0.191 0 CA-C-O 121.155 0.398 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 52.5 m-85 -71.93 151.37 43.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.579 -174.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -146.59 152.58 39.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.868 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.696 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.3 mp -83.53 122.07 37.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.517 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.93 -48.45 74.07 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 21.5 t -112.51 87.55 9.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.404 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 24.5 Cg_endo -61.71 107.11 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.12 2.546 . . . . 0.0 112.639 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 12.1 m-20 -96.33 -148.73 0.31 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.293 174.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.101 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -61.22 143.54 14.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.632 0.73 . . . . 0.0 111.459 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.43 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 74.4 m -135.24 179.54 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.746 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.591 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.3 m-85 -139.04 146.04 40.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.36 141.71 7.62 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.632 -1.27 . . . . 0.0 112.396 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.773 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.22 11.59 41.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.761 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.535 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 14.6 mt -55.22 -49.21 72.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.3 t30 57.24 36.27 27.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.986 0.898 . . . . 0.0 109.588 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.553 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 19.2 mt -102.98 124.27 48.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.267 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.638 ' HB3' ' HG3' ' A' ' 87' ' ' GLN . 22.6 p -131.13 138.52 49.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.058 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 131' ' ' VAL . 91.2 p -114.6 135.09 54.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 110.139 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 122' ' ' LEU . 8.4 mp -60.69 161.86 7.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.159 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.623 HE22 HG22 ' A' ' 75' ' ' THR . 13.7 tp60 -51.55 -56.32 14.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.41 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.06 17.25 4.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 121' ' ' SER . 21.5 mt-30 -77.13 -37.06 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.533 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.809 ' HA2' HG21 ' A' ' 83' ' ' THR . . . 77.88 -124.4 6.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.337 174.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -78.91 -14.88 58.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.617 ' HA ' HE21 ' A' ' 133' ' ' GLN . 38.9 t70 -85.84 -16.11 39.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.872 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.56 125.2 30.74 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.216 -0.992 . . . . 0.0 110.641 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.579 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 23.9 m -52.8 -35.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.635 HG22 ' OG ' ' A' ' 121' ' ' SER . 25.5 m -65.18 -41.24 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.462 0.574 . . . . 0.0 110.48 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.504 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.2 t-160 -60.69 -38.38 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.545 0.688 . . . . 0.0 109.448 175.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.617 HE21 ' HA ' ' A' ' 128' ' ' ASP . 2.8 mt-30 -67.26 -60.62 2.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.868 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 130' ' ' VAL . 18.9 m -60.28 -37.92 75.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.807 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.829 HG11 HD23 ' A' ' 84' ' ' LEU . 8.9 p -68.3 -46.3 81.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.83 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.61 -30.28 66.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 110.198 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.31 -54.98 32.76 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.658 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -50.25 -47.76 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.016 0.527 . . . . 0.0 111.013 176.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 1.1 ' HG2' HG13 ' A' ' 56' ' ' ILE . 53.0 mtp -56.09 -33.59 65.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.822 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.9 m -91.55 -13.52 31.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.413 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.51 10.26 53.81 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.93 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.67 120.74 30.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.11 0.481 . . . . 0.0 110.969 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.854 HG21 ' HB3' ' A' ' 19' ' ' LEU . 17.3 p -108.5 9.15 27.55 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.606 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.12 -27.44 68.4 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.955 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.26 -30.31 23.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.991 0.424 . . . . 0.0 110.053 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -64.78 -47.91 76.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.035 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.575 ' HB2' HG21 ' A' ' 161' ' ' VAL . 1.5 pt-20 -55.15 -34.04 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.054 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.479 ' N ' ' HG3' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -75.1 -36.76 61.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.059 0.457 . . . . 0.0 109.8 -175.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.79 -47.15 69.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.527 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 98.3 mt -55.26 -43.49 74.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.048 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -55.29 -13.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.315 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.13 -37.65 55.38 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.39 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.2 mp -85.31 -46.26 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.744 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.74 -44.2 81.44 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.98 -24.73 67.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.99 -38.09 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.511 . . . . 0.0 110.219 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.532 ' HE2' HG22 ' A' ' 153' ' ' ILE . 13.7 m-85 -97.18 -7.71 31.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.91 16.63 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.379 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.548 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 1.9 mm? -110.85 -174.25 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.258 0.529 . . . . 0.0 110.335 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.5 p -165.39 -176.2 3.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.381 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 147' ' ' GLU . 2.5 m -61.1 -13.15 6.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -88.75 4.49 47.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.565 ' HB2' HG22 ' A' ' 168' ' ' VAL . 19.5 m -92.28 152.44 19.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.858 176.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.5 m -70.72 142.77 51.45 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.573 ' HD2' ' O ' ' A' ' 10' ' ' PHE . 4.1 m-30 -37.72 -64.38 0.4 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.386 0.674 . . . . 0.0 112.58 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.17 -40.85 82.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.112 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.57 -42.3 87.26 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.827 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.744 HG13 HD11 ' A' ' 154' ' ' LEU . 92.7 t -65.02 -52.02 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.33 78.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.727 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.34 83.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.611 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.63 -33.56 74.22 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.363 0.601 . . . . 0.0 110.864 -173.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.542 HG21 ' CD2' ' A' ' 2' ' ' PHE . 12.2 p -83.01 -25.2 32.43 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.009 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.312 179.898 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.835 ' O ' ' HB ' ' A' ' 172' ' ' THR . 38.7 t80 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.464 0.173 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.0 m -161.51 163.35 30.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.394 0.678 . . . . 0.0 109.335 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.582 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.3 128.16 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.5 m-80 -105.35 49.57 0.8 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.625 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 1.075 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 25.5 p90 -73.18 152.84 40.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.547 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.2 t70 -62.15 100.71 0.18 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.497 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 22.3 t -35.46 75.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.665 1.586 . . . . 0.0 113.722 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.2 t -172.96 -30.64 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.859 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.466 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 53.7 m-85 -91.21 22.06 4.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.793 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.8 66.98 0.82 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.209 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -165.13 2.16 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.629 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 38.6 m-85 -83.23 141.8 31.62 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.5 m -71.44 138.08 48.77 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 159.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.757 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -47.01 -48.14 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 119.098 0.863 . . . . 0.0 110.842 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.492 ' HB2' HG13 ' A' ' 161' ' ' VAL . 44.4 t-80 -55.23 -32.23 62.13 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.74 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -65.46 -55.79 16.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.946 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 112' ' ' VAL . 83.2 t80 -66.59 -43.51 84.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.359 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.846 HD22 ' HE2' ' A' ' 93' ' ' PHE . 8.8 mt -55.88 -46.81 78.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.719 0.295 . . . . 0.0 110.573 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.52 -43.37 98.91 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.829 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.25 -43.01 99.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.578 0.351 . . . . 0.0 111.877 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.466 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 54.0 t90 -60.44 -43.55 96.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.04 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.85 71.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.481 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -62.4 -49.08 76.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 -28.18 67.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.59 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.403 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 38.6 t80 -62.25 -50.05 73.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.236 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -19.87 75.14 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.378 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.04 96.39 1.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.537 0.684 . . . . 0.0 110.906 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.851 HG12 ' HB1' ' A' ' 60' ' ' ALA . 16.8 m . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.489 ' HB3' HG23 ' A' ' 36' ' ' VAL . 36.2 t-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.835 0.35 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 3.73 20.21 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.273 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -106.11 -0.62 24.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.496 . . . . 0.0 109.887 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.489 HG23 ' HB3' ' A' ' 33' ' ' ASN . 19.9 t -89.93 122.88 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.973 -177.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -92.37 -81.09 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.327 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -75.23 -62.1 1.67 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.755 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.437 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . . . 66.78 80.63 0.21 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.622 -172.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -78.7 134.19 37.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.497 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.4 m -79.84 -31.77 40.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.146 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.65 -172.43 44.75 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.413 ' CA ' ' HE2' ' A' ' 105' ' ' TYR . . . -148.15 -83.36 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.858 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.62 60.97 2.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.744 0.783 . . . . 0.0 109.073 -158.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -84.22 71.72 10.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.617 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.635 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -157.97 -36.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.945 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.35 -125.14 0.97 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.253 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -73.51 -38.95 65.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.576 0.227 . . . . 0.0 111.524 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -168.73 28.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.375 0.607 . . . . 0.0 110.623 -175.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -154.04 175.97 12.78 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.549 -176.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.635 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 149.83 -164.78 29.6 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.284 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -91.64 -18.54 23.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.661 0.267 . . . . 0.0 111.212 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 40.8 tt0 -135.9 147.63 48.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 111.216 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.12 108.51 3.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.114 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.83 155.39 17.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.466 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.106 HG13 ' HG2' ' A' ' 139' ' ' MET . 8.6 mm -148.8 137.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.887 0.742 . . . . 0.0 109.166 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 20.7 t -129.76 150.93 50.86 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.744 0.307 . . . . 0.0 110.38 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 30.0 t -50.55 122.37 7.04 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.733 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 p -83.04 40.77 0.72 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.673 0.749 . . . . 0.0 110.179 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.851 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -146.52 -45.08 0.19 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.599 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -122.65 -1.83 8.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.18 0.514 . . . . 0.0 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.5 mt-30 31.59 41.42 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.437 HG23 HG21 ' A' ' 36' ' ' VAL . 14.5 p -127.91 -43.94 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.032 170.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 13.6 m -67.2 96.11 0.45 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -111.12 -179.9 3.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 112.346 -171.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.826 ' HE1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -157.7 131.31 7.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.245 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.637 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 35.2 t -110.17 118.63 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . . . -94.12 149.9 20.82 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.27 123.02 1.49 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -179.59 -109.17 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -149.27 41.12 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.0 mt -58.54 131.53 51.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.906 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.0 m -136.98 132.14 33.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.344 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB3' HD13 ' A' ' 49' ' ' LEU . 37.2 t80 -90.16 127.38 36.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.1 p -63.03 -37.27 86.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.051 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.485 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 9.9 tp 49.64 -93.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.696 0.798 . . . . 0.0 112.161 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.485 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 5.4 m-85 -99.09 8.66 44.71 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.165 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -80.27 178.87 7.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.823 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.641 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 12.1 mm-40 -52.55 -54.91 37.41 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 52.1 Cg_exo -55.36 -37.65 94.48 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.671 1.581 . . . . 0.0 112.445 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.46 116.81 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.767 0.794 . . . . 0.0 112.878 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 54.01 58.06 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.741 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.21 162.56 39.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.005 -178.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.791 HD23 HG11 ' A' ' 135' ' ' VAL . 12.5 tp -101.73 151.37 22.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.464 0.174 . . . . 0.0 110.741 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -155.82 -152.02 0.37 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.58 -167.5 24.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.99 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 6.3 tm0? -99.97 164.7 11.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.389 0.614 . . . . 0.0 111.608 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.519 ' HB2' HG22 ' A' ' 131' ' ' VAL . 22.3 tp -155.41 135.14 12.68 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.675 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -133.96 -53.48 0.86 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.188 0.518 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 115' ' ' GLY . 2.3 p -108.43 153.69 22.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.944 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.826 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.9 mm? -137.77 169.84 17.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.637 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 20.6 t -163.52 111.99 1.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.636 -175.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.846 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.4 m-30 -103.92 131.88 50.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.19 169.15 41.65 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.934 -1.126 . . . . 0.0 112.224 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -89.78 115.05 26.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.205 0.526 . . . . 0.0 111.374 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.54 112.14 0.64 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.625 170.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 67' ' ' VAL . 13.1 mt -89.39 160.26 16.91 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.474 0.654 . . . . 0.0 110.476 170.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 t -131.57 166.93 20.3 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.992 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.263 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.19 -174.61 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 CA--C 1.532 0.422 0 N-CA-C 114.275 0.836 . . . . 0.0 114.275 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.413 ' HE2' ' CA ' ' A' ' 43' ' ' GLY . 27.0 m-85 -68.22 164.15 21.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.435 -173.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 p -149.45 154.22 38.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.865 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.829 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -83.84 126.51 40.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -177.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 46.3 mt-30 -65.85 -50.95 62.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.129 175.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.416 HG21 HD21 ' A' ' 33' ' ' ASN . 23.9 t -112.62 85.6 7.58 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.46 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.71 106.28 1.44 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.637 2.892 . . . . 0.0 113.034 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.522 ' OD1' HG23 ' A' ' 112' ' ' VAL . 4.2 t70 -100.45 -140.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.075 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 38.8 t -62.01 143.62 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.691 0.757 . . . . 0.0 111.572 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.567 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 53.2 m -143.94 179.09 7.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.411 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.631 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.2 m-85 -137.57 150.24 47.32 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.058 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -162.31 131.89 2.65 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.353 175.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.753 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 106.6 16.03 15.43 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.794 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.509 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 11.8 mt -56.72 -44.18 81.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 51.63 50.58 18.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.63 0.728 . . . . 0.0 110.428 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 27.1 mt -109.15 118.87 37.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.894 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 13.1 p -116.64 133.08 56.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.313 . . . . 0.0 110.479 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 53.1 p -103.76 154.22 19.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 64.5 mt -82.06 165.94 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.575 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -58.84 -57.13 14.38 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -75.73 5.19 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 122' ' ' LEU . 31.3 mt-30 -80.03 57.24 2.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.74 102.32 0.49 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.847 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 132' ' ' HIS . 2.8 t-80 81.13 -30.53 0.11 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.97 0.908 . . . . 0.0 111.553 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.535 ' HA ' HE21 ' A' ' 133' ' ' GLN . 8.6 t70 -81.23 -27.68 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.082 0.239 . . . . 0.0 111.357 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -56.09 128.14 44.94 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.613 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 28.0 m -56.48 -25.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -68.17 -48.53 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.685 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.4 t-160 -61.6 -38.75 88.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.819 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.613 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 21.1 mm-40 -56.21 -67.65 0.28 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.157 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 130' ' ' VAL . 17.7 m -58.05 -40.17 75.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.191 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.791 HG11 HD23 ' A' ' 84' ' ' LEU . 11.4 p -68.56 -47.37 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 121.289 -0.165 . . . . 0.0 111.083 -176.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.416 ' HD1' HG13 ' A' ' 135' ' ' VAL . 9.2 m-85 -72.26 -23.07 61.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.85 -55.59 23.71 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.657 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -48.29 -52.72 20.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.29 0.567 . . . . 0.0 110.747 176.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 1.106 ' HG2' HG13 ' A' ' 56' ' ' ILE . 51.9 mtp -54.53 -35.57 63.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.297 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.2 m -91.63 -1.99 57.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.829 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.56 44.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.92 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -109.73 134.33 52.12 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.46 0.304 . . . . 0.0 110.286 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 19' ' ' LEU . 43.8 p -112.4 -11.29 13.68 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.404 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.14 -38.68 56.72 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.523 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.37 -38.0 68.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.693 -0.298 . . . . 0.0 111.021 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 45.2 tp -67.64 -38.63 84.12 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.858 ' HG2' HG21 ' A' ' 161' ' ' VAL . 67.6 mt-10 -55.93 -38.16 69.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.68 -34.71 58.21 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.12 0.486 . . . . 0.0 109.91 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.06 85.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.939 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.3 mt -55.92 -45.97 78.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.445 174.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -53.94 -16.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.76 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.34 46.51 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.11 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.608 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.8 mp -81.09 -47.01 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.83 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.99 -37.84 69.64 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.319 . . . . 0.0 111.498 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.71 -30.37 69.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.332 0.587 . . . . 0.0 110.014 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.481 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.0 m-85 -103.39 -9.74 19.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.1 20.55 25.41 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.824 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -105.51 -166.8 1.25 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.475 0.638 . . . . 0.0 110.915 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.8 m -159.74 179.28 8.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.858 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.0 p -56.61 -25.6 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.313 0.578 . . . . 0.0 110.965 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -89.64 33.65 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.124 -0.36 . . . . 0.0 111.637 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.633 ' HB3' HG22 ' A' ' 168' ' ' VAL . 18.7 t -101.93 150.62 23.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.9 m -72.8 133.55 44.54 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 119.003 -0.522 . . . . 0.0 111.649 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.685 ' CD1' HD13 ' A' ' 15' ' ' ILE . 3.4 m-30 -38.89 -53.97 1.67 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.23 -46.2 86.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.483 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -70.99 -35.85 72.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.739 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 154' ' ' LEU . 37.1 t -62.4 -52.93 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -55.31 -46.78 76.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.022 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -64.78 -33.56 76.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.524 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.49 -32.63 62.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.227 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.835 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 31.0 p -85.15 -12.9 51.73 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.092 0.948 . . . . 0.0 109.611 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.831 172.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.895 0.379 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.865 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.6 t80 -80.49 158.85 25.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.174 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 p -173.9 165.3 4.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.307 0.575 . . . . 0.0 110.945 174.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.645 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.97 125.69 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-N 115.311 -0.858 . . . . 0.0 108.779 171.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.591 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 30.9 m-80 -101.75 49.4 0.86 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.746 0.784 . . . . 0.0 110.402 -176.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.982 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 26.1 p90 -74.42 148.48 41.1 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.589 175.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.7 t70 -63.27 106.62 0.91 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 170.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.715 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 10.2 t -39.25 80.48 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.841 1.338 . . . . 0.0 112.502 178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 7' ' ' ASP . 13.5 t -173.7 -29.17 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 113.405 -1.725 . . . . 0.0 107.967 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.526 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 85.5 m-85 -94.23 15.16 18.04 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.071 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.18 68.62 1.38 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.679 -171.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -168.26 8.61 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 164' ' ' THR . 22.1 m-85 -92.57 146.88 23.33 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 122.163 0.185 . . . . 0.0 110.968 175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 m -71.11 132.62 45.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.755 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -46.15 -53.31 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 118.569 0.622 . . . . 0.0 111.377 -174.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.498 ' HB2' HG22 ' A' ' 161' ' ' VAL . 23.0 t-80 -61.07 -24.57 66.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.582 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.15 -44.82 28.91 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -71.12 -41.97 69.85 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.354 178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.93 ' HB3' HG21 ' A' ' 143' ' ' THR . 14.3 mt -56.33 -39.78 73.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.304 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.0 -42.18 96.78 Favored Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.113 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 24' ' ' SER . 8.2 tt0 -61.89 -38.21 87.47 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 120.965 0.412 . . . . 0.0 111.311 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.534 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 49.0 t90 -60.43 -46.36 90.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.867 175.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 26' ' ' PHE . . . -65.83 -26.59 67.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.295 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.533 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 36.0 t -57.75 -55.51 33.88 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.038 0.447 . . . . 0.0 109.997 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.85 -32.39 73.88 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.603 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.476 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.0 t80 -61.78 -47.16 86.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.95 -30.67 76.37 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.284 -0.484 . . . . 0.0 113.766 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -75.27 109.0 8.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.661 HG12 ' HB1' ' A' ' 60' ' ' ALA . 17.1 m -64.46 -29.45 47.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -174.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -94.88 1.5 55.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.851 0.358 . . . . 0.0 111.667 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -67.25 109.07 2.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 p -102.85 -177.63 3.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.467 173.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -155.41 121.05 5.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.4 -8.13 54.6 Favored Glycine 0 C--O 1.227 -0.326 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.088 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -98.29 -5.88 32.13 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.382 0.61 . . . . 0.0 109.563 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.499 HG21 HG23 ' A' ' 63' ' ' VAL . 41.1 t -102.18 114.41 41.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.179 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 m -100.18 -73.55 0.63 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.52 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -57.14 8.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.069 -173.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 62.48 73.52 0.46 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 122.064 0.935 . . . . 0.0 111.035 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 98' ' ' SER . 13.7 m-80 -84.58 135.03 34.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.456 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 69.2 m -74.86 -40.3 61.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.036 -175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.474 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 124.79 -124.97 5.56 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.447 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 59.79 2.96 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.548 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 53' ' ' GLN . 61.3 m-85 60.6 -178.44 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.712 0.768 . . . . 0.0 112.976 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.502 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 36.9 t80 -142.02 -69.21 0.36 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.503 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.16 55.82 3.24 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.153 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' O ' ' A' ' 50' ' ' SER . . . 168.43 157.06 10.86 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.33 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.483 ' O ' HD23 ' A' ' 49' ' ' LEU . 4.0 m -82.06 -27.89 32.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.322 0.582 . . . . 0.0 109.896 176.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 48' ' ' SER . 6.8 mt -154.67 -40.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.452 -172.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.771 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 10.4 p -116.04 148.25 40.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.839 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.8 -137.76 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.782 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.2 p -94.71 -57.92 2.33 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 44' ' ' PHE . 54.2 tt0 -114.75 152.24 32.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.105 -167.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.736 ' CD1' HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -145.12 94.77 2.58 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.723 0.773 . . . . 0.0 111.47 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 97' ' ' LEU . . . -95.43 151.44 19.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.824 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.982 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.8 mm -146.45 129.42 8.97 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 123.197 0.599 . . . . 0.0 110.618 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.3 t -112.87 147.3 37.29 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 174.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 43.2 t -45.6 117.4 1.44 Allowed 'General case' 0 C--O 1.207 -1.163 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.535 -174.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -12.93 56.52 Favored 'General case' 0 C--N 1.317 -0.821 0 O-C-N 121.977 -0.452 . . . . 0.0 110.843 176.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.661 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -80.66 -60.73 2.2 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.834 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -115.5 -0.67 13.0 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.942 0.401 . . . . 0.0 111.793 -173.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.8 mt-30 33.77 42.35 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -173.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.499 HG23 HG21 ' A' ' 36' ' ' VAL . 7.3 p -121.83 -53.98 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.858 166.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 32.5 m -64.19 103.89 0.68 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.9 0.381 . . . . 0.0 110.216 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.02 -176.95 3.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -169.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.779 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -159.82 120.15 3.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.267 -176.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.67 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 69.1 t -102.46 109.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.567 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.779 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -97.18 151.62 19.63 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.56 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.29 139.56 6.52 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.014 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.99 -117.87 0.48 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.373 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.759 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 2.5 t-20 -145.91 73.15 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.736 HD11 ' CD1' ' A' ' 54' ' ' TYR . 16.4 mt -83.29 161.08 21.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.657 -164.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.59 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 52.8 m -155.75 121.57 5.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.481 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.922 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 44.1 t80 -94.8 116.87 29.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.421 0.629 . . . . 0.0 109.991 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.498 ' CA ' ' HB2' ' A' ' 78' ' ' ASN . 13.0 p -81.87 47.61 1.12 Allowed 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -171.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.922 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.9 OUTLIER -60.02 -57.74 11.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.245 1.384 . . . . 0.0 111.987 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.402 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 11.5 m-30 -89.92 1.72 55.9 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.508 0.67 . . . . 0.0 109.514 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' HB2' ' CA ' ' A' ' 75' ' ' THR . 29.7 m-80 -89.02 179.07 6.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.349 -173.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.906 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 33.7 mm-40 -53.27 -67.8 0.54 Allowed Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 51.6 Cg_exo -56.66 -28.16 73.89 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 121.666 1.578 . . . . 0.0 113.13 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.36 115.43 0.05 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.655 0.74 . . . . 0.0 112.64 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 54.04 51.36 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.277 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.733 HG22 ' CE1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -134.97 178.98 6.6 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.703 -174.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.4 tp -125.75 142.23 51.61 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -153.95 -159.53 0.98 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.93 -163.32 19.35 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.307 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.759 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 1.2 tm0? -93.36 165.94 12.53 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.788 0.804 . . . . 0.0 112.137 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.423 HD13 ' OH ' ' A' ' 54' ' ' TYR . 25.3 tp -156.12 132.83 10.35 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.571 -1.65 . . . . 0.0 108.985 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -132.14 -45.0 0.93 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.262 0.553 . . . . 0.0 110.794 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.52 134.39 46.06 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.535 HD12 ' HE1' ' A' ' 66' ' ' PHE . 3.1 mm? -108.13 175.55 5.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.903 169.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.67 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 12.6 t -167.22 103.78 0.53 Allowed 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.502 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.779 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.4 m-30 -95.87 145.19 25.57 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.78 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 177.04 170.92 40.07 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.906 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.8 114.63 26.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 111.594 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . 85.01 107.44 0.65 Allowed Glycine 0 C--O 1.223 -0.558 0 CA-C-N 115.527 -0.76 . . . . 0.0 113.781 169.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 105' ' ' TYR . 48.1 mt -86.59 155.77 20.31 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.231 0.539 . . . . 0.0 110.29 174.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.446 ' HA ' HD22 ' A' ' 40' ' ' ASN . 1.8 m -145.42 173.67 11.8 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.13 175.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.1 -125.34 8.23 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -172.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.61 ' HA3' ' CE1' ' A' ' 105' ' ' TYR . . . 58.03 49.0 79.11 Favored Glycine 0 C--N 1.322 -0.232 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.914 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.47 ' OD2' HG23 ' A' ' 102' ' ' THR . 19.6 t70 -144.81 -70.15 0.29 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.47 HG23 ' OD2' ' A' ' 101' ' ' ASP . 47.2 p -122.69 -8.31 8.48 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.561 174.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.7 p -121.91 154.19 60.83 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.407 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.502 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 25.6 Cg_exo -67.24 160.58 46.91 Favored 'Trans proline' 0 C--N 1.333 -0.266 0 C-N-CA 123.475 2.784 . . . . 0.0 111.452 177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.61 ' CE1' ' HA3' ' A' ' 100' ' ' GLY . 48.3 m-85 -68.06 141.74 56.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.815 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.0 p -150.79 147.09 26.86 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.335 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.78 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.1 mp -79.42 130.17 36.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.109 0.48 . . . . 0.0 110.82 -174.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.79 -44.48 93.2 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.156 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.92 82.82 2.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.8 111.21 1.86 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 123.523 2.815 . . . . 0.0 112.908 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 49.4 m-20 -104.48 -150.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.376 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.982 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 48.4 t -59.71 143.25 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.698 0.761 . . . . 0.0 111.572 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.591 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -140.74 178.83 7.06 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.339 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.516 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.8 m-85 -135.19 148.27 49.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -162.51 140.51 6.59 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.824 178.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.865 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 99.17 11.87 44.25 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.2 177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.529 ' HA ' HD11 ' A' ' 153' ' ' ILE . 16.7 mt -57.98 -50.53 73.09 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.6 t30 56.15 52.2 10.7 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.764 0.792 . . . . 0.0 110.519 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 23.7 mt -113.74 110.14 19.69 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.478 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.636 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 72.4 p -115.02 130.71 57.0 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 81.2 p -98.02 147.2 24.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.723 0.297 . . . . 0.0 110.493 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -74.61 171.32 14.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.855 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -49.62 -55.39 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.536 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.92 10.23 8.31 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.447 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 19.3 mm-40 -79.84 67.78 5.73 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 173.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.52 -103.61 0.01 OUTLIER Glycine 0 C--O 1.224 -0.519 0 CA-C-N 115.07 -0.968 . . . . 0.0 113.434 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -83.41 -14.81 51.85 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.11 -0.641 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.559 ' HA ' HE21 ' A' ' 133' ' ' GLN . 17.3 t70 -87.43 -18.81 29.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA3' ' HB3' ' A' ' 125' ' ' GLN . . . -65.25 121.42 20.89 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.569 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.0 m -49.57 -32.77 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -173.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -64.11 -41.6 92.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 118.27 0.486 . . . . 0.0 110.718 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.733 ' CE1' HG22 ' A' ' 83' ' ' THR . 4.9 t-160 -65.28 -37.84 88.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 109.85 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.569 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 6.8 mt-30 -65.41 -58.14 6.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.731 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 130' ' ' VAL . 24.9 m -58.31 -39.35 73.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.712 -1.131 . . . . 0.0 112.373 -175.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.559 ' O ' ' HG3' ' A' ' 139' ' ' MET . 13.0 p -67.68 -50.04 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.755 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.427 ' HD1' HG13 ' A' ' 135' ' ' VAL . 14.0 m-85 -71.01 -27.19 63.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.695 0.283 . . . . 0.0 110.823 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.98 -56.8 18.69 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 170.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -49.5 -50.4 41.68 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.145 0.578 . . . . 0.0 111.1 176.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.982 ' HG2' HG13 ' A' ' 56' ' ' ILE . 48.6 mtp -54.87 -33.15 61.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.41 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.2 m -94.1 -6.41 45.08 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.764 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 91.17 23.44 29.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.506 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -107.76 135.48 49.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.93 HG21 ' HB3' ' A' ' 19' ' ' LEU . 37.4 p -117.94 10.16 13.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.798 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.498 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.03 -19.27 78.3 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.69 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.27 -36.02 14.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.858 0.361 . . . . 0.0 110.647 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.726 HD12 HD21 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -67.34 -39.59 85.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.929 -179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.664 ' HB2' HG11 ' A' ' 161' ' ' VAL . 10.9 pt-20 -56.61 -35.25 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.82 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 -35.69 53.15 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 120.996 0.426 . . . . 0.0 109.964 -177.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.4 -44.46 82.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.615 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 96.3 mt -55.96 -42.06 75.67 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.88 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -54.65 -10.35 0.43 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.171 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.0 -39.85 53.12 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.411 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.545 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.5 mp -85.52 -46.49 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 120.727 0.299 . . . . 0.0 110.436 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.495 HD11 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.28 -44.65 80.0 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.911 -177.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -63.63 -22.86 67.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.678 0.275 . . . . 0.0 111.514 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.12 -35.13 79.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.147 0.499 . . . . 0.0 110.019 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.447 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 34.5 m-85 -96.06 -14.68 22.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 99.19 24.11 10.69 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 113.756 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.447 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -104.4 -161.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.189 0.495 . . . . 0.0 110.377 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 66.7 p -162.61 -179.94 7.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.819 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.664 HG11 ' HB2' ' A' ' 147' ' ' GLU . 9.1 p -59.06 -20.35 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.062 0.458 . . . . 0.0 111.392 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.87 13.52 12.46 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.048 -0.408 . . . . 0.0 111.022 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.604 ' HB3' HG23 ' A' ' 168' ' ' VAL . 8.5 t -84.01 148.7 26.72 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.7 m -72.81 149.44 43.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.988 -175.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.686 ' CD1' HD13 ' A' ' 15' ' ' ILE . 10.7 m-30 -53.19 -22.7 7.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.585 0.754 . . . . 0.0 111.46 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -83.46 -51.04 7.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.457 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -66.85 -43.63 83.14 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.604 HG23 ' HB3' ' A' ' 163' ' ' SER . 3.2 t -55.58 -58.52 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.02 73.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.16 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -66.84 -35.83 80.94 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.76 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -76.57 -30.86 57.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.385 0.612 . . . . 0.0 110.245 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.3 p -85.2 -15.26 44.23 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.92 0.867 . . . . 0.0 109.034 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -70.48 -45.53 65.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.268 173.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.8 p -170.51 -31.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.317 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 171' ' ' ALA . . . 104.37 114.45 3.95 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -175.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.1 m -130.57 29.69 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.927 0.87 . . . . 0.0 110.235 -171.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -87.22 1.34 53.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.589 -171.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 C--O 1.245 0.828 0 CA-C-O 118.217 -0.896 . . . . 0.0 109.98 -178.635 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 116' ' ' GLY . . . . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.031 0.443 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.76 ' O ' ' HB ' ' A' ' 172' ' ' THR . 44.4 t80 -87.88 148.77 24.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.435 -174.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -162.41 168.35 22.23 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.729 0.812 . . . . 0.0 109.221 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.624 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -89.9 128.19 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.681 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 25.3 m-80 -103.9 49.97 0.81 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.908 0.861 . . . . 0.0 110.328 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.936 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 32.6 p90 -71.49 151.4 43.97 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.097 177.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 9' ' ' SER . 25.5 t70 -62.36 103.08 0.36 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.665 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 5.3 t -34.94 77.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 125.113 1.508 . . . . 0.0 112.974 176.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.4 t -173.35 -30.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.864 -1.516 . . . . 0.0 108.298 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.573 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 66.5 m-85 -95.74 19.81 10.73 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.004 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 59.2 2.31 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -172.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.402 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -166.32 16.9 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.558 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 26.4 m-85 -93.66 139.86 30.31 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.351 -0.425 . . . . 0.0 110.163 173.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 m -67.55 131.54 45.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 160.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.782 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 6.5 mm -45.65 -51.56 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 117.917 0.326 . . . . 0.0 111.499 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -56.14 -34.79 66.45 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.559 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -63.25 -53.35 54.32 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.394 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.481 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 73.6 t80 -68.86 -39.64 79.75 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.583 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 15' ' ' ILE . 12.1 mt -56.69 -40.84 76.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.955 0.407 . . . . 0.0 110.244 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.62 -41.58 99.61 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.017 173.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 24' ' ' SER . 6.0 tt0 -62.25 -39.85 94.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.399 178.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.641 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 44.8 t90 -59.16 -42.33 90.5 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.25 0.548 . . . . 0.0 110.202 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.38 -25.05 66.6 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 21.2 t -62.96 -55.78 22.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.024 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.3 -31.02 72.06 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.773 0.32 . . . . 0.0 111.073 177.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 32.1 t80 -58.85 -41.13 86.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.922 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.43 -18.64 78.46 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.954 -0.566 . . . . 0.0 113.433 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.57 90.33 2.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.414 0.626 . . . . 0.0 111.573 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.827 HG12 ' HB1' ' A' ' 60' ' ' ALA . 29.6 m -63.6 0.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -174.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -80.47 -20.21 44.25 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -172.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 52.9 t60 71.04 8.96 6.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.26 0.553 . . . . 0.0 112.188 169.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.9 p -87.62 133.7 33.77 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.302 0.572 . . . . 0.0 112.311 -173.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 44.2 t-20 -168.36 123.76 0.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.267 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -6.78 56.3 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.419 -0.42 . . . . 0.0 114.064 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -112.98 -5.29 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.492 0.646 . . . . 0.0 111.534 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.509 HG11 HG13 ' A' ' 63' ' ' VAL . 46.1 t -102.42 118.96 50.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.13 0.49 . . . . 0.0 111.743 -175.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.92 -62.83 1.39 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.46 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.91 -72.7 0.3 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.01 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 68.97 87.04 0.12 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.378 0.609 . . . . 0.0 112.247 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -83.72 154.38 23.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.86 175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -82.22 -37.65 25.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.406 -169.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.29 170.73 39.3 Favored Glycine 0 CA--C 1.506 -0.474 0 C-N-CA 119.541 -1.314 . . . . 0.0 113.154 -174.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.912 ' HA2' ' HE2' ' A' ' 105' ' ' TYR . . . -98.55 -111.67 3.12 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 115.157 0.823 . . . . 0.0 115.157 -168.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 55.96 64.96 1.57 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.952 0.882 . . . . 0.0 109.024 -164.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 52' ' ' SER . 2.2 t80 -73.12 -23.92 60.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.33 -1.305 . . . . 0.0 111.668 -173.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.857 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.95 -19.66 64.82 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.376 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.02 -145.59 8.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.453 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 m -75.04 -30.42 61.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.767 0.318 . . . . 0.0 110.958 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -166.43 40.76 0.05 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.284 0.564 . . . . 0.0 111.397 -175.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.8 p -164.67 177.65 7.87 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.35 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.857 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 106.49 -163.65 13.54 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.297 175.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 16.6 m -88.54 127.57 35.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 68' ' ' ALA . 5.3 tt0 80.21 105.72 0.07 Allowed 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.246 -0.888 . . . . 0.0 113.178 171.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -102.05 101.6 11.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.329 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.601 ' H ' ' HA3' ' A' ' 43' ' ' GLY . . . -90.52 152.78 20.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.003 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.026 HG13 ' HG2' ' A' ' 139' ' ' MET . 6.1 mm -147.18 132.86 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 123.318 0.647 . . . . 0.0 109.51 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 19.8 t -121.86 149.28 43.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 176.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 40.9 t -48.06 119.4 2.88 Favored 'General case' 0 C--O 1.209 -1.066 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.399 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -66.64 -10.3 44.66 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.821 -0.549 . . . . 0.0 111.089 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.827 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -83.81 -49.87 8.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.674 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 31' ' ' HIS . 39.2 p30 -127.76 -3.81 5.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.164 0.507 . . . . 0.0 111.86 -172.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 58' ' ' SER . 63.7 mt-30 33.8 45.39 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.947 1.299 . . . . 0.0 114.168 -170.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.509 HG13 HG11 ' A' ' 36' ' ' VAL . 7.4 t -116.66 -63.38 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 114.162 -1.381 . . . . 0.0 108.669 168.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 21.6 m -61.84 102.59 0.28 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.337 -175.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -115.45 -178.43 3.38 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.657 -0.702 . . . . 0.0 112.54 -169.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.692 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -157.74 126.01 5.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.757 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 29.0 t -108.67 111.27 35.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.627 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 53' ' ' GLN . . . -90.29 107.69 19.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.323 0.582 . . . . 0.0 111.03 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -91.86 117.91 5.36 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.852 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -179.67 -139.39 3.69 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.071 -1.061 . . . . 0.0 112.406 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.559 ' HB2' ' CB ' ' A' ' 87' ' ' GLN . 8.7 m-80 -136.24 47.74 2.2 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 122.027 0.918 . . . . 0.0 109.222 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 35.6 mt -70.31 149.92 46.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.639 -1.619 . . . . 0.0 112.015 -177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.7 m -155.05 137.19 14.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.142 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HE1' ' HB3' ' A' ' 76' ' ' LEU . 33.7 t80 -89.21 123.66 33.66 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.564 175.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.751 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 69.1 p -70.91 -32.55 69.52 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -171.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.745 ' HB3' ' HE1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER 42.09 -92.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.836 0.854 . . . . 0.0 113.117 -168.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.518 ' H ' ' HG ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -94.63 7.29 46.23 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.751 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 33.8 m-80 -77.16 176.57 8.6 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.412 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.802 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 39.8 mt-10 -48.52 -63.13 1.7 Allowed Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -170.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.802 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -55.65 -35.77 93.58 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.616 1.544 . . . . 0.0 112.433 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 72.63 128.37 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 O-C-N 123.894 0.746 . . . . 0.0 112.463 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 38.09 60.28 1.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.059 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -143.32 165.64 26.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.847 -174.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.761 HD23 HG11 ' A' ' 135' ' ' VAL . 11.7 tp -108.94 146.91 33.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 17.0 p90 -153.65 -160.7 1.14 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 85' ' ' TYR . . . 98.97 -166.56 21.35 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.929 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.683 HE22 ' HB2' ' A' ' 89' ' ' ASP . 17.8 tm0? -92.58 158.03 16.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.687 0.756 . . . . 0.0 111.906 -172.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.567 ' CD2' HG21 ' A' ' 134' ' ' VAL . 57.1 tp -143.76 110.24 5.5 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.045 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.683 ' HB2' HE22 ' A' ' 87' ' ' GLN . 36.1 t70 -126.54 -28.82 2.98 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.182 0.515 . . . . 0.0 110.882 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.498 ' O ' HD13 ' A' ' 91' ' ' LEU . 31.0 t -134.89 160.19 39.05 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.05 0.928 . . . . 0.0 112.327 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 3.0 mm? -144.46 163.7 33.04 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 19.9 t -162.82 106.93 1.1 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.163 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.781 ' CE2' HD22 ' A' ' 19' ' ' LEU . 2.4 m-30 -97.64 135.05 40.01 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.637 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.42 160.88 28.77 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.015 -1.088 . . . . 0.0 112.013 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.83 110.82 20.22 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.258 0.551 . . . . 0.0 110.734 -179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.96 110.51 2.36 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.801 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.523 HD21 HG22 ' A' ' 67' ' ' VAL . 6.6 mt -83.89 155.14 23.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.486 . . . . 0.0 109.846 170.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 t -145.95 170.2 17.1 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.908 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.26 -133.9 13.52 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.536 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.9 32.93 31.26 Favored Glycine 0 C--N 1.313 -0.729 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.127 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.89 -102.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.194 0.521 . . . . 0.0 109.61 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 p -104.59 5.13 33.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.744 0.783 . . . . 0.0 109.496 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -129.57 167.75 19.01 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.315 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.25 172.56 10.91 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.173 2.582 . . . . 0.0 112.421 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.912 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 48.8 m-85 -75.8 165.19 25.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.404 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 24.6 p -147.77 139.76 24.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.996 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.815 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -81.61 128.67 38.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.624 -174.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.14 -48.16 77.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.053 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.75 88.37 7.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 170.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.87 93.9 0.18 Allowed 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 123.142 2.561 . . . . 0.0 112.354 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.456 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 30.3 m-20 -93.45 -155.56 0.45 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.413 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.936 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 20.7 t -62.0 113.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.427 1.108 . . . . 0.0 112.422 -175.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.681 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 68.5 m -103.02 176.65 5.08 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.708 -1.587 . . . . 0.0 109.327 174.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.723 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.0 m-85 -137.07 141.28 42.39 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -156.45 128.92 2.3 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.155 -1.498 . . . . 0.0 113.047 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 111.38 10.0 20.68 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.25 174.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.649 ' CD2' ' H ' ' A' ' 117' ' ' LEU . 1.7 mm? -49.88 -53.04 28.3 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.063 0.945 . . . . 0.0 110.52 174.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.4 t30 53.68 47.62 23.38 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.58 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.4 mt -105.22 102.55 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.498 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.627 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 69.5 p -106.16 128.5 53.96 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.268 0.556 . . . . 0.0 110.851 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 36.7 t -108.71 119.16 38.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.7 0.762 . . . . 0.0 110.645 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 122' ' ' LEU . 9.9 mp -59.14 167.49 1.71 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.297 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -51.65 -57.84 8.05 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.877 -175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.582 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -83.36 15.15 3.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -165.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -72.98 -31.09 64.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.948 0.404 . . . . 0.0 111.487 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 66.18 -119.91 14.37 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.203 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.45 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 6.1 t-80 -88.77 -24.06 22.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.636 0.255 . . . . 0.0 110.42 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.551 ' HA ' HE21 ' A' ' 133' ' ' GLN . 32.7 t70 -81.06 -21.49 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.822 -173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 125.99 40.13 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.281 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 134' ' ' VAL . 18.6 m -51.18 -32.69 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -174.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.3 -42.23 94.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.823 0.344 . . . . 0.0 110.556 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.556 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.9 t-160 -65.05 -40.36 94.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.779 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.551 HE21 ' HA ' ' A' ' 128' ' ' ASP . 23.2 mm-40 -59.77 -65.31 0.7 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.926 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.567 HG21 ' CD2' ' A' ' 88' ' ' LEU . 27.1 m -55.86 -39.84 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.413 -1.267 . . . . 0.0 113.014 -174.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.761 HG11 HD23 ' A' ' 84' ' ' LEU . 8.3 p -69.68 -46.41 75.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.256 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -73.35 -24.77 60.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.701 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.54 -54.96 19.98 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 169.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.575 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -48.7 -50.72 32.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.158 0.583 . . . . 0.0 110.82 176.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 1.026 ' HG2' HG13 ' A' ' 56' ' ' ILE . 41.5 mtp -52.72 -34.61 53.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.133 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.0 m -90.99 -2.81 57.65 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.68 14.89 69.33 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.597 -176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -106.88 104.16 13.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.182 0.515 . . . . 0.0 110.302 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 19' ' ' LEU . 3.5 p -92.16 11.86 24.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.481 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -69.19 -29.1 72.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.776 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.73 39.46 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.434 -0.451 . . . . 0.0 110.431 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.562 HD22 HD21 ' A' ' 138' ' ' LEU . 47.1 tp -68.39 -43.13 77.96 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.589 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.678 ' HB2' HG21 ' A' ' 161' ' ' VAL . 10.6 pt-20 -57.85 -31.08 66.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.658 0.266 . . . . 0.0 110.975 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.47 -36.12 58.04 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.99 0.424 . . . . 0.0 109.971 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.57 75.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.928 175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.539 HD23 HD11 ' A' ' 117' ' ' LEU . 94.1 mt -55.45 -39.22 70.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.8 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -56.28 -10.19 0.83 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.451 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.35 -36.24 63.29 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.484 -0.865 . . . . 0.0 111.389 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.41 HG22 ' HE2' ' A' ' 157' ' ' TYR . 4.1 mp -84.4 -47.98 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 122.705 -0.291 . . . . 0.0 110.58 175.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.638 HD11 HG22 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.63 -43.09 75.86 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -58.8 -30.78 67.86 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.94 -31.84 72.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.137 0.494 . . . . 0.0 110.818 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.41 ' HE2' HG22 ' A' ' 153' ' ' ILE . 47.0 m-85 -98.86 -6.11 29.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.299 177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.38 39.31 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.308 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.1 mp -101.4 -167.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.401 . . . . 0.0 111.029 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.1 p -167.85 175.41 6.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.286 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' A' ' 147' ' ' GLU . 0.5 OUTLIER -61.71 -13.27 8.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.67 0.271 . . . . 0.0 111.669 172.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -89.73 10.62 22.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.956 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -87.17 -116.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.184 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 7.2 m -157.31 146.83 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.845 -0.161 . . . . 0.0 110.771 -174.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.691 ' CD1' HD13 ' A' ' 15' ' ' ILE . 6.7 m-30 -54.47 -45.26 73.12 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.455 0.302 . . . . 0.0 111.025 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -66.13 -41.1 90.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.656 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -66.78 -48.18 69.84 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.638 HG22 HD11 ' A' ' 154' ' ' LEU . 4.0 t -56.23 -54.95 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 120.686 0.279 . . . . 0.0 110.272 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.21 76.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.017 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.635 ' HB1' HG11 ' A' ' 176' ' ' VAL . . . -69.73 -38.71 76.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.278 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.419 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -75.4 -29.74 59.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.76 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 38.0 p -86.27 -11.84 51.19 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.06 0.933 . . . . 0.0 109.146 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -68.76 -46.24 69.33 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 113.868 -1.514 . . . . 0.0 108.949 171.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.5 p -167.87 -30.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.581 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 171' ' ' ALA . . . 120.67 126.41 3.35 Favored Glycine 0 N--CA 1.44 -1.059 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.635 HG11 ' HB1' ' A' ' 170' ' ' ALA . 25.9 m -135.41 129.24 49.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.317 0.58 . . . . 0.0 111.157 -172.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.405 ' CD ' ' H ' ' A' ' 177' ' ' GLN . 5.6 pm0 -87.12 148.84 25.05 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.745 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.032 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.705 ' O ' ' HB ' ' A' ' 172' ' ' THR . 42.7 t80 -70.38 133.43 46.91 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.175 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 m -160.75 168.42 24.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.965 172.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.616 HG21 ' CD1' ' A' ' 165' ' ' PHE . 0.5 OUTLIER -88.19 130.17 38.21 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 113' ' ' SER . 44.5 m-20 -106.32 46.82 0.9 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.871 0.844 . . . . 0.0 110.814 -177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.962 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 20.4 p90 -70.56 145.4 50.82 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.261 176.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 9' ' ' SER . 32.7 t70 -63.82 104.84 0.73 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.347 175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 p -25.15 73.56 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.726 1.61 . . . . 0.0 114.579 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 7' ' ' ASP . 42.2 t -174.64 -32.07 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.26 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.596 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 74.7 m-85 -94.21 16.86 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.191 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.15 70.81 0.61 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.511 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.62 23.24 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.666 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 25.7 m-85 -107.77 141.36 39.44 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.522 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -72.55 129.59 38.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 161.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 168' ' ' VAL . 5.0 mm -47.24 -43.06 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -170.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -63.2 -33.34 75.27 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.569 0.223 . . . . 0.0 111.316 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.28 -36.14 82.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.266 0.555 . . . . 0.0 110.766 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.895 ' CE1' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -72.1 -48.12 46.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.806 175.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.803 HD21 ' HZ ' ' A' ' 114' ' ' PHE . 15.9 mt -53.05 -46.54 68.55 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.774 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.2 -44.7 94.77 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.68 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -62.96 -43.46 98.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.661 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 55.6 t90 -58.69 -45.13 90.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.258 0.551 . . . . 0.0 109.916 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.4 -24.03 64.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.2 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -62.52 -53.2 58.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.1 p -65.61 -34.35 78.04 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.347 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.491 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 25.2 t80 -56.8 -42.41 79.46 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.945 0.402 . . . . 0.0 110.519 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.14 -21.41 79.21 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.239 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 7.3 t70 -75.96 104.03 6.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.041 0.448 . . . . 0.0 111.0 -174.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.837 HG12 ' HB1' ' A' ' 60' ' ' ALA . 20.1 m -68.0 2.64 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -171.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -81.75 -11.04 59.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -168.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.512 ' HA ' ' HB2' ' A' ' 61' ' ' ASN . 85.9 t60 61.68 24.57 14.65 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.403 0.62 . . . . 0.0 111.551 172.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.7 p -90.38 130.86 36.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.512 0.672 . . . . 0.0 112.726 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -173.22 120.49 0.35 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.097 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.62 -6.77 63.42 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.996 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -118.37 3.88 11.87 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 117.628 0.714 . . . . 0.0 111.745 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 63' ' ' VAL . 25.5 t -98.11 112.21 29.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.293 0.568 . . . . 0.0 112.378 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.78 -67.07 0.91 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.653 172.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -75.35 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.148 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.523 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 65.11 63.3 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.459 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 40.1 m-80 -86.23 147.99 25.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.365 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' ' CB ' ' A' ' 57' ' ' SER . 71.8 m -93.65 -39.11 10.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.997 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.725 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 114.3 -129.13 8.55 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.397 176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.95 62.44 2.01 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 121.201 -0.524 . . . . 0.0 113.067 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 66.33 130.66 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.488 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 17.5 t80 -107.88 -24.65 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.269 172.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.48 19.8 8.28 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.132 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.76 -132.02 7.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.633 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -75.89 -52.18 10.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.543 0.211 . . . . 0.0 111.419 -173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -164.44 21.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.1 p -161.62 156.65 23.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.82 -64.81 0.5 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.407 -0.902 . . . . 0.0 113.243 172.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.615 ' C ' ' HA2' ' A' ' 70' ' ' GLY . 23.1 t -148.77 -144.75 0.16 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 121.349 -0.14 . . . . 0.0 110.631 -170.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 69' ' ' GLY . 12.3 mt-30 -43.93 141.75 1.56 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.806 0.842 . . . . 0.0 112.104 -175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.423 ' HB3' HD12 ' A' ' 72' ' ' LEU . 3.9 t80 -130.99 96.98 4.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.504 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -89.76 146.77 24.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.558 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.03 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.3 mm -145.12 121.1 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.564 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.692 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.1 t -104.73 165.97 10.7 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.436 175.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 33.4 t -61.13 152.78 27.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.09 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.9 p -101.53 -14.09 17.62 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.019 0.438 . . . . 0.0 110.115 168.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.837 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -75.47 -54.5 6.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.293 177.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.512 ' HB2' ' HA ' ' A' ' 31' ' ' HIS . 37.9 p30 -115.3 0.98 13.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.154 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 58' ' ' SER . 69.5 mt-30 30.0 43.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -174.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.509 ' CG2' HG21 ' A' ' 36' ' ' VAL . 9.8 p -128.64 -51.64 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.459 171.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 17.1 m -63.33 107.5 1.1 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.692 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -121.27 -178.22 3.72 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -170.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.779 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -156.37 131.78 9.41 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.869 -176.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 58.1 t -110.98 119.99 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.542 0.211 . . . . 0.0 110.694 178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.78 14.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.949 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.629 ' O ' ' HG2' ' A' ' 53' ' ' GLN . . . -63.29 -99.3 0.01 OUTLIER Glycine 0 C--O 1.217 -0.921 0 N-CA-C 116.61 1.404 . . . . 0.0 116.61 -167.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.615 ' HA2' ' C ' ' A' ' 52' ' ' SER . . . -179.68 34.13 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 118.826 -1.654 . . . . 0.0 115.495 -170.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -146.39 27.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.756 1.278 . . . . 0.0 111.03 169.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.585 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 73.1 mt -79.05 144.6 34.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.973 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.9 m -144.38 124.33 13.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.383 -176.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.549 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 58.3 t80 -82.07 123.09 28.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.866 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 80.7 p -61.4 -38.96 88.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.626 -171.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.5 tp 55.53 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 123.812 0.695 . . . . 0.0 111.337 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -100.76 8.39 43.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.742 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.866 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 94.2 m-20 -76.44 179.03 6.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 111.536 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.776 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 6.0 mm-40 -51.4 -56.83 17.27 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -173.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.1 Cg_exo -57.6 -37.3 97.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.754 1.636 . . . . 0.0 112.513 176.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.86 125.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.833 0.708 . . . . 0.0 112.372 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 47.53 58.82 4.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.11 169.05 20.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.333 -175.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.773 HD23 HG11 ' A' ' 135' ' ' VAL . 12.2 tp -108.81 138.8 44.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -157.01 139.01 14.44 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 166.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 72' ' ' LEU . . . -168.65 -131.2 1.27 Allowed Glycine 0 C--N 1.298 -1.542 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.187 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.721 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 1.8 tm0? -142.42 151.59 41.95 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 113.889 -1.155 . . . . 0.0 108.831 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.564 HD21 HD11 ' A' ' 91' ' ' LEU . 18.9 tp -138.99 116.25 11.11 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.376 0.608 . . . . 0.0 110.252 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.574 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 16.6 t70 -110.89 -56.62 2.34 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.645 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.503 ' O ' HD13 ' A' ' 91' ' ' LEU . 4.9 p -107.74 155.07 20.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.323 -176.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.721 HD12 ' HE1' ' A' ' 66' ' ' PHE . 3.0 mm? -141.15 160.52 39.93 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.663 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 58.0 m -149.76 111.33 4.49 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.675 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.75 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.9 m-30 -99.72 129.38 45.84 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.04 165.32 35.83 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.371 -0.918 . . . . 0.0 111.535 177.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -90.11 123.13 33.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.197 0.523 . . . . 0.0 111.618 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.76 110.04 0.47 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.144 -0.935 . . . . 0.0 113.469 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.538 HD11 ' HB1' ' A' ' 55' ' ' ALA . 77.0 mt -87.01 151.59 23.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.052 0.453 . . . . 0.0 109.979 172.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 p -131.19 154.04 48.81 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.998 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.29 23.91 53.04 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.673 174.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.29 52.05 4.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.641 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -94.22 -92.38 0.19 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.1 p -121.72 13.86 10.83 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.2 172.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.1 m -110.16 168.16 8.04 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.353 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.8 Cg_exo -72.8 142.65 35.8 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.222 2.615 . . . . 0.0 111.917 -177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.725 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 64.1 m-85 -67.74 150.7 48.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.322 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 97' ' ' LEU . 18.2 p -144.06 152.75 41.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.544 -177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.661 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.0 mp -85.98 119.08 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.643 0.259 . . . . 0.0 110.907 -177.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.523 ' NE2' ' H ' ' A' ' 39' ' ' ALA . 41.7 mt-30 -65.04 -47.22 78.14 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.025 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 33.5 t -105.16 87.83 2.17 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 174.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 34.0 Cg_endo -63.25 100.7 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 123.372 2.715 . . . . 0.0 112.453 -176.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.515 ' OD2' HG23 ' A' ' 112' ' ' VAL . 10.1 t70 -106.1 -147.19 0.4 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.962 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 15.4 t -69.79 149.07 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.355 0.598 . . . . 0.0 111.892 -177.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 5' ' ' ASN . 36.2 m -142.9 -177.49 5.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.123 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.803 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.0 m-85 -134.35 152.7 51.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.114 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.35 135.74 4.09 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.515 172.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.94 13.63 31.21 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.969 -0.634 . . . . 0.0 114.551 172.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.506 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 mt -55.41 -51.71 65.97 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.574 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 64.8 t30 53.4 43.26 31.59 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.208 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -106.29 128.8 54.25 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 171.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.693 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 51.2 p -131.17 139.04 49.68 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.983 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 69.5 p -98.55 151.44 20.64 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.864 0.364 . . . . 0.0 111.392 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.59 162.94 26.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.969 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -48.13 -55.56 9.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.54 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -82.7 11.35 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 15.0 mm100 -77.44 55.42 1.26 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.043 0.449 . . . . 0.0 112.134 176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 128' ' ' ASP . . . -64.24 104.33 0.88 Allowed Glycine 0 C--O 1.225 -0.422 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.526 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 74.95 -26.17 0.2 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.609 0.764 . . . . 0.0 111.35 177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 126' ' ' GLY . 24.1 t70 -83.65 -23.21 31.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.091 0.472 . . . . 0.0 110.207 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -60.34 122.14 28.9 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.095 173.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.516 ' O ' HG22 ' A' ' 134' ' ' VAL . 22.9 m -51.52 -33.34 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -172.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 86' ' ' GLY . 12.5 m -64.83 -44.87 96.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.561 0.22 . . . . 0.0 110.958 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.583 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.5 t-160 -60.38 -40.42 90.79 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.443 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 32.6 mt-30 -59.09 -63.24 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 130' ' ' VAL . 23.7 m -60.01 -40.49 83.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.022 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.779 HG23 ' HZ ' ' A' ' 66' ' ' PHE . 10.7 p -68.99 -45.47 80.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 121.244 -0.182 . . . . 0.0 111.325 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -72.92 -22.44 60.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 0.0 110.601 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.9 -54.8 19.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.646 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -47.95 -52.17 20.71 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.344 0.658 . . . . 0.0 110.88 176.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 1.03 ' HG2' HG13 ' A' ' 56' ' ' ILE . 45.4 mtp -54.63 -33.64 60.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.392 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.5 t -89.67 -15.47 32.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.25 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.5 16.58 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.635 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -101.61 127.1 48.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.027 0.441 . . . . 0.0 110.463 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.583 HG21 ' HB3' ' A' ' 19' ' ' LEU . 21.7 p -114.61 5.48 15.44 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.119 0.485 . . . . 0.0 110.979 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.494 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -72.99 -20.93 80.16 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.583 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.02 -35.45 21.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 36.1 tp -68.06 -40.93 82.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.492 -178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.633 ' HB2' HG11 ' A' ' 161' ' ' VAL . 11.8 pt-20 -56.67 -34.53 67.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.716 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -35.4 61.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.116 0.484 . . . . 0.0 110.053 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.21 -46.27 74.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.525 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 95.9 mt -55.26 -41.91 72.82 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.049 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -52.8 -14.32 0.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.331 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -72.87 -43.65 40.87 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.711 -0.756 . . . . 0.0 111.78 -175.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.411 HG22 ' HE2' ' A' ' 157' ' ' TYR . 3.8 mp -80.27 -43.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.285 177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.714 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -59.18 -44.63 92.18 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.28 -25.73 67.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.652 0.263 . . . . 0.0 111.389 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.09 -29.5 70.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.471 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 25.5 m-85 -100.47 -12.54 19.26 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.276 175.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 97.37 18.24 29.11 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.796 -0.638 . . . . 0.0 113.429 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.508 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -102.83 -163.07 0.96 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 117.421 0.611 . . . . 0.0 110.522 177.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.9 p -161.69 -176.66 5.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.974 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 147' ' ' GLU . 8.5 p -58.02 -23.16 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.153 0.501 . . . . 0.0 111.034 174.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -88.77 18.39 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.006 0.431 . . . . 0.0 111.295 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.703 ' HB3' HG22 ' A' ' 168' ' ' VAL . 16.6 t -83.76 143.42 30.01 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 168' ' ' VAL . 47.0 m -75.36 141.04 43.38 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.567 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 13' ' ' TYR . 7.0 m-30 -39.82 -49.96 2.38 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.833 0.853 . . . . 0.0 113.187 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.19 -38.58 88.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.948 0.404 . . . . 0.0 110.742 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.525 HE21 ' HB ' ' A' ' 164' ' ' THR . 52.5 mt-30 -73.99 -38.95 63.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.289 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.714 HG13 HD11 ' A' ' 154' ' ' LEU . 17.9 t -62.07 -52.33 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 109.986 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -56.74 -45.38 82.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.84 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -65.83 -35.35 80.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.74 -28.04 60.61 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.364 0.602 . . . . 0.0 110.638 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.705 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.8 p -89.96 -12.94 37.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.071 0.938 . . . . 0.0 109.594 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -69.24 -36.81 77.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.512 173.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.2 p -174.27 -30.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.302 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 119.29 120.62 2.91 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.857 HG23 ' HG2' ' A' ' 177' ' ' GLN . 17.1 m -143.54 176.78 2.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.296 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.857 ' HG2' HG23 ' A' ' 176' ' ' VAL . 12.1 mm100 67.93 13.86 9.25 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.963 0.789 . . . . 0.0 112.445 174.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.518 -0.753 . . . . 0.0 111.081 179.113 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.025 0.44 . . . . 0.0 110.745 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.814 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 17.0 t80 -113.81 160.66 18.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.177 178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -173.7 160.53 3.73 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.221 0.534 . . . . 0.0 110.967 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.674 HG11 HD12 ' A' ' 15' ' ' ILE . 11.8 m -97.86 115.96 39.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.752 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.496 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 34.4 m-80 -96.45 59.32 1.82 Allowed 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.623 -169.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.679 ' CE2' ' HA ' ' A' ' 8' ' ' SER . 38.9 p90 -74.23 149.7 40.69 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.049 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 9' ' ' SER . 16.5 t70 -62.73 94.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.679 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.5 p -24.99 72.41 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 114.92 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 7' ' ' ASP . 20.7 t -173.79 -26.23 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.392 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.531 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 83.6 m-85 -90.04 10.24 24.94 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.931 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.2 69.23 1.09 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.974 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.61 21.83 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 164' ' ' THR . 21.8 m-85 -107.42 140.14 40.83 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.942 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m -68.89 133.24 47.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 162.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.674 HD12 HG11 ' A' ' 4' ' ' VAL . 6.3 mm -51.26 -47.65 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 118.134 0.424 . . . . 0.0 111.604 -170.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -65.21 -25.22 67.6 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.947 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.43 -51.12 25.65 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.859 0.361 . . . . 0.0 110.537 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 56.8 t80 -69.51 -49.2 56.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.808 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' A' ' 93' ' ' PHE . 16.3 mt -57.42 -38.99 75.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.029 0.442 . . . . 0.0 110.242 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.29 -41.01 94.76 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.86 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -62.84 -45.44 92.58 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.953 0.406 . . . . 0.0 110.988 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.738 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 9.3 t90 -52.69 -51.08 61.86 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.816 174.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.67 -28.92 68.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.124 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -57.79 -52.09 66.88 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -27.37 66.49 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.421 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.542 ' CE2' ' HE1' ' A' ' 66' ' ' PHE . 18.0 t80 -60.44 -49.9 75.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.54 0.209 . . . . 0.0 110.488 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.83 -28.26 73.7 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.254 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -73.25 103.9 4.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.074 0.464 . . . . 0.0 110.962 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.701 HG12 ' HB1' ' A' ' 60' ' ' ALA . 27.9 m -63.04 -16.17 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.384 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -90.28 -13.59 34.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 120.935 0.398 . . . . 0.0 111.04 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -66.83 127.74 33.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.327 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.35 -176.08 4.34 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.364 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -158.44 125.14 4.79 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.15 -10.32 62.0 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 116.279 -0.418 . . . . 0.0 113.065 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.77 -7.12 53.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.593 0.711 . . . . 0.0 109.293 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.546 ' HA ' ' OE1' ' A' ' 108' ' ' GLN . 23.4 t -94.91 120.42 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.513 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.2 m -92.7 -57.45 2.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.407 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 4.5 t70 -98.44 -68.81 0.79 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.286 -178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' H ' HE22 ' A' ' 108' ' ' GLN . . . 79.92 81.25 0.05 Allowed 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 124.972 1.42 . . . . 0.0 109.66 -172.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.67 ' HB3' ' HE1' ' A' ' 105' ' ' TYR . 8.3 m-80 -78.51 135.74 37.41 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.256 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.542 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 60.2 p -76.56 -45.69 29.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.428 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.0 178.06 27.21 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.57 ' O ' ' HB2' ' A' ' 44' ' ' PHE . . . -167.56 -45.24 0.03 OUTLIER Glycine 0 CA--C 1.523 0.56 0 C-N-CA 117.311 -2.376 . . . . 0.0 117.725 -171.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 12.8 m-85 70.29 95.38 0.07 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.916 0.858 . . . . 0.0 109.543 -153.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -79.53 -17.42 54.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.55 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -86.36 17.58 37.82 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.939 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.08 -118.71 4.31 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.351 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.4 m -76.85 -54.35 6.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.769 0.318 . . . . 0.0 111.778 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -164.99 43.48 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.664 0.745 . . . . 0.0 110.781 -173.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 p -158.29 -178.32 7.2 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.356 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.86 -166.35 25.67 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.99 175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.5 t -87.83 -39.1 15.13 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 68' ' ' ALA . 27.2 mt-30 -117.77 155.24 30.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.48 0.657 . . . . 0.0 111.609 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -145.5 101.57 3.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.07 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 97' ' ' LEU . . . -92.91 142.49 27.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.776 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 139' ' ' MET . 31.7 mm -143.49 129.6 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 O-C-N 123.679 0.612 . . . . 0.0 109.945 177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.542 ' HB3' ' HA ' ' A' ' 41' ' ' SER . 22.9 t -112.95 155.79 24.15 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.627 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 38.1 t -48.81 128.85 16.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.829 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 p -76.55 -14.88 59.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.171 0.51 . . . . 0.0 109.866 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.701 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -80.82 -60.06 2.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.891 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -116.33 1.52 13.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.053 0.454 . . . . 0.0 111.503 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.1 mm-40 39.0 36.24 0.15 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -175.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.9 p -124.08 -51.11 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.686 172.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 m -64.54 102.98 0.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -120.62 175.51 5.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.299 0.571 . . . . 0.0 112.205 -170.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -159.73 131.36 6.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.592 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 49.1 t -108.52 115.03 48.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.222 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.703 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -86.96 155.25 20.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.61 125.27 1.72 Allowed Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.524 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -177.93 -104.19 0.18 Allowed Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.694 ' HB3' ' HB3' ' A' ' 87' ' ' GLN . 2.4 t-20 -150.4 41.26 0.79 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -63.5 145.3 55.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.081 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.2 m -154.55 131.81 11.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.475 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' HB3' HD13 ' A' ' 49' ' ' LEU . 55.0 t80 -90.46 129.15 36.67 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.608 HG22 HE22 ' A' ' 123' ' ' GLN . 71.0 p -65.29 -35.81 82.15 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -172.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.529 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 8.8 tp 51.7 -96.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.689 0.796 . . . . 0.0 112.166 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.529 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 4.9 m-85 -101.58 7.78 42.08 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.103 -174.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.75 178.44 6.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.938 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 41.0 mt-10 -48.35 -62.23 2.44 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -169.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.79 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 86.8 Cg_exo -50.73 -51.4 11.21 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.978 1.786 . . . . 0.0 112.992 175.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 71.68 130.39 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.882 0.739 . . . . 0.0 112.402 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 51.8 m80 54.49 49.91 17.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.268 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.652 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.6 OUTLIER -146.49 166.34 26.72 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 -175.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.668 ' CD2' HG11 ' A' ' 135' ' ' VAL . 13.9 tp -110.74 151.53 27.65 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -153.49 -153.46 0.47 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.19 -144.46 17.35 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.199 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.716 ' CG ' ' HB3' ' A' ' 120' ' ' SER . 24.7 tm0? -140.97 158.79 43.44 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -169.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.568 HD21 HD21 ' A' ' 91' ' ' LEU . 32.0 tp -144.22 135.15 25.21 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.128 0.489 . . . . 0.0 109.891 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.565 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 19.0 t70 -133.02 -55.14 0.92 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.431 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.636 ' O ' HD22 ' A' ' 91' ' ' LEU . 5.7 p -108.31 158.33 17.57 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.515 -176.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 68' ' ' ALA . 2.4 mm? -140.23 156.89 46.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 172.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.511 ' HB3' HD11 ' A' ' 107' ' ' ILE . 3.7 m -147.09 106.02 3.85 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.285 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.67 ' CE2' HD22 ' A' ' 19' ' ' LEU . 2.4 m-30 -91.97 147.64 22.81 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.76 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 173.36 163.56 27.2 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 119.345 -1.407 . . . . 0.0 112.781 173.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.0 117.98 29.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.336 0.589 . . . . 0.0 111.043 176.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.46 104.87 0.88 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.42 172.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.54 ' CD1' ' HB1' ' A' ' 55' ' ' ALA . 50.5 mt -88.93 161.12 16.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.208 0.528 . . . . 0.0 110.263 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.6 t -146.96 168.47 21.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.42 32.55 84.58 Favored Glycine 0 C--O 1.224 -0.517 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.699 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.65 ' HA3' ' CE1' ' A' ' 105' ' ' TYR . . . -87.41 19.58 31.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.829 -0.7 . . . . 0.0 114.33 -175.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.16 -79.93 0.37 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.353 0.577 . . . . 0.0 110.983 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 p -113.01 9.68 18.72 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.339 0.59 . . . . 0.0 110.819 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.53 168.27 13.57 Favored Pre-proline 0 N--CA 1.444 -0.76 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.944 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -77.55 151.14 28.67 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.286 2.657 . . . . 0.0 110.762 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.67 ' HE1' ' HB3' ' A' ' 40' ' ' ASN . 38.4 m-85 -65.38 144.25 57.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.584 0.707 . . . . 0.0 111.614 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.4 p -143.21 138.11 29.45 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.388 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.76 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.0 mp -79.62 123.83 37.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.672 -176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.546 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 78.2 mt-30 -64.58 -48.43 75.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.308 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.8 t -111.77 90.23 12.57 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 172.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -59.79 102.09 0.16 Allowed 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.816 3.011 . . . . 0.0 113.919 -174.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.6 m-20 -84.7 -164.67 1.01 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.716 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 84.5 t -63.28 138.02 23.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.824 0.821 . . . . 0.0 112.393 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 58.4 m -116.77 179.7 3.94 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.635 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 91.7 m-85 -143.56 153.16 42.28 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -161.26 134.09 3.42 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.636 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.814 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 103.89 15.67 21.54 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.308 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.432 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 22.6 mt -58.52 -45.74 88.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.644 0.722 . . . . 0.0 109.632 175.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.565 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 14.9 t30 59.98 19.0 8.08 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.436 172.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -92.36 132.08 37.03 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.559 0.695 . . . . 0.0 110.236 -179.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.716 ' HB3' ' CG ' ' A' ' 87' ' ' GLN . 59.9 p -133.21 165.15 25.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.657 -178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.45 ' OG ' HG22 ' A' ' 131' ' ' VAL . 78.2 p -144.48 150.86 38.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 111.027 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.43 165.84 15.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.6 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.608 HE22 HG22 ' A' ' 75' ' ' THR . 19.6 tp60 -51.06 -56.3 13.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.995 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.597 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -81.77 15.79 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -172.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.95 -15.86 60.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.363 . . . . 0.0 111.321 177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 44.47 -123.83 5.35 Favored Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.705 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.434 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 1.4 t-80 -78.52 -20.14 51.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HA ' HE21 ' A' ' 133' ' ' GLN . 17.0 t70 -85.17 -17.26 37.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.01 122.98 31.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.18 173.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.626 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 16.2 m -50.2 -33.62 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.45 HG22 ' OG ' ' A' ' 121' ' ' SER . 27.2 m -64.74 -41.25 91.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.952 0.406 . . . . 0.0 110.54 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.652 ' HE1' HG22 ' A' ' 83' ' ' THR . 3.9 t-160 -64.0 -38.28 90.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.626 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 4.2 mm-40 -63.4 -62.77 1.46 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.59 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 130' ' ' VAL . 15.9 m -58.75 -37.1 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.264 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.668 HG11 ' CD2' ' A' ' 84' ' ' LEU . 7.1 p -66.35 -43.97 91.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.779 0.323 . . . . 0.0 110.379 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.581 ' HD1' HG13 ' A' ' 135' ' ' VAL . 22.2 m-85 -71.94 -27.47 62.82 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.308 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -54.29 38.07 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 170.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.599 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.25 -60.62 2.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.544 0.688 . . . . 0.0 110.085 176.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.721 ' HA ' ' CZ ' ' A' ' 66' ' ' PHE . 71.2 mtm -55.59 -25.97 41.28 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.463 -1.244 . . . . 0.0 114.071 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 m -94.09 -3.2 51.57 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.563 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.32 28.42 48.67 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.16 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -106.95 135.18 48.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.161 0.505 . . . . 0.0 110.616 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.418 HG21 ' HB3' ' A' ' 19' ' ' LEU . 23.7 p -111.75 8.5 20.66 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.677 177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.536 ' O ' ' HG2' ' A' ' 147' ' ' GLU . . . -74.71 -42.94 30.43 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.553 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.62 -27.02 60.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.219 0.533 . . . . 0.0 109.688 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.619 HD11 ' HZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -73.74 -48.05 34.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.271 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.58 ' HB2' HG11 ' A' ' 161' ' ' VAL . 10.3 pt-20 -56.69 -36.16 69.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -72.2 -38.28 69.09 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.187 0.518 . . . . 0.0 109.767 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.72 -47.35 75.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.427 ' O ' HD22 ' A' ' 154' ' ' LEU . 96.1 mt -55.74 -46.47 77.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.517 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -55.93 -15.86 3.97 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.753 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.86 -39.94 58.59 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.623 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.405 HG22 ' HE2' ' A' ' 157' ' ' TYR . 4.0 mp -81.43 -51.12 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.774 -0.371 . . . . 0.0 110.281 175.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.737 HD11 HG13 ' A' ' 168' ' ' VAL . 0.3 OUTLIER -54.77 -41.93 71.09 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -176.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.77 -23.15 67.07 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.26 -24.11 63.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.337 0.589 . . . . 0.0 110.106 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.517 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 9.2 m-85 -112.29 0.82 15.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.188 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 90.49 16.96 54.26 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.78 -0.646 . . . . 0.0 113.847 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 2.2 mm? -98.7 -170.88 2.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.627 0.713 . . . . 0.0 109.536 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 78.6 p -164.21 176.92 8.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.22 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.58 HG11 ' HB2' ' A' ' 147' ' ' GLU . 4.9 p -57.55 -26.45 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.083 0.468 . . . . 0.0 110.632 174.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -90.26 28.91 1.33 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.824 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 14' ' ' SER . 25.3 t -84.55 -134.62 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.684 ' HB ' HE21 ' A' ' 167' ' ' GLN . 98.6 m -158.25 142.39 15.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.58 ' CD1' HD13 ' A' ' 15' ' ' ILE . 10.9 m-30 -44.12 -49.76 8.84 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -173.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.69 -23.23 62.45 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.234 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.684 HE21 ' HB ' ' A' ' 164' ' ' THR . 49.8 mt-30 -84.26 -51.52 6.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.737 HG13 HD11 ' A' ' 154' ' ' LEU . 61.5 t -56.34 -57.03 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.255 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.17 69.89 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.301 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.72 -36.72 84.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.795 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -73.28 -29.29 62.63 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.194 0.521 . . . . 0.0 110.81 -174.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.675 HG21 ' CD2' ' A' ' 2' ' ' PHE . 40.5 p -88.98 -21.1 23.69 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.851 0.834 . . . . 0.0 109.645 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.84 -46.28 45.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.973 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.419 ' H ' ' H ' ' A' ' 175' ' ' GLY . 3.6 p -157.23 -10.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.538 -170.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.795 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -65.12 -20.85 67.48 Favored Glycine 0 CA--C 1.502 -0.723 0 CA-C-O 122.029 0.794 . . . . 0.0 112.015 176.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.48 HG12 ' CZ ' ' A' ' 157' ' ' TYR . 16.1 m -40.55 113.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 112.789 -1.706 . . . . 0.0 112.707 175.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 64.66 104.8 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.989 -174.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 48.9 m80 . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.818 179.686 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.874 0.369 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.809 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 47.0 t80 -82.91 145.75 29.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.674 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -163.42 168.75 19.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.845 0.715 . . . . 0.0 109.094 172.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.595 HG13 ' HB2' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -88.26 122.59 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 165.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.496 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 63.9 m-20 -97.94 45.65 1.02 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 122.186 0.994 . . . . 0.0 110.366 -174.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.934 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -72.26 150.47 43.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.627 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 9' ' ' SER . 27.6 t70 -64.58 110.28 2.28 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.172 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.46 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.3 p -39.4 77.21 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.241 1.416 . . . . 0.0 113.338 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.7 t -170.84 -32.85 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.114 -1.403 . . . . 0.0 109.131 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.428 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 45.8 m-85 -89.44 18.39 5.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.099 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.6 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.39 76.82 0.92 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.619 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -174.27 -8.53 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.487 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 36.3 m-85 -73.5 133.58 43.66 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 122.825 -0.22 . . . . 0.0 110.478 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 17' ' ' ASP . 15.5 m -66.37 132.95 49.47 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 163.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.697 HD13 ' CD1' ' A' ' 165' ' ' PHE . 4.8 mm -46.78 -49.53 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 118.062 0.392 . . . . 0.0 111.697 -172.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.514 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 2.4 t-80 -58.48 -29.88 66.55 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.298 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' SER . 4.0 m-20 -68.2 -58.96 3.61 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.452 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.41 ' HB2' ' CG ' ' A' ' 13' ' ' TYR . 59.5 t80 -63.94 -45.56 88.67 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.661 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.934 ' HB3' HG21 ' A' ' 143' ' ' THR . 13.1 mt -57.13 -42.04 80.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.151 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.64 -40.4 97.89 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.08 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.08 -42.04 99.55 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 122.631 0.373 . . . . 0.0 111.354 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 39.9 t90 -60.35 -42.7 96.29 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.408 0.623 . . . . 0.0 109.724 176.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.091 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.0 t -63.58 -54.38 36.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 p -64.34 -35.18 80.03 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.808 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 19.7 t80 -55.65 -42.93 75.72 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.213 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.98 -21.21 79.15 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.919 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' OD2' ' HB2' ' A' ' 30' ' ' ASN . 29.9 t70 -73.81 104.6 4.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 117.201 0.5 . . . . 0.0 111.374 -175.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.655 HG12 ' HB1' ' A' ' 60' ' ' ALA . 24.9 m -67.27 -0.95 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.499 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 50.0 m-80 -81.42 -13.89 57.74 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.084 -0.385 . . . . 0.0 111.875 -171.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.538 ' CG ' ' H ' ' A' ' 32' ' ' THR . 8.9 t-160 55.68 -146.67 0.56 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 123.441 0.463 . . . . 0.0 110.26 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.538 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 27.0 p 57.5 138.28 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.225 1.41 . . . . 0.0 113.938 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 36' ' ' VAL . 46.6 t-20 -163.43 125.35 2.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.882 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.72 -13.56 63.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.001 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -111.13 15.68 21.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.663 0.268 . . . . 0.0 111.624 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.727 HG22 ' NE2' ' A' ' 108' ' ' GLN . 0.5 OUTLIER -134.82 134.32 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -177.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -112.56 -74.69 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.043 0.449 . . . . 0.0 111.745 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.16 -67.0 0.5 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.513 -173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.38 80.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.754 0.659 . . . . 0.0 111.592 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.447 HD22 ' HA ' ' A' ' 98' ' ' SER . 33.2 m-80 -79.79 157.76 26.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.449 177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.485 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 58.0 m -93.26 -24.43 18.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -168.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.17 135.93 3.09 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.005 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.36 59.63 0.16 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.245 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 39.2 m-85 62.93 159.17 0.07 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.996 0.903 . . . . 0.0 112.553 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.859 ' HE1' ' HD3' ' A' ' 104' ' ' PRO . 5.3 t80 -126.72 -36.2 2.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.054 -0.976 . . . . 0.0 112.072 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.85 -21.83 58.84 Favored Glycine 0 C--N 1.329 0.16 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.21 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.61 -138.87 4.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.467 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 m -77.08 -30.17 55.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.725 0.298 . . . . 0.0 110.912 -174.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.609 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.3 OUTLIER -164.25 27.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.604 -175.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.9 p -149.25 176.3 10.65 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.602 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.56 173.45 15.92 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.175 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.6 t -85.97 -3.17 58.87 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 28.6 tt0 -147.23 150.97 35.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.278 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -154.33 97.17 2.0 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.644 ' HB3' ' CD2' ' A' ' 105' ' ' TYR . . . -91.72 155.69 18.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.996 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.713 HG21 ' HG2' ' A' ' 139' ' ' MET . 9.4 mm -150.76 146.81 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 123.551 0.741 . . . . 0.0 109.254 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 18.0 t -122.36 170.95 9.42 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 173.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 30.0 t -55.54 141.51 36.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.384 0.611 . . . . 0.0 111.403 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 p -85.92 -20.36 29.12 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.113 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.655 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.11 -54.08 5.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.6 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 28' ' ' ASP . 34.4 p30 -119.64 -1.15 10.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.122 0.487 . . . . 0.0 111.909 -173.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.9 mm-40 42.11 38.01 1.0 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 36' ' ' VAL . 11.7 p -122.78 -57.15 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 O-C-N 122.306 -0.247 . . . . 0.0 110.783 169.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.557 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 19.8 m -58.87 106.84 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 110.495 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -116.74 179.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -168.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.712 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -157.42 133.43 9.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.753 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 22.4 t -115.05 114.18 45.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.264 -0.272 . . . . 0.0 110.684 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 53' ' ' GLN . . . -89.34 149.55 22.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.708 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.69 124.95 1.88 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.139 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -178.91 -115.5 0.46 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.449 ' HB3' ' CB ' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -148.38 48.62 1.04 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 176.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.2 mt -62.86 144.87 56.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.909 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.9 m -149.92 138.62 20.83 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.795 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' A' ' 49' ' ' LEU . 58.1 t80 -93.61 133.8 36.56 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.764 HG22 HE22 ' A' ' 123' ' ' GLN . 31.9 p -62.52 -42.83 99.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -173.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.438 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 8.2 tp 56.4 -94.45 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.079 0.552 . . . . 0.0 111.143 -176.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.438 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 3.5 m-85 -98.57 -1.75 40.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.137 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -75.45 167.05 22.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.647 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 23.8 mm-40 -46.99 -60.08 4.4 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -165.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HB2' HG21 ' A' ' 75' ' ' THR . 99.7 Cg_exo -49.75 -38.27 46.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.769 1.646 . . . . 0.0 113.17 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 65.07 117.0 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.427 0.632 . . . . 0.0 112.617 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 10.7 m-70 56.7 60.16 3.2 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.512 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.834 HG21 ' HA2' ' A' ' 126' ' ' GLY . 26.5 m -149.3 153.36 37.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.147 -172.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.746 HD23 HG11 ' A' ' 135' ' ' VAL . 14.8 tp -101.12 148.05 25.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.424 175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -156.05 -153.55 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 172.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.33 -167.31 24.81 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.258 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.591 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 12.5 tm0? -95.96 165.57 12.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.395 0.617 . . . . 0.0 111.594 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 33.5 tp -152.85 136.71 16.22 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.007 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -137.03 -54.48 0.71 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.112 0.482 . . . . 0.0 110.716 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.453 ' C ' HD22 ' A' ' 91' ' ' LEU . 4.5 p -112.56 155.37 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -175.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 3.0 mm? -138.59 161.52 36.9 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 172.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.644 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 55.5 m -151.6 112.53 4.26 Favored 'General case' 0 N--CA 1.435 -1.201 0 O-C-N 122.187 -0.321 . . . . 0.0 110.783 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.793 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.6 m-30 -99.77 139.13 35.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.605 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -179.79 163.86 31.38 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.522 174.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.43 132.79 34.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 117.129 0.464 . . . . 0.0 110.705 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.529 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . 68.23 112.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 174.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.441 HD11 ' HB1' ' A' ' 55' ' ' ALA . 54.8 mt -87.04 156.36 19.78 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.199 -0.589 . . . . 0.0 109.953 169.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.447 ' HA ' HD22 ' A' ' 40' ' ' ASN . 10.1 t -150.8 -177.55 6.06 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.789 174.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.56 -109.76 3.69 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.914 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.55 55.29 26.18 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -80.94 -71.88 0.45 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.255 -0.473 . . . . 0.0 110.092 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.1 p -97.26 -27.57 14.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 169.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.637 ' N ' ' HD2' ' A' ' 104' ' ' PRO . 3.0 m 178.45 -55.39 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.216 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.859 ' HD3' ' HE1' ' A' ' 45' ' ' TYR . 7.2 Cg_endo -49.56 131.81 28.98 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 124.139 3.226 . . . . 0.0 114.522 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.644 ' CD2' ' HB3' ' A' ' 55' ' ' ALA . 50.4 m-85 -76.45 169.42 18.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.91 170.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 69.9 p -151.49 142.64 23.21 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.1 mp -84.31 120.46 35.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 -176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.727 ' NE2' HG22 ' A' ' 36' ' ' VAL . 20.0 mt-30 -65.45 -41.44 93.43 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.138 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.48 89.9 6.56 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 171.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.51 92.37 0.13 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.3 2.667 . . . . 0.0 112.49 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 72.9 m-20 -99.32 -153.61 0.44 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.331 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.934 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -62.83 144.66 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.521 0.676 . . . . 0.0 111.549 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.496 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 72.0 m -136.6 179.31 6.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.397 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 95.6 m-85 -138.79 148.71 44.14 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.7 145.22 10.22 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.693 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.809 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.57 8.23 46.67 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.628 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.513 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 19.4 mt -56.73 -51.68 67.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.073 0.436 . . . . 0.0 109.947 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.411 ' HA ' ' NE2' ' A' ' 87' ' ' GLN . 63.0 t30 49.28 50.98 17.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.693 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 21.5 mt -106.8 107.62 18.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.704 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.591 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 17.9 p -105.82 131.07 53.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.974 0.416 . . . . 0.0 110.802 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.4 t -103.73 141.96 35.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.653 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 77.6 mt -74.22 169.45 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.805 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.764 HE22 HG22 ' A' ' 75' ' ' THR . 21.8 tp60 -58.96 -56.73 18.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.136 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.02 8.33 3.29 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.525 ' NE2' ' HA2' ' A' ' 129' ' ' GLY . 4.9 mm100 -77.04 52.86 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.165 0.507 . . . . 0.0 110.892 175.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.834 ' HA2' HG21 ' A' ' 83' ' ' THR . . . -62.95 109.22 2.55 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 113.066 -176.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.429 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 1.9 t-80 73.4 -40.16 0.46 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.137 0.975 . . . . 0.0 111.926 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HA ' HE21 ' A' ' 133' ' ' GLN . 27.2 t70 -81.86 -11.03 59.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.938 0.399 . . . . 0.0 110.5 -176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.525 ' HA2' ' NE2' ' A' ' 125' ' ' GLN . . . -64.37 125.73 32.03 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 170.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.512 ' O ' HG22 ' A' ' 134' ' ' VAL . 4.8 p -55.31 -29.4 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -169.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.0 m -65.9 -44.69 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.629 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.594 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.4 t-160 -62.49 -36.38 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.471 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.505 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 26.3 mt-30 -63.38 -63.73 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.885 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 130' ' ' VAL . 20.6 m -58.58 -39.46 75.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.387 -1.279 . . . . 0.0 112.807 -174.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.746 HG11 HD23 ' A' ' 84' ' ' LEU . 10.1 p -68.03 -44.39 84.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.593 0.235 . . . . 0.0 110.784 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.457 ' HD1' HG13 ' A' ' 135' ' ' VAL . 9.7 m-85 -73.03 -31.37 64.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.577 0.227 . . . . 0.0 110.453 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.54 -53.22 45.63 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.606 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -50.47 -50.91 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.07 0.462 . . . . 0.0 110.568 175.265 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.713 ' HG2' HG21 ' A' ' 56' ' ' ILE . 55.7 mtp -57.72 -27.55 63.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.486 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m -95.45 -12.27 26.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.6 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.75 29.01 19.84 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.868 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -116.14 126.11 53.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.012 0.434 . . . . 0.0 110.725 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.934 HG21 ' HB3' ' A' ' 19' ' ' LEU . 20.1 p -111.4 15.22 21.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.335 0.588 . . . . 0.0 110.794 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.12 -15.8 81.26 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.558 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.31 -32.2 15.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.095 0.474 . . . . 0.0 110.22 173.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.446 ' CD1' ' HZ ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -66.01 -37.6 86.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.322 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.669 ' HA ' ' CG1' ' A' ' 161' ' ' VAL . 11.8 pt-20 -54.45 -38.78 66.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.529 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -38.83 69.87 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.072 0.463 . . . . 0.0 110.251 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.71 -47.48 72.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.432 ' O ' HD22 ' A' ' 154' ' ' LEU . 90.8 mt -56.48 -42.67 78.66 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.156 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -56.8 -7.49 0.46 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.673 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.65 -38.64 61.24 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.526 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.78 -48.35 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.061 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.629 ' HB3' ' HB2' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -53.85 -37.4 63.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -176.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -59.62 -27.93 66.76 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.92 -29.5 69.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.472 0.653 . . . . 0.0 110.07 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.581 ' OH ' HG12 ' A' ' 176' ' ' VAL . 20.1 m-85 -106.55 -3.05 21.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.092 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 83.29 18.36 64.74 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.78 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.629 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 19.3 mt -95.2 -172.5 2.68 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.851 0.326 . . . . 0.0 111.0 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.5 p -166.69 -172.18 2.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.892 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.669 ' CG1' ' HA ' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -58.5 -25.53 28.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 176.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.427 ' HA ' ' HB3' ' A' ' 14' ' ' SER . 8.2 p30 -86.3 14.25 6.83 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.334 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.3 m -89.88 148.15 23.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.1 p -69.76 158.42 35.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.697 ' CD1' HD13 ' A' ' 15' ' ' ILE . 15.7 m-30 -54.47 -31.78 56.43 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 169.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.37 -62.17 1.86 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.938 174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.2 -48.39 80.25 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.593 HG13 HD11 ' A' ' 154' ' ' LEU . 93.9 t -59.33 -55.54 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.58 0.229 . . . . 0.0 111.324 -177.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.595 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -57.22 -48.02 79.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.21 81.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.748 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -76.5 -27.29 55.99 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.065 0.46 . . . . 0.0 111.144 -176.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.792 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 22.5 p -91.95 -19.9 21.94 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.999 0.904 . . . . 0.0 109.981 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.83 -49.04 16.72 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.047 177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.08 -10.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.451 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.748 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -67.21 -19.67 70.5 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-O 121.984 0.769 . . . . 0.0 111.241 175.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.581 HG12 ' OH ' ' A' ' 157' ' ' TYR . 16.1 m -50.94 78.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 112.665 -1.768 . . . . 0.0 112.845 171.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 175' ' ' GLY . 27.9 mt-30 -87.92 5.74 39.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.939 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 45.2 t60 . . . . . 0 C--O 1.249 1.05 0 O-C-N 123.856 0.723 . . . . 0.0 110.133 -178.735 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 121.016 0.436 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.79 ' O ' ' HB ' ' A' ' 172' ' ' THR . 28.5 t80 -68.22 153.99 42.62 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.124 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 p -169.37 159.29 8.59 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.93 174.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' A' ' 169' ' ' ALA . 25.6 m -93.43 114.36 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.257 174.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.572 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.0 m-80 -94.55 52.42 1.54 Allowed 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.934 0.873 . . . . 0.0 110.648 -173.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.844 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 17.4 p90 -76.95 151.18 35.81 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.234 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 9' ' ' SER . 18.5 t70 -62.74 103.85 0.48 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 172.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 6.2 p -37.01 78.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 O-C-N 124.74 1.275 . . . . 0.0 113.464 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 7' ' ' ASP . 22.9 t -174.63 -29.08 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.684 175.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.51 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 68.2 m-85 -93.67 15.15 16.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.286 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.533 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -69.22 70.55 0.47 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.57 -173.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' H ' ' H ' ' A' ' 13' ' ' TYR . . . -169.78 0.02 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.516 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 28.5 m-85 -86.25 136.02 33.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.73 -0.235 . . . . 0.0 110.411 173.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 163' ' ' SER . 19.7 m -68.99 134.5 49.56 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 160.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.596 HD13 ' CD1' ' A' ' 165' ' ' PHE . 5.1 mm -48.31 -48.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 118.389 0.54 . . . . 0.0 111.705 -172.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -57.65 -30.86 65.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.628 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.0 -46.87 55.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.795 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.42 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 68.7 t80 -72.64 -46.13 55.53 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.906 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.622 ' HB3' HG21 ' A' ' 143' ' ' THR . 14.6 mt -56.59 -34.2 66.95 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.288 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -57.69 -45.06 93.77 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.137 173.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -61.65 -41.37 97.42 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.858 0.361 . . . . 0.0 111.136 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.68 ' HZ2' ' CD1' ' A' ' 66' ' ' PHE . 22.3 t90 -54.71 -51.72 64.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.638 176.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.03 -24.41 63.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.052 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.2 t -61.5 -51.14 69.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.727 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -65.45 -32.12 73.57 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.759 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.686 ' HB2' HG21 ' A' ' 64' ' ' THR . 19.8 t80 -59.4 -37.2 77.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.848 0.356 . . . . 0.0 110.264 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.99 -18.41 77.71 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.292 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.603 ' O ' ' HB2' ' A' ' 61' ' ' ASN . 25.1 t70 -75.57 93.29 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.185 0.517 . . . . 0.0 111.835 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.922 HG12 ' HB1' ' A' ' 60' ' ' ALA . 22.8 m -63.24 -3.14 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.768 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -88.0 -20.42 25.85 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -170.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.573 ' CG ' ' H ' ' A' ' 32' ' ' THR . 0.8 OUTLIER 57.91 -137.68 0.91 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.608 0.363 . . . . 0.0 111.209 172.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.573 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 56.2 p 63.52 128.64 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.764 1.625 . . . . 0.0 113.912 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -170.93 131.58 0.83 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.006 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.42 -9.28 61.0 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.466 0.947 . . . . 0.0 115.466 -170.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.548 ' ND2' HG21 ' A' ' 109' ' ' VAL . 9.8 p30 -104.83 -18.73 14.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.807 0.813 . . . . 0.0 110.718 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' A' ' 63' ' ' VAL . 49.3 t -87.72 114.04 25.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.376 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -101.24 -70.3 0.75 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.773 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.43 -73.19 0.31 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.848 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 69.18 86.5 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.784 -173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -80.89 141.58 34.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.234 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 51.5 m -71.81 -36.35 70.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.78 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.587 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 108.13 -123.09 6.96 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.584 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.56 64.18 2.11 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.898 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 60.56 -176.98 0.11 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.43 0.634 . . . . 0.0 112.708 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -144.61 -56.63 0.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.826 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.31 22.18 21.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.076 -173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.25 -179.47 40.84 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.453 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.3 m -81.48 -68.3 0.7 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.851 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 14.0 mt -76.56 -31.03 57.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.578 -176.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.54 ' HB3' ' HA ' ' A' ' 73' ' ' THR . 11.0 p -147.9 163.74 35.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.558 -175.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 172.3 39.59 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.65 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.6 m 65.87 -60.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.517 0.727 . . . . 0.0 112.709 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -95.66 159.53 14.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.881 0.372 . . . . 0.0 111.072 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' HD2' HG21 ' A' ' 135' ' ' VAL . 1.5 t80 -153.32 99.22 2.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.858 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -93.12 144.96 24.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.433 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.676 HG13 ' HG2' ' A' ' 139' ' ' MET . 27.8 mm -146.25 127.65 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.036 0.446 . . . . 0.0 110.85 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.553 ' HB3' ' HA ' ' A' ' 41' ' ' SER . 18.9 t -112.69 151.87 29.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.523 174.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.507 ' OG ' ' HB3' ' A' ' 61' ' ' ASN . 47.0 t -49.99 136.05 19.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.121 0.486 . . . . 0.0 112.079 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.74 27.57 3.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.296 0.569 . . . . 0.0 111.321 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.922 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -157.65 -33.39 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.991 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.603 ' HB2' ' O ' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -103.33 -14.61 16.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.672 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' SER . 3.8 mm-40 31.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 113.748 -1.569 . . . . 0.0 115.213 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.534 ' HB ' ' CE1' ' A' ' 31' ' ' HIS . 10.4 p -138.21 -44.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.269 169.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 26' ' ' PHE . 38.6 m -63.03 97.54 0.11 Allowed 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -117.1 171.12 8.14 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.293 -174.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.68 ' CD1' ' HZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -158.0 123.89 4.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.009 -178.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.2 t -105.56 102.57 14.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.886 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.417 ' HA ' HD13 ' A' ' 91' ' ' LEU . . . -85.43 154.58 21.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.033 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.96 127.99 2.35 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.777 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.11 -108.52 0.22 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -146.75 45.34 1.19 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.511 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 41.6 mt -64.26 124.75 22.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.279 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 31.6 m -137.35 119.13 15.13 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.931 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.505 ' HB3' ' HB3' ' A' ' 49' ' ' LEU . 47.1 t80 -68.36 122.94 19.44 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.597 HG22 HE22 ' A' ' 123' ' ' GLN . 82.7 p -63.7 -33.48 75.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.448 ' HB3' ' H ' ' A' ' 77' ' ' PHE . 11.7 tp 52.3 -92.27 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.448 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 20.2 m-85 -98.91 0.1 43.39 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.738 -174.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.547 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 93.1 m-20 -73.18 170.34 15.17 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.066 -0.254 . . . . 0.0 110.954 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.624 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 10.9 mm-40 -48.94 -53.51 37.08 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -169.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 53.0 Cg_exo -56.83 -41.95 69.91 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 121.513 1.475 . . . . 0.0 112.221 176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 67.95 130.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.77 0.795 . . . . 0.0 112.837 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 54.59 47.56 22.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.605 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.515 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -142.79 178.25 7.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.65 -174.123 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.842 HD23 HG11 ' A' ' 135' ' ' VAL . 18.1 tp -126.38 82.51 2.08 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -173.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -89.23 146.56 24.67 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 171.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.576 ' H ' HG21 ' A' ' 131' ' ' VAL . . . -168.09 178.31 41.86 Favored Glycine 0 N--CA 1.439 -1.155 0 C-N-CA 119.401 -1.38 . . . . 0.0 114.006 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 11.4 tm0? -97.65 167.7 10.8 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 165.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.559 ' HG ' HD12 ' A' ' 117' ' ' LEU . 27.9 tp -148.72 126.35 11.74 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.584 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HA ' ' H ' ' A' ' 118' ' ' ASN . 12.6 t70 -126.7 -48.9 1.51 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.172 0.51 . . . . 0.0 110.485 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.461 ' O ' HD22 ' A' ' 91' ' ' LEU . 19.4 p -132.81 158.92 41.25 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 122.005 0.907 . . . . 0.0 113.034 -173.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.1 mm? -134.9 169.11 17.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.772 -1.558 . . . . 0.0 106.878 174.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 19.8 t -163.06 99.38 0.96 Allowed 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.819 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.685 ' CE1' HD11 ' A' ' 138' ' ' LEU . 1.2 m-30 -93.39 134.74 35.32 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.505 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -169.82 163.42 36.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 118.151 -1.976 . . . . 0.0 115.18 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.58 104.83 15.69 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.466 -0.867 . . . . 0.0 111.448 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.63 112.37 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.649 -1.159 . . . . 0.0 113.808 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD13 ' HB3' ' A' ' 105' ' ' TYR . 46.7 mt -85.9 160.59 19.37 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.101 -0.646 . . . . 0.0 110.041 171.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 t -143.4 172.9 12.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.252 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.42 -123.55 6.29 Favored Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.2 21.61 75.77 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.571 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -87.4 -85.6 0.17 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -126.9 29.06 5.71 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.008 0.908 . . . . 0.0 108.883 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.5 p -141.46 161.0 54.84 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.65 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -65.19 156.42 63.06 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.534 2.822 . . . . 0.0 111.659 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.587 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 62.9 m-85 -73.63 149.08 42.25 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.366 -174.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 p -146.38 140.65 26.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.954 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.716 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.3 mp -78.63 133.26 30.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 -173.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -64.92 -44.22 90.22 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.421 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.548 HG21 ' ND2' ' A' ' 35' ' ' ASN . 16.9 t -118.17 91.64 40.79 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 13.3 Cg_endo -56.66 101.91 0.1 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 123.234 2.622 . . . . 0.0 112.969 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -93.02 -162.39 0.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.924 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.844 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 41.3 t -60.11 128.69 21.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 122.333 1.063 . . . . 0.0 112.453 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.572 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 61.2 m -119.37 178.94 4.35 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.306 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.532 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 94.0 m-85 -140.42 146.35 38.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -161.29 140.44 6.64 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 119.704 -1.236 . . . . 0.0 112.402 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.725 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.51 12.84 37.06 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.996 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.559 HD12 ' HG ' ' A' ' 88' ' ' LEU . 48.5 mt -56.41 -53.92 51.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.557 ' H ' ' HA ' ' A' ' 89' ' ' ASP . 52.7 t30 51.39 50.87 18.0 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.158 0.98 . . . . 0.0 110.257 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 19.4 mt -104.79 105.99 16.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.087 175.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 9.8 p -105.3 129.97 53.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.161 0.505 . . . . 0.0 110.617 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.883 ' HB3' HE22 ' A' ' 125' ' ' GLN . 74.7 m -103.73 165.91 10.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.418 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.542 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 44.4 mt -87.15 154.22 20.9 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.355 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.597 HE22 HG22 ' A' ' 75' ' ' THR . 17.7 tp60 -57.88 -60.0 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.828 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.616 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -77.0 17.35 0.45 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -168.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 1.066 ' HB3' ' HA ' ' A' ' 128' ' ' ASP . 26.9 mt-30 -74.67 -40.31 61.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.829 0.347 . . . . 0.0 110.852 173.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 80' ' ' PRO . . . 83.47 -106.89 2.86 Favored Glycine 0 CA--C 1.51 -0.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.872 177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.606 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 5.6 t-80 -68.01 -12.68 61.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 168.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 1.066 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 0.0 OUTLIER 78.49 172.5 0.18 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 156.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.417 ' N ' ' CG ' ' A' ' 128' ' ' ASP . . . -85.31 -35.69 11.85 Favored Glycine 0 N--CA 1.433 -1.531 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.314 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.551 ' O ' HG22 ' A' ' 134' ' ' VAL . 9.8 p -154.08 -40.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.576 HG21 ' H ' ' A' ' 86' ' ' GLY . 13.6 m -67.17 -54.62 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 119.963 1.256 . . . . 0.0 112.697 -174.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.606 ' ND1' ' HA ' ' A' ' 127' ' ' HIS . 4.5 t-160 -58.67 -37.13 75.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.424 ' HG2' ' OD1' ' A' ' 128' ' ' ASP . 51.6 mm-40 -61.56 -65.91 0.62 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.502 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 130' ' ' VAL . 31.5 m -56.62 -39.29 61.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.937 -1.029 . . . . 0.0 113.035 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.842 HG11 HD23 ' A' ' 84' ' ' LEU . 10.0 p -67.96 -40.57 83.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -74.34 -30.68 62.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.328 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.93 -49.32 79.97 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 173.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.685 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -49.42 -59.53 3.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.576 0.703 . . . . 0.0 109.566 174.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.676 ' HG2' HG13 ' A' ' 56' ' ' ILE . 71.8 mtm -55.97 -25.27 43.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.486 -1.234 . . . . 0.0 113.183 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.4 m -91.66 0.04 57.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.665 0.269 . . . . 0.0 111.502 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.08 29.49 64.59 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.232 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -115.76 121.93 43.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.467 . . . . 0.0 110.315 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.641 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 49.8 p -91.23 -16.96 26.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.022 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -51.38 -42.69 50.77 Favored Glycine 0 C--N 1.334 0.444 0 O-C-N 123.836 0.71 . . . . 0.0 113.477 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.75 -42.19 82.16 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -66.73 -39.76 88.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -178.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.971 ' HG2' HG21 ' A' ' 161' ' ' VAL . 52.5 mt-10 -54.13 -43.2 70.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.266 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.2 -34.59 75.13 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.902 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.2 71.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.171 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 90.6 mt -54.2 -44.2 71.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.904 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -55.52 -8.87 0.41 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.359 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.75 -45.16 45.51 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.235 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.3 mp -81.0 -45.92 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-O 120.645 0.259 . . . . 0.0 110.924 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.797 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -57.89 -42.95 85.73 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.0 -20.71 66.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.441 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.67 -33.14 75.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.363 0.601 . . . . 0.0 109.852 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -99.31 -5.65 29.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.018 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 88.42 17.36 57.27 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.991 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 17.3 mt -97.24 -174.28 2.9 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.938 0.369 . . . . 0.0 110.158 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -156.57 -176.77 6.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.971 HG21 ' HG2' ' A' ' 147' ' ' GLU . 11.9 p -56.99 -26.71 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.903 0.382 . . . . 0.0 111.707 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.53 30.55 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.06 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 14' ' ' SER . 13.7 t -98.62 147.76 24.49 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 168' ' ' VAL . 3.5 m -70.74 145.22 50.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.442 -175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.596 ' CD1' HD13 ' A' ' 15' ' ' ILE . 12.9 m-30 -47.98 -38.63 17.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 0.0 110.385 172.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.86 -54.02 47.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.18 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -63.57 -51.05 67.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.222 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.797 HG13 HD11 ' A' ' 154' ' ' LEU . 17.4 t -58.24 -55.91 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 O-C-N 123.019 0.2 . . . . 0.0 110.984 -177.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.455 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . . . -53.54 -45.51 69.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.307 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -64.9 -36.51 84.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.205 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.09 -25.81 58.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.31 0.576 . . . . 0.0 110.496 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.79 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 40.1 p -88.97 -13.05 39.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.081 0.943 . . . . 0.0 109.556 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -69.89 -33.34 72.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.944 175.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.8 p -175.71 -29.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.317 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 115.65 112.11 2.81 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.6 m -139.95 166.49 20.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.83 0.348 . . . . 0.0 111.391 -170.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -152.56 121.35 6.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.589 176.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.315 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.03 0.443 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.82 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 36.1 t80 -91.58 147.28 23.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.424 -176.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -166.0 166.87 17.02 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.879 0.737 . . . . 0.0 109.146 171.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.788 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -91.28 126.96 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.607 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 31.5 m-80 -104.25 56.2 0.72 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.72 0.771 . . . . 0.0 111.207 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.862 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 53.8 p90 -69.14 152.25 45.36 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.62 176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -69.0 67.67 0.15 Allowed 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 t 17.66 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.702 1.601 . . . . 0.0 113.811 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.1 t -168.99 -28.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.489 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.564 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 82.9 m-85 -87.73 12.71 12.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.702 -176.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 165' ' ' PHE . . . -70.4 68.89 0.7 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.062 -0.59 . . . . 0.0 113.44 -172.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.66 19.74 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 27.6 m-85 -106.17 135.26 47.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.672 -0.264 . . . . 0.0 110.316 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' HIS . 1.8 m -74.74 67.93 1.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.719 HD13 ' CD1' ' A' ' 165' ' ' PHE . 3.4 mm 28.28 -76.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 114.141 -172.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.485 ' H ' HG22 ' A' ' 161' ' ' VAL . 11.5 t-160 -50.74 -29.16 10.72 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.673 0.389 . . . . 0.0 111.186 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -53.35 -62.73 1.46 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.881 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.421 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 84.5 t80 -66.95 -38.78 86.75 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.341 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.887 HD22 ' HE2' ' A' ' 93' ' ' PHE . 14.3 mt -54.31 -40.42 67.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.07 93.24 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.138 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 24' ' ' SER . 5.5 tt0 -61.15 -38.49 86.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 122.989 0.516 . . . . 0.0 111.52 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.488 ' O ' HG21 ' A' ' 64' ' ' THR . 40.7 t90 -55.63 -45.06 77.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.957 173.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 26' ' ' PHE . . . -72.8 -13.69 61.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.909 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 36.9 t -63.54 -56.22 17.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.701 0.286 . . . . 0.0 110.536 176.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.6 p -65.2 -31.16 72.19 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.188 0.518 . . . . 0.0 110.331 176.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.656 ' HA ' ' HB3' ' A' ' 62' ' ' GLN . 31.7 t80 -64.45 -28.17 69.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.876 175.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.25 75.71 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 116.039 -0.528 . . . . 0.0 113.795 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 32.6 t70 -78.51 165.64 23.51 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.462 0.631 . . . . 0.0 111.446 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.1 m -142.02 14.88 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.662 0.785 . . . . 0.0 112.144 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' A' ' 31' ' ' HIS . 37.8 m-80 -83.06 -22.77 33.42 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.455 ' H ' ' HB2' ' A' ' 61' ' ' ASN . 41.9 t-80 79.66 62.38 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.925 0.89 . . . . 0.0 112.258 169.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.17 145.62 25.55 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.877 ' HB3' HG23 ' A' ' 36' ' ' VAL . 56.1 t-20 -166.29 127.26 1.75 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.152 171.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.08 -1.51 19.98 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.46 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -115.02 6.81 15.35 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.788 0.327 . . . . 0.0 110.91 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.877 HG23 ' HB3' ' A' ' 33' ' ' ASN . 12.6 t -87.55 114.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.271 0.558 . . . . 0.0 111.804 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.6 p -100.22 -73.9 0.62 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.284 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -89.24 -67.02 0.87 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.744 -172.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.496 ' H ' ' NE2' ' A' ' 108' ' ' GLN . . . 74.14 74.79 0.12 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.656 176.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -86.71 156.09 20.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.783 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.411 ' HA ' ' HB3' ' A' ' 57' ' ' SER . 58.5 m -96.84 -33.57 11.6 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.675 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 112.96 -135.8 12.95 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.944 -1.122 . . . . 0.0 112.932 176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.609 ' HA2' ' HE1' ' A' ' 54' ' ' TYR . . . 80.99 74.61 1.13 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.753 -176.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.576 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 46.0 m-85 66.11 -178.19 0.19 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.54 ' CZ ' ' HG3' ' A' ' 104' ' ' PRO . 23.0 t80 -152.95 -71.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.247 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.04 45.45 3.3 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.203 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 170.69 36.51 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.808 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.9 m -76.04 -25.49 55.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.035 0.445 . . . . 0.0 110.113 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -167.79 32.33 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 p -158.86 166.9 30.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.205 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 146.81 -134.33 5.21 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.632 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.447 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 31.6 m -135.54 6.07 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.496 0.188 . . . . 0.0 110.918 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -141.61 143.33 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.318 . . . . 0.0 110.776 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.609 ' HE1' ' HA2' ' A' ' 43' ' ' GLY . 2.6 t80 -154.94 96.06 1.81 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.595 ' HB1' HD11 ' A' ' 97' ' ' LEU . . . -96.05 157.77 15.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.022 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.009 HG13 ' HG2' ' A' ' 139' ' ' MET . 11.6 mm -147.31 121.5 2.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.574 0.749 . . . . 0.0 110.15 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.54 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 8.9 t -138.28 112.51 8.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.316 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.702 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER 41.53 160.41 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 118.574 2.805 . . . . 0.0 118.574 -178.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.421 ' H ' ' HG3' ' A' ' 62' ' ' GLN . 20.7 p -132.06 13.39 4.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.726 -2.033 . . . . 0.0 109.915 163.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -166.04 -58.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.264 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.628 ' O ' HG12 ' A' ' 63' ' ' VAL . 7.2 t30 -146.1 -33.68 0.32 Allowed 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.702 HE21 ' HA ' ' A' ' 58' ' ' SER . 0.5 OUTLIER -53.05 54.7 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 126.564 2.415 . . . . 0.0 113.457 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.802 HG21 HG22 ' A' ' 36' ' ' VAL . 1.4 p -66.4 -6.64 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.513 ' N ' ' C ' ' A' ' 62' ' ' GLN . 92.9 m -53.14 112.05 0.8 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 110.099 -3.228 . . . . 0.0 107.366 161.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.41 -179.39 4.18 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.35 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.849 ' HZ ' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -160.3 121.64 3.09 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.813 -177.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.6 112.82 41.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.269 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.634 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -88.92 152.71 21.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.797 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 52' ' ' SER . . . -150.84 122.96 1.44 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.91 -110.16 0.26 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.624 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 2.7 t-20 -147.86 37.4 0.88 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.503 0.668 . . . . 0.0 109.235 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -59.24 139.92 56.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.787 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -149.62 134.39 17.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.722 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.622 ' HB3' ' HB2' ' A' ' 49' ' ' LEU . 58.4 t80 -84.61 127.44 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.637 HG22 HE22 ' A' ' 123' ' ' GLN . 44.5 p -62.55 -33.55 75.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.648 -170.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.469 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 9.6 tp 51.57 -95.53 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 123.954 0.784 . . . . 0.0 111.827 -176.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.469 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 5.3 m-85 -98.84 2.58 46.88 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.938 -175.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -76.04 178.34 6.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.549 0.214 . . . . 0.0 111.206 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.826 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 19.6 mm-40 -47.51 -62.71 1.88 Allowed Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -170.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 54.2 Cg_exo -55.35 -38.02 94.17 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.777 1.651 . . . . 0.0 112.873 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 66.63 122.96 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.837 0.827 . . . . 0.0 112.855 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 93.4 m-70 53.27 54.41 10.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.425 -1.261 . . . . 0.0 111.484 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -146.49 169.0 19.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.307 -176.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.672 HD23 HG11 ' A' ' 135' ' ' VAL . 11.2 tp -106.58 149.06 27.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.819 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 86' ' ' GLY . 20.0 p90 -156.45 -154.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.417 ' O ' HG11 ' A' ' 131' ' ' VAL . . . 99.03 -164.25 20.48 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.904 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 71' ' ' ASN . 6.3 tm0? -99.98 164.51 11.97 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.442 0.639 . . . . 0.0 111.59 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.51 ' CB ' HG12 ' A' ' 131' ' ' VAL . 30.4 tp -151.58 129.95 12.08 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.726 178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.572 ' HA ' ' HB2' ' A' ' 117' ' ' LEU . 17.4 t70 -136.0 -60.22 0.73 Allowed 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.387 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.431 ' C ' HD22 ' A' ' 91' ' ' LEU . 13.2 p -97.99 149.81 22.04 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.762 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.66 ' HB2' ' HB2' ' A' ' 114' ' ' PHE . 2.9 mm? -134.53 169.55 17.12 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 113' ' ' SER . 9.5 t -163.76 109.55 1.07 Allowed 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.147 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.887 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.9 m-30 -97.77 140.43 32.16 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.661 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.97 172.01 42.8 Favored Glycine 0 C--N 1.314 -0.684 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 173.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.85 ' H ' HG13 ' A' ' 109' ' ' VAL . 24.9 m-20 -97.77 124.86 42.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 119.362 1.581 . . . . 0.0 111.414 -177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 63' ' ' VAL . . . 87.47 116.06 1.13 Allowed Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.477 -0.783 . . . . 0.0 113.091 171.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.595 HD11 ' HB1' ' A' ' 55' ' ' ALA . 41.0 mt -86.55 153.75 21.59 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.12 168.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.8 t -138.59 168.8 18.99 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.45 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.33 -123.57 10.42 Favored Glycine 0 N--CA 1.443 -0.875 0 O-C-N 123.947 0.779 . . . . 0.0 111.65 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.04 29.68 74.89 Favored Glycine 0 C--N 1.318 -0.45 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.309 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -89.47 -88.76 0.16 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 p -112.68 4.81 17.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.83 0.824 . . . . 0.0 108.835 168.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -112.52 165.43 13.05 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.432 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.54 ' HG3' ' CZ ' ' A' ' 45' ' ' TYR . 14.9 Cg_exo -73.15 167.49 27.21 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 123.155 2.57 . . . . 0.0 112.364 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.675 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 37.8 m-85 -71.85 151.62 43.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.361 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.9 p -149.07 143.95 26.37 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.681 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.674 ' H ' HD12 ' A' ' 107' ' ' ILE . 3.5 mp -80.88 129.21 37.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.044 0.45 . . . . 0.0 110.857 -175.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.496 ' NE2' ' H ' ' A' ' 39' ' ' ALA . 71.7 mt-30 -64.23 -59.07 4.85 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.578 176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.85 HG13 ' H ' ' A' ' 95' ' ' ASP . 2.4 p -109.15 87.53 4.91 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 121.628 0.728 . . . . 0.0 110.017 172.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 31.7 Cg_endo -65.09 122.71 10.55 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.95 2.433 . . . . 0.0 111.597 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' OD1' HG23 ' A' ' 112' ' ' VAL . 3.9 t0 -118.91 -143.27 0.36 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.862 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 19.4 t -61.16 115.15 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 122.338 1.066 . . . . 0.0 112.344 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.607 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 69.1 m -101.86 177.3 4.94 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.811 174.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.66 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 95.5 m-85 -138.56 149.62 45.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -163.57 141.67 7.29 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.191 -1.004 . . . . 0.0 111.807 177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.82 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 102.02 11.83 35.95 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.704 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 89' ' ' ASP . 16.8 mt -55.8 -46.73 77.94 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 117.343 0.572 . . . . 0.0 109.723 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 t30 49.46 45.61 23.81 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 122.022 0.915 . . . . 0.0 110.244 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 20.7 mt -108.6 115.82 30.82 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.015 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 38.8 p -111.2 132.64 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.283 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.5 m -101.76 147.97 25.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.28 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 69.9 mt -80.41 157.13 26.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.782 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.637 HE22 HG22 ' A' ' 75' ' ' THR . 19.0 tp60 -48.27 -54.41 13.78 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.488 0.493 . . . . 0.0 112.16 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.448 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -77.54 3.06 14.53 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -170.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.602 ' HB3' ' N ' ' A' ' 129' ' ' GLY . 37.2 mt-30 -78.86 58.16 2.29 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.014 0.435 . . . . 0.0 110.516 176.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.83 103.96 0.65 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.454 ' HA ' ' CG ' ' A' ' 132' ' ' HIS . 3.3 t-80 79.39 -29.06 0.14 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.845 0.858 . . . . 0.0 111.397 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.588 ' HA ' HE21 ' A' ' 133' ' ' GLN . 14.7 t70 -80.38 -30.43 37.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.543 0.211 . . . . 0.0 111.307 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.602 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -55.79 129.48 47.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.627 -0.796 . . . . 0.0 111.565 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.5 m -50.87 -33.21 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.51 HG12 ' CB ' ' A' ' 88' ' ' LEU . 33.1 m -63.35 -47.16 93.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.796 0.331 . . . . 0.0 110.594 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.65 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 3.8 t-160 -63.5 -39.43 94.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.966 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.588 HE21 ' HA ' ' A' ' 128' ' ' ASP . 27.1 mm-40 -59.85 -64.7 0.85 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.842 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.4 t -53.89 -46.51 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.348 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.849 HG23 ' HZ ' ' A' ' 66' ' ' PHE . 11.0 p -65.86 -45.97 89.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.259 -175.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.414 ' HD1' HG13 ' A' ' 135' ' ' VAL . 12.5 m-85 -72.24 -27.5 62.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.818 0.342 . . . . 0.0 110.796 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.35 -53.29 33.44 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.596 HD21 HD12 ' A' ' 146' ' ' LEU . 0.2 OUTLIER -49.63 -49.59 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.1 0.56 . . . . 0.0 111.095 177.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 1.009 ' HG2' HG13 ' A' ' 56' ' ' ILE . 83.4 mtp -57.67 -30.75 65.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.034 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.6 t -91.3 -0.67 57.7 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.95 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.401 ' HA2' ' CZ3' ' A' ' 22' ' ' TRP . . . 84.26 9.47 81.95 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.698 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -98.82 103.96 15.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.565 0.698 . . . . 0.0 110.79 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.461 ' CB ' ' HB3' ' A' ' 19' ' ' LEU . 2.8 p -89.48 2.42 54.58 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.069 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.542 ' HA2' ' OE2' ' A' ' 147' ' ' GLU . . . -62.78 -31.21 79.47 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.735 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.59 -33.29 64.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.029 0.442 . . . . 0.0 110.557 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.623 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.4 OUTLIER -67.76 -33.6 75.17 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.612 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.921 ' HG2' HG21 ' A' ' 161' ' ' VAL . 46.1 mt-10 -52.91 -44.72 67.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.126 0.489 . . . . 0.0 110.165 175.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.78 -33.17 73.42 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.952 -175.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.57 64.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.32 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.2 mt -55.49 -45.37 77.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.831 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -58.64 -8.32 1.24 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.968 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -76.08 -41.68 26.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.541 -0.837 . . . . 0.0 111.035 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' A' ' 117' ' ' LEU . 3.8 mp -86.51 -49.03 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 C-N-CA 121.179 -0.208 . . . . 0.0 110.787 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.942 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -53.08 -40.93 64.42 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -61.67 -27.17 68.49 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.39 -34.22 77.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.227 0.537 . . . . 0.0 109.845 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.464 ' HE2' HG22 ' A' ' 153' ' ' ILE . 41.6 m-85 -95.63 -13.58 24.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.284 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 94.75 27.94 10.8 Favored Glycine 0 CA--C 1.521 0.42 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.602 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.427 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 2.0 mm? -109.15 -166.98 1.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.135 0.468 . . . . 0.0 110.952 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.6 p -163.52 171.91 15.17 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.38 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.921 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.5 p -52.55 -36.43 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -88.82 40.22 0.96 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -88.9 -105.51 0.08 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.744 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 168' ' ' VAL . 15.6 m -163.05 146.91 11.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.719 ' CD1' HD13 ' A' ' 15' ' ' ILE . 6.1 m-30 -52.96 -42.35 65.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.353 0.524 . . . . 0.0 111.111 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.63 -52.22 33.69 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.853 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -59.74 -46.3 89.57 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -176.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.942 HG13 HD11 ' A' ' 154' ' ' LEU . 89.6 t -60.52 -56.67 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.491 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.606 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -54.36 -44.65 72.37 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 123.447 0.467 . . . . 0.0 110.993 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.53 ' HB1' ' CG2' ' A' ' 176' ' ' VAL . . . -62.64 -40.87 98.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.648 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -74.49 -29.91 61.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.208 0.528 . . . . 0.0 110.57 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.694 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 38.3 p -85.74 -14.15 46.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.865 0.84 . . . . 0.0 109.624 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -67.48 -42.77 82.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.653 173.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.675 HG12 HG13 ' A' ' 176' ' ' VAL . 1.2 p 179.61 -28.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.599 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 171' ' ' ALA . . . 140.44 -56.52 0.61 Allowed Glycine 0 CA--C 1.498 -1.02 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.635 175.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.675 HG13 HG12 ' A' ' 174' ' ' VAL . 15.7 m 46.26 44.68 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.06 0.944 . . . . 0.0 113.389 169.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -141.76 152.63 43.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.223 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 83.3 t60 . . . . . 0 C--N 1.319 -0.732 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.588 177.196 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.87 0.366 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.796 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 t80 -86.62 149.63 24.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.98 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -172.22 167.51 5.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.62 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.66 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -90.35 125.54 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.579 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 27.0 m-80 -101.82 48.84 0.87 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.729 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.0 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.0 p90 -70.5 150.04 46.56 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.487 -1.233 . . . . 0.0 107.735 174.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 9' ' ' SER . 20.8 t70 -62.06 105.35 0.57 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.646 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 4.4 p -37.52 74.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 125.082 1.489 . . . . 0.0 113.894 177.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.1 t -174.2 -25.62 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.75 -1.568 . . . . 0.0 108.341 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.494 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 96.0 m-85 -92.39 15.5 13.81 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.731 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -73.08 68.12 1.38 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.322 -173.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.45 22.85 0.16 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.562 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 45.3 m-85 -114.31 131.26 56.58 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.017 175.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 163' ' ' SER . 11.4 p -68.13 132.44 47.21 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 161.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 165' ' ' PHE . 4.8 mm -46.56 -48.76 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -167.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -60.14 -30.37 69.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.648 0.261 . . . . 0.0 111.007 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -69.28 -49.17 58.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.371 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.462 ' HB2' ' CG ' ' A' ' 13' ' ' TYR . 72.0 t80 -70.72 -45.34 65.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.608 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.784 HD22 ' CE2' ' A' ' 93' ' ' PHE . 12.0 mt -56.92 -44.4 82.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 -177.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.77 -38.18 94.81 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.975 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 24' ' ' SER . 3.7 tt0 -64.87 -43.34 93.27 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 122.89 0.476 . . . . 0.0 111.463 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 54.4 t90 -62.43 -42.21 99.28 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.919 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.14 67.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.791 176.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 25.1 t -62.23 -54.14 45.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -35.64 81.45 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.056 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.605 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 20.0 t80 -56.07 -39.43 72.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.346 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.89 -29.51 73.68 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.463 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 61' ' ' ASN . 11.9 t70 -76.12 100.88 5.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.975 0.417 . . . . 0.0 110.705 -176.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.716 HG12 ' HB1' ' A' ' 60' ' ' ALA . 35.4 m -65.99 -1.68 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.426 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 52.1 m-80 -84.87 -5.8 59.34 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -169.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.5 t60 56.05 92.48 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 168.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.1 p -142.21 134.65 27.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.941 0.4 . . . . 0.0 111.659 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -171.52 129.0 0.68 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.198 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.04 -7.49 76.54 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 114.446 0.538 . . . . 0.0 114.446 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -116.38 3.57 13.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.849 0.825 . . . . 0.0 111.684 -175.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.537 HG22 ' HA3' ' A' ' 96' ' ' GLY . 45.6 t -101.83 116.39 45.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.6 p -103.08 -76.11 0.59 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.295 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.89 -68.92 0.3 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.902 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 72.41 83.86 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.527 0.68 . . . . 0.0 111.972 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -83.88 137.86 33.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.956 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -74.62 -37.74 62.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.49 134.74 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.135 -1.031 . . . . 0.0 112.348 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.55 59.19 0.11 Allowed Glycine 0 CA--C 1.518 0.246 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.901 -175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 49' ' ' LEU . 57.8 m-85 62.1 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.941 0.877 . . . . 0.0 113.326 -175.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 53' ' ' GLN . 50.5 t80 -91.75 -13.24 31.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.768 -178.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.83 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -81.58 -28.02 44.98 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.382 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.45 -118.6 0.75 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.899 -1.143 . . . . 0.0 113.084 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.1 m -76.62 -50.13 14.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.956 0.408 . . . . 0.0 110.281 -176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HA ' ' CD2' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -167.35 43.29 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.765 0.793 . . . . 0.0 109.782 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.642 ' HB3' ' HD1' ' A' ' 74' ' ' TYR . 20.9 p -154.03 -176.28 5.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.228 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.83 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 128.1 -172.43 19.14 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 t -92.95 -14.22 27.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.828 0.314 . . . . 0.0 111.265 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 14.9 tt0 -134.0 151.84 51.6 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.323 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.777 ' CD1' HD11 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -149.19 94.76 2.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.879 -173.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 67' ' ' VAL . . . -94.82 153.16 17.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.861 177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.042 HG13 ' HG2' ' A' ' 139' ' ' MET . 10.0 mm -146.43 140.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 10.9 t -131.92 97.36 4.15 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.542 0.211 . . . . 0.0 110.517 174.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.605 ' HA ' ' CZ ' ' A' ' 26' ' ' PHE . 33.1 t 18.48 115.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -175.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -19.5 65.89 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.425 -0.797 . . . . 0.0 110.472 171.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.716 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.02 -61.48 1.95 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.062 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 35.0 p30 -114.75 3.35 14.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.119 0.485 . . . . 0.0 111.59 -172.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 57' ' ' SER . 2.3 mm-40 39.79 38.26 0.43 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -176.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 64' ' ' THR . 9.1 p -129.37 -55.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.714 168.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 63' ' ' VAL . 4.5 m -58.0 101.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.243 0.544 . . . . 0.0 110.206 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -110.28 173.19 6.44 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -165.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.77 ' CE1' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -160.67 118.07 2.43 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.73 -176.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 79.2 t -103.53 107.46 22.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.627 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.77 ' HB2' ' CE1' ' A' ' 66' ' ' PHE . . . -91.12 157.14 17.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.91 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.11 135.62 4.95 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.201 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.34 -128.82 1.08 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.94 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 1.6 t-20 -146.34 72.89 1.3 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 0.0 109.383 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 54' ' ' TYR . 6.5 mt -92.14 166.93 12.39 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 122.377 1.084 . . . . 0.0 113.629 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.6 m -164.52 134.05 3.79 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 112.416 -2.175 . . . . 0.0 106.76 171.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.958 ' CE2' ' HB2' ' A' ' 76' ' ' LEU . 1.8 p90 -95.47 144.76 25.7 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.681 HG22 HE22 ' A' ' 123' ' ' GLN . 77.6 p -72.11 -68.4 0.47 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.958 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . 13.4 tp 57.4 -87.55 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.018 0.927 . . . . 0.0 111.295 -169.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.442 ' H ' ' HB3' ' A' ' 76' ' ' LEU . 21.8 m-85 -91.76 0.04 57.51 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.194 0.521 . . . . 0.0 110.897 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.524 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-80 -77.05 166.67 22.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.443 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.769 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 47.4 mm-40 -46.42 -61.54 2.56 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -168.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 77.2 Cg_exo -55.43 -40.42 85.61 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.935 1.756 . . . . 0.0 113.759 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 70.83 134.86 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.398 0.618 . . . . 0.0 112.483 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.4 m80 47.67 54.33 9.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.84 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.683 HG22 ' HE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -151.03 162.58 40.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.768 -171.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.0 tp -108.83 156.02 20.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.974 178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -158.21 -161.49 1.01 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.8 -159.04 22.81 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.26 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 120' ' ' SER . 3.3 tm0? -97.94 169.95 9.28 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.543 0.687 . . . . 0.0 112.742 -170.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.566 ' CD2' HG21 ' A' ' 134' ' ' VAL . 27.3 tp -155.34 135.51 13.06 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.53 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -134.94 -50.26 0.76 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.958 0.408 . . . . 0.0 111.28 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.508 ' O ' HD13 ' A' ' 91' ' ' LEU . 5.7 p -130.2 157.12 43.34 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -171.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.739 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.4 mm? -138.02 160.55 39.05 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 66' ' ' PHE . 9.1 m -147.93 108.82 4.22 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 117.824 0.284 . . . . 0.0 110.951 176.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.784 ' CE2' HD22 ' A' ' 19' ' ' LEU . 4.6 m-30 -91.56 147.87 22.69 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.649 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.5 -152.33 11.35 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.732 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.57 126.97 30.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.074 0.464 . . . . 0.0 110.742 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 36' ' ' VAL . . . 76.2 110.09 0.12 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.836 174.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.0 mt -83.96 141.4 31.26 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.38 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -99.08 154.42 18.13 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.535 174.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.08 114.74 5.06 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.202 -166.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.48 -13.87 75.07 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 168.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.41 ' OD2' HG23 ' A' ' 102' ' ' THR . 26.9 t70 64.81 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.108 0.963 . . . . 0.0 111.118 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.41 HG23 ' OD2' ' A' ' 101' ' ' ASP . 76.3 p -99.42 -0.08 41.63 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.813 0.815 . . . . 0.0 109.213 176.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.0 m -113.87 166.18 11.95 Favored Pre-proline 0 N--CA 1.443 -0.819 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.171 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -64.27 152.05 82.92 Favored 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.983 2.455 . . . . 0.0 113.035 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -66.03 155.03 37.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.579 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 p -142.38 155.64 45.15 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.347 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.706 ' H ' HD12 ' A' ' 107' ' ' ILE . 1.1 mp -89.1 122.76 40.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.414 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -63.98 -39.71 94.75 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.185 176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.0 88.16 9.75 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.487 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.16 96.55 0.27 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 123.268 2.645 . . . . 0.0 112.838 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 33.1 m-20 -94.66 -154.47 0.42 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.264 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.0 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 46.6 t -58.31 138.5 19.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.707 0.765 . . . . 0.0 111.931 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.579 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 75.6 m -129.11 178.8 6.15 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.391 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.535 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 95.9 m-85 -138.82 146.79 41.72 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -160.58 142.06 7.86 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.921 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.796 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 101.22 11.15 40.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.433 -0.889 . . . . 0.0 113.411 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.442 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 26.3 mt -57.08 -50.5 72.59 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.0 t30 55.43 43.35 28.85 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.695 0.76 . . . . 0.0 110.576 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 28.8 mt -106.11 112.56 25.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.381 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 34.5 p -107.04 130.84 54.6 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.815 0.341 . . . . 0.0 110.523 177.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.498 ' HB2' HG22 ' A' ' 131' ' ' VAL . 26.0 m -108.28 145.8 33.83 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.827 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -80.96 165.14 22.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.503 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.681 HE22 HG22 ' A' ' 75' ' ' THR . 17.8 tp60 -52.93 -61.1 2.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.583 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.487 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -79.66 14.61 1.62 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -168.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.462 ' HB3' ' CA ' ' A' ' 129' ' ' GLY . 34.8 mt-30 -77.15 -25.9 52.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.289 174.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 56.38 -118.1 10.72 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.221 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.476 ' HA ' ' ND1' ' A' ' 132' ' ' HIS . 4.7 t-80 -80.24 -22.76 41.41 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 122.537 0.335 . . . . 0.0 110.765 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.643 ' HA ' HE21 ' A' ' 133' ' ' GLN . 15.1 t70 -84.82 -19.63 32.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.462 ' CA ' ' HB3' ' A' ' 125' ' ' GLN . . . -59.45 126.59 42.63 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 174.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.651 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 18.2 m -52.69 -32.62 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -172.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.76 ' O ' HG23 ' A' ' 135' ' ' VAL . 18.1 m -63.63 -49.67 81.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.157 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.683 ' HE1' HG22 ' A' ' 83' ' ' THR . 4.8 t-160 -57.02 -41.25 78.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.035 0.445 . . . . 0.0 110.008 178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.651 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 6.1 mm-40 -56.73 -63.97 1.03 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.31 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 88' ' ' LEU . 16.1 m -56.63 -39.21 61.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.637 -1.165 . . . . 0.0 113.469 -172.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 131' ' ' VAL . 2.2 t -66.1 -57.81 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.05 0 CA-C-O 121.455 0.645 . . . . 0.0 110.061 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.34 -18.21 64.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.808 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.34 -56.23 7.04 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 167.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.623 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -49.92 -52.61 31.94 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.111 0.564 . . . . 0.0 111.226 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 1.042 ' HG2' HG13 ' A' ' 56' ' ' ILE . 50.7 mtp -55.82 -26.74 47.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.924 -1.035 . . . . 0.0 112.111 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.1 m -99.45 -6.53 27.49 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.752 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 85.36 32.14 20.45 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.244 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -121.11 130.59 53.81 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.647 HG21 ' HB3' ' A' ' 19' ' ' LEU . 53.9 p -108.15 2.03 22.62 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.78 -39.44 61.72 Favored Glycine 0 C--N 1.333 0.4 0 O-C-N 123.523 0.514 . . . . 0.0 114.04 -172.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.76 -26.92 29.26 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.411 -0.464 . . . . 0.0 110.824 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -68.92 -51.02 44.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.717 ' HB3' HG21 ' A' ' 161' ' ' VAL . 5.0 pt-20 -58.0 -33.51 69.01 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.283 0.563 . . . . 0.0 110.181 178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 28.0 m -67.67 -47.95 68.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.848 177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.01 99.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.219 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 99.1 mt -55.58 -43.15 75.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.398 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -57.08 -9.08 0.78 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.331 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -75.39 -40.16 33.96 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.299 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.482 HG22 ' HE2' ' A' ' 157' ' ' TYR . 3.9 mp -86.47 -48.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 121.056 -0.257 . . . . 0.0 111.029 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.613 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -53.31 -41.51 65.73 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -178.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.66 -23.85 63.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -72.95 -28.97 62.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.699 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.519 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.1 m-85 -101.8 -7.37 22.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.105 0.479 . . . . 0.0 110.14 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.13 29.77 12.1 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.352 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 1.9 mm? -111.19 -165.91 1.03 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.34 0.57 . . . . 0.0 110.513 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.6 p -163.1 -178.91 6.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.069 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.717 HG21 ' HB3' ' A' ' 147' ' ' GLU . 9.7 p -57.5 -23.3 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 111.375 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.79 14.45 4.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.707 0.289 . . . . 0.0 111.716 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.661 ' HB3' HG22 ' A' ' 168' ' ' VAL . 12.8 t -88.96 143.68 26.69 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 168' ' ' VAL . 38.3 m -69.2 141.26 54.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.479 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.669 ' CD1' HD13 ' A' ' 15' ' ' ILE . 5.2 m-30 -38.24 -53.01 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.71 0.804 . . . . 0.0 112.739 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.53 -48.42 79.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.708 0.29 . . . . 0.0 110.224 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 1.7 mp0 -69.04 -5.33 21.23 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 163' ' ' SER . 34.0 t -96.31 -54.05 7.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.249 0.547 . . . . 0.0 109.819 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -58.0 -46.61 84.95 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.622 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.05 72.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.707 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.884 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -70.32 -35.83 73.88 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 121.533 0.682 . . . . 0.0 110.581 -176.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.517 HG21 ' CD2' ' A' ' 2' ' ' PHE . 16.5 p -82.56 -18.97 39.51 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.993 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -77.06 -44.31 31.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.939 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 176' ' ' VAL . 4.3 p -176.18 6.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 121.5 0.667 . . . . 0.0 110.703 -172.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.884 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -86.89 91.15 1.72 Allowed Glycine 0 CA--C 1.499 -0.909 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.672 -173.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 174' ' ' VAL . 5.5 m -145.16 30.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 121.654 0.74 . . . . 0.0 110.208 -168.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -154.0 70.5 0.82 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.366 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 C--O 1.248 0.989 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.033 -178.527 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 172' ' ' THR . . . . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.773 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 31.7 t80 59.26 156.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.032 0.833 . . . . 0.0 112.184 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -174.1 160.02 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.761 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.669 HG11 HD12 ' A' ' 15' ' ' ILE . 10.5 m -91.68 111.7 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.43 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 51.7 m-20 -94.62 50.18 1.31 Allowed 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.186 -167.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.101 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 27.6 p90 -67.58 149.03 50.63 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.547 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.3 t70 -62.16 100.06 0.16 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.515 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 8.4 m -30.14 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.827 1.651 . . . . 0.0 114.397 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 7' ' ' ASP . 47.6 t -172.21 -31.84 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.098 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.573 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 81.9 m-85 -88.97 15.67 8.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.0 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -72.6 71.75 1.05 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.518 -172.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.45 5.73 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.515 ' HB2' ' CE2' ' A' ' 165' ' ' PHE . 32.2 m-85 -95.17 140.76 29.63 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.78 -0.21 . . . . 0.0 110.762 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 m -70.22 129.54 39.63 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 160.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.669 HD12 HG11 ' A' ' 4' ' ' VAL . 3.4 mm -44.89 -48.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -172.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.482 ' HB2' ' HB ' ' A' ' 161' ' ' VAL . 40.1 t-80 -57.13 -32.61 66.52 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.145 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.31 -51.52 23.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.24 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.443 ' HB2' ' CD2' ' A' ' 13' ' ' TYR . 57.6 t80 -68.13 -41.28 81.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.961 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.854 ' HB3' HG21 ' A' ' 143' ' ' THR . 17.0 mt -55.52 -41.13 72.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.874 0.369 . . . . 0.0 110.457 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -59.7 -43.54 97.71 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.062 173.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -62.81 -40.53 97.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.757 0.423 . . . . 0.0 111.945 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -61.46 -43.64 98.51 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.59 -33.05 74.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.839 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.0 t -60.05 -51.77 68.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 p -68.25 -31.14 70.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.615 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 58' ' ' SER . 10.7 t80 -61.05 -52.78 63.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 0.0 110.231 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.41 -26.34 74.33 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.267 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -73.09 108.84 6.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 110.942 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.619 HG12 ' HB1' ' A' ' 60' ' ' ALA . 35.6 m -64.13 -14.36 15.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.062 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -90.43 -11.08 41.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.291 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.596 ' HB3' ' ND2' ' A' ' 61' ' ' ASN . 14.7 t-80 -71.53 114.41 9.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.976 0.417 . . . . 0.0 111.465 -174.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.7 p -119.16 -176.06 3.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.515 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -158.66 119.95 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.46 56.0 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.979 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.8 1.5 37.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.571 0.7 . . . . 0.0 109.84 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.456 HG21 ' CG2' ' A' ' 63' ' ' VAL . 32.3 t -95.63 114.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.925 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 -71.5 0.66 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.725 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -71.86 -59.9 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.518 -171.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 66.89 74.29 0.34 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 122.021 0.915 . . . . 0.0 111.0 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -85.34 136.06 33.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.007 178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.473 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 70.4 m -73.02 -38.0 66.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.283 -172.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA2' ' CE2' ' A' ' 105' ' ' TYR . . . 109.51 -135.87 13.17 Favored Glycine 0 C--N 1.317 -0.475 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.892 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.34 70.38 1.32 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.763 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.545 ' H ' ' HD1' ' A' ' 54' ' ' TYR . 64.1 m-85 56.87 -171.36 0.09 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.494 0.317 . . . . 0.0 111.765 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.406 ' HB2' ' O ' ' A' ' 44' ' ' PHE . 29.3 t80 -178.4 -21.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.329 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -80.76 7.95 57.24 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.853 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.06 -98.74 0.13 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.1 m -152.18 -63.15 0.17 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 1.9 mp -77.27 -44.07 31.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.557 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.575 ' HB3' ' H ' ' A' ' 74' ' ' TYR . 17.7 p -140.33 170.12 16.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.744 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 158.57 45.0 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.212 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.1 m 68.33 -54.04 0.53 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.464 ' HG2' ' N ' ' A' ' 54' ' ' TYR . 7.7 tt0 -93.74 149.62 21.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 0.0 111.184 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.545 ' HD1' ' H ' ' A' ' 44' ' ' PHE . 2.3 t80 -147.96 103.36 3.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 146.6 23.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.366 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.1 HG13 ' HG2' ' A' ' 139' ' ' MET . 9.1 mm -146.52 122.06 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.56 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 92.5 p -106.23 158.77 16.61 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.378 174.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' A' ' 62' ' ' GLN . 42.0 t -51.46 139.39 19.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.292 0.568 . . . . 0.0 111.968 -178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.8 p -85.45 -19.44 31.26 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.425 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.619 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -81.04 -60.52 2.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.596 ' ND2' ' HB3' ' A' ' 31' ' ' HIS . 30.7 p30 -111.73 1.32 16.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.501 . . . . 0.0 110.824 -174.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 58' ' ' SER . 2.9 mm-40 40.12 37.42 0.4 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.477 -1.238 . . . . 0.0 114.214 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.456 ' CG2' HG21 ' A' ' 36' ' ' VAL . 14.8 p -126.6 -51.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.921 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 23.2 m -62.65 103.55 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 110.525 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -112.46 179.59 3.94 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.687 0.756 . . . . 0.0 112.924 -169.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.741 ' HE1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -156.99 131.81 8.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.811 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 92' ' ' SER . 61.6 t -120.62 114.96 45.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.166 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.55 148.04 22.44 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.6 104.79 0.26 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.018 -177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -164.48 -92.29 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.194 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -147.92 30.14 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.482 0.641 . . . . 0.0 110.906 -176.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 77.9 mt -59.24 143.73 48.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.34 0.591 . . . . 0.0 111.774 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 50' ' ' SER . 99.2 m -148.61 129.99 14.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.67 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.575 ' H ' ' HB3' ' A' ' 50' ' ' SER . 48.1 t80 -86.07 122.76 30.56 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 78' ' ' ASN . 48.2 p -64.87 -41.29 95.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.623 -171.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.5 tp 51.08 -88.02 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.755 0.822 . . . . 0.0 111.978 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -95.08 -3.04 48.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 123.557 0.535 . . . . 0.0 111.711 -175.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.663 ' HB2' ' HB ' ' A' ' 75' ' ' THR . 94.5 m-20 -75.51 -179.4 4.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.72 0.295 . . . . 0.0 111.623 -178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.912 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 32.7 mm-40 -45.83 -67.79 0.35 Allowed Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.912 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 50.9 Cg_exo -56.88 -36.6 99.01 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.415 1.41 . . . . 0.0 112.441 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 68.67 123.53 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.578 0.751 . . . . 0.0 112.247 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 60.35 59.99 2.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.992 -175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.809 HG21 ' HA2' ' A' ' 126' ' ' GLY . 0.2 OUTLIER -143.88 166.34 25.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.074 -171.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.829 HD23 HG11 ' A' ' 135' ' ' VAL . 13.6 tp -119.23 144.18 46.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 72' ' ' LEU . 7.9 p90 -158.15 -157.92 0.68 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 71' ' ' ASN . . . 95.04 -163.93 24.63 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.606 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.638 ' HG3' ' HB3' ' A' ' 120' ' ' SER . 0.0 OUTLIER -103.43 172.96 6.52 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 110.475 -179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.714 HD23 ' H ' ' A' ' 89' ' ' ASP . 1.5 pt? -139.62 -41.43 0.45 Allowed 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.794 -0.762 . . . . 0.0 111.974 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.714 ' H ' HD23 ' A' ' 88' ' ' LEU . 37.2 t70 61.28 -58.04 0.1 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.685 1.194 . . . . 0.0 113.654 175.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 114' ' ' PHE . 8.0 m -136.29 135.26 38.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.902 0.858 . . . . 0.0 112.36 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.741 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.5 mm? -102.63 166.44 10.51 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.868 -1.515 . . . . 0.0 108.997 171.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.408 ' HB2' ' HB ' ' A' ' 67' ' ' VAL . 22.4 m -151.64 111.54 4.05 Favored 'General case' 0 N--CA 1.433 -1.276 0 O-C-N 122.315 -0.241 . . . . 0.0 110.863 174.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.839 ' HE2' HD22 ' A' ' 19' ' ' LEU . 4.8 m-30 -97.62 141.56 30.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . 178.28 164.71 31.83 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.015 172.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -87.08 120.83 28.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.159 0.504 . . . . 0.0 111.221 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.13 113.24 0.43 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.146 -0.934 . . . . 0.0 113.593 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.3 mt -89.03 153.89 20.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.321 0.582 . . . . 0.0 110.549 172.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 p -131.67 167.9 18.66 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.274 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.25 -130.49 10.35 Favored Glycine 0 N--CA 1.44 -1.095 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 77.07 8.42 86.89 Favored Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.482 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -91.69 -73.53 0.54 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.195 0.498 . . . . 0.0 110.388 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.1 p -126.69 -0.47 6.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.162 0.506 . . . . 0.0 110.69 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.71 156.99 79.04 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 174.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -67.15 175.67 5.46 Favored 'Trans proline' 0 C--N 1.33 -0.421 0 C-N-CA 123.739 2.959 . . . . 0.0 112.721 -172.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.437 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 52.5 m-85 -71.93 151.37 43.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.579 -174.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.8 p -146.59 152.58 39.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.868 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.696 HG21 ' HA3' ' A' ' 94' ' ' GLY . 3.3 mp -83.53 122.07 37.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.517 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.93 -48.45 74.07 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.64 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 110' ' ' PRO . 21.5 t -112.51 87.55 9.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.404 172.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 109' ' ' VAL . 24.5 Cg_endo -61.71 107.11 0.48 Allowed 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.12 2.546 . . . . 0.0 112.639 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 112' ' ' VAL . 12.1 m-20 -96.33 -148.73 0.31 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.293 174.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.101 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 53.7 t -61.22 143.54 14.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.632 0.73 . . . . 0.0 111.459 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.43 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 74.4 m -135.24 179.54 6.26 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.746 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.591 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 96.3 m-85 -139.04 146.04 40.33 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.36 141.71 7.62 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 119.632 -1.27 . . . . 0.0 112.396 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.773 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 100.22 11.59 41.81 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.761 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.535 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 14.6 mt -55.22 -49.21 72.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.3 t30 57.24 36.27 27.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.986 0.898 . . . . 0.0 109.588 -176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.553 ' O ' ' HG2' ' A' ' 87' ' ' GLN . 19.2 mt -102.98 124.27 48.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.267 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.638 ' HB3' ' HG3' ' A' ' 87' ' ' GLN . 22.6 p -131.13 138.52 49.53 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.058 177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.635 ' OG ' HG22 ' A' ' 131' ' ' VAL . 91.2 p -114.6 135.09 54.52 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 110.139 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 122' ' ' LEU . 8.4 mp -60.69 161.86 7.32 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.159 -175.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.623 HE22 HG22 ' A' ' 75' ' ' THR . 13.7 tp60 -51.55 -56.32 14.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.41 -176.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.06 17.25 4.31 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 121' ' ' SER . 21.5 mt-30 -77.13 -37.06 54.85 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.533 172.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.809 ' HA2' HG21 ' A' ' 83' ' ' THR . . . 77.88 -124.4 6.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.337 174.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -78.91 -14.88 58.97 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.617 ' HA ' HE21 ' A' ' 133' ' ' GLN . 38.9 t70 -85.84 -16.11 39.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.872 -177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.56 125.2 30.74 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.216 -0.992 . . . . 0.0 110.641 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.579 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 23.9 m -52.8 -35.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.635 HG22 ' OG ' ' A' ' 121' ' ' SER . 25.5 m -65.18 -41.24 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.462 0.574 . . . . 0.0 110.48 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.504 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.2 t-160 -60.69 -38.38 84.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.545 0.688 . . . . 0.0 109.448 175.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.617 HE21 ' HA ' ' A' ' 128' ' ' ASP . 2.8 mt-30 -67.26 -60.62 2.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.868 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 130' ' ' VAL . 18.9 m -60.28 -37.92 75.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.807 -176.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.829 HG11 HD23 ' A' ' 84' ' ' LEU . 8.9 p -68.3 -46.3 81.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.21 -0.196 . . . . 0.0 110.83 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -70.61 -30.28 66.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 110.198 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.31 -54.98 32.76 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 170.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.658 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -50.25 -47.76 55.03 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.016 0.527 . . . . 0.0 111.013 176.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 1.1 ' HG2' HG13 ' A' ' 56' ' ' ILE . 53.0 mtp -56.09 -33.59 65.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.822 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.9 m -91.55 -13.52 31.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.413 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 97.51 10.26 53.81 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.93 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.67 120.74 30.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.11 0.481 . . . . 0.0 110.969 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.854 HG21 ' HB3' ' A' ' 19' ' ' LEU . 17.3 p -108.5 9.15 27.55 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.606 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.12 -27.44 68.4 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.955 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.26 -30.31 23.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.991 0.424 . . . . 0.0 110.053 173.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 0.2 OUTLIER -64.78 -47.91 76.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.035 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.575 ' HB2' HG21 ' A' ' 161' ' ' VAL . 1.5 pt-20 -55.15 -34.04 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.054 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.479 ' N ' ' HG3' ' A' ' 147' ' ' GLU . 0.3 OUTLIER -75.1 -36.76 61.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.059 0.457 . . . . 0.0 109.8 -175.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.79 -47.15 69.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.527 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 98.3 mt -55.26 -43.49 74.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.048 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -55.29 -13.97 1.6 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.315 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -73.13 -37.65 55.38 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.39 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.2 mp -85.31 -46.26 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.744 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -56.74 -44.2 81.44 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.98 -24.73 67.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.99 -38.09 89.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.511 . . . . 0.0 110.219 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.536 ' CD1' HG12 ' A' ' 176' ' ' VAL . 13.7 m-85 -97.18 -7.71 31.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.335 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.91 16.63 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.839 -0.618 . . . . 0.0 113.379 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.548 ' C ' ' HB3' ' A' ' 154' ' ' LEU . 1.9 mm? -110.85 -174.25 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.258 0.529 . . . . 0.0 110.335 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.5 p -165.39 -176.2 3.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.381 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.575 HG21 ' HB2' ' A' ' 147' ' ' GLU . 2.5 m -61.1 -13.15 6.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 174.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -88.75 4.49 47.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.565 ' HB2' HG22 ' A' ' 168' ' ' VAL . 19.5 m -92.28 152.44 19.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.858 176.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 168' ' ' VAL . 9.5 m -70.72 142.77 51.45 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.573 ' HD2' ' O ' ' A' ' 10' ' ' PHE . 4.1 m-30 -37.72 -64.38 0.4 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.386 0.674 . . . . 0.0 112.58 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.17 -40.85 82.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.112 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.57 -42.3 87.26 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.827 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.744 HG13 HD11 ' A' ' 154' ' ' LEU . 92.7 t -65.02 -52.02 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.33 78.05 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.727 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.34 83.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.611 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 1.011 ' HA ' ' HA3' ' A' ' 175' ' ' GLY . . . -68.63 -33.56 74.22 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.363 0.601 . . . . 0.0 110.864 -173.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.542 HG21 ' CD2' ' A' ' 2' ' ' PHE . 12.2 p -83.01 -25.2 32.43 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.009 -178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.05 -42.15 48.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.543 -1.662 . . . . 0.0 111.312 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.414 ' H ' ' H ' ' A' ' 175' ' ' GLY . 4.0 p -176.57 5.62 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.564 0.697 . . . . 0.0 110.934 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 1.011 ' HA3' ' HA ' ' A' ' 171' ' ' ALA . . . -76.1 -2.69 73.19 Favored Glycine 0 CA--C 1.503 -0.712 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.339 -173.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.536 HG12 ' CD1' ' A' ' 157' ' ' TYR . 19.8 m -49.96 73.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 125.919 1.688 . . . . 0.0 114.528 178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -97.4 39.46 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.581 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 26.0 m170 . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.748 178.612 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.433 ' O ' ' HA3' ' A' ' 116' ' ' GLY . . . . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.937 0.398 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.835 ' O ' ' HB ' ' A' ' 172' ' ' THR . 38.7 t80 -93.8 149.69 21.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.335 -172.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.0 m -161.51 163.35 30.31 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.394 0.678 . . . . 0.0 109.335 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.582 HG22 ' HD1' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.3 128.16 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 170.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 28.5 m-80 -105.35 49.57 0.8 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.625 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 1.075 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 25.5 p90 -73.18 152.84 40.94 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.547 175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 9' ' ' SER . 33.2 t70 -62.15 100.71 0.18 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.497 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 22.3 t -35.46 75.95 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.665 1.586 . . . . 0.0 113.722 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 7' ' ' ASP . 23.2 t -172.96 -30.64 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.859 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.466 ' O ' ' HD2' ' A' ' 165' ' ' PHE . 53.7 m-85 -91.21 22.06 4.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.793 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 165' ' ' PHE . . . -70.8 66.98 0.82 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.209 -176.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' ' CG2' ' A' ' 164' ' ' THR . . . -165.13 2.16 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.629 ' HB2' ' CD2' ' A' ' 165' ' ' PHE . 38.6 m-85 -83.23 141.8 31.62 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 170.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.5 m -71.44 138.08 48.77 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 159.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.757 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 5.5 mm -47.01 -48.14 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 119.098 0.863 . . . . 0.0 110.842 -175.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.492 ' HB2' HG13 ' A' ' 161' ' ' VAL . 44.4 t-80 -55.23 -32.23 62.13 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.74 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -65.46 -55.79 16.0 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.946 -176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' A' ' 112' ' ' VAL . 83.2 t80 -66.59 -43.51 84.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.259 -0.577 . . . . 0.0 110.359 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.846 HD22 ' HE2' ' A' ' 93' ' ' PHE . 8.8 mt -55.88 -46.81 78.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.719 0.295 . . . . 0.0 110.573 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.52 -43.37 98.91 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.829 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -63.25 -43.01 99.22 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.578 0.351 . . . . 0.0 111.877 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.466 ' CD1' ' HB3' ' A' ' 93' ' ' PHE . 54.0 t90 -60.44 -43.55 96.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.04 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.0 -30.85 71.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.481 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.1 t -62.4 -49.08 76.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.601 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -67.27 -28.18 67.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.59 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.403 ' HA ' ' HB ' ' A' ' 64' ' ' THR . 38.6 t80 -62.25 -50.05 73.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.236 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -19.87 75.14 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.378 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.04 96.39 1.74 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.537 0.684 . . . . 0.0 110.906 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG12 ' HB1' ' A' ' 60' ' ' ALA . 16.8 m -62.23 -25.26 37.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -90.84 -7.62 51.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -66.18 127.42 32.09 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.159 0.504 . . . . 0.0 111.173 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 31.3 p -131.32 -176.19 3.94 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.828 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.489 ' HB3' HG23 ' A' ' 36' ' ' VAL . 36.2 t-20 -160.57 118.12 2.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.835 0.35 . . . . 0.0 110.556 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.04 3.73 20.21 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.273 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -106.11 -0.62 24.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.496 . . . . 0.0 109.887 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.489 HG23 ' HB3' ' A' ' 33' ' ' ASN . 19.9 t -89.93 122.88 41.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.973 -177.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 p -92.37 -81.09 0.35 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.327 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -75.23 -62.1 1.67 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.755 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.437 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . . . 66.78 80.63 0.21 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.622 -172.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -78.7 134.19 37.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.497 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.4 m -79.84 -31.77 40.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.146 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.65 -172.43 44.75 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.413 ' CA ' ' HE2' ' A' ' 105' ' ' TYR . . . -148.15 -83.36 0.04 OUTLIER Glycine 0 CA--C 1.52 0.352 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.858 -172.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.62 60.97 2.08 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.744 0.783 . . . . 0.0 109.073 -158.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -84.22 71.72 10.59 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.617 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.635 ' HA3' ' HA3' ' A' ' 51' ' ' GLY . . . -157.97 -36.5 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.945 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.35 -125.14 0.97 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.253 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.7 m -73.51 -38.95 65.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.576 0.227 . . . . 0.0 111.524 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -168.73 28.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.375 0.607 . . . . 0.0 110.623 -175.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.3 p -154.04 175.97 12.78 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.549 -176.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.635 ' HA3' ' HA3' ' A' ' 46' ' ' GLY . . . 149.83 -164.78 29.6 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.284 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -91.64 -18.54 23.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.661 0.267 . . . . 0.0 111.212 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 68' ' ' ALA . 40.8 tt0 -135.9 147.63 48.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.274 0.559 . . . . 0.0 111.216 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -150.12 108.51 3.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.114 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.83 155.39 17.23 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.466 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.106 HG13 ' HG2' ' A' ' 139' ' ' MET . 8.6 mm -148.8 137.97 15.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.887 0.742 . . . . 0.0 109.166 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 65' ' ' ALA . 20.7 t -129.76 150.93 50.86 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 120.744 0.307 . . . . 0.0 110.38 175.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 30.0 t -50.55 122.37 7.04 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.733 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.5 p -83.04 40.77 0.72 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.673 0.749 . . . . 0.0 110.179 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.851 ' HB1' HG12 ' A' ' 29' ' ' VAL . . . -146.52 -45.08 0.19 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.599 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -122.65 -1.83 8.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.18 0.514 . . . . 0.0 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 58' ' ' SER . 61.5 mt-30 31.59 41.42 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -174.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.437 HG23 HG21 ' A' ' 36' ' ' VAL . 14.5 p -127.91 -43.94 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.032 170.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 26' ' ' PHE . 13.6 m -67.2 96.11 0.45 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 57' ' ' SER . . . -111.12 -179.9 3.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 112.346 -171.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.826 ' HE1' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -157.7 131.31 7.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.245 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.637 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 35.2 t -110.17 118.63 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.649 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . . . -94.12 149.9 20.82 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.27 123.02 1.49 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.459 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 88' ' ' LEU . . . -179.59 -109.17 0.25 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 87' ' ' GLN . 0.2 OUTLIER -149.27 41.12 0.88 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.0 mt -58.54 131.53 51.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.906 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.0 m -136.98 132.14 33.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.344 -176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB3' HD13 ' A' ' 49' ' ' LEU . 37.2 t80 -90.16 127.38 36.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 71.1 p -63.03 -37.27 86.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.051 -174.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.485 ' HG ' ' HD1' ' A' ' 77' ' ' PHE . 9.9 tp 49.64 -93.91 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.696 0.798 . . . . 0.0 112.161 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.485 ' HD1' ' HG ' ' A' ' 76' ' ' LEU . 5.4 m-85 -99.09 8.66 44.71 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.165 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -80.27 178.87 7.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.823 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.641 ' HB2' ' HD3' ' A' ' 80' ' ' PRO . 12.1 mm-40 -52.55 -54.91 37.41 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 52.1 Cg_exo -55.36 -37.65 94.48 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.671 1.581 . . . . 0.0 112.445 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.46 116.81 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.767 0.794 . . . . 0.0 112.878 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 54.01 58.06 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.741 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.505 ' OG1' ' HB2' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -148.21 162.56 39.22 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.005 -178.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.791 HD23 HG11 ' A' ' 135' ' ' VAL . 12.5 tp -101.73 151.37 22.12 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.464 0.174 . . . . 0.0 110.741 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -155.82 -152.02 0.37 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.58 -167.5 24.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.99 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 120' ' ' SER . 6.3 tm0? -99.97 164.7 11.89 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.389 0.614 . . . . 0.0 111.608 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.519 ' HB2' HG22 ' A' ' 131' ' ' VAL . 22.3 tp -155.41 135.14 12.68 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.675 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -133.96 -53.48 0.86 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.188 0.518 . . . . 0.0 110.167 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.463 ' HA ' ' HA2' ' A' ' 115' ' ' GLY . 2.3 p -108.43 153.69 22.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.3 -0.863 . . . . 0.0 112.944 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.826 HD12 ' HE1' ' A' ' 66' ' ' PHE . 2.9 mm? -137.77 169.84 17.09 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 172.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.637 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 20.6 t -163.52 111.99 1.23 Allowed 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.636 -175.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.846 ' HE2' HD22 ' A' ' 19' ' ' LEU . 3.4 m-30 -103.92 131.88 50.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.467 ' HA3' HG21 ' A' ' 107' ' ' ILE . . . -176.19 169.15 41.65 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.934 -1.126 . . . . 0.0 112.224 176.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -89.78 115.05 26.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.205 0.526 . . . . 0.0 111.374 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.54 112.14 0.64 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.625 170.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.452 HD11 HG22 ' A' ' 67' ' ' VAL . 13.1 mt -89.39 160.26 16.91 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.474 0.654 . . . . 0.0 110.476 170.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 t -131.57 166.93 20.3 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.564 -1.198 . . . . 0.0 107.992 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 101' ' ' ASP . . . -99.23 127.75 9.35 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.19 -174.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.03 31.08 1.79 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 99' ' ' GLY . 29.6 t70 67.96 -90.29 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.999 0.919 . . . . 0.0 110.283 -177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.0 p -120.69 11.73 11.28 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.999 0.904 . . . . 0.0 108.835 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.412 ' HB3' ' CD ' ' A' ' 104' ' ' PRO . 9.1 m -117.17 167.46 10.8 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.44 175.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.412 ' CD ' ' HB3' ' A' ' 103' ' ' SER . 50.1 Cg_exo -60.47 163.88 14.28 Favored 'Trans proline' 0 C--N 1.329 -0.45 0 C-N-CA 123.147 2.564 . . . . 0.0 114.275 -171.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.413 ' HE2' ' CA ' ' A' ' 43' ' ' GLY . 27.0 m-85 -68.22 164.15 21.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.435 -173.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.1 p -149.45 154.22 38.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.865 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.829 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -83.84 126.51 40.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.043 -177.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 36' ' ' VAL . 46.3 mt-30 -65.85 -50.95 62.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.129 175.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.416 HG21 HD21 ' A' ' 33' ' ' ASN . 23.9 t -112.62 85.6 7.58 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.46 171.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.71 106.28 1.44 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.637 2.892 . . . . 0.0 113.034 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.522 ' OD1' HG23 ' A' ' 112' ' ' VAL . 4.2 t70 -100.45 -140.71 0.33 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 176.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.075 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 38.8 t -62.01 143.62 14.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.691 0.757 . . . . 0.0 111.572 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.567 ' HB2' ' CB ' ' A' ' 5' ' ' ASN . 53.2 m -143.94 179.09 7.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.411 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.631 ' HZ ' HD21 ' A' ' 19' ' ' LEU . 97.2 m-85 -137.57 150.24 47.32 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.058 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 2' ' ' PHE . . . -162.31 131.89 2.65 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.353 175.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.753 ' HA3' ' HA ' ' A' ' 2' ' ' PHE . . . 106.6 16.03 15.43 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.794 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.509 ' HB3' ' HG ' ' A' ' 119' ' ' LEU . 11.8 mt -56.72 -44.18 81.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.8 t30 51.63 50.58 18.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.63 0.728 . . . . 0.0 110.428 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.509 ' HG ' ' HB3' ' A' ' 117' ' ' LEU . 27.1 mt -109.15 118.87 37.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.894 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 87' ' ' GLN . 13.1 p -116.64 133.08 56.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.313 . . . . 0.0 110.479 176.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 53.1 p -103.76 154.22 19.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 64.5 mt -82.06 165.94 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.575 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -58.84 -57.13 14.38 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HA ' ' HG3' ' A' ' 80' ' ' PRO . . . -75.73 5.19 6.56 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -170.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 122' ' ' LEU . 31.3 mt-30 -80.03 57.24 2.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.8 0.333 . . . . 0.0 110.679 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.74 102.32 0.49 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.847 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 132' ' ' HIS . 2.8 t-80 81.13 -30.53 0.11 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.97 0.908 . . . . 0.0 111.553 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.535 ' HA ' HE21 ' A' ' 133' ' ' GLN . 8.6 t70 -81.23 -27.68 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.082 0.239 . . . . 0.0 111.357 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 125' ' ' GLN . . . -56.09 128.14 44.94 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.613 ' HA ' ' HG3' ' A' ' 133' ' ' GLN . 28.0 m -56.48 -25.14 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -171.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.519 HG22 ' HB2' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -68.17 -48.53 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.685 ' CE1' ' H ' ' A' ' 84' ' ' LEU . 4.4 t-160 -61.6 -38.75 88.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.819 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.613 ' HG3' ' HA ' ' A' ' 130' ' ' VAL . 21.1 mm-40 -56.21 -67.65 0.28 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.157 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 130' ' ' VAL . 17.7 m -58.05 -40.17 75.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.191 -174.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.791 HG11 HD23 ' A' ' 84' ' ' LEU . 11.4 p -68.56 -47.37 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 121.289 -0.165 . . . . 0.0 111.083 -176.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.416 ' HD1' HG13 ' A' ' 135' ' ' VAL . 9.2 m-85 -72.26 -23.07 61.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.687 0.279 . . . . 0.0 110.696 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.85 -55.59 23.71 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.657 HD11 ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -48.29 -52.72 20.1 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.29 0.567 . . . . 0.0 110.747 176.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 1.106 ' HG2' HG13 ' A' ' 56' ' ' ILE . 51.9 mtp -54.53 -35.57 63.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.297 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.2 m -91.63 -1.99 57.25 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.829 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 84.92 24.56 44.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.92 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -109.73 134.33 52.12 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 122.46 0.304 . . . . 0.0 110.286 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 19' ' ' LEU . 43.8 p -112.4 -11.29 13.68 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.404 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.14 -38.68 56.72 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 113.523 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.37 -38.0 68.62 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.693 -0.298 . . . . 0.0 111.021 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 45.2 tp -67.64 -38.63 84.12 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.858 ' HG2' HG21 ' A' ' 161' ' ' VAL . 67.6 mt-10 -55.93 -38.16 69.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.68 -34.71 58.21 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.12 0.486 . . . . 0.0 109.91 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.69 -43.06 85.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.939 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 146' ' ' LEU . 89.3 mt -55.92 -45.97 78.56 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.445 174.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -53.94 -16.17 1.73 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.76 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.34 46.51 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.11 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.608 HG21 ' HB3' ' A' ' 2' ' ' PHE . 3.8 mp -81.09 -47.01 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.83 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 168' ' ' VAL . 0.4 OUTLIER -55.99 -37.84 69.64 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.319 . . . . 0.0 111.498 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.71 -30.37 69.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.332 0.587 . . . . 0.0 110.014 175.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.481 ' HB2' ' CD2' ' A' ' 159' ' ' LEU . 20.0 m-85 -103.39 -9.74 19.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.403 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.1 20.55 25.41 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.824 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 157' ' ' TYR . 2.1 mm? -105.51 -166.8 1.25 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.475 0.638 . . . . 0.0 110.915 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.8 m -159.74 179.28 8.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.382 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.858 HG21 ' HG2' ' A' ' 147' ' ' GLU . 8.0 p -56.61 -25.6 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.313 0.578 . . . . 0.0 110.965 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -89.64 33.65 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.124 -0.36 . . . . 0.0 111.637 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.633 ' HB3' HG22 ' A' ' 168' ' ' VAL . 18.7 t -101.93 150.62 23.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.564 ' O ' HG23 ' A' ' 168' ' ' VAL . 2.9 m -72.8 133.55 44.54 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 119.003 -0.522 . . . . 0.0 111.649 -174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.685 ' CD1' HD13 ' A' ' 15' ' ' ILE . 3.4 m-30 -38.89 -53.97 1.67 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -58.23 -46.2 86.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.011 0.434 . . . . 0.0 111.483 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -70.99 -35.85 72.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.739 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 154' ' ' LEU . 37.1 t -62.4 -52.93 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 4' ' ' VAL . . . -55.31 -46.78 76.25 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.022 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.471 ' O ' ' HB3' ' A' ' 173' ' ' ALA . . . -64.78 -33.56 76.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.524 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.462 ' HA ' ' HA2' ' A' ' 175' ' ' GLY . . . -74.49 -32.63 62.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.188 0.518 . . . . 0.0 110.227 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.835 ' HB ' ' O ' ' A' ' 2' ' ' PHE . 31.0 p -85.15 -12.9 51.73 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.092 0.948 . . . . 0.0 109.611 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 170' ' ' ALA . . . -68.85 -40.86 79.16 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.987 -1.46 . . . . 0.0 108.831 172.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.3 p -170.61 -32.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.469 -177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 171' ' ' ALA . . . 115.57 113.1 2.86 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.01 147.16 33.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.985 -169.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 61.99 -174.65 0.14 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.598 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 6.5 p80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.132 178.779 . . . . . . . . 0 0 . 1 stop_ save_